epoxiconazole - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	epoxiconazole	go back to main search page
Accession:	CHEBI:4811	browse the term
Definition:	A racemate composed of equimolar amounts of (2S,3R)- and (2R,3S)-epoxiconazole. A broad-spectrum fungicide for control of diseases caused by Ascomycetes, Basidiomycetes and Deuteromycetes. Epoxiconazole is moderately toxic to birds, honeybees, earthworms and most aquatic organisms.
Synonyms:	related_synonym:	(2RS,3SR)-1-[3-(2-chlorophenyl)-2,3-epoxy-2-(4-fluorophenyl)propyl]-1H-1,2,4-triazole; rac-1-{[3-(2-chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole; rel-1-[[(2R,3S)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-2-oxiranyl]methyl]-1H-1,2,4-triazole
	xref:	CAS:133855-98-8
	xref_mesh:	MESH:C109476
	xref:	Pesticides:epoxiconazole; Reaxys:8150613; kegg.compound:C11229; pubmed:24274332; pubmed:24364671; pubmed:24550150; wikipedia.en:Epoxiconazole
	chemrof_formula:	C17H13ClFN3O

show annotations for term's descendants Sort by:
Rat (3665 ) Mouse (4055 ) Human (3682 ) Chinchilla (0 ) Bonobo (0 ) Dog (0 ) Squirrel (0 ) Pig (0 ) Green Monkey (0) Naked Mole-rat (0 ) All
Genes (3682)

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

acetoacetyl-CoA synthetase

decreases expression

ISO

epoxiconazole results in decreased expression of AACS mRNA

NCBI chr12:125,065,435...125,143,316
Ensembl chr12:125,065,364...125,143,333

G

arylacetamide deacetylase like 4

increases expression

ISO

epoxiconazole results in increased expression of AADACL4 mRNA

NCBI chr 1:12,644,085...12,667,076
Ensembl chr 1:12,644,085...12,667,076

G

AP2 associated kinase 1

decreases expression

ISO

epoxiconazole results in decreased expression of AAK1 mRNA

NCBI chr 2:69,457,997...69,643,739
Ensembl chr 2:69,457,997...69,674,349

G

angio associated migratory cell protein

decreases expression

ISO

epoxiconazole results in decreased expression of AAMP mRNA

NCBI chr 2:218,264,129...218,270,137
Ensembl chr 2:218,264,125...218,270,178

G

AAR2 splicing factor

decreases expression

ISO

epoxiconazole results in decreased expression of AAR2 mRNA

NCBI chr20:36,236,478...36,256,933
Ensembl chr20:36,236,131...36,270,918

G

alanyl-tRNA synthetase 2, mitochondrial

decreases expression

ISO

epoxiconazole results in decreased expression of AARS2 mRNA

NCBI chr 6:44,298,731...44,313,347
Ensembl chr 6:44,298,726...44,313,347

G

aminoadipate-semialdehyde synthase

decreases expression

ISO

epoxiconazole results in decreased expression of AASS mRNA

NCBI chr 7:122,073,549...122,144,249
Ensembl chr 7:122,064,583...122,144,489

G

ATP binding cassette subfamily A member 13

increases expression

ISO

epoxiconazole results in increased expression of ABCA13 mRNA

NCBI chr 7:48,171,458...48,647,497
Ensembl chr 7:48,171,458...48,647,497

G

ATP binding cassette subfamily A member 17, pseudogene

increases expression

ISO

epoxiconazole results in increased expression of ABCA17 mRNA

NCBI chr16:2,340,922...2,426,699
Ensembl chr16:2,361,144...2,425,685
Ensembl chr16:2,361,144...2,425,685

G

ATP binding cassette subfamily B member 1

increases expression
decreases expression
multiple interactions

ISO

epoxiconazole results in increased expression of ABCB1A mRNA
epoxiconazole results in decreased expression of ABCB1A mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ABCB1A mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ABCB1A mRNA

PMID:25182419 PMID:29038839 PMID:35436446

NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,375

G

ATP binding cassette subfamily B member 10

decreases expression

ISO

epoxiconazole results in decreased expression of ABCB10 mRNA

NCBI chr 1:229,516,582...229,558,707
Ensembl chr 1:229,516,582...229,558,957

G

ATP binding cassette subfamily B member 11

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ABCB11 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ABCB11 mRNA

NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324

G

ATP binding cassette subfamily B member 6 (LAN blood group)

decreases expression

ISO

epoxiconazole results in decreased expression of ABCB6 mRNA

NCBI chr 2:219,209,772...219,218,958
Ensembl chr 2:219,209,766...219,219,012

G

ATP binding cassette subfamily B member 7

decreases expression

ISO

epoxiconazole results in decreased expression of ABCB7 mRNA

NCBI chr X:75,051,048...75,156,283
Ensembl chr X:75,051,048...75,156,732

G

ATP binding cassette subfamily B member 8

decreases expression

ISO

epoxiconazole results in decreased expression of ABCB8 mRNA

NCBI chr 7:151,028,450...151,047,782
Ensembl chr 7:151,028,422...151,047,782

G

ATP binding cassette subfamily B member 9

increases expression

ISO

epoxiconazole results in increased expression of ABCB9 mRNA

NCBI chr12:122,918,610...122,975,114
Ensembl chr12:122,920,951...122,981,649

G

ATP binding cassette subfamily C member 1 (ABCC1 blood group)

decreases expression

ISO

epoxiconazole results in decreased expression of ABCC1 mRNA

NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257

G

ATP binding cassette subfamily C member 2

increases expression
multiple interactions

ISO

epoxiconazole results in increased expression of ABCC2 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ABCC2 mRNA

NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594

G

ATP binding cassette subfamily C member 3

increases expression
multiple interactions
decreases expression

ISO

epoxiconazole results in increased expression of ABCC3 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ABCC3 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ABCC3 mRNA
epoxiconazole results in decreased expression of ABCC3 mRNA

PMID:22334560 PMID:29038839 PMID:35436446

NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,609...50,692,631

G

ATP binding cassette subfamily C member 4 (PEL blood group)

increases expression

ISO

epoxiconazole results in increased expression of ABCC4 mRNA

PMID:22334560 PMID:23970803

NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,822

G

ATP binding cassette subfamily C member 6

decreases expression

ISO

epoxiconazole results in decreased expression of ABCC6 mRNA

NCBI chr16:16,149,565...16,223,494
Ensembl chr16:16,149,565...16,223,637

G

ATP binding cassette subfamily D member 1

decreases expression

ISO

epoxiconazole results in decreased expression of ABCD1 mRNA

NCBI chr X:153,724,856...153,744,755
Ensembl chr X:153,724,495...153,744,755

G

ATP binding cassette subfamily D member 2

decreases expression

ISO

epoxiconazole results in decreased expression of ABCD2 mRNA

NCBI chr12:39,531,025...39,619,803
Ensembl chr12:39,550,033...39,619,803

G

ATP binding cassette subfamily D member 3

decreases expression

ISO

epoxiconazole results in decreased expression of ABCD3 mRNA

NCBI chr 1:94,385,131...94,518,663
Ensembl chr 1:94,418,242...94,518,666

G

ATP binding cassette subfamily F member 2

decreases expression

ISO

epoxiconazole results in decreased expression of ABCF2 mRNA

NCBI chr 7:151,211,484...151,227,205
Ensembl chr 7:151,211,484...151,227,241

G

ATP binding cassette subfamily F member 3

affects expression

ISO

epoxiconazole affects the expression of ABCF3 mRNA

NCBI chr 3:184,186,199...184,194,005
Ensembl chr 3:184,186,095...184,194,013

G

ATP binding cassette subfamily G member 5

decreases expression

ISO

epoxiconazole results in decreased expression of ABCG5 mRNA

NCBI chr 2:43,806,211...43,839,231
Ensembl chr 2:43,812,472...43,838,865

G

ATP binding cassette subfamily G member 8

decreases expression

ISO

epoxiconazole results in decreased expression of ABCG8 mRNA

NCBI chr 2:43,838,971...43,882,988
Ensembl chr 2:43,831,942...43,882,988

G

abhydrolase domain containing 14B

decreases expression

ISO

epoxiconazole results in decreased expression of ABHD14B mRNA

NCBI chr 3:51,968,510...51,974,630
Ensembl chr 3:51,968,510...51,983,409

G

abhydrolase domain containing 15

decreases expression

ISO

epoxiconazole results in decreased expression of ABHD15 mRNA

NCBI chr17:29,560,547...29,567,037
Ensembl chr17:29,560,547...29,567,037

G

abhydrolase domain containing 4, N-acyl phospholipase B

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of ABHD4 mRNA
epoxiconazole results in decreased expression of ABHD4 mRNA

PMID:22334560 PMID:35436446

NCBI chr14:22,598,300...22,612,963
Ensembl chr14:22,598,249...22,612,963

G

abhydrolase domain containing 6, acylglycerol lipase

affects expression

ISO

epoxiconazole affects the expression of ABHD6 mRNA

NCBI chr 3:58,237,792...58,294,734
Ensembl chr 3:58,237,516...58,295,693

G

ABI family member 3 binding protein

decreases expression

ISO

epoxiconazole results in decreased expression of ABI3BP mRNA

NCBI chr 3:100,749,156...100,993,421
Ensembl chr 3:100,749,155...100,993,515

G

ABL proto-oncogene 1, non-receptor tyrosine kinase

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole] results in increased expression of ABL1 mRNA

NCBI chr 9:130,713,043...130,887,675
Ensembl chr 9:130,713,043...130,887,675

G

actin binding LIM protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of ABLIM1 mRNA

NCBI chr10:114,431,110...114,801,373
Ensembl chr10:114,431,110...114,768,061

G

ABRA C-terminal like

increases expression

ISO

epoxiconazole results in increased expression of ABRACL mRNA

NCBI chr 6:139,028,745...139,043,302
Ensembl chr 6:139,027,494...139,043,742

G

acetyl-CoA acyltransferase 1

decreases expression

ISO

epoxiconazole results in decreased expression of ACAA1B mRNA

NCBI chr 3:38,122,715...38,137,127
Ensembl chr 3:38,103,129...38,137,647

G

acetyl-CoA acyltransferase 2

decreases expression

ISO

epoxiconazole results in decreased expression of ACAA2 mRNA

NCBI chr18:49,782,164...49,813,533
Ensembl chr18:49,782,164...49,813,953

G

acetyl-CoA carboxylase alpha

decreases expression

ISO

epoxiconazole results in decreased expression of ACACA mRNA

NCBI chr17:37,084,992...37,406,836
Ensembl chr17:37,084,992...37,406,836

G

acyl-CoA dehydrogenase family member 8

decreases expression

ISO

epoxiconazole results in decreased expression of ACAD8 mRNA

NCBI chr11:134,253,568...134,265,855
Ensembl chr11:134,253,514...134,265,855

G

acyl-CoA dehydrogenase family member 9

increases expression

ISO

epoxiconazole results in increased expression of ACAD9 mRNA

NCBI chr 3:128,879,620...128,913,114
Ensembl chr 3:128,879,596...128,924,003

G

acyl-CoA dehydrogenase very long chain

decreases expression

ISO

epoxiconazole results in decreased expression of ACADVL mRNA

NCBI chr17:7,217,125...7,225,266
Ensembl chr17:7,217,125...7,225,269

G

acetyl-CoA acetyltransferase 1

decreases expression

ISO

epoxiconazole results in decreased expression of ACAT1 mRNA

NCBI chr11:108,116,705...108,147,603
Ensembl chr11:108,116,695...108,148,957

G

acetyl-CoA acetyltransferase 2

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole] results in increased expression of ACAT2 mRNA

NCBI chr 6:159,762,045...159,779,112
Ensembl chr 6:159,761,981...159,779,821

G

1-aminocyclopropane-1-carboxylate synthase homolog (inactive)

increases expression

ISO

epoxiconazole results in increased expression of ACCS mRNA

NCBI chr11:44,066,270...44,084,237
Ensembl chr11:44,065,916...44,084,241

G

1-aminocyclopropane-1-carboxylate synthase homolog (inactive) like

increases expression

ISO

epoxiconazole results in increased expression of ACCSL mRNA

NCBI chr11:43,921,068...44,059,977
Ensembl chr11:44,047,981...44,059,977

G

alkaline ceramidase 2

decreases expression

ISO

epoxiconazole results in decreased expression of ACER2 mRNA

NCBI chr 9:19,409,009...19,452,505
Ensembl chr 9:19,409,009...19,452,505

G

atypical chemokine receptor 4

increases expression

ISO

epoxiconazole results in increased expression of ACKR4 mRNA

NCBI chr 3:132,597,270...132,602,644
Ensembl chr 3:132,597,270...132,618,967

G

ATP citrate lyase

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of ACLY mRNA
epoxiconazole results in decreased expression of ACLY mRNA

PMID:29038839 PMID:35436446

NCBI chr17:41,866,917...41,930,545
Ensembl chr17:41,866,916...41,930,545

G

aconitase 1

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ACO1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ACO1 mRNA

NCBI chr 9:32,384,643...32,454,769
Ensembl chr 9:32,384,603...32,454,769

G

aconitase 2

decreases expression

ISO

epoxiconazole results in decreased expression of ACO2 mRNA

NCBI chr22:41,469,117...41,528,974
Ensembl chr22:41,447,830...41,529,273

G

acyl-CoA thioesterase 1

increases expression

ISO

epoxiconazole results in increased expression of ACOT1 mRNA

NCBI chr14:73,490,933...73,543,796
Ensembl chr14:73,537,143...73,543,796

G

acyl-CoA thioesterase 11

decreases expression

ISO

epoxiconazole results in decreased expression of ACOT11 mRNA

NCBI chr 1:54,548,228...54,639,192
Ensembl chr 1:54,542,257...54,639,192

G

acyl-CoA thioesterase 13

increases expression

ISO

epoxiconazole results in increased expression of ACOT13 mRNA

NCBI chr 6:24,667,077...24,705,046
Ensembl chr 6:24,666,921...24,705,065

G

acyl-CoA thioesterase 2

increases expression

ISO

epoxiconazole results in increased expression of ACOT2 mRNA

NCBI chr14:73,567,620...73,575,658
Ensembl chr14:73,567,620...73,575,658

G

acyl-CoA thioesterase 4

affects expression

ISO

epoxiconazole affects the expression of ACOT4 mRNA

NCBI chr14:73,591,873...73,595,766
Ensembl chr14:73,591,873...73,595,766

G

acyl-CoA thioesterase 9

multiple interactions
increases expression

ISO

[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ACOT9 mRNA
epoxiconazole results in increased expression of ACOT9 mRNA

PMID:29038839 PMID:35436446

NCBI chr X:23,701,055...23,743,276
Ensembl chr X:23,699,396...23,766,475

G

acyl-CoA oxidase 2

decreases expression

ISO

epoxiconazole results in decreased expression of ACOX2 mRNA

NCBI chr 3:58,505,136...58,537,190
Ensembl chr 3:58,504,544...58,537,387

G

acid phosphatase 2, lysosomal

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of ACP2 mRNA
epoxiconazole results in decreased expression of ACP2 mRNA

PMID:22334560 PMID:35436446

NCBI chr11:47,239,302...47,248,814
Ensembl chr11:47,238,400...47,249,288

G

acyl-CoA synthetase family member 2

decreases expression

ISO

epoxiconazole results in decreased expression of ACSF2 mRNA

NCBI chr17:50,426,218...50,474,845
Ensembl chr17:50,426,158...50,474,845

G

acyl-CoA synthetase long chain family member 1

decreases expression

ISO

epoxiconazole results in decreased expression of ACSL1 mRNA

NCBI chr 4:184,755,595...184,826,594
Ensembl chr 4:184,755,501...184,826,853

G

acyl-CoA synthetase long chain family member 4

decreases expression

ISO

epoxiconazole results in decreased expression of ACSL4 mRNA

NCBI chr X:109,641,335...109,733,257
Ensembl chr X:109,624,244...109,733,403

G

acyl-CoA synthetase long chain family member 6

decreases expression

ISO

epoxiconazole results in decreased expression of ACSL6 mRNA

NCBI chr 5:131,949,973...132,012,213
Ensembl chr 5:131,949,973...132,012,243

G

acyl-CoA synthetase medium chain family member 3

decreases expression

ISO

epoxiconazole results in decreased expression of ACSM3 mRNA

NCBI chr16:20,674,405...20,797,581
Ensembl chr16:20,610,243...20,797,843

G

acyl-CoA synthetase medium chain family member 5

decreases expression

ISO

epoxiconazole results in decreased expression of ACSM5 mRNA

NCBI chr16:20,409,534...20,441,336
Ensembl chr16:20,409,308...20,441,337

G

acyl-CoA synthetase short chain family member 2

decreases expression

ISO

epoxiconazole results in decreased expression of ACSS2 mRNA

NCBI chr20:34,874,989...34,927,959
Ensembl chr20:34,872,146...34,927,962

G

actin like 9

increases expression

ISO

epoxiconazole results in increased expression of ACTL9 mRNA

NCBI chr19:8,697,400...8,698,795
Ensembl chr19:8,697,400...8,698,795

G

actinin alpha 1

multiple interactions
decreases expression

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ACTN1 mRNA
epoxiconazole results in decreased expression of ACTN1 mRNA

PMID:25607892 PMID:35436446

NCBI chr14:68,874,128...68,979,302
Ensembl chr14:68,874,121...68,980,277

G

actinin alpha 4

decreases expression

ISO

epoxiconazole results in decreased expression of ACTN4 mRNA

NCBI chr19:38,647,649...38,731,589
Ensembl chr19:38,647,605...38,731,589

G

activin A receptor type 1B

decreases expression

ISO

epoxiconazole results in decreased expression of ACVR1B mRNA

NCBI chr12:51,951,699...51,997,078
Ensembl chr12:51,951,679...51,997,082

G

aminoacylase 1

decreases expression

ISO

epoxiconazole results in decreased expression of ACY1 mRNA

NCBI chr 3:51,983,535...51,989,197
Ensembl chr 3:51,983,047...51,989,205

G

aminoacylase 3

decreases expression

ISO

epoxiconazole results in decreased expression of ACY3 mRNA

NCBI chr11:67,642,555...67,650,730
Ensembl chr11:67,642,551...67,650,900

G

acylphosphatase 1

decreases expression

ISO

epoxiconazole results in decreased expression of ACYP1 mRNA

NCBI chr14:75,053,243...75,069,490
Ensembl chr14:75,053,221...75,069,483

G

ADAM metallopeptidase domain 11

increases expression

ISO

epoxiconazole results in increased expression of ADAM11 mRNA

NCBI chr17:44,758,988...44,781,846
Ensembl chr17:44,758,988...44,781,846

G

ADAM metallopeptidase domain 2

affects expression

ISO

epoxiconazole affects the expression of ADAM2 mRNA

NCBI chr 8:39,743,735...39,838,227
Ensembl chr 8:39,743,735...39,838,227

G

ADAM metallopeptidase domain 20

increases expression

ISO

epoxiconazole results in increased expression of ADAM20 mRNA

NCBI chr14:70,522,358...70,579,452
Ensembl chr14:70,522,358...70,535,015

G

ADAM metallopeptidase domain 21

increases expression

ISO

epoxiconazole results in increased expression of ADAM21 mRNA

NCBI chr14:70,452,174...70,459,905
Ensembl chr14:70,417,107...70,460,427

G

ADAM metallopeptidase domain 23

decreases expression

ISO

epoxiconazole results in decreased expression of ADAM23 mRNA

NCBI chr 2:206,443,532...206,621,127
Ensembl chr 2:206,443,498...206,621,301

G

ADAM metallopeptidase domain 30

increases expression

ISO

epoxiconazole results in increased expression of ADAM30 mRNA

NCBI chr 1:119,893,533...119,896,515
Ensembl chr 1:119,893,533...119,896,515

G

ADAM metallopeptidase domain 6 (pseudogene)

increases expression

ISO

epoxiconazole results in increased expression of ADAM6A mRNA

NCBI chr14:105,969,729...105,972,269
Ensembl chr14:105,969,729...105,972,269
Ensembl chr14:105,969,729...105,972,269

G

ADAM metallopeptidase domain 9

decreases expression

ISO

epoxiconazole results in decreased expression of ADAM9 mRNA

NCBI chr 8:38,996,973...39,105,261
Ensembl chr 8:38,996,754...39,105,445

G

ADAM like decysin 1

increases expression

ISO

epoxiconazole results in increased expression of ADAMDEC1 mRNA

NCBI chr 8:24,384,285...24,406,013
Ensembl chr 8:24,384,285...24,406,013

G

ADAM metallopeptidase with thrombospondin type 1 motif 6

increases expression

ISO

epoxiconazole results in increased expression of ADAMTS6 mRNA

NCBI chr 5:65,148,738...65,481,920
Ensembl chr 5:65,148,738...65,481,920

G

ADAM metallopeptidase with thrombospondin type 1 motif 8

increases expression

ISO

epoxiconazole results in increased expression of ADAMTS8 mRNA

NCBI chr11:130,404,923...130,428,609
Ensembl chr11:130,404,923...130,428,609

G

ADAM metallopeptidase with thrombospondin type 1 motif 9

decreases expression

ISO

epoxiconazole results in decreased expression of ADAMTS9 mRNA

NCBI chr 3:64,515,654...64,688,000
Ensembl chr 3:64,515,654...64,688,000

G

ArfGAP with dual PH domains 2

decreases expression

ISO

epoxiconazole results in decreased expression of ADAP2 mRNA

NCBI chr17:30,921,945...30,959,322
Ensembl chr17:30,906,344...30,959,945

G

adenosine deaminase RNA specific B1

decreases expression

ISO

epoxiconazole results in decreased expression of ADARB1 mRNA

NCBI chr21:45,074,578...45,226,563
Ensembl chr21:45,073,839...45,226,560

G

aarF domain containing kinase 5

decreases expression

ISO

epoxiconazole results in decreased expression of ADCK5 mRNA

NCBI chr 8:144,373,088...144,393,242
Ensembl chr 8:144,373,101...144,393,242

G

adenylate cyclase 4

decreases expression

ISO

epoxiconazole results in decreased expression of ADCY4 mRNA

NCBI chr14:24,318,359...24,335,071
Ensembl chr14:24,318,349...24,335,093

G

adenylate cyclase 9

decreases expression

ISO

epoxiconazole results in decreased expression of ADCY9 mRNA

NCBI chr16:3,953,387...4,116,442
Ensembl chr16:3,953,387...4,116,442

G

adhesion G protein-coupled receptor D1

decreases expression

ISO

epoxiconazole results in decreased expression of ADGRD1 mRNA

NCBI chr12:130,953,907...131,141,469
Ensembl chr12:130,953,055...131,142,466

G

adhesion G protein-coupled receptor E4, pseudogene

increases expression

ISO

epoxiconazole results in increased expression of ADGRE4 mRNA

NCBI chr19:6,950,758...6,997,851
Ensembl chr19:6,954,659...6,990,798

G

adhesion G protein-coupled receptor G4

increases expression

ISO

epoxiconazole results in increased expression of ADGRG4 mRNA

NCBI chr X:136,300,963...136,416,890
Ensembl chr X:136,300,963...136,416,890

G

adhesion G protein-coupled receptor L2

decreases expression

ISO

epoxiconazole results in decreased expression of ADGRL2 mRNA

NCBI chr 1:81,306,132...81,993,932
Ensembl chr 1:81,306,112...81,993,940

G

adhesion G protein-coupled receptor V1

increases expression

ISO

epoxiconazole results in increased expression of ADGRV1 mRNA

NCBI chr 5:90,558,797...91,164,437
Ensembl chr 5:90,529,344...91,164,437

G

alcohol dehydrogenase 1C (class I), gamma polypeptide

decreases expression

ISO

epoxiconazole results in decreased expression of ADH1 mRNA

NCBI chr 4:99,336,497...99,352,746
Ensembl chr 4:99,336,093...99,353,887

G

alcohol dehydrogenase 4 (class II), pi polypeptide

increases expression

ISO

epoxiconazole results in increased expression of ADH4 mRNA

NCBI chr 4:99,123,658...99,144,297
Ensembl chr 4:99,123,657...99,157,792

G

ADP-ribosylarginine hydrolase

increases expression

ISO

epoxiconazole results in increased expression of ADPRH mRNA

NCBI chr 3:119,579,492...119,589,945
Ensembl chr 3:119,579,268...119,590,165

G

ADP-ribosylhydrolase like 1

increases expression

ISO

epoxiconazole results in increased expression of ADPRHL1 mRNA

NCBI chr13:113,399,610...113,453,488
Ensembl chr13:113,399,611...113,453,488

G

adrenoceptor alpha 1A

decreases expression

ISO

epoxiconazole results in decreased expression of ADRA1A mRNA

NCBI chr 8:26,748,150...26,867,379
Ensembl chr 8:26,748,150...26,867,278

G

adenylosuccinate synthase 1

increases expression

ISO

epoxiconazole results in increased expression of ADSS1 mRNA

NCBI chr14:104,724,229...104,747,325
Ensembl chr14:104,724,174...104,747,325

G

ALF transcription elongation factor 1

affects expression

ISO

epoxiconazole affects the expression of AFF1 mRNA

NCBI chr 4:86,935,011...87,141,039
Ensembl chr 4:86,934,237...87,141,073

G

ALF transcription elongation factor 2

increases expression

ISO

epoxiconazole results in increased expression of AFF2 mRNA

NCBI chr X:148,500,617...149,000,663
Ensembl chr X:148,500,617...149,000,663

G

AFG1 like ATPase

decreases expression

ISO

epoxiconazole results in decreased expression of AFG1L mRNA

NCBI chr 6:108,295,054...108,526,001
Ensembl chr 6:108,294,926...108,526,796

G

AFG3 like matrix AAA peptidase subunit 2

decreases expression

ISO

epoxiconazole results in decreased expression of AFG3L2 mRNA

NCBI chr18:12,328,944...12,377,227
Ensembl chr18:12,328,932...12,377,473

G

arylformamidase

decreases expression

ISO

epoxiconazole results in decreased expression of AFMID mRNA

NCBI chr17:78,187,362...78,207,702
Ensembl chr17:78,187,330...78,207,703

G

ArfGAP with GTPase domain, ankyrin repeat and PH domain 3

decreases expression

ISO

epoxiconazole results in decreased expression of AGAP3 mRNA

NCBI chr 7:151,085,867...151,144,434
Ensembl chr 7:151,085,831...151,144,436

G

AGBL carboxypeptidase 2

increases expression

ISO

epoxiconazole results in increased expression of AGBL2 mRNA

NCBI chr11:47,659,591...47,715,369
Ensembl chr11:47,659,591...47,715,389

G

ArfGAP with FG repeats 2

decreases expression

ISO

epoxiconazole results in decreased expression of AGFG2 mRNA

NCBI chr 7:100,539,203...100,568,220
Ensembl chr 7:100,539,190...100,568,220

G

agmatinase (putative)

decreases expression

ISO

epoxiconazole results in decreased expression of AGMAT mRNA

NCBI chr 1:15,571,699...15,585,051
Ensembl chr 1:15,571,699...15,585,078

G

1-acylglycerol-3-phosphate O-acyltransferase 2

decreases expression

ISO

epoxiconazole results in decreased expression of AGPAT2 mRNA

NCBI chr 9:136,673,143...136,687,457
Ensembl chr 9:136,673,142...136,687,457

G

1-acylglycerol-3-phosphate O-acyltransferase 3

decreases expression

ISO

epoxiconazole results in decreased expression of AGPAT3 mRNA

NCBI chr21:43,865,223...43,987,592
Ensembl chr21:43,865,223...43,987,592

G

angiotensin II receptor type 2

increases expression

ISO

epoxiconazole results in increased expression of AGTR2 mRNA

NCBI chr X:116,170,744...116,174,974
Ensembl chr X:116,170,744...116,174,974

G

AT-hook containing transcription factor 1

decreases expression

ISO

epoxiconazole results in decreased expression of AHCTF1 mRNA

NCBI chr 1:246,839,098...246,931,948
Ensembl chr 1:246,839,098...246,932,063

G

aryl hydrocarbon receptor

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of AHR mRNA
epoxiconazole results in decreased expression of AHR mRNA

PMID:22334560 PMID:25182419 PMID:29038839 PMID:35436446

NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152

G

activator of HSP90 ATPase activity 1

decreases expression

ISO

epoxiconazole results in decreased expression of AHSA1 mRNA

NCBI chr14:77,457,867...77,469,472
Ensembl chr14:77,457,743...77,469,482

G

alpha 2-HS glycoprotein

decreases expression

ISO

epoxiconazole results in decreased expression of AHSG mRNA

NCBI chr 3:186,613,060...186,621,318
Ensembl chr 3:186,612,776...186,621,318

G

AIF family member 2

decreases expression

ISO

epoxiconazole results in decreased expression of AIFM2 mRNA

NCBI chr10:70,112,271...70,132,825
Ensembl chr10:70,097,053...70,133,269

G

absent in melanoma 2

decreases expression

ISO

epoxiconazole results in decreased expression of AIM2 mRNA

NCBI chr 1:159,055,051...159,147,132
Ensembl chr 1:159,056,129...159,188,222

G

adenylate kinase 2

decreases expression

ISO

epoxiconazole results in decreased expression of AK2 mRNA

NCBI chr 1:33,007,940...33,036,883
Ensembl chr 1:33,007,986...33,080,996

G

adenylate kinase 4

affects expression

ISO

epoxiconazole affects the expression of AK4 mRNA

NCBI chr 1:65,147,552...65,232,145
Ensembl chr 1:65,146,902...65,232,145

G

A-kinase anchoring protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of AKAP1 mRNA

NCBI chr17:57,085,246...57,121,344
Ensembl chr17:57,085,092...57,121,349

G

A-kinase anchoring protein 12

decreases expression

ISO

epoxiconazole results in decreased expression of AKAP12 mRNA

NCBI chr 6:151,239,967...151,358,559
Ensembl chr 6:151,239,936...151,358,563

G

A-kinase anchoring protein 13

decreases expression

ISO

epoxiconazole results in decreased expression of AKAP13 mRNA

PMID:22334560 PMID:35436446

NCBI chr15:85,380,603...85,749,358
Ensembl chr15:85,380,571...85,749,358

G

A-kinase anchoring protein 14

increases expression

ISO

epoxiconazole results in increased expression of AKAP14 mRNA

NCBI chr X:119,895,893...119,920,716
Ensembl chr X:119,895,837...119,920,720

G

A-kinase anchoring protein 9

decreases expression

ISO

epoxiconazole results in decreased expression of AKAP9 mRNA

NCBI chr 7:91,940,862...92,110,673
Ensembl chr 7:91,940,840...92,110,673

G

A-kinase interacting protein 1

affects expression

ISO

epoxiconazole affects the expression of AKIP1 mRNA

NCBI chr11:8,911,189...8,920,079
Ensembl chr11:8,911,113...8,922,406

G

AKNA domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of AKNAD1 mRNA

NCBI chr 1:108,815,901...108,858,244
Ensembl chr 1:108,815,898...108,963,484

G

aldo-keto reductase family 1 member B15

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of AKR1B7 mRNA
epoxiconazole results in decreased expression of AKR1B7 mRNA

PMID:22334560 PMID:23970803 PMID:35436446

NCBI chr 7:134,549,110...134,579,869
Ensembl chr 7:134,549,110...134,579,875

G

aldo-keto reductase family 1 member C2

increases expression

ISO

epoxiconazole results in increased expression of AKR1C21 mRNA

NCBI chr10:4,987,775...5,018,000
Ensembl chr10:4,987,775...5,018,031

G

aldo-keto reductase family 1 member E2

decreases expression

ISO

epoxiconazole results in decreased expression of AKR1E1 mRNA

NCBI chr10:4,824,973...4,873,237
Ensembl chr10:4,786,629...4,848,062

G

aldo-keto reductase family 7 member A2

increases expression

ISO

epoxiconazole results in increased expression of AKR7A5 mRNA

NCBI chr 1:19,302,708...19,312,146
Ensembl chr 1:19,301,991...19,312,144

G

AKT serine/threonine kinase 2

decreases expression

ISO

epoxiconazole results in decreased expression of AKT2 mRNA

NCBI chr19:40,230,317...40,285,345
Ensembl chr19:40,230,317...40,285,536

G

5'-aminolevulinate synthase 1

decreases expression

ISO

epoxiconazole results in decreased expression of ALAS1 mRNA

NCBI chr 3:52,198,083...52,214,327
Ensembl chr 3:52,198,086...52,214,585

G

5'-aminolevulinate synthase 2

increases expression

ISO

epoxiconazole results in increased expression of ALAS2 mRNA

NCBI chr X:55,009,055...55,030,977
Ensembl chr X:55,009,055...55,030,986

G

activated leukocyte cell adhesion molecule

increases expression

ISO

epoxiconazole results in increased expression of ALCAM mRNA

NCBI chr 3:105,366,909...105,576,900
Ensembl chr 3:105,366,706...105,576,909

G

aldehyde dehydrogenase 1 family member A1

increases expression
multiple interactions

ISO

epoxiconazole results in increased expression of ALDH1A1 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ALDH1A1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ALDH1A1 mRNA

PMID:25182419 PMID:29038839

NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,670...73,080,442

G

aldehyde dehydrogenase 1 family member A2

increases expression

ISO

epoxiconazole results in increased expression of ALDH1A2 mRNA

NCBI chr15:57,953,429...58,065,711
Ensembl chr15:57,953,424...58,497,866

G

aldehyde dehydrogenase 1 family member B1

decreases expression

ISO

epoxiconazole results in decreased expression of ALDH1B1 mRNA

NCBI chr 9:38,392,702...38,398,661
Ensembl chr 9:38,392,623...38,398,661

G

aldehyde dehydrogenase 2 family member

decreases expression

ISO

epoxiconazole results in decreased expression of ALDH2 mRNA

NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532

G

aldehyde dehydrogenase 3 family member A2

decreases expression

ISO

epoxiconazole results in decreased expression of ALDH3A2 mRNA

NCBI chr17:19,648,136...19,677,596
Ensembl chr17:19,647,291...19,685,760

G

aldehyde dehydrogenase 7 family member A1

decreases expression

ISO

epoxiconazole results in decreased expression of ALDH7A1 mRNA

NCBI chr 5:126,541,841...126,595,219
Ensembl chr 5:126,531,200...126,595,362

G

aldehyde dehydrogenase 8 family member A1

decreases expression

ISO

epoxiconazole results in decreased expression of ALDH8A1 mRNA

NCBI chr 6:134,917,393...134,950,101
Ensembl chr 6:134,917,298...134,950,129

G

aldolase, fructose-bisphosphate A

decreases expression

ISO

epoxiconazole results in decreased expression of ALDOA mRNA

NCBI chr16:30,053,151...30,070,414
Ensembl chr16:30,053,090...30,070,420
Ensembl chr16:30,053,090...30,070,420
Ensembl chr16:30,053,090...30,070,420

G

ALG12 alpha-1,6-mannosyltransferase

decreases expression

ISO

epoxiconazole results in decreased expression of ALG12 mRNA

NCBI chr22:49,859,311...49,918,438
Ensembl chr22:49,900,229...49,918,458

G

ALG3 alpha-1,3- mannosyltransferase

decreases expression

ISO

epoxiconazole results in decreased expression of ALG3 mRNA

NCBI chr 3:184,242,301...184,249,525
Ensembl chr 3:184,242,301...184,249,548

G

ALG6 alpha-1,3-glucosyltransferase

decreases expression

ISO

epoxiconazole results in decreased expression of ALG6 mRNA

NCBI chr 1:63,367,627...63,438,553
Ensembl chr 1:63,367,575...63,438,553

G

ALK receptor tyrosine kinase

increases expression

ISO

epoxiconazole results in increased expression of ALK mRNA

NCBI chr 2:29,192,774...29,921,586
Ensembl chr 2:29,192,774...29,921,586

G

ALK and LTK ligand 1

increases expression

ISO

epoxiconazole results in increased expression of ALKAL1 mRNA

NCBI chr 8:52,534,037...52,565,430
Ensembl chr 8:52,534,037...52,565,430

G

alkB homolog 3, alpha-ketoglutarate dependent dioxygenase

decreases expression

ISO

epoxiconazole results in decreased expression of ALKBH3 mRNA

NCBI chr11:43,880,831...43,920,274
Ensembl chr11:43,880,811...43,920,274

G

alkB homolog 6

decreases expression

ISO

epoxiconazole results in decreased expression of ALKBH6 mRNA

NCBI chr19:36,009,120...36,014,239
Ensembl chr19:36,009,120...36,014,297

G

alkB homolog 7

increases expression

ISO

epoxiconazole results in increased expression of ALKBH7 mRNA

NCBI chr19:6,372,794...6,375,250
Ensembl chr19:6,372,763...6,375,250

G

alkaline phosphatase, biomineralization associated

decreases expression

ISO

epoxiconazole results in decreased expression of ALPL mRNA

NCBI chr 1:21,508,984...21,578,410
Ensembl chr 1:21,509,397...21,578,410

G

alsin Rho guanine nucleotide exchange factor ALS2

decreases expression

ISO

epoxiconazole results in decreased expression of ALS2 mRNA

NCBI chr 2:201,700,267...201,780,933
Ensembl chr 2:201,700,267...201,782,112

G

alpha-methylacyl-CoA racemase

decreases expression

ISO

epoxiconazole results in decreased expression of AMACR mRNA

NCBI chr 5:33,986,165...34,008,050
Ensembl chr 5:33,986,165...34,008,104

G

autophagy and beclin 1 regulator 1

decreases expression

ISO

epoxiconazole results in decreased expression of AMBRA1 mRNA

NCBI chr11:46,396,412...46,594,023
Ensembl chr11:46,396,414...46,594,125

G

anaphase promoting complex subunit 1

decreases expression

ISO

epoxiconazole results in decreased expression of ANAPC1 mRNA

NCBI chr 2:111,766,231...111,884,193
Ensembl chr 2:111,611,639...111,884,690

G

anaphase promoting complex subunit 11

increases expression

ISO

epoxiconazole results in increased expression of ANAPC11 mRNA

NCBI chr17:81,890,790...81,900,533
Ensembl chr17:81,890,669...81,900,991

G

angel homolog 2

decreases expression

ISO

epoxiconazole results in decreased expression of ANGEL2 mRNA

NCBI chr 1:212,992,182...213,015,867
Ensembl chr 1:212,992,182...213,015,867

G

angiopoietin 2

increases expression

ISO

epoxiconazole results in increased expression of ANGPT2 mRNA

NCBI chr 8:6,499,632...6,563,245
Ensembl chr 8:6,499,632...6,563,409

G

angiopoietin 4

increases expression

ISO

epoxiconazole results in increased expression of ANGPT4 mRNA

NCBI chr20:869,900...916,334
Ensembl chr20:869,900...916,334

G

angiopoietin like 2

decreases expression

ISO

epoxiconazole results in decreased expression of ANGPTL2 mRNA

NCBI chr 9:127,087,348...127,122,635
Ensembl chr 9:127,087,348...127,122,645

G

angiopoietin like 4

decreases expression

ISO

epoxiconazole results in decreased expression of ANGPTL4 mRNA

NCBI chr19:8,364,155...8,374,370
Ensembl chr19:8,363,223...8,374,371

G

angiopoietin like 6

affects expression

ISO

epoxiconazole affects the expression of ANGPTL6 mRNA

NCBI chr19:10,092,338...10,106,190
Ensembl chr19:10,092,337...10,106,612

G

ankyrin 3

decreases expression

ISO

epoxiconazole results in decreased expression of ANK3 mRNA

NCBI chr10:60,026,298...60,733,528
Ensembl chr10:60,026,298...60,733,490

G

ankyrin repeat and MYND domain containing 2

decreases expression

ISO

epoxiconazole results in decreased expression of ANKMY2 mRNA

NCBI chr 7:16,599,779...16,645,754
Ensembl chr 7:16,599,779...16,645,831

G

ankyrin repeat domain 13C

increases expression

ISO

epoxiconazole results in increased expression of ANKRD13C mRNA

NCBI chr 1:70,258,999...70,354,722
Ensembl chr 1:70,258,999...70,354,734

G

ankyrin repeat domain 27

decreases expression

ISO

epoxiconazole results in decreased expression of ANKRD27 mRNA

NCBI chr19:32,597,006...32,675,180
Ensembl chr19:32,597,000...32,676,597

G

ankyrin repeat domain 29

increases expression

ISO

epoxiconazole results in increased expression of ANKRD29 mRNA

NCBI chr18:23,598,926...23,662,911
Ensembl chr18:23,598,926...23,663,088

G

ankyrin repeat domain 33B

increases expression

ISO

epoxiconazole results in increased expression of ANKRD33B mRNA

NCBI chr 5:10,564,070...10,657,816
Ensembl chr 5:10,564,070...10,657,816

G

ANKRD40 C-terminal like

increases expression

ISO

epoxiconazole results in increased expression of ANKRD40CL mRNA

NCBI chr17:50,761,030...50,767,518
Ensembl chr17:50,760,971...50,767,570

G

ankyrin repeat domain 44

decreases expression

ISO

epoxiconazole results in decreased expression of ANKRD44 mRNA

NCBI chr 2:196,967,014...197,310,780
Ensembl chr 2:196,967,017...197,311,173

G

ankyrin repeat domain 46

increases expression

ISO

epoxiconazole results in increased expression of ANKRD46 mRNA

NCBI chr 8:100,509,752...100,559,759
Ensembl chr 8:100,509,752...100,559,784

G

ankyrin repeat domain 53

decreases expression

ISO

epoxiconazole results in decreased expression of ANKRD53 mRNA

NCBI chr 2:70,978,445...70,985,499
Ensembl chr 2:70,978,380...70,985,499

G

ankyrin repeat and sterile alpha motif domain containing 1A

decreases expression

ISO

epoxiconazole results in decreased expression of ANKS1 mRNA

NCBI chr 6:34,889,255...35,097,990
Ensembl chr 6:34,889,243...35,091,421

G

ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1

decreases expression

ISO

epoxiconazole results in decreased expression of ANKZF1 mRNA

NCBI chr 2:219,229,806...219,236,679
Ensembl chr 2:219,229,769...219,236,679

G

anoctamin 4

increases expression

ISO

epoxiconazole results in increased expression of ANO4 mRNA

NCBI chr12:100,717,261...101,128,641
Ensembl chr12:100,717,244...101,128,648

G

acidic nuclear phosphoprotein 32 family member A

decreases expression

ISO

epoxiconazole results in decreased expression of ANP32A mRNA

NCBI chr15:68,778,535...68,820,895
Ensembl chr15:68,778,534...68,820,924

G

ANTXR cell adhesion molecule 1

decreases expression

ISO

epoxiconazole results in decreased expression of ANTXR1 mRNA

NCBI chr 2:69,013,144...69,249,327
Ensembl chr 2:69,013,176...69,249,327

G

annexin A10

increases expression

EXP

epoxiconazole results in increased expression of ANXA10 mRNA

NCBI chr 4:168,092,537...168,187,736
Ensembl chr 4:168,092,537...168,187,736

G

annexin A11

decreases expression

ISO

epoxiconazole results in decreased expression of ANXA11 mRNA

NCBI chr10:80,150,889...80,205,808
Ensembl chr10:80,150,889...80,205,583

G

annexin A7

increases expression
affects expression

ISO

epoxiconazole results in increased expression of ANXA7 mRNA
epoxiconazole affects the expression of ANXA7 mRNA

PMID:22334560 PMID:35436446

NCBI chr10:73,375,101...73,414,058
Ensembl chr10:73,375,101...73,414,731

G

aldehyde oxidase 1

increases expression

ISO

epoxiconazole results in increased expression of AOX1 mRNA

NCBI chr 2:200,586,014...200,682,241
Ensembl chr 2:200,585,864...200,677,064

G

aldehyde oxidase 3, pseudogene

decreases expression

ISO

epoxiconazole results in decreased expression of AOX3 mRNA

NCBI chr 2:200,695,723...200,738,781
Ensembl chr 2:200,678,233...200,732,539

G

adaptor related protein complex 1 subunit gamma 2

decreases expression

ISO

epoxiconazole results in decreased expression of AP1G2 mRNA

NCBI chr14:23,559,567...23,567,791
Ensembl chr14:23,559,557...23,568,070

G

adaptor related protein complex 1 subunit sigma 1

decreases expression

ISO

epoxiconazole results in decreased expression of AP1S1 mRNA

NCBI chr 7:101,154,476...101,161,276
Ensembl chr 7:101,154,352...101,161,596

G

adaptor related protein complex 2 subunit alpha 2

increases expression

ISO

epoxiconazole results in increased expression of AP2A2 mRNA

NCBI chr11:925,870...1,012,240
Ensembl chr11:924,881...1,012,245

G

adaptor related protein complex 2 subunit sigma 1

decreases expression

ISO

epoxiconazole results in decreased expression of AP2S1 mRNA

NCBI chr19:46,838,167...46,850,846
Ensembl chr19:46,838,136...46,850,882

G

adaptor related protein complex 3 subunit delta 1

decreases expression

ISO

epoxiconazole results in decreased expression of AP3D1 mRNA

NCBI chr19:2,100,988...2,164,616
Ensembl chr19:2,100,982...2,164,468

G

adaptor related protein complex 3 subunit sigma 1

increases expression

ISO

epoxiconazole results in increased expression of AP3S1 mRNA

NCBI chr 5:115,841,935...115,914,081
Ensembl chr 5:115,841,422...115,914,086

G

adaptor related protein complex 4 subunit mu 1

decreases expression

ISO

epoxiconazole results in decreased expression of AP4M1 mRNA

NCBI chr 7:100,100,794...100,109,039
Ensembl chr 7:100,100,841...100,110,345

G

amyloid beta precursor protein binding family B member 2

decreases expression

ISO

epoxiconazole results in decreased expression of APBB2 mRNA

NCBI chr 4:40,810,027...41,214,542
Ensembl chr 4:40,810,027...41,216,714

G

amyloid beta precursor protein binding family B member 3

affects expression

ISO

epoxiconazole affects the expression of APBB3 mRNA

NCBI chr 5:140,558,268...140,564,598
Ensembl chr 5:140,558,268...140,564,781

G

amyloid P component, serum

affects expression

ISO

epoxiconazole affects the expression of APCS mRNA

NCBI chr 1:159,587,826...159,588,865
Ensembl chr 1:159,587,826...159,588,865

G

acylaminoacyl-peptide hydrolase

decreases expression

ISO

epoxiconazole results in decreased expression of APEH mRNA

NCBI chr 3:49,673,117...49,683,971
Ensembl chr 3:49,673,981...49,683,971

G

apurinic/apyrimidinic endodeoxyribonuclease 1

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of APEX1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of APEX1 mRNA

NCBI chr14:20,455,226...20,457,767
Ensembl chr14:20,454,525...20,457,779

G

apurinic/apyrimidinic endodeoxyribonuclease 2

decreases expression

ISO

epoxiconazole results in decreased expression of APEX2 mRNA

NCBI chr X:55,000,363...55,009,057
Ensembl chr X:55,000,331...55,009,057

G

amyloid beta precursor like protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of APLP2 mRNA

NCBI chr11:130,069,894...130,144,805
Ensembl chr11:130,068,147...130,144,811

G

apolipoprotein A5

decreases expression

ISO

epoxiconazole results in decreased expression of APOA5 mRNA

NCBI chr11:116,789,367...116,792,420
Ensembl chr11:116,789,014...116,793,026

G

apolipoprotein B mRNA editing enzyme catalytic subunit 1

affects expression

ISO

epoxiconazole affects the expression of APOBEC1 mRNA

NCBI chr12:7,649,400...7,670,599
Ensembl chr12:7,649,400...7,665,908

G

apolipoprotein E

increases expression

ISO

epoxiconazole results in increased expression of APOE mRNA

NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,903,787...44,909,396

G

apolipoprotein F

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole] results in increased expression of APOF mRNA

NCBI chr12:56,360,568...56,362,857
Ensembl chr12:56,360,568...56,362,857

G

apolipoprotein L4

decreases expression

ISO

epoxiconazole results in decreased expression of APOL9A mRNA

NCBI chr22:36,189,128...36,204,833
Ensembl chr22:36,189,124...36,204,840

G

apolipoprotein L6

decreases expression

ISO

epoxiconazole results in decreased expression of APOL6 mRNA

NCBI chr22:35,648,446...35,668,404
Ensembl chr22:35,648,386...35,668,404

G

apolipoprotein L domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of APOLD1 mRNA

NCBI chr12:12,725,917...12,791,466
Ensembl chr12:12,725,917...12,829,975

G

adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1

increases expression

ISO

epoxiconazole results in increased expression of APPL1 mRNA

NCBI chr 3:57,227,729...57,273,471
Ensembl chr 3:57,227,726...57,278,127

G

adenine phosphoribosyltransferase

increases expression

ISO

epoxiconazole results in increased expression of APRT mRNA

NCBI chr16:88,809,339...88,811,928
Ensembl chr16:88,809,339...88,811,963

G

aquaporin 8

decreases expression

ISO

epoxiconazole results in decreased expression of AQP8 mRNA

NCBI chr16:25,216,947...25,228,932
Ensembl chr16:25,215,731...25,228,932

G

androgen receptor

increases expression
multiple interactions

ISO
EXP

epoxiconazole results in increased expression of AR mRNA
epoxiconazole inhibits the reaction [Metribolone results in increased activity of AR protein]

PMID:18324785 PMID:35436446

NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,543,353...67,730,619

G

apoptosis resistant E3 ubiquitin protein ligase 1

decreases expression

ISO

epoxiconazole results in decreased expression of AREL1 mRNA

NCBI chr14:74,661,256...74,713,080
Ensembl chr14:74,653,437...74,713,117

G

ARF GTPase 4

increases expression

ISO

epoxiconazole results in increased expression of ARF4 mRNA

NCBI chr 3:57,571,363...57,597,344
Ensembl chr 3:57,571,363...57,598,220

G

ARF GTPase activating protein 3

decreases expression

ISO

epoxiconazole results in decreased expression of ARFGAP3 mRNA

NCBI chr22:42,796,502...42,857,273
Ensembl chr22:42,796,502...42,858,106

G

ARF interacting protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of ARFIP2 mRNA

NCBI chr11:6,476,519...6,481,331
Ensembl chr11:6,474,683...6,481,479

G

arginase 1

decreases expression

EXP

epoxiconazole results in decreased expression of ARG1 mRNA

NCBI chr 6:131,573,226...131,584,329
Ensembl chr 6:131,470,832...131,584,332

G

Rho GTPase activating protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of ARHGAP1 mRNA

NCBI chr11:46,677,080...46,700,619
Ensembl chr11:46,677,075...46,700,977

G

Rho GTPase activating protein 11A

increases expression

ISO

epoxiconazole results in increased expression of ARHGAP11A mRNA

NCBI chr15:32,615,144...32,639,941
Ensembl chr15:32,615,144...32,639,952

G

Rho GTPase activating protein 17

decreases expression

ISO

epoxiconazole results in decreased expression of ARHGAP17 mRNA

NCBI chr16:24,919,389...25,015,369
Ensembl chr16:24,919,389...25,015,666

G

Rho GTPase activating protein 21

decreases expression

ISO

epoxiconazole results in decreased expression of ARHGAP21 mRNA

NCBI chr10:24,583,614...24,723,887
Ensembl chr10:24,583,609...24,723,887

G

Rho GTPase activating protein 23

decreases expression

ISO

epoxiconazole results in decreased expression of ARHGAP23 mRNA

NCBI chr17:38,419,275...38,512,385
Ensembl chr17:38,419,280...38,512,385

G

Rho GTPase activating protein 30

decreases expression

ISO

epoxiconazole results in decreased expression of ARHGAP30 mRNA

NCBI chr 1:161,046,946...161,069,891
Ensembl chr 1:161,046,946...161,069,970

G

Rho GTPase activating protein 32

increases expression

ISO

epoxiconazole results in increased expression of ARHGAP32 mRNA

NCBI chr11:128,965,060...129,279,632
Ensembl chr11:128,965,060...129,279,324

G

Rho guanine nucleotide exchange factor 1

decreases expression

ISO

epoxiconazole results in decreased expression of ARHGEF1 mRNA

NCBI chr19:41,883,184...41,930,141
Ensembl chr19:41,883,079...41,930,150

G

Rho guanine nucleotide exchange factor 15

increases expression

ISO

epoxiconazole results in increased expression of ARHGEF15 mRNA

NCBI chr17:8,310,241...8,322,511
Ensembl chr17:8,310,241...8,323,127

G

Rho/Rac guanine nucleotide exchange factor 18

increases expression

ISO

epoxiconazole results in increased expression of ARHGEF18 mRNA

NCBI chr19:7,348,937...7,479,989
Ensembl chr19:7,348,937...7,472,485

G

Rho guanine nucleotide exchange factor 19

affects expression

ISO

epoxiconazole affects the expression of ARHGEF19 mRNA

NCBI chr 1:16,197,854...16,212,652
Ensembl chr 1:16,197,854...16,212,893

G

Rho guanine nucleotide exchange factor 26

decreases expression

ISO

epoxiconazole results in decreased expression of ARHGEF26 mRNA

NCBI chr 3:154,121,003...154,257,825
Ensembl chr 3:154,121,003...154,257,827

G

Rho guanine nucleotide exchange factor 38

increases expression

ISO

epoxiconazole results in increased expression of ARHGEF38 mRNA

NCBI chr 4:105,552,620...105,682,566
Ensembl chr 4:105,552,620...105,708,093

G

Rho guanine nucleotide exchange factor 5

decreases expression

ISO

epoxiconazole results in decreased expression of ARHGEF5 mRNA

NCBI chr 7:144,355,402...144,380,632
Ensembl chr 7:144,355,288...144,380,632

G

Rac/Cdc42 guanine nucleotide exchange factor 6

decreases expression

ISO

epoxiconazole results in decreased expression of ARHGEF6 mRNA

NCBI chr X:136,665,550...136,780,932
Ensembl chr X:136,665,547...136,781,688

G

AT-rich interaction domain 5B

decreases expression

ISO

epoxiconazole results in decreased expression of ARID5B mRNA

NCBI chr10:61,901,699...62,096,944
Ensembl chr10:61,901,684...62,096,944

G

arkadia (RNF111) C-terminal like ring finger ubiquitin ligase 2C

decreases expression

ISO

epoxiconazole results in decreased expression of ARK2C mRNA

NCBI chr18:46,334,018...46,463,140
Ensembl chr18:46,326,809...46,463,140

G

ARF like GTPase 10

increases expression

ISO

epoxiconazole results in increased expression of ARL10 mRNA

NCBI chr 5:176,365,487...176,415,063
Ensembl chr 5:176,365,487...176,401,865

G

ARF like GTPase 3

increases expression

ISO

epoxiconazole results in increased expression of ARL3 mRNA

NCBI chr10:102,673,731...102,714,397
Ensembl chr10:102,673,731...102,714,437

G

ARF like GTPase 4D

decreases expression

ISO

epoxiconazole results in decreased expression of ARL4D mRNA

NCBI chr17:43,398,993...43,401,137
Ensembl chr17:43,398,150...43,401,137

G

ARF like GTPase 5A

decreases expression

ISO

epoxiconazole results in decreased expression of ARL5A mRNA

NCBI chr 2:151,798,797...151,828,421
Ensembl chr 2:151,788,984...151,828,531

G

ARF like GTPase 6

increases expression

ISO

epoxiconazole results in increased expression of ARL6 mRNA

NCBI chr 3:97,764,521...97,801,242
Ensembl chr 3:97,764,521...97,801,229

G

ARL6 interacting reticulophagy regulator 1

decreases expression

ISO

epoxiconazole results in decreased expression of ARL6IP1 mRNA

NCBI chr16:18,791,667...18,801,549
Ensembl chr16:18,791,609...18,801,572

G

armadillo repeat containing X-linked 1

increases expression

ISO

epoxiconazole results in increased expression of ARMCX1 mRNA

NCBI chr X:101,550,547...101,554,700
Ensembl chr X:101,550,411...101,554,704

G

armadillo repeat containing X-linked 3

decreases expression

ISO

epoxiconazole results in decreased expression of ARMCX3 mRNA

NCBI chr X:101,623,151...101,627,843
Ensembl chr X:101,622,797...101,627,843

G

armadillo like helical domain containing 4

increases expression

ISO

epoxiconazole results in increased expression of ARMH4 mRNA

NCBI chr14:58,000,761...58,152,213
Ensembl chr14:57,999,735...58,298,139

G

aryl hydrocarbon receptor nuclear translocator

decreases expression

ISO

epoxiconazole results in decreased expression of ARNT mRNA

NCBI chr 1:150,809,713...150,876,599
Ensembl chr 1:150,808,617...150,876,771

G

actin related protein 2/3 complex subunit 1B

decreases expression

ISO

epoxiconazole results in decreased expression of ARPC1B mRNA

NCBI chr 7:99,374,259...99,394,816
Ensembl chr 7:99,374,226...99,394,827

G

actin related protein 2/3 complex subunit 3

increases expression

ISO

epoxiconazole results in increased expression of ARPC3 mRNA

NCBI chr12:110,434,823...110,450,337
Ensembl chr12:110,434,582...110,450,422

G

actin related protein 2/3 complex inhibitor

decreases expression

ISO

epoxiconazole results in decreased expression of ARPIN mRNA

NCBI chr15:89,895,006...89,912,952
Ensembl chr15:89,895,006...89,912,952

G

cAMP regulated phosphoprotein 19

increases expression

ISO

epoxiconazole results in increased expression of ARPP19 mRNA

PMID:22334560 PMID:35436446

NCBI chr15:52,547,045...52,569,446
Ensembl chr15:52,547,045...52,569,883

G

arrestin domain containing 2

decreases expression

ISO

epoxiconazole results in decreased expression of ARRDC2 mRNA

NCBI chr19:18,001,124...18,014,102
Ensembl chr19:18,001,126...18,014,102

G

arrestin domain containing 3

increases expression

ISO

epoxiconazole results in increased expression of ARRDC3 mRNA

NCBI chr 5:91,368,631...91,383,317
Ensembl chr 5:91,368,631...91,383,317

G

arylsulfatase G

decreases expression

ISO

epoxiconazole results in decreased expression of ARSG mRNA

NCBI chr17:68,259,170...68,452,019
Ensembl chr17:68,259,182...68,422,731

G

N-acylsphingosine amidohydrolase 1

increases expression

ISO

epoxiconazole results in increased expression of ASAH1 mRNA

NCBI chr 8:18,055,992...18,084,961
Ensembl chr 8:18,055,992...18,084,998

G

ArfGAP with SH3 domain, ankyrin repeat and PH domain 2

increases expression

ISO

epoxiconazole results in increased expression of ASAP2 mRNA

NCBI chr 2:9,206,812...9,405,678
Ensembl chr 2:9,206,758...9,405,683

G

ankyrin repeat and SOCS box containing 4

affects expression

ISO

epoxiconazole affects the expression of ASB4 mRNA

NCBI chr 7:95,470,656...95,551,317
Ensembl chr 7:95,478,444...95,540,233

G

ankyrin repeat and SOCS box containing 6

increases expression

ISO

epoxiconazole results in increased expression of ASB6 mRNA

NCBI chr 9:129,634,605...129,642,151
Ensembl chr 9:129,634,602...129,642,169

G

ankyrin repeat and SOCS box containing 7

decreases expression

ISO

epoxiconazole results in decreased expression of ASB7 mRNA

NCBI chr15:100,602,589...100,651,701
Ensembl chr15:100,602,547...100,651,703

G

activating signal cointegrator 1 complex subunit 1

increases expression

ISO

epoxiconazole results in increased expression of ASCC1 mRNA

NCBI chr10:72,096,032...72,217,134
Ensembl chr10:72,096,018...72,217,653

G

anti-silencing function 1B histone chaperone

increases expression

ISO

epoxiconazole results in increased expression of ASF1B mRNA

NCBI chr19:14,119,512...14,136,589
Ensembl chr19:14,119,512...14,136,622

G

argininosuccinate lyase

decreases expression

ISO

epoxiconazole results in decreased expression of ASL mRNA

NCBI chr 7:66,075,819...66,093,576
Ensembl chr 7:66,075,800...66,094,697

G

asparagine synthetase (glutamine-hydrolyzing)

increases expression
multiple interactions

ISO

epoxiconazole results in increased expression of ASNS mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ASNS mRNA

PMID:29038839 PMID:35436446

NCBI chr 7:97,851,677...97,928,441
Ensembl chr 7:97,851,677...97,872,542

G

aspartoacylase

decreases expression

ISO

epoxiconazole results in decreased expression of ASPA mRNA

NCBI chr17:3,474,110...3,503,405
Ensembl chr17:3,472,374...3,503,405

G

asporin

decreases expression

ISO

epoxiconazole results in decreased expression of ASPN mRNA

NCBI chr 9:92,456,205...92,482,506
Ensembl chr 9:92,456,205...92,492,208

G

ASPSCR1 tether for SLC2A4, UBX domain containing

decreases expression

ISO

epoxiconazole results in decreased expression of ASPSCR1 mRNA

NCBI chr17:81,977,629...82,017,406
Ensembl chr17:81,976,807...82,017,406

G

asparaginase and isoaspartyl peptidase 1

decreases expression

ISO

epoxiconazole results in decreased expression of ASRGL1 mRNA

NCBI chr11:62,337,448...62,401,431
Ensembl chr11:62,337,439...62,393,412

G

ATPase family AAA domain containing 3A

decreases expression

ISO

epoxiconazole results in decreased expression of ATAD3A mRNA

NCBI chr 1:1,512,162...1,534,685
Ensembl chr 1:1,512,147...1,534,686

G

activating transcription factor 3

affects expression

ISO

epoxiconazole affects the expression of ATF3 mRNA

NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777

G

activating transcription factor 5

decreases expression
increases expression

ISO

epoxiconazole results in decreased expression of ATF5 mRNA
epoxiconazole results in increased expression of ATF5 mRNA

PMID:22334560 PMID:35436446

NCBI chr19:49,928,906...49,933,935
Ensembl chr19:49,923,910...49,933,935

G

activating transcription factor 6

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole] results in increased expression of ATF6 mRNA

NCBI chr 1:161,766,320...161,964,070
Ensembl chr 1:161,766,261...161,977,574

G

activating transcription factor 7 interacting protein 2

increases expression

ISO

epoxiconazole results in increased expression of ATF7IP2 mRNA

NCBI chr16:10,386,061...10,483,638
Ensembl chr16:10,326,434...10,483,640

G

autophagy related 10

affects expression

ISO

epoxiconazole affects the expression of ATG10 mRNA

NCBI chr 5:81,972,023...82,256,133
Ensembl chr 5:81,971,615...82,276,857

G

autophagy related 16 like 1

decreases expression

ISO

epoxiconazole results in decreased expression of ATG16L1 mRNA

NCBI chr 2:233,251,673...233,295,669
Ensembl chr 2:233,210,051...233,295,674

G

autophagy related 16 like 2

increases expression

ISO

epoxiconazole results in increased expression of ATG16L2 mRNA

PMID:22334560 PMID:35436446

NCBI chr11:72,814,411...72,843,740
Ensembl chr11:72,814,138...72,843,674

G

autophagy related 2A

decreases expression

ISO

epoxiconazole results in decreased expression of ATG2A mRNA

NCBI chr11:64,894,546...64,917,209
Ensembl chr11:64,894,531...64,917,245

G

autophagy related 4D cysteine peptidase

decreases expression

ISO

epoxiconazole results in decreased expression of ATG4D mRNA

NCBI chr19:10,543,904...10,553,418
Ensembl chr19:10,543,533...10,553,423

G

autophagy related 7

decreases expression

ISO

epoxiconazole results in decreased expression of ATG7 mRNA

NCBI chr 3:11,272,397...11,576,353
Ensembl chr 3:11,272,309...11,557,665

G

autophagy related 9A

decreases expression

ISO

epoxiconazole results in decreased expression of ATG9A mRNA

NCBI chr 2:219,219,380...219,229,636
Ensembl chr 2:219,219,380...219,229,717

G

ATM serine/threonine kinase

increases expression
multiple interactions

ISO

epoxiconazole results in increased expression of ATM mRNA
[cyproconazole co-treated with epoxiconazole] results in increased expression of ATM mRNA

NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,222,804...108,369,102

G

atrophin 1

decreases expression

ISO

epoxiconazole results in decreased expression of ATN1 mRNA

NCBI chr12:6,924,459...6,942,321
Ensembl chr12:6,924,463...6,942,322

G

ATPase phospholipid transporting 10A (putative)

increases expression

ISO

epoxiconazole results in increased expression of ATP10A mRNA

NCBI chr15:25,672,237...25,865,088
Ensembl chr15:25,677,273...25,865,184

G

ATPase phospholipid transporting 11A

affects expression

ISO

epoxiconazole affects the expression of ATP11A mRNA

NCBI chr13:112,690,038...112,887,168
Ensembl chr13:112,689,911...112,887,168

G

ATPase 13A1

decreases expression

ISO

epoxiconazole results in decreased expression of ATP13A1 mRNA

NCBI chr19:19,645,198...19,663,676
Ensembl chr19:19,645,198...19,663,700

G

ATPase cation transporting 13A2

increases expression

ISO

epoxiconazole results in increased expression of ATP13A2 mRNA

NCBI chr 1:16,985,958...17,011,928
Ensembl chr 1:16,985,958...17,011,928

G

ATPase Na+/K+ transporting subunit alpha 1

decreases expression

ISO

epoxiconazole results in decreased expression of ATP1A1 mRNA

NCBI chr 1:116,373,244...116,404,774
Ensembl chr 1:116,372,668...116,410,261

G

ATP23 metallopeptidase and ATP synthase assembly factor homolog

decreases expression

ISO

epoxiconazole results in decreased expression of ATP23 mRNA

NCBI chr12:57,941,567...57,959,148
Ensembl chr12:57,906,039...57,959,148

G

ATPase plasma membrane Ca2+ transporting 2

increases expression

ISO

epoxiconazole results in increased expression of ATP2B2 mRNA

NCBI chr 3:10,324,023...10,708,116
Ensembl chr 3:10,324,023...10,708,007

G

ATPase plasma membrane Ca2+ transporting 4

increases expression

ISO

epoxiconazole results in increased expression of ATP2B4 mRNA

NCBI chr 1:203,626,832...203,744,081
Ensembl chr 1:203,626,778...203,744,081

G

ATPase secretory pathway Ca2+ transporting 1

decreases expression

ISO

epoxiconazole results in decreased expression of ATP2C1 mRNA

NCBI chr 3:130,850,595...131,016,712
Ensembl chr 3:130,850,511...131,016,712

G

ATP synthase F1 subunit delta

increases expression

ISO

epoxiconazole results in increased expression of ATP5F1D mRNA

NCBI chr19:1,241,751...1,244,825
Ensembl chr19:1,241,746...1,244,825

G

ATP synthase F1 subunit epsilon

increases expression

ISO

epoxiconazole results in increased expression of ATP5F1E mRNA

NCBI chr20:59,025,475...59,032,335
Ensembl chr20:59,025,475...59,032,358

G

ATP synthase membrane subunit e

increases expression

ISO

epoxiconazole results in increased expression of ATP5ME mRNA

NCBI chr 4:672,436...674,276
Ensembl chr 4:672,423...674,369

G

ATP synthase membrane subunit f

increases expression

ISO

epoxiconazole results in increased expression of ATP5MF mRNA

NCBI chr 7:99,458,195...99,466,167
Ensembl chr 7:99,448,475...99,466,199

G

ATP synthase membrane subunit g

increases expression

ISO

epoxiconazole results in increased expression of ATP5MG mRNA

NCBI chr11:118,401,606...118,409,847
Ensembl chr11:118,401,346...118,433,278

G

ATP synthase membrane subunit j

increases expression

ISO

epoxiconazole results in increased expression of ATP5MJ mRNA

NCBI chr14:103,912,288...103,921,529
Ensembl chr14:103,912,281...103,928,269

G

ATPase H+ transporting accessory protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of ATP6AP1 mRNA

NCBI chr X:154,428,677...154,436,516
Ensembl chr X:154,428,618...154,436,517

G

ATPase H+ transporting accessory protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of ATP6AP2 mRNA

NCBI chr X:40,580,970...40,606,848
Ensembl chr X:40,579,372...40,606,848

G

ATPase H+ transporting V0 subunit a2

decreases expression

ISO

epoxiconazole results in decreased expression of ATP6V0A2 mRNA

NCBI chr12:123,712,353...123,761,755
Ensembl chr12:123,712,342...123,761,755

G

ATPase H+ transporting V0 subunit c

decreases expression

ISO

epoxiconazole results in decreased expression of ATP6V0C mRNA

NCBI chr16:2,513,726...2,520,218
Ensembl chr16:2,513,713...2,520,218

G

ATPase H+ transporting V0 subunit e1

increases expression

ISO

epoxiconazole results in increased expression of ATP6V0E mRNA

PMID:22334560 PMID:35436446

NCBI chr 5:172,983,771...173,035,445
Ensembl chr 5:172,983,771...173,035,445

G

ATPase H+ transporting V1 subunit A

decreases expression

ISO

epoxiconazole results in decreased expression of ATP6V1A mRNA

NCBI chr 3:113,747,035...113,812,056
Ensembl chr 3:113,746,770...113,812,056

G

ATPase H+ transporting V1 subunit D

decreases expression

ISO

epoxiconazole results in decreased expression of ATP6V1D mRNA

NCBI chr14:67,337,872...67,359,804
Ensembl chr14:67,294,371...67,360,265

G

ATPase copper transporting beta

decreases expression

ISO

epoxiconazole results in decreased expression of ATP7B mRNA

NCBI chr13:51,932,669...52,012,132
Ensembl chr13:51,930,436...52,012,166

G

ATPase phospholipid transporting 8B1

increases expression
decreases expression
multiple interactions

ISO

epoxiconazole results in increased expression of ATP8B1 mRNA
epoxiconazole results in decreased expression of ATP8B1 mRNA
[cyproconazole co-treated with epoxiconazole] results in increased expression of ATP8B1 mRNA

PMID:29038839 PMID:35436446

NCBI chr18:57,646,426...57,803,315
Ensembl chr18:57,646,426...57,803,560

G

ATPase phospholipid transporting 8B3

increases expression

ISO

epoxiconazole results in increased expression of ATP8B3 mRNA

NCBI chr19:1,782,075...1,812,276
Ensembl chr19:1,782,075...1,812,276

G

ataxin 1

affects expression

ISO

epoxiconazole affects the expression of ATXN1 mRNA

NCBI chr 6:16,299,112...16,761,460
Ensembl chr 6:16,299,112...16,761,491

G

ataxin 2

affects expression

ISO

epoxiconazole affects the expression of ATXN2 mRNA

NCBI chr12:111,452,214...111,599,673
Ensembl chr12:111,443,485...111,599,676

G

ataxin 7 like 1

increases expression

ISO

epoxiconazole results in increased expression of ATXN7L1 mRNA

NCBI chr 7:105,604,772...105,876,599
Ensembl chr 7:105,604,772...105,876,599

G

ataxin 7 like 3

increases expression

ISO

epoxiconazole results in increased expression of ATXN7L3 mRNA

NCBI chr17:44,191,805...44,199,884
Ensembl chr17:44,191,805...44,200,961

G

ataxin 7 like 3B

decreases expression

ISO

epoxiconazole results in decreased expression of ATXN7L3B mRNA

PMID:22334560 PMID:35436446

NCBI chr12:74,537,835...74,545,430
Ensembl chr12:74,537,835...74,545,430

G

aurora kinase B

increases expression

ISO

epoxiconazole results in increased expression of AURKB mRNA

NCBI chr17:8,204,731...8,210,575
Ensembl chr17:8,204,335...8,210,634

G

apoptosis and caspase activation inhibitor

increases expression

ISO

epoxiconazole results in increased expression of AVEN mRNA

NCBI chr15:33,851,781...34,075,325
Ensembl chr15:33,858,782...34,075,155

G

AVL9 cell migration associated

decreases expression

ISO

epoxiconazole results in decreased expression of AVL9 mRNA

NCBI chr 7:32,495,489...32,588,726
Ensembl chr 7:32,495,426...32,588,726

G

arginine vasopressin receptor 1A

affects expression

ISO

epoxiconazole affects the expression of AVPR1A mRNA

NCBI chr12:63,142,759...63,151,201
Ensembl chr12:63,142,759...63,151,201

G

AXL receptor tyrosine kinase

decreases expression

ISO

epoxiconazole results in decreased expression of AXL mRNA

NCBI chr19:41,219,223...41,261,766
Ensembl chr19:41,219,174...41,261,766

G

antizyme inhibitor 1

decreases expression

ISO

epoxiconazole results in decreased expression of AZIN1 mRNA

NCBI chr 8:102,826,302...102,864,200
Ensembl chr 8:102,826,111...102,893,864

G

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3

decreases expression

ISO

epoxiconazole results in decreased expression of B3GNT3 mRNA

NCBI chr19:17,794,791...17,813,576
Ensembl chr19:17,794,697...17,814,175

G

beta-1,4-N-acetyl-galactosaminyltransferase 1

decreases expression

ISO

epoxiconazole results in decreased expression of B4GALNT1 mRNA

NCBI chr12:57,623,409...57,633,201
Ensembl chr12:57,623,409...57,633,239

G

beta-1,4-N-acetyl-galactosaminyltransferase 3

increases expression

ISO

epoxiconazole results in increased expression of B4GALNT3 mRNA

NCBI chr12:459,939...563,509
Ensembl chr12:459,923...563,509

G

beta-1,4-galactosyltransferase 1

decreases expression

ISO

epoxiconazole results in decreased expression of B4GALT1 mRNA

NCBI chr 9:33,104,077...33,185,089
Ensembl chr 9:33,100,493...33,167,359

G

beta-1,4-galactosyltransferase 5

decreases expression

ISO

epoxiconazole results in decreased expression of B4GALT5 mRNA

NCBI chr20:49,632,945...49,713,878
Ensembl chr20:49,632,945...49,713,908

G

BRISC and BRCA1 A complex member 2

decreases expression

ISO

epoxiconazole results in decreased expression of BABAM2 mRNA

NCBI chr 2:27,888,709...28,338,901
Ensembl chr 2:27,888,667...28,338,901

G

beta-secretase 1

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BACE1 mRNA

NCBI chr11:117,285,698...117,316,256
Ensembl chr11:117,285,232...117,316,286

G

beta-secretase 2

decreases expression
multiple interactions

ISO

epoxiconazole results in decreased expression of BACE2 mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA

PMID:25607892 PMID:35436446

NCBI chr21:41,168,160...41,282,530
Ensembl chr21:41,167,801...41,282,530

G

BTB domain and CNC homolog 1

decreases expression

ISO

epoxiconazole results in decreased expression of BACH1 mRNA

NCBI chr21:29,298,922...29,361,894
Ensembl chr21:29,194,071...29,630,751

G

BTB domain and CNC homolog 2

decreases expression

ISO

epoxiconazole results in decreased expression of BACH2 mRNA

NCBI chr 6:89,926,528...90,296,843
Ensembl chr 6:89,926,528...90,296,923

G

BCL2 associated agonist of cell death

increases expression

ISO

epoxiconazole results in increased expression of BAD mRNA

NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,828...64,291,946

G

BAG cochaperone 1

increases expression

ISO

epoxiconazole results in increased expression of BAG1 mRNA

NCBI chr 9:33,252,471...33,264,708
Ensembl chr 9:33,247,820...33,264,720

G

BAG cochaperone 3

decreases expression

ISO

epoxiconazole results in decreased expression of BAG3 mRNA

NCBI chr10:119,651,380...119,677,819
Ensembl chr10:119,650,879...119,677,913

G

BAG cochaperone 6

decreases expression

ISO

epoxiconazole results in decreased expression of BAG6 mRNA

NCBI chr 6:31,639,028...31,652,661
Ensembl chr 6:31,638,544...31,652,747

G

BAR/IMD domain containing adaptor protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of BAIAP2 mRNA

NCBI chr17:81,035,151...81,117,434
Ensembl chr17:81,035,122...81,117,434

G

B cell scaffold protein with ankyrin repeats 1

increases expression

ISO

epoxiconazole results in increased expression of BANK1 mRNA

NCBI chr 4:101,790,730...102,074,812
Ensembl chr 4:101,411,286...102,074,812

G

BTG3 associated nuclear protein

decreases expression

ISO

epoxiconazole results in decreased expression of BANP mRNA

NCBI chr16:87,949,238...88,077,318
Ensembl chr16:87,949,127...88,077,321

G

BCL2 associated X, apoptosis regulator

decreases expression

ISO

epoxiconazole results in decreased expression of BAX mRNA

NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798

G

bromodomain adjacent to zinc finger domain 1B

decreases expression

ISO

epoxiconazole results in decreased expression of BAZ1B mRNA

NCBI chr 7:73,440,406...73,522,293
Ensembl chr 7:73,440,406...73,522,293

G

bromodomain adjacent to zinc finger domain 2B

decreases expression

ISO

epoxiconazole results in decreased expression of BAZ2B mRNA

NCBI chr 2:159,315,312...159,712,442
Ensembl chr 2:159,315,312...159,617,282

G

BCAR1 scaffold protein, Cas family member

increases expression

ISO

epoxiconazole results in increased expression of BCAR1 mRNA

NCBI chr16:75,228,181...75,268,007
Ensembl chr16:75,228,181...75,268,053

G

brain enriched myelin associated protein 1

increases expression

ISO

epoxiconazole results in increased expression of BCAS1 mRNA

NCBI chr20:53,943,541...54,070,594
Ensembl chr20:53,936,777...54,070,641

G

BRCA2 and CDKN1A interacting protein

decreases expression

ISO

epoxiconazole results in decreased expression of BCCIP mRNA

NCBI chr10:125,823,546...125,853,695
Ensembl chr10:125,823,525...125,853,695

G

BCL2 like 11

increases expression

ISO

epoxiconazole results in increased expression of BCL2L11 mRNA

NCBI chr 2:111,120,914...111,168,445
Ensembl chr 2:111,119,378...111,168,444

G

BCL3 transcription coactivator

decreases expression

ISO

epoxiconazole results in decreased expression of BCL3 mRNA

NCBI chr19:44,747,705...44,760,044
Ensembl chr19:44,747,705...44,760,044

G

BCL6 transcription repressor

affects expression

ISO

epoxiconazole affects the expression of BCL6 mRNA

NCBI chr 3:187,721,377...187,745,468
Ensembl chr 3:187,721,377...187,745,725

G

BAF chromatin remodeling complex subunit BCL7A

decreases expression

ISO

epoxiconazole results in decreased expression of BCL7A mRNA

NCBI chr12:122,021,884...122,062,044
Ensembl chr12:122,019,422...122,062,044

G

BAF chromatin remodeling complex subunit BCL7C

increases expression

ISO

epoxiconazole results in increased expression of BCL7C mRNA

NCBI chr16:30,833,626...30,894,077
Ensembl chr16:30,833,626...30,894,302

G

BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone

decreases expression

ISO

epoxiconazole results in decreased expression of BCS1L mRNA

NCBI chr 2:218,658,743...218,663,443
Ensembl chr 2:218,658,764...218,663,466

G

3-hydroxybutyrate dehydrogenase 1

decreases expression

ISO

epoxiconazole results in decreased expression of BDH1 mRNA

NCBI chr 3:197,509,783...197,573,343
Ensembl chr 3:197,509,776...197,573,382

G

3-hydroxybutyrate dehydrogenase 2

increases expression

ISO

epoxiconazole results in increased expression of BDH2 mRNA

NCBI chr 4:103,077,592...103,099,834
Ensembl chr 4:103,077,592...103,099,880

G

bradykinin receptor B1

decreases expression

ISO

epoxiconazole results in decreased expression of BDKRB1 mRNA

NCBI chr14:96,256,210...96,264,763
Ensembl chr14:96,256,182...96,268,967

G

brain derived neurotrophic factor

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BDNF mRNA

NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058

G

beclin 1

decreases expression

ISO

epoxiconazole results in decreased expression of BECN1 mRNA

NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,809,870...42,833,350

G

Bet1 golgi vesicular membrane trafficking protein like

decreases expression

ISO

epoxiconazole results in decreased expression of BET1L mRNA

NCBI chr11:202,924...207,399
Ensembl chr11:167,784...207,399

G

biglycan

affects expression

ISO

epoxiconazole affects the expression of BGN mRNA

NCBI chr X:153,494,980...153,509,546
Ensembl chr X:153,488,654...153,510,299

G

basic helix-loop-helix family member e40

decreases expression

ISO

epoxiconazole results in decreased expression of BHLHE40 mRNA

NCBI chr 3:4,979,437...4,985,323
Ensembl chr 3:4,978,715...4,985,323

G

basic helix-loop-helix family member e41

decreases expression

ISO

epoxiconazole results in decreased expression of BHLHE41 mRNA

NCBI chr12:26,120,030...26,125,037
Ensembl chr12:26,120,030...26,125,037

G

betaine--homocysteine S-methyltransferase

affects expression

ISO

epoxiconazole affects the expression of BHMT mRNA

NCBI chr 5:79,111,809...79,132,288
Ensembl chr 5:79,111,807...79,132,289

G

betaine--homocysteine S-methyltransferase 2

decreases expression

ISO

epoxiconazole results in decreased expression of BHMT2 mRNA

PMID:22334560 PMID:35436446

NCBI chr 5:79,069,767...79,090,069
Ensembl chr 5:79,069,636...79,090,069

G

BRD4 interacting chromatin remodeling complex associated protein

decreases expression

ISO

epoxiconazole results in decreased expression of BICRA mRNA

NCBI chr19:47,608,196...47,703,277
Ensembl chr19:47,608,196...47,703,277

G

BH3 interacting domain death agonist

decreases expression

ISO

epoxiconazole results in decreased expression of BID mRNA

NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770

G

baculoviral IAP repeat containing 3

decreases expression

ISO

epoxiconazole results in decreased expression of BIRC3 mRNA

NCBI chr11:102,317,484...102,339,403
Ensembl chr11:102,317,484...102,339,403

G

BLCAP apoptosis inducing factor

decreases expression

ISO

epoxiconazole results in decreased expression of BLCAP mRNA

NCBI chr20:37,517,417...37,527,876
Ensembl chr20:37,492,472...37,528,100

G

biogenesis of lysosomal organelles complex 1 subunit 5

decreases expression

ISO

epoxiconazole results in decreased expression of BLOC1S5 mRNA

NCBI chr 6:8,013,567...8,064,414
Ensembl chr 6:8,013,566...8,064,414

G

bridge-like lipid transfer protein family member 2

decreases expression

ISO

epoxiconazole results in decreased expression of BLTP2 mRNA

NCBI chr17:28,614,440...28,645,159
Ensembl chr17:28,614,440...28,645,454

G

bridge-like lipid transfer protein family member 3A

decreases expression

ISO

epoxiconazole results in decreased expression of BLTP3A mRNA

NCBI chr 6:34,792,083...34,877,514
Ensembl chr 6:34,792,083...34,877,514

G

biliverdin reductase A

decreases expression

ISO

epoxiconazole results in decreased expression of BLVRA mRNA

NCBI chr 7:43,758,122...43,807,342
Ensembl chr 7:43,758,009...43,808,097

G

biliverdin reductase B

decreases expression

ISO

epoxiconazole results in decreased expression of BLVRB mRNA

NCBI chr19:40,447,768...40,465,745
Ensembl chr19:40,447,765...40,465,826

G

basic helix-loop-helix ARNT like 1

affects expression

ISO

epoxiconazole affects the expression of BMAL1 mRNA

NCBI chr11:13,276,652...13,387,266
Ensembl chr11:13,276,647...13,388,048

G

basic helix-loop-helix ARNT like 2

increases expression

ISO

epoxiconazole results in increased expression of BMAL2 mRNA

NCBI chr12:27,332,836...27,425,286
Ensembl chr12:27,332,836...27,425,289

G

Bcl2 modifying factor

increases expression

ISO

epoxiconazole results in increased expression of BMF mRNA

NCBI chr15:40,087,890...40,108,879
Ensembl chr15:40,087,889...40,108,928

G

BMI1 proto-oncogene, polycomb ring finger

increases expression

ISO

epoxiconazole results in increased expression of BMI1 mRNA

NCBI chr10:22,321,099...22,331,706
Ensembl chr10:22,321,078...22,331,485

G

bone morphogenetic protein 7

decreases expression

ISO

epoxiconazole results in decreased expression of BMP7 mRNA

NCBI chr20:57,168,753...57,266,641
Ensembl chr20:57,168,753...57,266,641

G

BMP binding endothelial regulator

increases expression

ISO

epoxiconazole results in increased expression of BMPER mRNA

NCBI chr 7:33,904,915...34,156,427
Ensembl chr 7:33,904,308...34,156,427

G

BCL2 interacting protein 3

decreases expression

ISO

epoxiconazole results in decreased expression of BNIP3 mRNA

NCBI chr10:131,967,684...131,981,923
Ensembl chr10:131,966,461...131,981,984

G

bolA family member 3

increases expression

ISO

epoxiconazole results in increased expression of BOLA3 mRNA

NCBI chr 2:74,135,400...74,147,912
Ensembl chr 2:74,135,397...74,147,977

G

boule homolog, RNA binding protein

increases expression

ISO

epoxiconazole results in increased expression of BOLL mRNA

NCBI chr 2:197,726,890...197,786,206
Ensembl chr 2:197,726,879...197,786,762

G

BORA aurora kinase A activator

decreases expression

ISO

epoxiconazole results in decreased expression of BORA mRNA

NCBI chr13:72,727,923...72,756,196
Ensembl chr13:72,727,749...72,756,198

G

BLOC-1 related complex subunit 8

decreases expression

ISO

epoxiconazole results in decreased expression of BORCS8 mRNA

NCBI chr19:19,176,906...19,192,152
Ensembl chr19:19,176,902...19,192,591

G

BRCA1 associated ATM activator 1

increases expression

ISO

epoxiconazole results in increased expression of BRAT1 mRNA

NCBI chr 7:2,537,810...2,555,524
Ensembl chr 7:2,537,810...2,555,782

G

bromodomain containing 2

increases expression

ISO

epoxiconazole results in increased expression of BRD2 mRNA

NCBI chr 6:32,968,594...32,981,505
Ensembl chr 6:32,968,594...32,981,505

G

bromodomain testis associated

decreases expression

ISO

epoxiconazole results in decreased expression of BRDT mRNA

NCBI chr 1:91,949,371...92,014,428
Ensembl chr 1:91,949,343...92,014,426

G

BRF1 general transcription factor IIIB subunit

decreases expression

ISO

epoxiconazole results in decreased expression of BRF1 mRNA

NCBI chr14:105,209,286...105,315,589
Ensembl chr14:105,209,277...105,315,589

G

brain protein I3

affects expression

ISO

epoxiconazole affects the expression of BRI3 mRNA

NCBI chr 7:98,281,686...98,323,430
Ensembl chr 7:98,252,379...98,310,441

G

biogenesis of ribosomes BRX1

increases expression

ISO

epoxiconazole results in increased expression of BRIX1 mRNA

NCBI chr 5:34,915,711...34,925,996
Ensembl chr 5:34,915,273...34,926,622

G

BSCL2 lipid droplet biogenesis associated, seipin

decreases expression

ISO

epoxiconazole results in decreased expression of BSCL2 mRNA

NCBI chr11:62,690,262...62,709,537
Ensembl chr11:62,689,289...62,709,845

G

bassoon presynaptic cytomatrix protein

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BSN mRNA

NCBI chr 3:49,554,477...49,673,130
Ensembl chr 3:49,554,477...49,671,549

G

bone marrow stromal cell antigen 2

decreases expression

ISO

epoxiconazole results in decreased expression of BST2 mRNA

NCBI chr19:17,402,939...17,405,630
Ensembl chr19:17,402,933...17,405,665

G

B-TFIID TATA-box binding protein associated factor 1

decreases expression

ISO

epoxiconazole results in decreased expression of BTAF1 mRNA

NCBI chr10:91,923,770...92,031,437
Ensembl chr10:91,923,770...92,031,437

G

BTB domain containing 7

decreases expression

ISO

epoxiconazole results in decreased expression of BTBD7 mRNA

NCBI chr14:93,237,550...93,333,036
Ensembl chr14:93,237,550...93,333,092

G

basic transcription factor 3 like 4

increases expression

ISO

epoxiconazole results in increased expression of BTF3L4 mRNA

NCBI chr 1:52,056,295...52,090,716
Ensembl chr 1:52,056,199...52,090,716

G

BTG anti-proliferation factor 2

increases expression

ISO

epoxiconazole results in increased expression of BTG2 mRNA

NCBI chr 1:203,305,519...203,309,602
Ensembl chr 1:203,305,491...203,309,602

G

butyrophilin subfamily 1 member A1

increases expression

ISO

epoxiconazole results in increased expression of BTN1A1 mRNA

NCBI chr 6:26,500,303...26,510,425
Ensembl chr 6:26,500,303...26,510,425

G

butyrophilin like 2

increases expression

ISO

epoxiconazole results in increased expression of BTNL2 mRNA

NCBI chr 6:32,393,339...32,407,181
Ensembl chr 6:32,393,339...32,407,181

G

BUB1 mitotic checkpoint serine/threonine kinase B

increases expression

ISO

epoxiconazole results in increased expression of BUB1B mRNA

NCBI chr15:40,161,069...40,221,123
Ensembl chr15:40,161,023...40,221,136

G

BUD13 homolog

affects expression

ISO

epoxiconazole affects the expression of BUD13 mRNA

NCBI chr11:116,748,173...116,772,987
Ensembl chr11:116,748,170...116,773,039

G

bystin like

decreases expression

ISO

epoxiconazole results in decreased expression of BYSL mRNA

NCBI chr 6:41,908,759...41,933,046
Ensembl chr 6:41,921,229...41,933,050

G

C1GALT1 specific chaperone 1

increases expression

ISO

epoxiconazole results in increased expression of C1GALT1C1 mRNA

NCBI chr X:120,625,674...120,630,054
Ensembl chr X:120,625,674...120,630,054

G

complement C1r subcomponent like

decreases expression

ISO

epoxiconazole results in decreased expression of C1RL mRNA

NCBI chr12:7,094,554...7,109,214
Ensembl chr12:7,089,587...7,109,245

G

complement C2

decreases expression

ISO

epoxiconazole results in decreased expression of C2 mRNA

NCBI chr 6:31,897,783...31,945,672
Ensembl chr 6:31,897,785...31,945,674

G

C2 calcium dependent domain containing 2

decreases expression

ISO

epoxiconazole results in decreased expression of C2CD2 mRNA

PMID:22334560 PMID:23970803 PMID:35436446

NCBI chr21:41,885,112...41,954,018
Ensembl chr21:41,885,112...41,954,018

G

C2CD2 like

decreases expression

ISO

epoxiconazole results in decreased expression of C2CD2L mRNA

NCBI chr11:119,102,249...119,118,544
Ensembl chr11:119,102,198...119,118,544

G

C2 calcium dependent domain containing 5

increases expression

ISO

epoxiconazole results in increased expression of C2CD5 mRNA

NCBI chr12:22,448,583...22,544,542
Ensembl chr12:22,448,567...22,544,574

G

chromosome 2 open reading frame 42

decreases expression

ISO

epoxiconazole results in decreased expression of C87436 mRNA

NCBI chr 2:70,149,885...70,191,019
Ensembl chr 2:70,149,882...70,248,615

G

complement C4B (Chido/Rodgers blood group)

decreases expression

ISO

epoxiconazole results in decreased expression of C4B mRNA

NCBI chr 6:32,014,795...32,035,418
Ensembl chr 6:32,014,730...32,035,973

G

complement C5

decreases expression

ISO

epoxiconazole results in decreased expression of HC mRNA

NCBI chr 9:120,952,335...121,074,865
Ensembl chr 9:120,932,987...121,075,195

G

complement C8 beta chain

decreases expression

ISO

epoxiconazole results in decreased expression of C8B mRNA

NCBI chr 1:56,929,207...56,966,015
Ensembl chr 1:56,929,099...56,974,383

G

complement C9

increases expression

ISO

epoxiconazole results in increased expression of C9 mRNA

NCBI chr 5:39,284,140...39,364,495
Ensembl chr 5:39,283,982...39,371,324

G

carbonic anhydrase 1

decreases expression

ISO

epoxiconazole results in decreased expression of CAR1 mRNA

NCBI chr 8:85,327,608...85,378,113
Ensembl chr 8:85,327,608...85,379,014

G

carbonic anhydrase 11

increases expression

ISO

epoxiconazole results in increased expression of CAR11 mRNA

NCBI chr19:48,637,946...48,646,187
Ensembl chr19:48,637,946...48,646,386

G

carbonic anhydrase 5A

decreases expression

ISO

epoxiconazole results in decreased expression of CAR5A mRNA

NCBI chr16:87,881,549...87,936,529
Ensembl chr16:87,881,546...87,936,580

G

carbonic anhydrase 6

increases expression

ISO

epoxiconazole results in increased expression of CAR6 mRNA

NCBI chr 1:8,945,868...8,975,092
Ensembl chr 1:8,945,867...8,975,092

G

calcium binding tyrosine phosphorylation regulated

affects expression

ISO

epoxiconazole affects the expression of CABYR mRNA

NCBI chr18:24,139,062...24,161,600
Ensembl chr18:24,138,987...24,161,603

G

cache domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of CACHD1 mRNA

NCBI chr 1:64,470,129...64,693,053
Ensembl chr 1:64,469,765...64,693,058

G

calcium voltage-gated channel subunit alpha1 A

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1A mRNA

NCBI chr19:13,206,442...13,506,479
Ensembl chr19:13,206,442...13,624,489

G

calcium voltage-gated channel subunit alpha1 B

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1B mRNA

NCBI chr 9:137,877,782...138,124,619
Ensembl chr 9:137,877,782...138,124,624

G

calcium voltage-gated channel subunit alpha1 C

multiple interactions
increases expression

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1C mRNA
epoxiconazole results in increased expression of CACNA1C mRNA

PMID:25607892 PMID:35436446

NCBI chr12:1,970,780...2,697,950
Ensembl chr12:1,970,772...2,697,950

G

calcium voltage-gated channel subunit alpha1 D

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1D mRNA

NCBI chr 3:53,494,611...53,813,733
Ensembl chr 3:53,328,963...53,813,733

G

calcium voltage-gated channel subunit alpha1 F

increases expression

ISO

epoxiconazole results in increased expression of CACNA1F mRNA

NCBI chr X:49,205,063...49,233,340
Ensembl chr X:49,205,063...49,233,371

G

calcium voltage-gated channel subunit alpha1 G

decreases expression
multiple interactions

ISO

epoxiconazole results in decreased expression of CACNA1G mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1G mRNA

PMID:25607892 PMID:35436446

NCBI chr17:50,560,715...50,627,474
Ensembl chr17:50,560,715...50,627,474

G

calcium voltage-gated channel subunit alpha1 I

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNA1I mRNA

NCBI chr22:39,570,753...39,689,735
Ensembl chr22:39,570,753...39,689,735

G

calcium voltage-gated channel auxiliary subunit alpha2delta 3

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of CACNA2D3 mRNA

NCBI chr 3:54,122,552...55,074,557
Ensembl chr 3:54,122,427...55,074,557

G

calcium voltage-gated channel auxiliary subunit beta 1

multiple interactions
increases expression

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNB1 mRNA
epoxiconazole results in increased expression of CACNB1 mRNA

PMID:25607892 PMID:35436446

NCBI chr17:39,173,453...39,197,669
Ensembl chr17:39,173,453...39,197,723

G

calcium voltage-gated channel auxiliary subunit beta 3

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNB3 mRNA

NCBI chr12:48,814,480...48,828,941
Ensembl chr12:48,813,794...48,828,941

G

calcium voltage-gated channel auxiliary subunit gamma 2

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNG2 mRNA

NCBI chr22:36,560,857...36,703,752
Ensembl chr22:36,560,857...36,703,752

G

calcium voltage-gated channel auxiliary subunit gamma 6

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNG6 mRNA

NCBI chr19:53,991,149...54,012,666
Ensembl chr19:53,991,637...54,012,666

G

calcium voltage-gated channel auxiliary subunit gamma 7

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNG7 mRNA

NCBI chr19:53,909,278...53,943,950
Ensembl chr19:53,909,278...53,943,950

G

cell adhesion molecule 1

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CADM1 mRNA

NCBI chr11:115,169,236...115,504,415
Ensembl chr11:115,169,218...115,504,957

G

calcium binding and coiled-coil domain 1

decreases expression

ISO

epoxiconazole results in decreased expression of CALCOCO1 mRNA

NCBI chr12:53,708,517...53,727,452
Ensembl chr12:53,708,517...53,727,745

G

caldesmon 1

decreases expression

ISO

epoxiconazole results in decreased expression of CALD1 mRNA

NCBI chr 7:134,711,499...134,970,729
Ensembl chr 7:134,744,252...134,970,729

G

calcium homeostasis modulator family member 4

decreases expression

ISO

epoxiconazole results in decreased expression of CALHM4 mRNA

NCBI chr 6:116,529,043...116,561,127
Ensembl chr 6:116,529,013...116,561,127

G

calmodulin like 5

increases expression

ISO

epoxiconazole results in increased expression of CALM4 mRNA

NCBI chr10:5,498,697...5,499,570
Ensembl chr10:5,498,697...5,499,570

G

calcium/calmodulin dependent protein kinase II beta

multiple interactions
decreases expression

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CAMK2B mRNA
epoxiconazole results in decreased expression of CAMK2B mRNA

PMID:25607892 PMID:35436446

NCBI chr 7:44,217,154...44,326,013
Ensembl chr 7:44,209,993...44,334,577

G

calcium/calmodulin dependent protein kinase II gamma

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of CAMK2G mRNA

NCBI chr10:73,812,501...73,874,555
Ensembl chr10:73,812,501...73,874,641

G

calmodulin binding transcription activator 1

increases expression

ISO

epoxiconazole results in increased expression of CAMTA1 mRNA

NCBI chr 1:6,785,454...7,769,706
Ensembl chr 1:6,785,454...7,769,706

G

cullin associated and neddylation dissociated 2 (putative)

increases expression

ISO

epoxiconazole results in increased expression of CAND2 mRNA

NCBI chr 3:12,796,680...12,834,803
Ensembl chr 3:12,796,472...12,834,818

G

cyclase associated actin cytoskeleton regulatory protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of CAP2 mRNA

NCBI chr 6:17,393,595...17,557,780
Ensembl chr 6:17,393,375...17,557,792

G

calpain 1

decreases expression

ISO

epoxiconazole results in decreased expression of CAPN1 mRNA

NCBI chr11:65,181,373...65,212,006
Ensembl chr11:65,180,566...65,212,006

G

calpain 10

decreases expression

ISO

epoxiconazole results in decreased expression of CAPN10 mRNA

NCBI chr 2:240,586,734...240,599,104
Ensembl chr 2:240,586,383...240,617,705

G

calpain 15

decreases expression

ISO

epoxiconazole results in decreased expression of CAPN15 mRNA

NCBI chr16:527,712...554,636
Ensembl chr16:527,712...554,636

G

calpain 2

increases expression

ISO

epoxiconazole results in increased expression of CAPN2 mRNA

NCBI chr 1:223,701,597...223,776,018
Ensembl chr 1:223,701,593...223,776,018

G

calpain 5

decreases expression

ISO

epoxiconazole results in decreased expression of CAPN5 mRNA

NCBI chr11:77,066,971...77,126,155
Ensembl chr11:77,066,961...77,126,155

G

calpain small subunit 1

increases expression

ISO

epoxiconazole results in increased expression of CAPNS1 mRNA

NCBI chr19:36,140,066...36,150,353
Ensembl chr19:36,139,953...36,150,356

G

cell cycle associated protein 1

increases expression

ISO

epoxiconazole results in increased expression of CAPRIN1 mRNA

NCBI chr11:34,051,731...34,102,610
Ensembl chr11:34,051,674...34,102,610

G

capping actin protein of muscle Z-line subunit beta

decreases expression

ISO

epoxiconazole results in decreased expression of CAPZB mRNA

NCBI chr 1:19,338,775...19,485,539
Ensembl chr 1:19,338,775...19,485,600

G

caspase recruitment domain family member 6

decreases expression

ISO

epoxiconazole results in decreased expression of CARD6 mRNA

NCBI chr 5:40,841,367...40,855,354
Ensembl chr 5:40,841,308...40,860,175

G

coactivator associated arginine methyltransferase 1

decreases expression

ISO

epoxiconazole results in decreased expression of CARM1 mRNA

NCBI chr19:10,871,553...10,923,075
Ensembl chr19:10,871,553...10,923,075

G

capping protein regulator and myosin 1 linker 1

decreases expression

ISO

epoxiconazole results in decreased expression of CARMIL1 mRNA

NCBI chr 6:25,279,374...25,620,530
Ensembl chr 6:25,279,078...25,620,537

G

cysteinyl-tRNA synthetase 1

decreases expression

ISO

epoxiconazole results in decreased expression of CARS1 mRNA

NCBI chr11:3,000,929...3,057,423
Ensembl chr11:3,000,922...3,057,613

G

caspase 12 (gene/pseudogene)

increases expression

ISO

epoxiconazole results in increased expression of CASP12 mRNA

NCBI chr11:104,883,286...104,898,460
Ensembl chr11:104,885,718...104,898,670

G

caspase 6

decreases expression

ISO

epoxiconazole results in decreased expression of CASP6 mRNA

NCBI chr 4:109,664,388...109,709,767
Ensembl chr 4:109,688,622...109,703,583

G

caspase 7

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole] results in increased expression of CASP7 mRNA

NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,731,290

G

caspase 8

decreases expression

ISO

epoxiconazole results in decreased expression of CASP8 mRNA

NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836

G

cation channel sperm associated 2

decreases expression

ISO

epoxiconazole results in decreased expression of CATSPER2 mRNA

NCBI chr15:43,628,503...43,648,884
Ensembl chr15:43,628,503...43,668,118

G

caveolin 2

decreases expression

ISO

epoxiconazole results in decreased expression of CAV2 mRNA

NCBI chr 7:116,499,738...116,508,541
Ensembl chr 7:116,287,380...116,508,541

G

carbonyl reductase 3

increases expression

ISO

epoxiconazole results in increased expression of CBR3 mRNA

NCBI chr21:36,135,079...36,146,562
Ensembl chr21:36,135,079...36,146,566

G

chromobox 4

increases expression

ISO

epoxiconazole results in increased expression of CBX4 mRNA

NCBI chr17:79,833,156...79,839,440
Ensembl chr17:79,833,156...79,839,469

G

coiled-coil domain containing 112

decreases expression

ISO

epoxiconazole results in decreased expression of CCDC112 mRNA

NCBI chr 5:115,267,190...115,296,654
Ensembl chr 5:115,267,190...115,296,756

G

coiled-coil domain containing 117

decreases expression

ISO

epoxiconazole results in decreased expression of CCDC117 mRNA

NCBI chr22:28,772,695...28,789,301
Ensembl chr22:28,772,674...28,789,301

G

coiled-coil domain containing 146

increases expression

ISO

epoxiconazole results in increased expression of CCDC146 mRNA

NCBI chr 7:77,122,615...77,295,204
Ensembl chr 7:77,122,434...77,329,533

G

coiled-coil domain containing 15

increases expression

ISO

epoxiconazole results in increased expression of CCDC15 mRNA

NCBI chr11:124,954,202...125,041,489
Ensembl chr11:124,954,095...125,041,649

G

coiled-coil domain containing 152

increases expression

ISO

epoxiconazole results in increased expression of CCDC152 mRNA

NCBI chr 5:42,756,818...42,802,439
Ensembl chr 5:42,756,799...42,802,439

G

coiled-coil domain containing 159

decreases expression

ISO

epoxiconazole results in decreased expression of CCDC159 mRNA

NCBI chr19:11,346,519...11,354,944
Ensembl chr19:11,344,684...11,354,944

G

coiled-coil domain containing 185

increases expression

ISO

epoxiconazole results in increased expression of CCDC185 mRNA

NCBI chr 1:223,393,415...223,395,465
Ensembl chr 1:223,393,415...223,395,465

G

coiled-coil domain containing 201

increases expression

ISO

epoxiconazole results in increased expression of CCDC201 mRNA

NCBI chr 7:45,859,994...45,885,172
Ensembl chr 7:45,859,994...45,873,082

G

coiled-coil domain containing 28A

decreases expression

ISO

epoxiconazole results in decreased expression of CCDC28A mRNA

NCBI chr 6:138,773,769...138,793,319
Ensembl chr 6:138,773,493...138,793,319

G

coiled-coil domain 40 molecular ruler complex subunit

decreases expression

ISO

epoxiconazole results in decreased expression of CCDC40 mRNA

NCBI chr17:80,036,642...80,100,613
Ensembl chr17:80,036,632...80,100,613

G

coiled-coil domain containing 54

increases expression

ISO

epoxiconazole results in increased expression of CCDC54 mRNA

NCBI chr 3:107,377,439...107,378,635
Ensembl chr 3:107,377,439...107,378,635

G

coiled-coil domain containing 59

increases expression

ISO

epoxiconazole results in increased expression of CCDC59 mRNA

NCBI chr12:82,352,303...82,358,805
Ensembl chr12:82,223,681...82,358,805

G

coiled-coil domain containing 66

affects expression

ISO

epoxiconazole affects the expression of CCDC66 mRNA

NCBI chr 3:56,557,156...56,621,837
Ensembl chr 3:56,557,161...56,621,837

G

coiled-coil domain containing 74A

decreases expression

ISO

epoxiconazole results in decreased expression of CCDC74A mRNA

NCBI chr 2:131,522,592...131,533,666
Ensembl chr 2:131,527,675...131,533,666

G

coiled-coil domain containing 77

increases expression

ISO

epoxiconazole results in increased expression of CCDC77 mRNA

NCBI chr12:389,347...442,642
Ensembl chr12:389,273...442,644

G

coiled-coil domain containing 85B

decreases expression

ISO

epoxiconazole results in decreased expression of CCDC85B mRNA

NCBI chr11:65,890,673...65,891,635
Ensembl chr11:65,890,673...65,891,635

G

coiled-coil domain containing 9

decreases expression

ISO

epoxiconazole results in decreased expression of CCDC9 mRNA

NCBI chr19:47,256,525...47,275,723
Ensembl chr19:47,255,980...47,274,055

G

coiled-coil domain containing 91

decreases expression

ISO

epoxiconazole results in decreased expression of CCDC91 mRNA

NCBI chr12:28,190,456...28,550,166
Ensembl chr12:28,133,249...28,581,511

G

coiled-coil domain containing 97

increases expression

ISO

epoxiconazole results in increased expression of CCDC97 mRNA

NCBI chr19:41,310,172...41,324,873
Ensembl chr19:41,310,172...41,324,873

G

C-C motif chemokine ligand 13

increases expression

ISO

epoxiconazole results in increased expression of CCL12 mRNA

NCBI chr17:34,356,480...34,358,610
Ensembl chr17:34,356,480...34,358,610

G

C-C motif chemokine ligand 23

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of CCL9 mRNA
epoxiconazole results in decreased expression of CCL9 mRNA

PMID:22334560 PMID:35436446

NCBI chr17:36,013,058...36,017,972
Ensembl chr17:36,013,056...36,017,972

G

C-C motif chemokine ligand 26

increases expression

ISO

epoxiconazole results in increased expression of CCL26 mRNA

NCBI chr 7:75,769,524...75,791,597
Ensembl chr 7:75,769,533...75,789,896

G

C-C motif chemokine ligand 3

increases expression

ISO

epoxiconazole results in increased expression of CCL3 mRNA

NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169

G

cellular communication network factor 6

decreases expression

ISO

epoxiconazole results in decreased expression of CCN6 mRNA

NCBI chr 6:112,052,813...112,069,686
Ensembl chr 6:112,054,075...112,069,686

G

cyclin D2

increases expression

ISO

epoxiconazole results in increased expression of CCND2 mRNA

NCBI chr12:4,273,762...4,305,353
Ensembl chr12:4,269,771...4,306,933

G

cyclin E1

decreases expression

ISO

epoxiconazole results in decreased expression of CCNE1 mRNA

NCBI chr19:29,811,991...29,824,312
Ensembl chr19:29,811,471...29,824,313

G

cyclin E2

affects expression

ISO

epoxiconazole affects the expression of CCNE2 mRNA

NCBI chr 8:94,880,224...94,896,693
Ensembl chr 8:94,879,641...94,896,678

G

cyclin G2

increases expression

ISO

epoxiconazole results in increased expression of CCNG2 mRNA

NCBI chr 4:77,157,207...77,170,060
Ensembl chr 4:77,157,207...77,433,388

G

cyclin J

decreases expression

ISO

epoxiconazole results in decreased expression of CCNJ mRNA

NCBI chr10:96,043,068...96,060,870
Ensembl chr10:96,043,394...96,060,870

G

cyclin T1

decreases expression

ISO

epoxiconazole results in decreased expression of CCNT1 mRNA

NCBI chr12:48,688,458...48,716,707
Ensembl chr12:48,688,458...48,716,998

G

cyclin Y like 1

decreases expression

ISO

epoxiconazole results in decreased expression of CCNYL1 mRNA

NCBI chr 2:207,711,640...207,756,174
Ensembl chr 2:207,711,524...207,761,839

G

C-C motif chemokine receptor 3

increases expression

ISO

epoxiconazole results in increased expression of CCR3 mRNA

NCBI chr 3:46,210,696...46,266,706
Ensembl chr 3:46,130,890...46,266,706

G

C-C motif chemokine receptor 8

increases expression

ISO

epoxiconazole results in increased expression of CCR8 mRNA

NCBI chr 3:39,329,709...39,333,680
Ensembl chr 3:39,329,709...39,336,269

G

centriole, cilia and spindle associated protein

increases expression

ISO

epoxiconazole results in increased expression of CCSAP mRNA

NCBI chr 1:229,321,015...229,343,047
Ensembl chr 1:229,321,011...229,343,294

G

chaperonin containing TCP1 subunit 2

decreases expression

ISO

epoxiconazole results in decreased expression of CCT2 mRNA

NCBI chr12:69,585,459...69,601,570
Ensembl chr12:69,585,423...69,601,577

G

chaperonin containing TCP1 subunit 8

increases expression

ISO

epoxiconazole results in increased expression of CCT8 mRNA

NCBI chr21:29,056,326...29,073,648
Ensembl chr21:29,055,805...29,073,797

G

CD14 molecule

decreases expression

ISO

epoxiconazole results in decreased expression of CD14 mRNA

NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700

G

CD180 molecule

affects expression

ISO

epoxiconazole affects the expression of CD180 mRNA

NCBI chr 5:67,179,613...67,196,799
Ensembl chr 5:67,179,613...67,196,799

G

CD276 molecule

affects expression

ISO

epoxiconazole affects the expression of CD276 mRNA

NCBI chr15:73,683,944...73,714,514
Ensembl chr15:73,683,966...73,714,518

G

CD2 cytoplasmic tail binding protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of CD2BP2 mRNA

NCBI chr16:30,350,773...30,355,308
Ensembl chr16:30,350,767...30,355,308

G

CD300 molecule like family member f

increases expression

ISO

epoxiconazole results in increased expression of CD300LF mRNA

NCBI chr17:74,694,317...74,712,923
Ensembl chr17:74,694,308...74,712,981

G

CD302 molecule

increases expression

ISO

epoxiconazole results in increased expression of CD302 mRNA

NCBI chr 2:159,768,628...159,798,208
Ensembl chr 2:159,768,628...159,798,255

G

CD36 molecule (CD36 blood group)

increases expression
multiple interactions

ISO

epoxiconazole results in increased expression of CD36 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CD36 mRNA

PMID:22334560 PMID:29038839

NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,532...80,679,277

G

CD4 molecule

increases expression

ISO

epoxiconazole results in increased expression of CD4 mRNA

NCBI chr12:6,789,528...6,820,799
Ensembl chr12:6,786,858...6,820,807

G

CD40 molecule

increases expression

ISO

epoxiconazole results in increased expression of CD40 mRNA

NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,249...46,129,872

G

CD44 molecule (IN blood group)

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CD44 mRNA

NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402

G

CD53 molecule

increases expression

ISO

epoxiconazole results in increased expression of CD53 mRNA

NCBI chr 1:110,871,210...110,899,922
Ensembl chr 1:110,871,176...110,899,936

G

CD81 molecule

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CD81 mRNA

NCBI chr11:2,376,180...2,397,397
Ensembl chr11:2,376,166...2,397,802

G

CD82 molecule

decreases expression

ISO

epoxiconazole results in decreased expression of CD82 mRNA

NCBI chr11:44,564,409...44,620,358
Ensembl chr11:44,564,414...44,620,924

G

CD84 molecule

increases expression

ISO

epoxiconazole results in increased expression of CD84 mRNA

NCBI chr 1:160,541,098...160,579,496
Ensembl chr 1:160,541,095...160,579,516

G

CD99 molecule (Xg blood group)

decreases expression

ISO

epoxiconazole results in decreased expression of CD99 mRNA

NCBI chr  X:2,691,295...2,741,309
NCBI chr  Y:2,691,295...2,741,309
Ensembl chr  Y:2,690,988...2,741,312
Ensembl chr  X:2,690,988...2,741,312

G

cytidine deaminase

affects expression

ISO

epoxiconazole affects the expression of CDA mRNA

NCBI chr 1:20,589,097...20,618,903
Ensembl chr 1:20,588,932...20,618,908

G

cell division cycle 14B

affects expression

ISO

epoxiconazole affects the expression of CDC14B mRNA

NCBI chr 9:96,490,939...96,619,843
Ensembl chr 9:96,490,241...96,619,855

G

cell division cycle 25C

decreases expression

ISO

epoxiconazole results in decreased expression of CDC25C mRNA

NCBI chr 5:138,285,265...138,338,355
Ensembl chr 5:138,285,251...138,338,355

G

cell division cycle 34, ubiqiutin conjugating enzyme

increases expression

ISO

epoxiconazole results in increased expression of CDC34 mRNA

NCBI chr19:531,760...542,087
Ensembl chr19:531,721...542,092

G

cell division cycle 37, HSP90 cochaperone

decreases expression

ISO

epoxiconazole results in decreased expression of CDC37 mRNA

NCBI chr19:10,391,133...10,403,542
Ensembl chr19:10,391,090...10,420,185

G

cell division cycle 40

decreases expression

ISO

epoxiconazole results in decreased expression of CDC40 mRNA

NCBI chr 6:110,180,427...110,232,232
Ensembl chr 6:110,180,141...110,254,275

G

CDC42 effector protein 4

decreases expression

ISO

epoxiconazole results in decreased expression of CDC42EP4 mRNA

NCBI chr17:73,283,624...73,312,001
Ensembl chr17:73,283,624...73,312,005

G

CUB domain containing protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of CDCP1 mRNA

NCBI chr 3:45,082,277...45,146,482
Ensembl chr 3:45,082,277...45,146,453

G

cadherin 1

decreases expression

ISO

epoxiconazole results in decreased expression of CDH1 mRNA

NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,540

G

cadherin 20

decreases expression

ISO

epoxiconazole results in decreased expression of CDH20 mRNA

NCBI chr18:61,333,430...61,555,779
Ensembl chr18:61,333,430...61,555,779

G

cadherin 22

decreases expression

ISO

epoxiconazole results in decreased expression of CDH22 mRNA

NCBI chr20:46,173,739...46,308,498
Ensembl chr20:46,173,737...46,309,009

G

cadherin related 23

decreases expression

ISO

epoxiconazole results in decreased expression of CDH23 mRNA

NCBI chr10:71,396,920...71,815,947
Ensembl chr10:71,396,920...71,815,947

G

cadherin 24

decreases expression

ISO

epoxiconazole results in decreased expression of CDH24 mRNA

NCBI chr14:23,047,067...23,057,520
Ensembl chr14:23,047,062...23,057,538

G

cadherin 5

increases expression

ISO

epoxiconazole results in increased expression of CDH5 mRNA

NCBI chr16:66,366,691...66,404,784
Ensembl chr16:66,366,636...66,404,784

G

cadherin related family member 4

decreases expression

ISO

epoxiconazole results in decreased expression of CDHR4 mRNA

NCBI chr 3:49,790,732...49,802,914
Ensembl chr 3:49,790,732...49,799,873

G

cadherin related family member 5

decreases expression

ISO

epoxiconazole results in decreased expression of CDHR5 mRNA

NCBI chr11:616,583...624,955
Ensembl chr11:616,405...626,078

G

cell death inducing p53 target 1

decreases expression

ISO

epoxiconazole results in decreased expression of CDIP1 mRNA

NCBI chr16:4,510,669...4,538,773
Ensembl chr16:4,510,619...4,538,828

G

cyclin dependent kinase 14

increases expression

ISO

epoxiconazole results in increased expression of CDK14 mRNA

NCBI chr 7:90,596,321...91,210,590
Ensembl chr 7:90,466,424...91,210,590

G

cyclin dependent kinase 18

decreases expression

ISO

epoxiconazole results in decreased expression of CDK18 mRNA

NCBI chr 1:205,504,669...205,532,790
Ensembl chr 1:205,504,561...205,532,976

G

cyclin dependent kinase 6

decreases expression

ISO

epoxiconazole results in decreased expression of CDK6 mRNA

NCBI chr 7:92,604,921...92,836,573
Ensembl chr 7:92,604,921...92,836,591

G

cyclin dependent kinase 7

increases expression

ISO

epoxiconazole results in increased expression of CDK7 mRNA

NCBI chr 5:69,234,795...69,277,430
Ensembl chr 5:69,234,795...69,277,430

G

cyclin dependent kinase inhibitor 1A

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in decreased expression of CDKN1A mRNA; [cyproconazole co-treated with epoxiconazole] results in decreased expression of CDKN1A mRNA

NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,441...36,687,397

G

cyclin dependent kinase inhibitor 1B

decreases expression

ISO

epoxiconazole results in decreased expression of CDKN1B mRNA

NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,373

G

cerebral dopamine neurotrophic factor

increases expression

ISO

epoxiconazole results in increased expression of CDNF mRNA

NCBI chr10:14,819,245...14,838,037
Ensembl chr10:14,818,270...14,838,575

G

CDP-diacylglycerol synthase 2

increases expression

ISO

epoxiconazole results in increased expression of CDS2 mRNA

NCBI chr20:5,127,008...5,197,887
Ensembl chr20:5,126,879...5,197,887

G

CEA cell adhesion molecule 18

increases expression

ISO

epoxiconazole results in increased expression of CEACAM18 mRNA

NCBI chr19:51,478,539...51,491,301
Ensembl chr19:51,478,539...51,491,301

G

CCAAT enhancer binding protein alpha

increases expression

ISO

epoxiconazole results in increased expression of CEBPA mRNA

NCBI chr19:33,299,934...33,302,534
Ensembl chr19:33,299,934...33,302,534

G

CCAAT enhancer binding protein delta

decreases expression

ISO

epoxiconazole results in decreased expression of CEBPD mRNA

NCBI chr 8:47,736,913...47,738,164
Ensembl chr 8:47,736,913...47,738,164

G

CCAAT enhancer binding protein zeta

decreases expression

ISO

epoxiconazole results in decreased expression of CEBPZ mRNA

NCBI chr 2:37,201,612...37,231,596
Ensembl chr 2:37,201,570...37,231,601

G

CECR2 histone acetyl-lysine reader

increases expression

ISO

epoxiconazole results in increased expression of CECR2 mRNA

NCBI chr22:17,359,949...17,558,151
Ensembl chr22:17,359,949...17,558,151

G

chymotrypsin like elastase 1

increases expression

ISO

epoxiconazole results in increased expression of CELA1 mRNA

NCBI chr12:51,328,442...51,346,679
Ensembl chr12:51,328,442...51,346,679

G

cell migration inducing hyaluronidase 2

decreases expression

ISO

epoxiconazole results in decreased expression of CEMIP2 mRNA

NCBI chr 9:71,683,366...71,769,466
Ensembl chr 9:71,683,364...71,816,690

G

centromere protein C

decreases expression

ISO

epoxiconazole results in decreased expression of CENPC1 mRNA

NCBI chr 4:67,468,762...67,545,503
Ensembl chr 4:67,468,762...67,545,563

G

centromere protein U

affects expression

ISO

epoxiconazole affects the expression of CENPU mRNA

NCBI chr 4:184,694,085...184,734,096
Ensembl chr 4:184,694,085...184,734,130

G

centrosomal protein 120

decreases expression

ISO

epoxiconazole results in decreased expression of CEP120 mRNA

NCBI chr 5:123,344,892...123,423,842
Ensembl chr 5:123,344,890...123,423,592

G

centrosomal protein 192

decreases expression

ISO

epoxiconazole results in decreased expression of CEP192 mRNA

NCBI chr18:12,991,362...13,125,036
Ensembl chr18:12,991,315...13,125,053

G

centrosomal protein 250

increases expression

ISO

epoxiconazole results in increased expression of CEP250 mRNA

NCBI chr20:35,455,165...35,519,280
Ensembl chr20:35,455,164...35,519,280

G

centrosomal protein 295

increases expression

ISO

epoxiconazole results in increased expression of CEP295 mRNA

NCBI chr11:93,661,682...93,730,358
Ensembl chr11:93,661,682...93,730,358

G

centrosomal protein 41

decreases expression

ISO

epoxiconazole results in decreased expression of CEP41 mRNA

NCBI chr 7:130,393,771...130,441,741
Ensembl chr 7:130,393,771...130,442,433

G

centrosomal protein 63

decreases expression

ISO

epoxiconazole results in decreased expression of CEP63 mRNA

NCBI chr 3:134,485,724...134,782,559
Ensembl chr 3:134,485,699...134,587,789

G

centrosomal protein 70

increases expression

ISO

epoxiconazole results in increased expression of CEP70 mRNA

NCBI chr 3:138,494,344...138,594,260
Ensembl chr 3:138,494,339...138,594,538

G

centrosomal protein 76

decreases expression

ISO

epoxiconazole results in decreased expression of CEP76 mRNA

NCBI chr18:12,661,956...12,702,777
Ensembl chr18:12,661,833...12,702,777

G

ceramide synthase 2

decreases expression

ISO

epoxiconazole results in decreased expression of CERS2 mRNA

NCBI chr 1:150,965,186...150,974,835
Ensembl chr 1:150,960,583...150,977,396

G

ceramide synthase 6

decreases expression

ISO

epoxiconazole results in decreased expression of CERS6 mRNA

NCBI chr 2:168,456,272...168,775,134
Ensembl chr 2:168,456,249...168,775,134

G

carboxylesterase 1

increases expression

ISO

epoxiconazole results in increased expression of CES1D mRNA

NCBI chr16:55,802,851...55,833,096
Ensembl chr16:55,802,845...55,833,337

G

carboxylesterase 2

increases expression

ISO

epoxiconazole results in increased expression of CES2 mRNA; epoxiconazole results in increased expression of CES2H mRNA

PMID:22334560 PMID:35436446

NCBI chr16:66,934,471...66,945,096
Ensembl chr16:66,934,444...66,945,096

G

carboxylesterase 3

affects expression

ISO

epoxiconazole affects the expression of CES3B mRNA

NCBI chr16:66,961,266...66,975,149
Ensembl chr16:66,961,245...66,975,149

G

carboxylesterase 4A

decreases expression

ISO

epoxiconazole results in decreased expression of CES4A mRNA

NCBI chr16:66,988,589...67,010,417
Ensembl chr16:66,988,585...67,010,417

G

centrin 3

increases expression

ISO

epoxiconazole results in increased expression of CETN3 mRNA

NCBI chr 5:90,392,257...90,409,756
Ensembl chr 5:90,392,257...90,409,786

G

centrin 4, pseudogene

increases expression

ISO

epoxiconazole results in increased expression of CETN4 mRNA

NCBI chr 4:122,730,189...122,732,458
Ensembl chr 4:122,730,548...122,732,193

G

cilia and flagella associated protein 107

decreases expression

ISO

epoxiconazole results in decreased expression of CFAP107 mRNA

NCBI chr 1:12,746,200...12,763,699
Ensembl chr 1:12,746,200...12,763,699

G

cilia and flagella associated protein 36

decreases expression

ISO

epoxiconazole results in decreased expression of CFAP36 mRNA

NCBI chr 2:55,519,718...55,545,079
Ensembl chr 2:55,519,559...55,545,080

G

cilia and flagella associated protein 52

increases expression

ISO

epoxiconazole results in increased expression of CFAP52 mRNA

NCBI chr17:9,576,642...9,645,554
Ensembl chr17:9,576,627...9,643,447

G

cilia and flagella associated protein 54

decreases expression

ISO

epoxiconazole results in decreased expression of CFAP54 mRNA

NCBI chr12:96,489,577...96,875,555
Ensembl chr12:96,489,571...96,875,555

G

cilia and flagella associated protein 65

increases expression

ISO

epoxiconazole results in increased expression of CFAP65 mRNA

NCBI chr 2:219,002,846...219,041,551
Ensembl chr 2:219,002,846...219,041,527

G

cilia and flagella associated protein 97

decreases expression

ISO

epoxiconazole results in decreased expression of CFAP97 mRNA

NCBI chr 4:185,159,665...185,210,248
Ensembl chr 4:185,159,665...185,210,815

G

craniofacial development protein 1

increases expression

ISO

epoxiconazole results in increased expression of CFDP1 mRNA

NCBI chr16:75,293,710...75,433,503
Ensembl chr16:75,293,698...75,433,503

G

CASP8 and FADD like apoptosis regulator

decreases expression

ISO

epoxiconazole results in decreased expression of CFLAR mRNA

NCBI chr 2:201,116,164...201,176,687
Ensembl chr 2:201,116,154...201,176,687

G

CGG triplet repeat binding protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of CGGBP1 mRNA

NCBI chr 3:88,051,950...88,149,870
Ensembl chr 3:88,051,944...88,149,885

G

cingulin like 1

decreases expression

ISO

epoxiconazole results in decreased expression of CGNL1 mRNA

NCBI chr15:57,376,505...57,550,717
Ensembl chr15:57,375,967...57,550,729

G

chromatin assembly factor 1 subunit B

decreases expression

ISO

epoxiconazole results in decreased expression of CHAF1B mRNA

NCBI chr21:36,385,392...36,419,015
Ensembl chr21:36,385,354...36,419,015

G

coiled-coil-helix-coiled-coil-helix domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of CHCHD1 mRNA

NCBI chr10:73,782,048...73,783,652
Ensembl chr10:73,782,047...73,783,652

G

coiled-coil-helix-coiled-coil-helix domain containing 10

increases expression

ISO

epoxiconazole results in increased expression of CHCHD10 mRNA

NCBI chr22:23,765,834...23,767,972
Ensembl chr22:23,765,834...23,767,982

G

coiled-coil-helix-coiled-coil-helix domain containing 5

decreases expression

ISO

epoxiconazole results in decreased expression of CHCHD5 mRNA

NCBI chr 2:112,584,447...112,589,040
Ensembl chr 2:112,584,240...112,589,275

G

coiled-coil-helix-coiled-coil-helix domain containing 7

increases expression

ISO

epoxiconazole results in increased expression of CHCHD7 mRNA

NCBI chr 8:56,211,789...56,218,809
Ensembl chr 8:56,211,686...56,218,809

G

chromodomain helicase DNA binding protein 1 like

increases expression

ISO

epoxiconazole results in increased expression of CHD1L mRNA

NCBI chr 1:147,172,747...147,295,762
Ensembl chr 1:147,242,643...147,295,767

G

chromodomain helicase DNA binding protein 7

decreases expression

ISO

epoxiconazole results in decreased expression of CHD7 mRNA

NCBI chr 8:60,678,740...60,868,028
Ensembl chr 8:60,678,740...60,868,028

G

chromodomain helicase DNA binding protein 8

decreases expression

ISO

epoxiconazole results in decreased expression of CHD8 mRNA

NCBI chr14:21,385,199...21,456,123
Ensembl chr14:21,385,194...21,456,126

G

chromodomain helicase DNA binding protein 9

decreases expression

ISO

epoxiconazole results in decreased expression of CHD9 mRNA

NCBI chr16:53,054,991...53,327,497
Ensembl chr16:53,054,991...53,329,150

G

choline dehydrogenase

decreases expression

ISO

epoxiconazole results in decreased expression of CHDH mRNA

NCBI chr 3:53,812,335...53,846,419
Ensembl chr 3:53,812,335...53,846,466

G

checkpoint kinase 1

increases expression

ISO

epoxiconazole results in increased expression of CHEK1 mRNA

NCBI chr11:125,625,136...125,681,124
Ensembl chr11:125,625,163...125,676,255

G

chromogranin A

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CHGA mRNA

NCBI chr14:92,922,664...92,935,285
Ensembl chr14:92,922,630...92,935,293

G

choline kinase alpha

decreases expression

ISO

epoxiconazole results in decreased expression of CHKA mRNA

PMID:22334560 PMID:23970803

NCBI chr11:68,052,859...68,121,388
Ensembl chr11:68,052,859...68,121,444

G

choline kinase beta

decreases expression

ISO

epoxiconazole results in decreased expression of CHKB mRNA

NCBI chr22:50,578,963...50,582,849
Ensembl chr22:50,578,959...50,601,455

G

charged multivesicular body protein 2B

increases expression

ISO

epoxiconazole results in increased expression of CHMP2B mRNA

NCBI chr 3:87,227,309...87,255,556
Ensembl chr 3:87,227,271...87,255,556

G

charged multivesicular body protein 4C

decreases expression

ISO

epoxiconazole results in decreased expression of CHMP4C mRNA

NCBI chr 8:81,732,448...81,759,515
Ensembl chr 8:81,732,448...81,759,515

G

charged multivesicular body protein 5

increases expression

ISO

epoxiconazole results in increased expression of CHMP5 mRNA

NCBI chr 9:33,265,049...33,282,070
Ensembl chr 9:33,264,017...33,282,071

G

charged multivesicular body protein 6

decreases expression

ISO

epoxiconazole results in decreased expression of CHMP6 mRNA

NCBI chr17:80,991,841...81,000,133
Ensembl chr17:80,991,598...81,009,517

G

chimerin 2

decreases expression

ISO

epoxiconazole results in decreased expression of CHN2 mRNA

NCBI chr 7:29,146,591...29,514,328
Ensembl chr 7:29,146,547...29,514,334

G

calcineurin like EF-hand protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of CHP1 mRNA

NCBI chr15:41,231,268...41,281,887
Ensembl chr15:41,230,824...41,281,888

G

cholinergic receptor nicotinic alpha 2 subunit

decreases expression

ISO

epoxiconazole results in decreased expression of CHRNA2 mRNA

NCBI chr 8:27,459,756...27,479,261
Ensembl chr 8:27,459,756...27,479,883

G

cholinergic receptor nicotinic alpha 4 subunit

decreases expression

ISO

epoxiconazole results in decreased expression of CHRNA4 mRNA

NCBI chr20:63,343,223...63,361,349
Ensembl chr20:63,343,223...63,378,401

G

cholinergic receptor nicotinic alpha 7 subunit

decreases expression

ISO

epoxiconazole results in decreased expression of CHRNA7 mRNA

NCBI chr15:32,030,483...32,173,018
Ensembl chr15:31,923,438...32,173,018

G

cholinergic receptor nicotinic beta 1 subunit

decreases expression

ISO

epoxiconazole results in decreased expression of CHRNB1 mRNA

NCBI chr17:7,445,061...7,457,710
Ensembl chr17:7,445,061...7,457,710

G

carbohydrate sulfotransferase 1

decreases expression

ISO

epoxiconazole results in decreased expression of CHST1 mRNA

NCBI chr11:45,647,689...45,665,622
Ensembl chr11:45,647,689...45,666,096

G

carbohydrate sulfotransferase 15

decreases expression

ISO

epoxiconazole results in decreased expression of CHST15 mRNA

NCBI chr10:124,007,668...124,093,598
Ensembl chr10:124,007,668...124,093,698

G

carbohydrate sulfotransferase 8

increases expression

ISO

epoxiconazole results in increased expression of CHST8 mRNA

NCBI chr19:33,621,953...33,773,509
Ensembl chr19:33,621,942...33,773,509

G

cytosolic iron-sulfur assembly component 1

decreases expression

ISO

epoxiconazole results in decreased expression of CIAO1 mRNA

NCBI chr 2:96,266,225...96,274,173
Ensembl chr 2:96,266,159...96,274,173

G

circadian associated repressor of transcription

affects expression

ISO

epoxiconazole affects the expression of CIART mRNA

NCBI chr 1:150,282,554...150,287,093
Ensembl chr 1:150,282,543...150,287,093

G

calcium and integrin binding family member 2

increases expression

ISO

epoxiconazole results in increased expression of CIB2 mRNA

NCBI chr15:78,104,606...78,131,535
Ensembl chr15:78,104,606...78,131,535

G

CBY1 interacting BAR domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of CIBAR1 mRNA

NCBI chr 8:93,700,550...93,731,527
Ensembl chr 8:93,698,561...93,731,527

G

capicua transcriptional repressor

decreases expression

ISO

epoxiconazole results in decreased expression of CIC mRNA

NCBI chr19:42,268,530...42,295,796
Ensembl chr19:42,268,537...42,295,801

G

cell death inducing DFFA like effector b

decreases expression

ISO

epoxiconazole results in decreased expression of CIDEB mRNA

NCBI chr14:24,305,187...24,311,435
Ensembl chr14:24,305,187...24,311,440

G

ciliary microtubule associated protein 1B

increases expression

ISO

epoxiconazole results in increased expression of CIMAP1B mRNA

NCBI chr22:50,530,426...50,532,498
Ensembl chr22:50,529,710...50,532,520

G

CIMAP1 family member D

decreases expression

ISO

epoxiconazole results in decreased expression of CIMAP1D mRNA

NCBI chr19:463,361...491,624
Ensembl chr19:463,346...474,983

G

ciliary microtubule inner protein 4

decreases expression

ISO

epoxiconazole results in decreased expression of CIMIP4 mRNA

NCBI chr22:36,991,125...37,007,851
Ensembl chr22:36,991,120...37,007,851

G

cold inducible RNA binding protein

decreases expression

ISO

epoxiconazole results in decreased expression of CIRBP mRNA

NCBI chr19:1,269,332...1,274,880
Ensembl chr19:1,259,384...1,274,880

G

CDGSH iron sulfur domain 1

increases expression

ISO

epoxiconazole results in increased expression of CISD1 mRNA

NCBI chr10:58,269,162...58,289,586
Ensembl chr10:58,269,151...58,289,586

G

CDGSH iron sulfur domain 3

increases expression

ISO

epoxiconazole results in increased expression of CISD3 mRNA

NCBI chr17:38,730,341...38,735,605
Ensembl chr17:38,730,318...38,735,605

G

cytokine inducible SH2 containing protein

decreases expression

ISO

epoxiconazole results in decreased expression of CISH mRNA

NCBI chr 3:50,606,489...50,611,774
Ensembl chr 3:50,606,456...50,611,774

G

citron rho-interacting serine/threonine kinase

increases expression

ISO

epoxiconazole results in increased expression of CIT mRNA

NCBI chr12:119,685,791...119,877,320
Ensembl chr12:119,685,791...119,877,332

G

Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2

increases expression

ISO

epoxiconazole results in increased expression of CITED2 mRNA

NCBI chr 6:139,371,807...139,374,648
Ensembl chr 6:139,371,807...139,375,909

G

cytoskeleton associated protein 2 like

decreases expression

ISO

epoxiconazole results in decreased expression of CKAP2L mRNA

NCBI chr 2:112,736,349...112,764,609
Ensembl chr 2:112,736,349...112,764,664

G

chemokine like factor

decreases expression

ISO

epoxiconazole results in decreased expression of CKLF mRNA

NCBI chr16:66,552,563...66,566,287
Ensembl chr16:66,552,563...66,566,251

G

cytoplasmic linker associated protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of CLASP1 mRNA

NCBI chr 2:121,337,776...121,649,462
Ensembl chr 2:121,337,776...121,649,599

G

chloride voltage-gated channel 4

decreases expression

ISO

epoxiconazole results in decreased expression of CLCN4 mRNA

NCBI chr X:10,156,975...10,237,660
Ensembl chr X:10,156,943...10,237,660

G

chloride voltage-gated channel 6

affects expression

ISO

epoxiconazole affects the expression of CLCN6 mRNA

NCBI chr 1:11,806,191...11,843,130
Ensembl chr 1:11,806,096...11,848,079

G

claudin 1

increases expression
affects expression

ISO

epoxiconazole results in increased expression of CLDN1 mRNA
epoxiconazole affects the expression of CLDN1 mRNA

NCBI chr 3:190,305,707...190,322,446
Ensembl chr 3:190,305,707...190,322,446

G

claudin 12

decreases expression

ISO

epoxiconazole results in decreased expression of CLDN12 mRNA

NCBI chr 7:90,403,461...90,415,954
Ensembl chr 7:90,383,721...90,513,402

G

claudin 2

decreases expression

ISO

epoxiconazole results in decreased expression of CLDN2 mRNA

NCBI chr X:106,900,164...106,930,861
Ensembl chr X:106,900,125...106,930,862

G

claudin 3

increases expression

ISO

epoxiconazole results in increased expression of CLDN3 mRNA

NCBI chr 7:73,768,997...73,770,270
Ensembl chr 7:73,768,997...73,770,270

G

claudin 34

decreases expression

ISO

epoxiconazole results in decreased expression of CLDN34B4 mRNA

NCBI chr X:9,967,358...9,968,352
Ensembl chr X:9,961,424...9,968,352

G

C-type lectin domain containing 10A

decreases expression

ISO

epoxiconazole results in decreased expression of CLEC10A mRNA

NCBI chr17:7,074,537...7,080,251
Ensembl chr17:7,074,537...7,081,166

G

C-type lectin domain family 12 member B

increases expression

ISO

epoxiconazole results in increased expression of CLEC12B mRNA

NCBI chr12:10,006,209...10,018,800
Ensembl chr12:10,010,627...10,018,796

G

C-type lectin domain family 2 member D

affects expression

ISO

epoxiconazole affects the expression of CLEC2H mRNA

NCBI chr12:9,669,713...9,699,553
Ensembl chr12:9,664,969...9,699,553

G

C-type lectin domain family 4 member A

increases expression

ISO

epoxiconazole results in increased expression of CLEC4A3 mRNA

NCBI chr12:8,102,907...8,138,607
Ensembl chr12:8,123,617...8,138,607

G

C-type lectin domain containing 6A

increases expression

ISO

epoxiconazole results in increased expression of CLEC4N mRNA

NCBI chr12:8,455,962...8,478,330
Ensembl chr12:8,455,962...8,478,330

G

C-type lectin domain containing 7A

increases expression

ISO

epoxiconazole results in increased expression of CLEC7A mRNA

NCBI chr12:10,116,777...10,130,304
Ensembl chr12:10,116,777...10,130,258

G

C-type lectin domain containing 9A

decreases expression

ISO

epoxiconazole results in decreased expression of CLEC9A mRNA

NCBI chr12:10,030,682...10,066,031
Ensembl chr12:10,030,678...10,066,031

G

clathrin interactor 1

decreases expression

ISO

epoxiconazole results in decreased expression of CLINT1 mRNA

NCBI chr 5:157,785,747...157,859,145
Ensembl chr 5:157,785,743...157,859,169

G

CDC like kinase 1

increases expression

ISO

epoxiconazole results in increased expression of CLK1 mRNA

NCBI chr 2:200,853,009...200,864,658
Ensembl chr 2:200,853,009...200,864,697

G

calmin

decreases expression

ISO

epoxiconazole results in decreased expression of CLMN mRNA

NCBI chr14:95,181,940...95,319,908
Ensembl chr14:95,181,940...95,319,921

G

CLN3 lysosomal/endosomal transmembrane protein, battenin

decreases expression

ISO

epoxiconazole results in decreased expression of CLN3 mRNA

NCBI chr16:28,466,653...28,492,082
Ensembl chr16:28,474,111...28,495,575

G

CLN6 transmembrane ER protein

increases expression

ISO

epoxiconazole results in increased expression of CLN6 mRNA

NCBI chr15:68,206,992...68,257,211
Ensembl chr15:68,206,992...68,257,211

G

CLN8 transmembrane ER and ERGIC protein

decreases expression

ISO

epoxiconazole results in decreased expression of CLN8 mRNA

NCBI chr 8:1,753,059...1,786,570
Ensembl chr 8:1,755,778...1,801,711

G

clock circadian regulator

affects expression

ISO

epoxiconazole affects the expression of CLOCK mRNA

NCBI chr 4:55,427,903...55,546,909
Ensembl chr 4:55,427,903...55,547,491

G

caseinolytic mitochondrial matrix peptidase chaperone subunit X

affects expression

ISO

epoxiconazole affects the expression of CLPX mRNA

NCBI chr15:65,148,219...65,185,342
Ensembl chr15:65,148,219...65,185,393

G

calsyntenin 1

increases expression

ISO

epoxiconazole results in increased expression of CLSTN1 mRNA

NCBI chr 1:9,728,926...9,824,526
Ensembl chr 1:9,728,926...9,823,993

G

clustered mitochondria homolog

decreases expression

ISO

epoxiconazole results in decreased expression of CLUH mRNA

NCBI chr17:2,689,387...2,712,020
Ensembl chr17:2,689,386...2,712,663

G

cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene

decreases expression

ISO

epoxiconazole results in decreased expression of CMAH mRNA

PMID:22334560 PMID:35436446

NCBI chr 6:25,081,067...25,138,392
Ensembl chr 6:25,081,862...25,138,081
Ensembl chr 6:25,081,862...25,138,081

G

c-Maf inducing protein

affects expression

ISO

epoxiconazole affects the expression of CMIP mRNA

NCBI chr16:81,444,808...81,711,762
Ensembl chr16:81,444,808...81,711,762

G

CKLF like MARVEL transmembrane domain containing 8

decreases expression

ISO

epoxiconazole results in decreased expression of CMTM8 mRNA

NCBI chr 3:32,238,192...32,370,321
Ensembl chr 3:32,237,207...32,370,699

G

cap methyltransferase 1

decreases expression

ISO

epoxiconazole results in decreased expression of CMTR1 mRNA

NCBI chr 6:37,423,985...37,481,508
Ensembl chr 6:37,433,094...37,482,827

G

cap methyltransferase 2

increases expression

ISO

epoxiconazole results in increased expression of CMTR2 mRNA

NCBI chr16:71,281,392...71,289,722
Ensembl chr16:71,281,389...71,289,715

G

cyclic nucleotide binding domain containing 2

increases expression

ISO

epoxiconazole results in increased expression of CNBD2 mRNA

NCBI chr20:35,954,386...36,030,700
Ensembl chr20:35,954,564...36,030,700

G

cornichon family member 1

increases expression

ISO

epoxiconazole results in increased expression of CNIH1 mRNA

NCBI chr14:54,423,561...54,441,374
Ensembl chr14:54,423,561...54,441,439

G

cornichon family member 4

increases expression

ISO

epoxiconazole results in increased expression of CNIH4 mRNA

NCBI chr 1:224,356,803...224,379,452
Ensembl chr 1:224,356,858...224,379,459

G

connector enhancer of kinase suppressor of Ras 2

increases expression

ISO

epoxiconazole results in increased expression of CNKSR2 mRNA

NCBI chr X:21,374,418...21,654,689
Ensembl chr X:21,372,801...21,654,695

G

calponin 3

decreases expression

ISO

epoxiconazole results in decreased expression of CNN3 mRNA

NCBI chr 1:94,896,957...94,927,110
Ensembl chr 1:94,896,949...94,927,696

G

cyclin and CBS domain divalent metal cation transport mediator 3

increases expression

ISO

epoxiconazole results in increased expression of CNNM3 mRNA

NCBI chr 2:96,816,268...96,837,466
Ensembl chr 2:96,816,245...96,835,382

G

cyclin and CBS domain divalent metal cation transport mediator 4

decreases expression

ISO

epoxiconazole results in decreased expression of CNNM4 mRNA

NCBI chr 2:96,760,902...96,811,874
Ensembl chr 2:96,760,898...96,811,888

G

CCR4-NOT transcription complex subunit 8

decreases expression

ISO

epoxiconazole results in decreased expression of CNOT8 mRNA

NCBI chr 5:154,858,249...154,876,792
Ensembl chr 5:154,857,529...154,876,793

G

centlein

decreases expression

ISO

epoxiconazole results in decreased expression of CNTLN mRNA

NCBI chr 9:17,135,040...17,528,634
Ensembl chr 9:17,134,982...17,503,923

G

contactin 6

increases expression

ISO

epoxiconazole results in increased expression of CNTN6 mRNA

NCBI chr 3:1,093,024...1,404,217
Ensembl chr 3:1,092,658...1,404,217

G

cytochrome c oxidase assembly factor 6

increases expression

ISO

epoxiconazole results in increased expression of COA6 mRNA

NCBI chr 1:234,373,456...234,385,080
Ensembl chr 1:234,373,456...234,385,080

G

Coenzyme A synthase

decreases expression

ISO

epoxiconazole results in decreased expression of COASY mRNA

NCBI chr17:42,562,148...42,566,277
Ensembl chr17:42,561,467...42,566,277

G

cochlin

increases expression

ISO

epoxiconazole results in increased expression of COCH mRNA

NCBI chr14:30,874,559...30,895,615
Ensembl chr14:30,874,438...30,895,065

G

component of oligomeric golgi complex 2

decreases expression

ISO

epoxiconazole results in decreased expression of COG2 mRNA

NCBI chr 1:230,642,481...230,693,982
Ensembl chr 1:230,642,464...230,693,985

G

component of oligomeric golgi complex 4

decreases expression

ISO

epoxiconazole results in decreased expression of COG4 mRNA

NCBI chr16:70,480,567...70,523,554
Ensembl chr16:70,480,568...70,523,560

G

collagen type XII alpha 1 chain

increases expression

ISO

epoxiconazole results in increased expression of COL12A1 mRNA

NCBI chr 6:75,084,326...75,206,053
Ensembl chr 6:75,084,326...75,206,267

G

collagen type XIII alpha 1 chain

increases expression

ISO

epoxiconazole results in increased expression of COL13A1 mRNA

NCBI chr10:69,801,906...69,959,144
Ensembl chr10:69,801,880...69,964,275

G

collagen type XVIII alpha 1 chain

increases expression

ISO

epoxiconazole results in increased expression of COL18A1 mRNA

NCBI chr21:45,405,165...45,513,720
Ensembl chr21:45,405,123...45,513,721

G

collagen type XIX alpha 1 chain

increases expression

ISO

epoxiconazole results in increased expression of COL19A1 mRNA

NCBI chr 6:69,866,556...70,212,468
Ensembl chr 6:69,866,556...70,212,468

G

collagen type XXIII alpha 1 chain

increases expression

ISO

epoxiconazole results in increased expression of COL23A1 mRNA

NCBI chr 5:178,237,618...178,590,393
Ensembl chr 5:178,237,476...178,590,393

G

collagen type XXIV alpha 1 chain

increases expression

ISO

epoxiconazole results in increased expression of COL24A1 mRNA

NCBI chr 1:85,729,233...86,156,984
Ensembl chr 1:85,729,233...86,156,943

G

collagen type XXVIII alpha 1 chain

increases expression

ISO

epoxiconazole results in increased expression of COL28A1 mRNA

NCBI chr 7:7,338,194...7,543,870
Ensembl chr 7:7,356,203...7,535,873

G

collagen type II alpha 1 chain

affects expression

ISO

epoxiconazole affects the expression of COL2A1 mRNA

NCBI chr12:47,972,967...48,006,212
Ensembl chr12:47,972,967...48,004,689

G

collagen type IV alpha 6 chain

increases expression

ISO

epoxiconazole results in increased expression of COL4A6 mRNA

NCBI chr X:108,155,614...108,439,458
Ensembl chr X:108,155,607...108,439,497

G

collagen type VI alpha 5 chain

decreases expression

ISO

epoxiconazole results in decreased expression of COL6A5 mRNA

NCBI chr 3:130,345,672...130,484,846
Ensembl chr 3:130,345,516...130,484,846

G

copper metabolism domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of COMMD1 mRNA

NCBI chr 2:61,888,391...62,136,058
Ensembl chr 2:61,888,724...62,147,629

G

COMM domain containing 2

affects expression

ISO

epoxiconazole affects the expression of COMMD2 mRNA

NCBI chr 3:149,738,472...149,752,489
Ensembl chr 3:149,734,667...149,752,495

G

COMM domain containing 4

decreases expression

ISO

epoxiconazole results in decreased expression of COMMD4 mRNA

NCBI chr15:75,336,063...75,343,227
Ensembl chr15:75,336,009...75,343,224

G

COMM domain containing 9

decreases expression

ISO

epoxiconazole results in decreased expression of COMMD9 mRNA

NCBI chr11:36,272,292...36,289,424
Ensembl chr11:36,269,284...36,289,449

G

catechol-O-methyltransferase

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole] results in increased expression of COMT mRNA

NCBI chr22:19,941,772...19,969,975
Ensembl chr22:19,941,371...19,969,975

G

COPI coat complex subunit alpha

decreases expression

ISO

epoxiconazole results in decreased expression of COPA mRNA

NCBI chr 1:160,288,594...160,343,250
Ensembl chr 1:160,288,594...160,343,566

G

COPI coat complex subunit gamma 2

decreases expression

ISO

epoxiconazole results in decreased expression of COPG2 mRNA

NCBI chr 7:130,506,238...130,668,748
Ensembl chr 7:130,506,238...130,668,748

G

COP9 signalosome subunit 2

increases expression

ISO

epoxiconazole results in increased expression of COPS2 mRNA

NCBI chr15:49,122,727...49,155,599
Ensembl chr15:49,106,068...49,155,661

G

COP9 signalosome subunit 3

increases expression

ISO

epoxiconazole results in increased expression of COPS3 mRNA

NCBI chr17:17,246,616...17,281,246
Ensembl chr17:17,246,616...17,281,303

G

COP9 signalosome subunit 7A

decreases expression

ISO

epoxiconazole results in decreased expression of COPS7A mRNA

NCBI chr12:6,724,046...6,731,865
Ensembl chr12:6,724,014...6,731,875

G

COP9 signalosome subunit 9

increases expression

ISO

epoxiconazole results in increased expression of COPS9 mRNA

NCBI chr 2:240,126,548...240,136,347
Ensembl chr 2:240,126,563...240,136,807

G

coenzyme Q10A

increases expression

ISO

epoxiconazole results in increased expression of COQ10A mRNA

NCBI chr12:56,266,942...56,270,966
Ensembl chr12:56,266,846...56,270,966

G

coenzyme Q10B

affects expression

ISO

epoxiconazole affects the expression of COQ10B mRNA

NCBI chr 2:197,453,552...197,475,310
Ensembl chr 2:197,453,493...197,475,310

G

coenzyme Q5, methyltransferase

decreases expression

ISO

epoxiconazole results in decreased expression of COQ5 mRNA

NCBI chr12:120,503,279...120,529,158
Ensembl chr12:120,503,279...120,534,434

G

coenzyme Q8A

decreases expression

ISO

epoxiconazole results in decreased expression of COQ8A mRNA

NCBI chr 1:226,940,294...226,987,544
Ensembl chr 1:226,938,143...226,987,569

G

coenzyme Q8B

decreases expression

ISO

epoxiconazole results in decreased expression of COQ8B mRNA

NCBI chr19:40,691,530...40,716,886
Ensembl chr19:40,691,514...40,725,784

G

corin, serine peptidase

decreases expression

ISO

epoxiconazole results in decreased expression of CORIN mRNA

NCBI chr 4:47,594,001...47,838,067
Ensembl chr 4:47,593,999...47,838,132

G

coronin 7

decreases expression

ISO

epoxiconazole results in decreased expression of CORO7 mRNA

NCBI chr16:4,354,542...4,416,596
Ensembl chr16:4,354,542...4,425,705

G

cytochrome c oxidase assembly homolog COX15

decreases expression

ISO

epoxiconazole results in decreased expression of COX15 mRNA

NCBI chr10:99,694,293...99,732,127
Ensembl chr10:99,710,868...99,732,160

G

cytochrome c oxidase assembly factor COX20

increases expression

ISO

epoxiconazole results in increased expression of COX20 mRNA

NCBI chr 1:244,835,306...244,845,063
Ensembl chr 1:244,835,616...244,845,480

G

cytochrome c oxidase subunit 6B1

increases expression

ISO

epoxiconazole results in increased expression of COX6B1 mRNA

NCBI chr19:35,648,323...35,658,782
Ensembl chr19:35,648,230...35,658,795

G

cytochrome c oxidase subunit 6B2

increases expression

ISO

epoxiconazole results in increased expression of COX6B2 mRNA

NCBI chr19:55,349,704...55,354,719
Ensembl chr19:55,349,306...55,354,719

G

cytochrome c oxidase subunit 7A2

increases expression

ISO

epoxiconazole results in increased expression of COX7A2 mRNA

NCBI chr 6:75,237,675...75,250,298
Ensembl chr 6:75,237,675...75,250,323

G

cytochrome c oxidase subunit 7B

increases expression

ISO

epoxiconazole results in increased expression of COX7B mRNA

NCBI chr X:77,899,468...77,907,376
Ensembl chr X:77,895,727...77,907,376

G

centrosome assembly and centriole elongation protein

decreases expression

ISO

epoxiconazole results in decreased expression of CPAP mRNA

NCBI chr13:24,882,279...24,934,000
Ensembl chr13:24,882,276...24,922,889

G

carboxypeptidase D

decreases expression

ISO

epoxiconazole results in decreased expression of CPD mRNA

NCBI chr17:30,378,927...30,469,989
Ensembl chr17:30,378,922...30,469,989

G

cytoplasmic polyadenylation element binding protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of CPEB1 mRNA

NCBI chr15:82,543,201...82,648,795
Ensembl chr15:82,543,201...82,648,861

G

cytoplasmic polyadenylation element binding protein 2

increases expression

ISO

epoxiconazole results in increased expression of CPEB2 mRNA

NCBI chr 4:15,002,481...15,070,151
Ensembl chr 4:15,002,481...15,070,153

G

cytoplasmic polyadenylation element binding protein 4

increases expression

ISO

epoxiconazole results in increased expression of CPEB4 mRNA

NCBI chr 5:173,888,349...173,961,980
Ensembl chr 5:173,888,349...173,961,980

G

cadherin like and PC-esterase domain containing 1

decreases expression

ISO

epoxiconazole results in decreased expression of CPED1 mRNA

NCBI chr 7:120,988,711...121,297,442
Ensembl chr 7:120,988,697...121,297,980

G

ciliogenesis and planar polarity effector complex subunit 2

increases expression

ISO

epoxiconazole results in increased expression of CPLANE2 mRNA

NCBI chr 1:16,231,692...16,237,183
Ensembl chr 1:16,231,692...16,237,183

G

complexin 3

increases expression

ISO

epoxiconazole results in increased expression of CPLX3 mRNA

NCBI chr15:74,826,627...74,831,802
Ensembl chr15:74,826,627...74,831,802

G

carboxypeptidase N subunit 1

decreases expression

ISO

epoxiconazole results in decreased expression of CPN1 mRNA

NCBI chr10:100,042,193...100,081,869
Ensembl chr10:100,042,193...100,081,907

G

coproporphyrinogen oxidase

decreases expression

ISO

epoxiconazole results in decreased expression of CPOX mRNA

NCBI chr 3:98,570,488...98,593,611
Ensembl chr 3:98,579,446...98,593,707

G

calcineurin like phosphoesterase domain containing 1

decreases expression

ISO

epoxiconazole results in decreased expression of CPPED1 mRNA

NCBI chr16:12,659,799...12,803,887
Ensembl chr16:12,659,799...12,803,887

G

cleavage and polyadenylation specific factor 4

decreases expression

ISO

epoxiconazole results in decreased expression of CPSF4 mRNA

NCBI chr 7:99,438,943...99,457,373
Ensembl chr 7:99,438,908...99,457,377

G

cleavage and polyadenylation specific factor 7

increases expression

ISO

epoxiconazole results in increased expression of CPSF7 mRNA

NCBI chr11:61,402,729...61,429,975
Ensembl chr11:61,402,641...61,430,105

G

carnitine palmitoyltransferase 1A

decreases expression

ISO

epoxiconazole results in decreased expression of CPT1A mRNA

NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410

G

carnitine palmitoyltransferase 2

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CPT2 mRNA

NCBI chr 1:53,196,824...53,214,197
Ensembl chr 1:53,196,792...53,214,197

G

ceramide-1-phosphate transfer protein

decreases expression

ISO

epoxiconazole results in decreased expression of CPTP mRNA

NCBI chr 1:1,324,802...1,328,896
Ensembl chr 1:1,324,756...1,328,897

G

cramped chromatin regulator homolog 1

decreases expression

ISO

epoxiconazole results in decreased expression of CRAMP1 mRNA

NCBI chr16:1,612,360...1,677,908
Ensembl chr16:1,612,337...1,677,908

G

carnitine O-acetyltransferase

increases expression

ISO

epoxiconazole results in increased expression of CRAT mRNA

NCBI chr 9:129,094,794...129,110,793
Ensembl chr 9:129,094,142...129,111,313

G

CGRP receptor component

decreases expression

ISO

epoxiconazole results in decreased expression of CRCP mRNA

NCBI chr 7:66,114,818...66,154,568
Ensembl chr 7:66,114,604...66,154,568

G

cAMP responsive element binding protein 3

decreases expression

ISO

epoxiconazole results in decreased expression of CREB3 mRNA

NCBI chr 9:35,732,666...35,736,999
Ensembl chr 9:35,732,296...35,738,886

G

cAMP responsive element binding protein 3 like 3

decreases expression

ISO

epoxiconazole results in decreased expression of CREB3L3 mRNA

NCBI chr19:4,153,631...4,173,054
Ensembl chr19:4,153,621...4,173,057

G

CREB3 regulatory factor

affects expression

ISO

epoxiconazole affects the expression of CREBRF mRNA

NCBI chr 5:173,056,352...173,139,284
Ensembl chr 5:173,056,352...173,139,284

G

cellular repressor of E1A stimulated genes 1

increases expression

ISO

epoxiconazole results in increased expression of CREG1 mRNA

NCBI chr 1:167,541,013...167,553,762
Ensembl chr 1:167,529,117...167,553,822

G

cysteine rich with EGF like domains 2

decreases expression

ISO

epoxiconazole results in decreased expression of CRELD2 mRNA

NCBI chr22:49,918,634...49,927,537
Ensembl chr22:49,917,989...49,927,544

G

cAMP responsive element modulator

increases expression

ISO

epoxiconazole results in increased expression of CREM mRNA

NCBI chr10:35,126,846...35,212,958
Ensembl chr10:35,126,791...35,212,958

G

cysteine rich transmembrane BMP regulator 1

decreases expression

ISO

epoxiconazole results in decreased expression of CRIM1 mRNA

NCBI chr 2:36,355,778...36,551,135
Ensembl chr 2:36,355,731...36,551,135

G

cysteine rich protein 2

increases expression

ISO

epoxiconazole results in increased expression of CRIP2 mRNA

NCBI chr14:105,472,945...105,480,170
Ensembl chr14:105,472,962...105,480,162

G

cardiolipin synthase 1

increases expression

ISO

epoxiconazole results in increased expression of CRLS1 mRNA

NCBI chr20:6,005,938...6,040,053
Ensembl chr20:6,006,052...6,040,053

G

collapsin response mediator protein 1

increases expression

ISO

epoxiconazole results in increased expression of CRMP1 mRNA

NCBI chr 4:5,820,764...5,893,086
Ensembl chr 4:5,748,084...5,893,086

G

carnitine O-octanoyltransferase

increases expression

ISO

epoxiconazole results in increased expression of CROT mRNA

NCBI chr 7:87,345,664...87,399,794
Ensembl chr 7:87,345,664...87,399,800

G

C-reactive protein

increases expression

ISO

epoxiconazole results in increased expression of CRP mRNA

NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589

G

cryptochrome circadian regulator 2

affects expression

ISO

epoxiconazole affects the expression of CRY2 mRNA

NCBI chr11:45,847,118...45,883,244
Ensembl chr11:45,847,118...45,883,248

G

crystallin beta B3

increases expression

ISO

epoxiconazole results in increased expression of CRYBB3 mRNA

NCBI chr22:25,199,858...25,207,359
Ensembl chr22:25,199,858...25,207,359

G

crystallin beta-gamma domain containing 3

decreases expression

ISO

epoxiconazole results in decreased expression of CRYBG3 mRNA

NCBI chr 3:97,822,011...97,944,984
Ensembl chr 3:97,822,011...97,944,984

G

crystallin zeta

decreases expression

ISO

epoxiconazole results in decreased expression of CRYZ mRNA

NCBI chr 1:74,705,486...74,733,050
Ensembl chr 1:74,701,488...74,733,104

G

crystallin zeta like 1

decreases expression

ISO

epoxiconazole results in decreased expression of CRYZL1 mRNA

NCBI chr21:33,589,341...33,641,741
Ensembl chr21:33,589,341...33,643,926

G

citrate synthase

decreases expression

ISO

epoxiconazole results in decreased expression of CS mRNA

NCBI chr12:56,271,699...56,300,330
Ensembl chr12:56,271,699...56,300,391

G

cysteine sulfinic acid decarboxylase

decreases expression

ISO

epoxiconazole results in decreased expression of CSAD mRNA

NCBI chr12:53,157,663...53,181,351
Ensembl chr12:53,157,663...53,180,933

G

colony stimulating factor 1

decreases expression

ISO

epoxiconazole results in decreased expression of CSF1 mRNA

NCBI chr 1:109,910,506...109,930,992
Ensembl chr 1:109,910,242...109,930,993

G

colony stimulating factor 1 receptor

affects expression

ISO

epoxiconazole affects the expression of CSF1R mRNA

NCBI chr 5:150,053,295...150,113,365
Ensembl chr 5:150,053,291...150,113,372

G

casein alpha s1

affects expression

ISO

epoxiconazole affects the expression of CSN1S1 mRNA

NCBI chr 4:69,931,068...69,946,574
Ensembl chr 4:69,931,068...69,946,574

G

casein kinase 1 gamma 1

increases expression

ISO

epoxiconazole results in increased expression of CSNK1G1 mRNA

NCBI chr15:64,165,525...64,356,173
Ensembl chr15:64,165,525...64,356,554

G

casein kinase 1 gamma 3

decreases expression

ISO

epoxiconazole results in decreased expression of CSNK1G3 mRNA

NCBI chr 5:123,512,177...123,617,049
Ensembl chr 5:123,512,067...123,617,049

G

chondroitin sulfate proteoglycan family member 4B, pseudogene

increases expression

ISO

epoxiconazole results in increased expression of CSPG4B mRNA

NCBI chr 5:54,810,139...54,872,034
Ensembl chr 5:54,808,210...54,872,551

G

chondroitin sulfate proteoglycan 5

increases expression

ISO

epoxiconazole results in increased expression of CSPG5 mRNA

NCBI chr 3:47,562,238...47,580,240
Ensembl chr 3:47,562,238...47,580,792

G

cysteine and serine rich nuclear protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of CSRNP1 mRNA

NCBI chr 3:39,141,855...39,154,641
Ensembl chr 3:39,141,854...39,154,852

G

cystatin A

increases expression

ISO

epoxiconazole results in increased expression of CSTA2 mRNA

NCBI chr 3:122,325,248...122,341,969
Ensembl chr 3:122,325,248...122,341,969

G

cystatin B

increases expression

ISO

epoxiconazole results in increased expression of CSTB mRNA

NCBI chr21:43,773,950...43,776,308
Ensembl chr21:43,772,511...43,776,579

G

chitobiase

decreases expression

ISO

epoxiconazole results in decreased expression of CTBS mRNA

NCBI chr 1:84,549,611...84,574,440
Ensembl chr 1:84,549,611...84,574,480

G

CTD small phosphatase 1

increases expression

ISO

epoxiconazole results in increased expression of CTDSP1 mRNA

NCBI chr 2:218,396,351...218,405,941
Ensembl chr 2:218,397,136...218,405,942

G

cystathionine gamma-lyase

increases expression

ISO

epoxiconazole results in increased expression of CTH mRNA

NCBI chr 1:70,411,268...70,439,851
Ensembl chr 1:70,406,194...70,442,771

G

cytotoxic T-lymphocyte associated protein 4

decreases expression

ISO

epoxiconazole results in decreased expression of CTLA4 mRNA

NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965

G

catenin beta like 1

decreases expression

ISO

epoxiconazole results in decreased expression of CTNNBL1 mRNA

NCBI chr20:37,694,030...37,872,118
Ensembl chr20:37,694,030...37,872,129

G

catenin delta 2

increases expression

ISO

epoxiconazole results in increased expression of CTNND2 mRNA

NCBI chr 5:10,971,836...11,904,446
Ensembl chr 5:10,971,836...11,904,446

G

cystinosin, lysosomal cystine transporter

decreases expression

ISO

epoxiconazole results in decreased expression of CTNS mRNA

NCBI chr17:3,636,459...3,663,103
Ensembl chr17:3,636,459...3,663,103

G

cathepsin A

decreases expression

ISO

epoxiconazole results in decreased expression of CTSA mRNA

NCBI chr20:45,891,335...45,898,820
Ensembl chr20:45,890,144...45,898,949

G

cathepsin C

increases expression

ISO

epoxiconazole results in increased expression of CTSC mRNA

NCBI chr11:88,293,592...88,337,736
Ensembl chr11:88,265,069...88,359,684

G

cathepsin D

increases expression

ISO

epoxiconazole results in increased expression of CTSD mRNA

NCBI chr11:1,752,755...1,763,927
Ensembl chr11:1,752,752...1,764,573

G

cathepsin E

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole] results in increased expression of CTSE mRNA

NCBI chr 1:206,009,264...206,023,895
Ensembl chr 1:206,008,535...206,023,909

G

cathepsin F

decreases expression

ISO

epoxiconazole results in decreased expression of CTSF mRNA

NCBI chr11:66,563,464...66,568,606
Ensembl chr11:66,563,463...66,568,879

G

cathepsin L

increases expression

ISO

epoxiconazole results in increased expression of CTSL mRNA

NCBI chr 9:87,726,119...87,731,469
Ensembl chr 9:87,724,051...87,731,469

G

cathepsin O

increases expression

ISO

epoxiconazole results in increased expression of CTSO mRNA

NCBI chr 4:155,924,118...155,953,866
Ensembl chr 4:155,921,580...155,953,912

G

cathepsin S

increases expression

ISO

epoxiconazole results in increased expression of CTSS mRNA

NCBI chr 1:150,730,188...150,765,778
Ensembl chr 1:150,730,079...150,765,957

G

CUE domain containing 2

decreases expression

ISO

epoxiconazole results in decreased expression of CUEDC2 mRNA

NCBI chr10:102,423,249...102,432,574
Ensembl chr10:102,423,242...102,432,718

G

cullin 7

decreases expression

ISO

epoxiconazole results in decreased expression of CUL7 mRNA

NCBI chr 6:43,037,617...43,053,851
Ensembl chr 6:43,037,617...43,053,943

G

cut like homeobox 2

affects expression

ISO

epoxiconazole affects the expression of CUX2 mRNA

NCBI chr12:111,034,165...111,350,554
Ensembl chr12:111,033,853...111,350,554

G

CWC15 spliceosome associated protein homolog

increases expression

ISO

epoxiconazole results in increased expression of CWC15 mRNA

NCBI chr11:94,962,620...94,973,556
Ensembl chr11:94,962,620...94,973,611

G

CWF19 like cell cycle control factor 2

increases expression

ISO

epoxiconazole results in increased expression of CWF19L2 mRNA

NCBI chr11:107,326,360...107,457,825
Ensembl chr11:107,321,601...107,457,842

G

CXADR Ig-like cell adhesion molecule

increases expression

ISO

epoxiconazole results in increased expression of CXADR mRNA

NCBI chr21:17,513,043...17,636,262
Ensembl chr21:17,512,971...17,593,579

G

C-X-C motif chemokine ligand 1

decreases expression

ISO

epoxiconazole results in decreased expression of CXCL1 mRNA

NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,392...73,871,308

G

C-X-C motif chemokine ligand 12

decreases expression

ISO

epoxiconazole results in decreased expression of CXCL12 mRNA

NCBI chr10:44,370,165...44,385,097
Ensembl chr10:44,370,165...44,386,493

G

C-X-C motif chemokine ligand 13

increases expression

ISO

epoxiconazole results in increased expression of CXCL13 mRNA

NCBI chr 4:77,511,753...77,611,834
Ensembl chr 4:77,511,753...77,611,834

G

C-X-C motif chemokine ligand 14

decreases expression

ISO

epoxiconazole results in decreased expression of CXCL14 mRNA

NCBI chr 5:135,570,679...135,578,991
Ensembl chr 5:135,570,679...135,579,279

G

C-X-C motif chemokine ligand 16

decreases expression

ISO

epoxiconazole results in decreased expression of CXCL16 mRNA

NCBI chr17:4,733,533...4,739,928
Ensembl chr17:4,733,533...4,739,934

G

C-X-C motif chemokine ligand 9

increases expression

ISO

epoxiconazole results in increased expression of CXCL9 mRNA

NCBI chr 4:76,001,275...76,007,509
Ensembl chr 4:76,001,275...76,007,509

G

C-X-C motif chemokine receptor 4

decreases expression

ISO

epoxiconazole results in decreased expression of CXCR4 mRNA

NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177

G

C-X-C motif chemokine receptor 6

decreases expression

ISO

epoxiconazole results in decreased expression of CXCR6 mRNA

NCBI chr 3:45,940,915...45,948,351
Ensembl chr 3:45,940,933...45,948,353

G

CXXC finger protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of CXXC1 mRNA

NCBI chr18:50,282,347...50,287,692
Ensembl chr18:50,282,331...50,287,857

G

CXXC finger protein 5

increases expression

ISO

epoxiconazole results in increased expression of CXXC5 mRNA

NCBI chr 5:139,647,299...139,683,882
Ensembl chr 5:139,646,375...139,683,882

G

cytochrome b561

increases expression

ISO

epoxiconazole results in increased expression of CYB561 mRNA

NCBI chr17:63,432,304...63,446,639
Ensembl chr17:63,432,298...63,447,108

G

cytochrome b561 family member D2

decreases expression

ISO

epoxiconazole results in decreased expression of CYB561D2 mRNA

NCBI chr 3:50,350,862...50,354,069
Ensembl chr 3:50,350,839...50,358,460

G

cytochrome b5 type A

increases expression

ISO

epoxiconazole results in increased expression of CYB5A mRNA

NCBI chr18:74,250,846...74,291,963
Ensembl chr18:74,250,846...74,291,995

G

cytochrome b5 type B

decreases expression

ISO

epoxiconazole results in decreased expression of CYB5B mRNA

NCBI chr16:69,424,619...69,466,264
Ensembl chr16:69,398,402...69,466,264

G

cytochrome b5 reductase 3

decreases expression

ISO

epoxiconazole results in decreased expression of CYB5R3 mRNA

NCBI chr22:42,617,840...42,649,392
Ensembl chr22:42,615,730...42,720,870

G

cytochrome c1

decreases expression

ISO

epoxiconazole results in decreased expression of CYC1 mRNA

NCBI chr 8:144,095,076...144,097,525
Ensembl chr 8:144,095,039...144,097,525

G

cytoplasmic FMR1 interacting protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of CYFIP2 mRNA

NCBI chr 5:157,266,123...157,395,594
Ensembl chr 5:157,266,079...157,395,595

G

cytoglobin

decreases expression

ISO

epoxiconazole results in decreased expression of CYGB mRNA

NCBI chr17:76,527,356...76,551,193
Ensembl chr17:76,527,356...76,551,175

G

CYLD lysine 63 deubiquitinase

decreases expression

ISO

epoxiconazole results in decreased expression of CYLD mRNA

NCBI chr16:50,742,086...50,801,935
Ensembl chr16:50,742,032...50,801,935

G

cytochrome P450 family 11 subfamily B member 1

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in decreased expression of CYP11B1 mRNA

NCBI chr 8:142,872,357...142,879,825
Ensembl chr 8:142,871,528...142,880,000

G

cytochrome P450 family 11 subfamily B member 2

increases expression

ISO

epoxiconazole results in increased expression of CYP11B2 mRNA

NCBI chr 8:142,910,559...142,917,843
Ensembl chr 8:142,910,559...142,917,850

G

cytochrome P450 family 17 subfamily A member 1

affects expression

ISO

epoxiconazole affects the expression of CYP17A1 mRNA

NCBI chr10:102,830,531...102,837,413
Ensembl chr10:102,830,461...102,837,501

G

cytochrome P450 family 19 subfamily A member 1

multiple interactions

EXP
ISO

[prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased expression of CYP19A1 mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CYP19A1 mRNA

PMID:25233012 PMID:25607892

NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601

G

cytochrome P450 family 1 subfamily A member 1

increases expression
multiple interactions
increases activity

ISO
EXP

epoxiconazole results in increased expression of CYP1A1 mRNA
[epoxiconazole co-treated with cyproconazole] results in increased activity of CYP1A1 protein; [epoxiconazole co-treated with cyproconazole] results in increased expression of CYP1A1 mRNA; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased activity of CYP1A1 protein; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased expression of CYP1A1 mRNA
epoxiconazole results in increased activity of CYP1A1 protein
epoxiconazole results in increased expression of CYP1A1 mRNA; epoxiconazole results in increased expression of CYP1A1 protein
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [epoxiconazole results in increased expression of CYP1A1 mRNA]; [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP1A1 mRNA; [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP1A1 protein

PMID:25182419 PMID:25233012 PMID:29038839 PMID:29294346 PMID:32194361

NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536

G

cytochrome P450 family 1 subfamily A member 2

increases expression

ISO

epoxiconazole results in increased expression of CYP1A2 mRNA

NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,795...74,756,607

G

cytochrome P450 family 1 subfamily B member 1

decreases expression

EXP

epoxiconazole results in decreased expression of CYP1B1 mRNA

NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902

G

cytochrome P450 family 21 subfamily A member 2

decreases expression

ISO

epoxiconazole results in decreased expression of CYP21A1 mRNA

NCBI chr 6:32,038,415...32,041,644
Ensembl chr 6:32,038,298...32,042,321

G

cytochrome P450 family 26 subfamily A member 1

decreases expression

ISO

epoxiconazole results in decreased expression of CYP26A1 mRNA

NCBI chr10:93,073,475...93,077,885
Ensembl chr10:93,073,475...93,077,885

G

cytochrome P450 family 2 subfamily A member 7

affects expression

ISO

epoxiconazole affects the expression of CYP2A4 mRNA

NCBI chr19:40,875,439...40,882,231
Ensembl chr19:40,875,432...40,882,752

G

cytochrome P450 family 2 subfamily B member 6

increases expression
decreases expression
multiple interactions

ISO
EXP

epoxiconazole results in increased expression of CYP2B10 mRNA
epoxiconazole results in decreased expression of CYP2B10 mRNA
[fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP2B6 mRNA; [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP2B6 protein

PMID:22334560 PMID:23970803 PMID:29294346 PMID:35436446

NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,281...41,018,398

G

cytochrome P450 family 2 subfamily C member 18

increases expression

ISO

epoxiconazole results in increased expression of CYP2C11 mRNA

NCBI chr10:94,683,729...94,736,190
Ensembl chr10:94,682,944...94,736,190

G

cytochrome P450 family 2 subfamily C member 19

increases expression
decreases expression

ISO
EXP

epoxiconazole results in increased expression of CYP2C6 mRNA
epoxiconazole results in decreased expression of CYP2C19 protein

PMID:25182419 PMID:32194361

NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,662...94,856,282

G

cytochrome P450 family 2 subfamily C member 9

increases expression

ISO

epoxiconazole results in increased expression of CYP2C65 mRNA

PMID:22334560 PMID:23970803

NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,588...94,990,148

G

cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)

decreases expression

ISO

epoxiconazole results in decreased expression of CYP2D22 mRNA

NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,125,962...42,131,236

G

cytochrome P450 family 2 subfamily E member 1

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole] results in increased expression of CYP2E1 mRNA

NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220

G

cytochrome P450 family 2 subfamily F member 1

decreases expression

ISO

epoxiconazole results in decreased expression of CYP2F2 mRNA

NCBI chr19:41,114,432...41,128,381
Ensembl chr19:41,114,432...41,128,381

G

cytochrome P450 family 2 subfamily G member 1, pseudogene

increases expression

ISO

epoxiconazole results in increased expression of CYP2G1 mRNA

NCBI chr19:40,890,826...40,900,508
Ensembl chr19:40,891,219...40,900,155
Ensembl chr19:40,891,219...40,900,155

G

cytochrome P450 family 2 subfamily J member 2

decreases expression

ISO

epoxiconazole results in decreased expression of CYP2J9 mRNA

NCBI chr 1:59,893,308...59,969,212
Ensembl chr 1:59,893,308...59,926,822

G

cytochrome P450 family 2 subfamily R member 1

increases expression

ISO

epoxiconazole results in increased expression of CYP2R1 mRNA

NCBI chr11:14,877,440...14,892,443
Ensembl chr11:14,877,440...14,892,247

G

cytochrome P450 family 39 subfamily A member 1

increases expression

ISO

epoxiconazole results in increased expression of CYP39A1 mRNA

NCBI chr 6:46,549,580...46,652,818
Ensembl chr 6:46,549,383...46,652,830

G

cytochrome P450 family 3 subfamily A member 4

increases expression
multiple interactions

EXP
ISO

epoxiconazole results in increased expression of CYP3A4 mRNA; epoxiconazole results in increased expression of CYP3A4 protein
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CYP3A2 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP3A2 mRNA
epoxiconazole results in increased expression of CYP3A2 mRNA
[fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP3A4 mRNA; [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP3A4 protein

PMID:29038839 PMID:29294346

NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,959...99,784,274

G

cytochrome P450 family 46 subfamily A member 1

increases expression

ISO

epoxiconazole results in increased expression of CYP46A1 mRNA

NCBI chr14:99,684,298...99,727,301
Ensembl chr14:99,684,250...99,727,318

G

cytochrome P450 family 4 subfamily A member 22

increases expression

ISO

epoxiconazole results in increased expression of CYP4A31 mRNA

NCBI chr 1:47,137,441...47,149,727
Ensembl chr 1:47,137,419...47,149,742

G

cytochrome P450 family 4 subfamily B member 1

increases expression

ISO

epoxiconazole results in increased expression of CYP4B1 mRNA

NCBI chr 1:46,799,046...46,819,413
Ensembl chr 1:46,757,838...46,819,413

G

cytochrome P450 family 4 subfamily F member 12

decreases expression

ISO

epoxiconazole results in decreased expression of CYP4F14 mRNA

NCBI chr19:15,673,087...15,697,174
Ensembl chr19:15,673,018...15,698,817

G

cytochrome P450 family 51 subfamily A member 1

decreases activity
increases expression

EXP

epoxiconazole results in decreased activity of CYP51A1 protein
epoxiconazole results in increased expression of CYP51A1 mRNA

PMID:16989930 PMID:34182286

NCBI chr 7:92,112,153...92,134,803
Ensembl chr 7:92,084,987...92,134,803

G

cytochrome P450 family 7 subfamily A member 1

multiple interactions
decreases expression

ISO
EXP

[cyproconazole co-treated with epoxiconazole] results in increased expression of CYP7A1 mRNA
epoxiconazole results in decreased expression of CYP7A1 mRNA

PMID:29038839 PMID:32194361 PMID:35436446

NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163

G

cytochrome P450 family 8 subfamily B member 1

decreases expression

ISO

epoxiconazole results in decreased expression of CYP8B1 mRNA

NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898

G

cytohesin 1

decreases expression

ISO

epoxiconazole results in decreased expression of CYTH1 mRNA

NCBI chr17:78,674,048...78,782,273
Ensembl chr17:78,674,048...78,782,298

G

D-2-hydroxyglutarate dehydrogenase

decreases expression

ISO

epoxiconazole results in decreased expression of D2HGDH mRNA

NCBI chr 2:241,734,630...241,768,811
Ensembl chr 2:241,734,596...241,768,816

G

DAB adaptor protein 2

increases expression

ISO

epoxiconazole results in increased expression of DAB2 mRNA

NCBI chr 5:39,371,677...39,424,980
Ensembl chr 5:39,371,675...39,462,300

G

DAB2 interacting protein

decreases expression

ISO

epoxiconazole results in decreased expression of DAB2IP mRNA

NCBI chr 9:121,567,074...121,785,530
Ensembl chr 9:121,567,057...121,785,530

G

dystroglycan 1

decreases expression

ISO

epoxiconazole results in decreased expression of DAG1 mRNA

NCBI chr 3:49,468,948...49,535,615
Ensembl chr 3:49,468,649...49,535,619

G

diacylglycerol lipase beta

decreases expression

ISO

epoxiconazole results in decreased expression of DAGLB mRNA

NCBI chr 7:6,409,129...6,447,954
Ensembl chr 7:6,407,846...6,484,190

G

DALR anticodon binding domain containing 3

decreases expression

ISO

epoxiconazole results in decreased expression of DALRD3 mRNA

NCBI chr 3:49,015,488...49,021,505
Ensembl chr 3:49,015,488...49,022,293

G

DAN domain BMP antagonist family member 5

decreases expression

ISO

epoxiconazole results in decreased expression of DAND5 mRNA

NCBI chr19:12,969,576...12,974,760
Ensembl chr19:12,965,159...12,974,760

G

aspartyl-tRNA synthetase 2, mitochondrial

decreases expression

ISO

epoxiconazole results in decreased expression of DARS2 mRNA

NCBI chr 1:173,824,673...173,858,546
Ensembl chr 1:173,824,540...173,858,808

G

drebrin like

increases expression

ISO

epoxiconazole results in increased expression of DBNL mRNA

NCBI chr 7:44,044,702...44,069,456
Ensembl chr 7:44,044,628...44,069,456

G

D-box binding PAR bZIP transcription factor

decreases expression

ISO

epoxiconazole results in decreased expression of DBP mRNA

NCBI chr19:48,630,030...48,637,379
Ensembl chr19:48,630,030...48,637,379

G

debranching RNA lariats 1

decreases expression

ISO

epoxiconazole results in decreased expression of DBR1 mRNA

NCBI chr 3:138,160,988...138,174,921
Ensembl chr 3:138,160,988...138,174,949

G

dihydrolipoamide branched chain transacylase E2

decreases expression

ISO

epoxiconazole results in decreased expression of DBT mRNA

NCBI chr 1:100,186,919...100,249,834
Ensembl chr 1:100,182,222...100,249,873

G

DDB1 and CUL4 associated factor 12 like 2

increases expression

ISO

epoxiconazole results in increased expression of DCAF12L2 mRNA

NCBI chr X:126,163,499...126,166,289
Ensembl chr X:126,163,499...126,166,289

G

DDB1 and CUL4 associated factor 8

decreases expression

ISO

epoxiconazole results in decreased expression of DCAF8 mRNA

NCBI chr 1:160,215,720...160,262,549
Ensembl chr 1:160,215,715...160,263,388

G

DDB1 and CUL4 associated factor 8 like 2

increases expression

ISO

epoxiconazole results in increased expression of DCAF8L mRNA

NCBI chr X:27,468,941...27,749,942
Ensembl chr X:27,590,281...27,749,942

G

DCC netrin 1 receptor

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DCC mRNA

NCBI chr18:52,340,197...53,535,899
Ensembl chr18:52,340,197...53,535,899

G

doublecortin domain containing 2

increases expression

ISO

epoxiconazole results in increased expression of DCDC2A mRNA

NCBI chr 6:24,171,755...24,383,292
Ensembl chr 6:24,171,755...24,360,249

G

doublecortin like kinase 3

decreases expression

ISO

epoxiconazole results in decreased expression of DCLK3 mRNA

NCBI chr 3:36,712,421...36,764,553
Ensembl chr 3:36,712,421...36,764,553

G

DNA cross-link repair 1A

decreases expression

ISO

epoxiconazole results in decreased expression of DCLRE1A mRNA

NCBI chr10:113,834,725...113,854,394
Ensembl chr10:113,834,725...113,854,383

G

DC-STAMP domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of DCST1 mRNA

NCBI chr 1:155,033,806...155,050,930
Ensembl chr 1:155,033,824...155,050,930

G

dynactin subunit 2

decreases expression

ISO

epoxiconazole results in decreased expression of DCTN2 mRNA

NCBI chr12:57,530,051...57,547,192
Ensembl chr12:57,529,633...57,547,242

G

dynactin subunit 6

decreases expression

ISO

epoxiconazole results in decreased expression of DCTN6 mRNA

NCBI chr 8:30,156,369...30,183,639
Ensembl chr 8:30,156,319...30,183,639

G

dopa decarboxylase

affects expression

ISO

epoxiconazole affects the expression of DDC mRNA

NCBI chr 7:50,458,442...50,565,405
Ensembl chr 7:50,458,436...50,565,468

G

D-aspartate oxidase

decreases expression

ISO

epoxiconazole results in decreased expression of DDO mRNA

NCBI chr 6:110,388,321...110,415,575
Ensembl chr 6:110,391,771...110,415,862

G

dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit

increases expression

ISO

epoxiconazole results in increased expression of DDOST mRNA

NCBI chr 1:20,651,777...20,661,369
Ensembl chr 1:20,651,767...20,661,544

G

D-dopachrome tautomerase

decreases expression

ISO

epoxiconazole results in decreased expression of DDT mRNA

NCBI chr22:23,971,370...23,980,504
Ensembl chr22:23,970,542...23,980,525

G

DEAD-box helicase 24

decreases expression

ISO

epoxiconazole results in decreased expression of DDX24 mRNA

NCBI chr14:94,048,287...94,081,202
Ensembl chr14:94,048,287...94,081,215

G

DEAD-box helicase 28

increases expression

ISO

epoxiconazole results in increased expression of DDX28 mRNA

NCBI chr16:68,020,916...68,023,232
Ensembl chr16:68,020,916...68,023,232

G

DEAD-box helicase 31

increases expression

ISO

epoxiconazole results in increased expression of DDX31 mRNA

NCBI chr 9:132,592,997...132,669,983
Ensembl chr 9:132,592,787...132,670,401

G

DEAD-box helicase 46

decreases expression

ISO

epoxiconazole results in decreased expression of DDX46 mRNA

PMID:22334560 PMID:23970803

NCBI chr 5:134,758,779...134,831,121
Ensembl chr 5:134,758,771...134,831,121

G

DEAD-box helicase 6

decreases expression

ISO

epoxiconazole results in decreased expression of DDX6 mRNA

NCBI chr11:118,747,763...118,791,744
Ensembl chr11:118,747,763...118,791,226

G

DEAF1 transcription factor

decreases expression

ISO

epoxiconazole results in decreased expression of DEAF1 mRNA

NCBI chr11:644,233...707,083
Ensembl chr11:644,224...707,118

G

2,4-dienoyl-CoA reductase 2

decreases expression

ISO

epoxiconazole results in decreased expression of DECR2 mRNA

NCBI chr16:401,885...412,482
Ensembl chr16:401,854...412,492

G

differentially expressed in FDCP 8 homolog

decreases expression

ISO

epoxiconazole results in decreased expression of DEF8 mRNA

NCBI chr16:89,948,755...89,968,060
Ensembl chr16:89,948,127...89,968,066

G

defensin beta 106A

increases expression

ISO

epoxiconazole results in increased expression of DEFB34 mRNA

NCBI chr 8:7,825,139...7,829,053
Ensembl chr 8:7,825,139...7,829,053
Ensembl chr 8:7,825,139...7,829,053

G

defensin beta 113

increases expression

ISO

epoxiconazole results in increased expression of DEFB18 mRNA

NCBI chr 6:49,968,677...49,969,625
Ensembl chr 6:49,968,677...49,969,625

G

defensin beta 123

increases expression

ISO

epoxiconazole results in increased expression of DEFB36 mRNA

NCBI chr20:31,440,632...31,450,257
Ensembl chr20:31,440,632...31,450,257

G

defensin beta 125

increases expression

ISO

epoxiconazole results in increased expression of DEFB26 mRNA

NCBI chr20:87,672...97,094
Ensembl chr20:87,250...97,094

G

DENN domain containing 1A

decreases expression

ISO

epoxiconazole results in decreased expression of DENND1A mRNA

NCBI chr 9:123,379,658...123,930,126
Ensembl chr 9:123,379,648...123,930,152

G

DENN domain containing 2B

affects expression

ISO

epoxiconazole affects the expression of DENND2B mRNA

NCBI chr11:8,693,352...8,910,951
Ensembl chr11:8,693,343...8,910,951

G

DEP domain containing 1B

increases expression

ISO

epoxiconazole results in increased expression of DEPDC1B mRNA

NCBI chr 5:60,596,912...60,700,166
Ensembl chr 5:60,596,912...60,700,194

G

DEP domain containing 7

increases expression

ISO

epoxiconazole results in increased expression of DEPDC7 mRNA

NCBI chr11:33,015,878...33,033,582
Ensembl chr11:33,015,876...33,033,582

G

DEPP autophagy regulator 1

affects expression

ISO

epoxiconazole affects the expression of DEPP1 mRNA

NCBI chr10:44,976,128...44,978,809
Ensembl chr10:44,970,981...44,978,809

G

DEP domain containing MTOR interacting protein

decreases expression

ISO

epoxiconazole results in decreased expression of DEPTOR mRNA

NCBI chr 8:119,873,722...120,050,918
Ensembl chr 8:119,873,717...120,050,918

G

derlin 3

increases expression

ISO

epoxiconazole results in increased expression of DERL3 mRNA

NCBI chr22:23,834,503...23,839,006
Ensembl chr22:23,834,503...23,839,128

G

desmin

increases expression

ISO

epoxiconazole results in increased expression of DES mRNA

NCBI chr 2:219,418,377...219,426,734
Ensembl chr 2:219,417,474...219,426,739

G

DET1 partner of COP1 E3 ubiquitin ligase

decreases expression

ISO

epoxiconazole results in decreased expression of DET1 mRNA

NCBI chr15:88,501,919...88,546,703
Ensembl chr15:88,494,440...88,547,321

G

Dexi homolog

decreases expression
increases expression

ISO

epoxiconazole results in decreased expression of DEXI mRNA
epoxiconazole results in increased expression of DEXI mRNA

PMID:22334560 PMID:35436446

NCBI chr16:10,928,891...10,942,468
Ensembl chr16:10,928,891...10,942,468

G

diacylglycerol O-acyltransferase 2

decreases expression

ISO

epoxiconazole results in decreased expression of DGAT2 mRNA

NCBI chr11:75,768,778...75,801,534
Ensembl chr11:75,759,512...75,801,542

G

diacylglycerol kinase alpha

decreases expression

ISO

epoxiconazole results in decreased expression of DGKA mRNA

NCBI chr12:55,927,316...55,954,023
Ensembl chr12:55,927,319...55,954,027

G

diacylglycerol kinase delta

decreases expression

ISO

epoxiconazole results in decreased expression of DGKD mRNA

NCBI chr 2:233,354,494...233,472,098
Ensembl chr 2:233,354,484...233,472,104

G

diacylglycerol kinase theta

decreases expression

ISO

epoxiconazole results in decreased expression of DGKQ mRNA

NCBI chr 4:958,887...973,569
Ensembl chr 4:958,884...986,895

G

D-glutamate cyclase

decreases expression

ISO

epoxiconazole results in decreased expression of DGLUCY mRNA

NCBI chr14:91,060,333...91,225,632
Ensembl chr14:91,060,044...91,226,929

G

7-dehydrocholesterol reductase

decreases expression
increases expression

ISO
EXP

epoxiconazole results in decreased expression of DHCR7 mRNA
epoxiconazole results in increased expression of DHCR7 mRNA

PMID:34182286 PMID:35436446

NCBI chr11:71,427,287...71,449,043
Ensembl chr11:71,428,193...71,452,868

G

dehydrodolichyl diphosphate synthase subunit

decreases expression

ISO

epoxiconazole results in decreased expression of DHDDS mRNA

NCBI chr 1:26,432,321...26,471,306
Ensembl chr 1:26,432,282...26,471,322

G

dihydroorotate dehydrogenase (quinone)

decreases expression

ISO

epoxiconazole results in decreased expression of DHODH mRNA

NCBI chr16:72,008,744...72,027,659
Ensembl chr16:72,008,588...72,027,664

G

dehydrogenase/reductase 13

increases expression

ISO

epoxiconazole results in increased expression of DHRS13 mRNA

NCBI chr17:28,897,781...28,903,079
Ensembl chr17:28,897,781...28,903,079

G

dehydrogenase/reductase 4

decreases expression

ISO

epoxiconazole results in decreased expression of DHRS4 mRNA

NCBI chr14:23,953,770...23,969,279
Ensembl chr14:23,953,713...23,969,279

G

dehydrogenase/reductase 7

decreases expression

ISO

epoxiconazole results in decreased expression of DHRS7 mRNA

NCBI chr14:60,144,119...60,169,889
Ensembl chr14:60,144,119...60,169,856

G

dehydrogenase/reductase 7C

increases expression

ISO

epoxiconazole results in increased expression of DHRS7C mRNA

NCBI chr17:9,771,438...9,791,592
Ensembl chr17:9,771,434...9,791,592

G

dehydrogenase/reductase 9

affects expression

ISO

epoxiconazole affects the expression of DHRS9 mRNA

NCBI chr 2:169,067,077...169,096,167
Ensembl chr 2:169,064,789...169,096,168

G

dehydrogenase E1 and transketolase domain containing 1

decreases expression

ISO

epoxiconazole results in decreased expression of DHTKD1 mRNA

NCBI chr10:12,068,954...12,123,221
Ensembl chr10:12,068,926...12,123,225

G

diablo IAP-binding mitochondrial protein

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole] results in increased expression of DIABLO mRNA

NCBI chr12:122,207,662...122,227,456
Ensembl chr12:122,207,394...122,226,062

G

diaphanous related formin 3

decreases expression

ISO

epoxiconazole results in decreased expression of DIAPH3 mRNA

NCBI chr13:59,665,583...60,163,928
Ensembl chr13:59,665,583...60,163,928

G

iodothyronine deiodinase 1

decreases expression

ISO

epoxiconazole results in decreased expression of DIO1 mRNA

NCBI chr 1:53,894,187...53,911,086
Ensembl chr 1:53,891,239...53,911,086

G

disco interacting protein 2 homolog C

decreases expression

ISO

epoxiconazole results in decreased expression of DIP2C mRNA

NCBI chr10:274,201...689,668
Ensembl chr10:274,201...689,937

G

divergent protein kinase domain 1A

increases expression

ISO

epoxiconazole results in increased expression of DIPK1A mRNA

NCBI chr 1:92,832,729...92,961,462
Ensembl chr 1:92,832,737...92,961,522

G

DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease

decreases expression

ISO

epoxiconazole results in decreased expression of DIS3 mRNA

NCBI chr13:72,752,169...72,781,900
Ensembl chr13:72,752,169...72,782,096

G

DIS3 like exosome 3'-5' exoribonuclease

decreases expression

ISO

epoxiconazole results in decreased expression of DIS3L mRNA

NCBI chr15:66,293,309...66,333,898
Ensembl chr15:66,293,217...66,333,898

G

dyskerin pseudouridine synthase 1

decreases expression

ISO

epoxiconazole results in decreased expression of DKC1 mRNA

NCBI chr X:154,762,864...154,777,689
Ensembl chr X:154,762,742...154,777,697

G

dihydrolipoamide S-acetyltransferase

increases expression

ISO

epoxiconazole results in increased expression of DLAT mRNA

NCBI chr11:112,025,408...112,064,404
Ensembl chr11:112,025,033...112,064,404

G

discs large MAGUK scaffold protein 1

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DLG1 mRNA

NCBI chr 3:197,042,560...197,299,321
Ensembl chr 3:197,042,560...197,299,330

G

discs large MAGUK scaffold protein 4

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of DLG4 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLG4 mRNA

NCBI chr17:7,187,187...7,220,050
Ensembl chr17:7,187,187...7,219,836

G

discs large MAGUK scaffold protein 5

decreases expression

ISO

epoxiconazole results in decreased expression of DLG5 mRNA

NCBI chr10:77,790,791...77,940,736
Ensembl chr10:77,790,778...77,927,220

G

DLG associated protein 3

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLGAP3 mRNA

NCBI chr 1:34,865,436...34,929,650
Ensembl chr 1:34,865,436...34,929,650

G

DLG associated protein 4

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLGAP4 mRNA

NCBI chr20:36,306,339...36,528,633
Ensembl chr20:36,306,302...36,528,637

G

delta like non-canonical Notch ligand 2

decreases expression

ISO

epoxiconazole results in decreased expression of DLK2 mRNA

NCBI chr 6:43,450,352...43,456,632
Ensembl chr 6:43,450,351...43,456,632

G

delta like canonical Notch ligand 1

increases expression

ISO

epoxiconazole results in increased expression of DLL1 mRNA

NCBI chr 6:170,282,206...170,291,078
Ensembl chr 6:170,282,202...170,306,565

G

delta like canonical Notch ligand 4

decreases expression

ISO

epoxiconazole results in decreased expression of DLL4 mRNA

NCBI chr15:40,929,340...40,939,073
Ensembl chr15:40,929,338...40,939,078

G

distal membrane arm assembly component 2

decreases expression

ISO

epoxiconazole results in decreased expression of DMAC2 mRNA

NCBI chr19:41,431,318...41,439,912
Ensembl chr19:41,431,318...41,440,717

G

dimethylglycine dehydrogenase

decreases expression

ISO

epoxiconazole results in decreased expression of DMGDH mRNA

NCBI chr 5:78,997,564...79,069,674
Ensembl chr 5:78,996,974...79,236,038

G

DM1 protein kinase

increases expression

ISO

epoxiconazole results in increased expression of DMPK mRNA

NCBI chr19:45,769,717...45,782,490
Ensembl chr19:45,769,709...45,782,552

G

DMRT like family C2

increases expression

ISO

epoxiconazole results in increased expression of DMRTC2 mRNA

NCBI chr19:41,844,916...41,852,333
Ensembl chr19:41,844,743...41,852,333

G

Dmx like 2

increases expression

ISO

epoxiconazole results in increased expression of DMXL2 mRNA

NCBI chr15:51,447,791...51,622,771
Ensembl chr15:51,447,711...51,622,981

G

dynein axonemal heavy chain 12

decreases expression

ISO

epoxiconazole results in decreased expression of DNAH12 mRNA

NCBI chr 3:57,293,700...57,556,034
Ensembl chr 3:57,293,699...57,544,344

G

dynein axonemal heavy chain 5

increases expression

ISO

epoxiconazole results in increased expression of DNAH5 mRNA

NCBI chr 5:13,690,328...14,011,818
Ensembl chr 5:13,690,328...14,011,818

G

dynein axonemal heavy chain 7

increases expression

ISO

epoxiconazole results in increased expression of DNAH7B mRNA

NCBI chr 2:195,737,703...196,068,837
Ensembl chr 2:195,737,703...196,068,837

G

dynein axonemal intermediate chain 1

decreases expression

ISO

epoxiconazole results in decreased expression of DNAI1 mRNA

PMID:22334560 PMID:23970803 PMID:35436446

NCBI chr 9:34,458,805...34,520,984
Ensembl chr 9:34,457,414...34,520,988

G

DnaJ heat shock protein family (Hsp40) member B1

affects expression
increases expression

ISO

epoxiconazole affects the expression of DNAJB1 mRNA
epoxiconazole results in increased expression of DNAJB1 mRNA

PMID:29038839 PMID:35436446

NCBI chr19:14,514,769...14,560,391
Ensembl chr19:14,513,789...14,560,391

G

DnaJ heat shock protein family (Hsp40) member B11

increases expression

ISO

epoxiconazole results in increased expression of DNAJB11 mRNA

NCBI chr 3:186,570,720...186,585,793
Ensembl chr 3:186,567,403...186,585,800

G

DnaJ heat shock protein family (Hsp40) member B9

decreases expression

ISO

epoxiconazole results in decreased expression of DNAJB9 mRNA

NCBI chr 7:108,569,874...108,574,850
Ensembl chr 7:108,569,847...108,574,850

G

DnaJ heat shock protein family (Hsp40) member C11

decreases expression

ISO

epoxiconazole results in decreased expression of DNAJC11 mRNA

NCBI chr 1:6,634,170...6,701,816
Ensembl chr 1:6,634,168...6,701,924

G

DnaJ heat shock protein family (Hsp40) member C15

increases expression

ISO

epoxiconazole results in increased expression of DNAJC15 mRNA

NCBI chr13:43,023,586...43,114,213
Ensembl chr13:43,023,203...43,114,213

G

DnaJ heat shock protein family (Hsp40) member C22

decreases expression

ISO

epoxiconazole results in decreased expression of DNAJC22 mRNA

NCBI chr12:49,346,888...49,353,690
Ensembl chr12:49,345,607...49,357,546

G

deoxyribonuclease 1 like 2

increases expression

ISO

epoxiconazole results in increased expression of DNASE1L2 mRNA

NCBI chr16:2,236,444...2,238,711
Ensembl chr16:2,235,816...2,238,711

G

deoxyribonuclease 1L3

increases expression

ISO

epoxiconazole results in increased expression of DNASE1L3 mRNA

NCBI chr 3:58,192,257...58,210,972
Ensembl chr 3:58,192,257...58,214,697

G

deoxyribonuclease 2 beta

decreases expression

ISO

epoxiconazole results in decreased expression of DNASE2B mRNA

NCBI chr 1:84,398,484...84,415,018
Ensembl chr 1:84,398,484...84,415,018

G

aspartyl aminopeptidase

decreases expression

ISO

epoxiconazole results in decreased expression of DNPEP mRNA

NCBI chr 2:219,372,043...219,400,007
Ensembl chr 2:219,372,029...219,400,022

G

2'-deoxynucleoside 5'-phosphate N-hydrolase 1

decreases expression

ISO

epoxiconazole results in decreased expression of DNPH1 mRNA

NCBI chr 6:43,225,629...43,229,481
Ensembl chr 6:43,225,629...43,229,484

G

double C2 domain alpha

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DOC2A mRNA

NCBI chr16:30,005,514...30,023,228
Ensembl chr16:30,005,507...30,023,270

G

dedicator of cytokinesis 3

increases expression

ISO

epoxiconazole results in increased expression of DOCK3 mRNA

NCBI chr 3:50,674,927...51,384,198
Ensembl chr 3:50,674,927...51,384,198

G

dedicator of cytokinesis 5

decreases expression

ISO

epoxiconazole results in decreased expression of DOCK5 mRNA

NCBI chr 8:25,184,689...25,415,711
Ensembl chr 8:25,184,689...25,418,082

G

dedicator of cytokinesis 6

decreases expression

ISO

epoxiconazole results in decreased expression of DOCK6 mRNA

NCBI chr19:11,199,295...11,262,524
Ensembl chr19:11,199,295...11,262,524

G

dedicator of cytokinesis 9

decreases expression

ISO

epoxiconazole results in decreased expression of DOCK9 mRNA

NCBI chr13:98,793,429...99,088,619
Ensembl chr13:98,793,429...99,086,625

G

DOP1 leucine zipper like protein A

increases expression

ISO

epoxiconazole results in increased expression of DOP1A mRNA

NCBI chr 6:83,067,671...83,171,350
Ensembl chr 6:83,067,666...83,171,350

G

DOP1 leucine zipper like protein B

decreases expression

ISO

epoxiconazole results in decreased expression of DOP1B mRNA

NCBI chr21:36,156,824...36,294,274
Ensembl chr21:36,156,758...36,294,275

G

dolichyl-phosphate N-acetylglucosaminephosphotransferase 1

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of DPAGT1 mRNA
epoxiconazole results in decreased expression of DPAGT1 mRNA

PMID:22334560 PMID:35436446

NCBI chr11:119,093,874...119,101,853
Ensembl chr11:119,096,025...119,108,331

G

double PHD fingers 2

decreases expression

ISO

epoxiconazole results in decreased expression of DPF2 mRNA

NCBI chr11:65,333,852...65,354,262
Ensembl chr11:65,333,821...65,354,262

G

diphthamide biosynthesis 5

decreases expression

ISO

epoxiconazole results in decreased expression of DPH5 mRNA

NCBI chr 1:100,989,623...101,025,784
Ensembl chr 1:100,989,623...101,026,110

G

diphthamine biosynthesis 6

affects expression

ISO

epoxiconazole affects the expression of DPH6 mRNA

NCBI chr15:35,144,977...35,546,165
Ensembl chr15:35,217,345...35,546,193

G

dolichyl-phosphate mannosyltransferase subunit 3, regulatory

increases expression

ISO

epoxiconazole results in increased expression of DPM3 mRNA

NCBI chr 1:155,139,891...155,140,531
Ensembl chr 1:155,139,886...155,140,595

G

dipeptidyl peptidase like 10

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPP10 mRNA

NCBI chr 2:114,442,641...115,845,780
Ensembl chr 2:114,442,299...115,845,780

G

dipeptidyl peptidase 3

decreases expression

ISO

epoxiconazole results in decreased expression of DPP3 mRNA

NCBI chr11:66,480,434...66,509,657
Ensembl chr11:66,479,990...66,510,188

G

dipeptidyl peptidase like 6

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DPP6 mRNA

NCBI chr 7:153,748,133...154,894,285
Ensembl chr 7:153,748,133...154,894,285

G

dipeptidyl peptidase 7

decreases expression

ISO

epoxiconazole results in decreased expression of DPP7 mRNA

NCBI chr 9:137,110,546...137,118,306
Ensembl chr 9:137,110,540...137,118,309

G

dipeptidyl peptidase 9

decreases expression

ISO

epoxiconazole results in decreased expression of DPP9 mRNA

NCBI chr19:4,675,227...4,723,842
Ensembl chr19:4,674,341...4,724,673

G

developmental pluripotency associated 4

increases expression

ISO

epoxiconazole results in increased expression of DPPA4 mRNA

NCBI chr 3:109,326,144...109,339,636
Ensembl chr 3:109,326,144...109,337,591

G

dpy-19 like 2

decreases expression

ISO

epoxiconazole results in decreased expression of DPY19L2 mRNA

NCBI chr12:63,558,913...63,668,805
Ensembl chr12:63,558,913...63,668,939

G

dihydropyrimidine dehydrogenase

multiple interactions
increases expression

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPYD mRNA
epoxiconazole results in increased expression of DPYD mRNA

PMID:25607892 PMID:35436446

NCBI chr 1:97,077,743...97,921,059
Ensembl chr 1:97,077,743...97,995,000

G

DNA replication and sister chromatid cohesion 1

increases expression

ISO

epoxiconazole results in increased expression of DSCC1 mRNA

NCBI chr 8:119,833,976...119,855,894
Ensembl chr 8:119,833,944...119,855,987

G

desmoglein 1

decreases expression

ISO

epoxiconazole results in decreased expression of DSG1A mRNA

NCBI chr18:31,318,160...31,359,246
Ensembl chr18:31,318,160...31,359,246

G

desmoglein 3

decreases expression

ISO

epoxiconazole results in decreased expression of DSG3 mRNA

NCBI chr18:31,447,741...31,478,702
Ensembl chr18:31,447,741...31,478,702

G

dystonin

decreases expression

ISO

epoxiconazole results in decreased expression of DST mRNA

NCBI chr 6:56,457,996...56,954,830
Ensembl chr 6:56,457,987...56,954,830

G

destrin, actin depolymerizing factor

increases expression

ISO

epoxiconazole results in increased expression of DSTN mRNA

NCBI chr20:17,570,075...17,609,919
Ensembl chr20:17,569,152...17,609,919

G

denticleless E3 ubiquitin protein ligase homolog

increases expression

ISO

epoxiconazole results in increased expression of DTL mRNA

NCBI chr 1:212,035,748...212,105,013
Ensembl chr 1:212,035,553...212,107,400

G

deltex E3 ubiquitin ligase 2

decreases expression

ISO

epoxiconazole results in decreased expression of DTX2 mRNA

NCBI chr 7:76,461,709...76,505,991
Ensembl chr 7:76,461,656...76,506,471

G

dual oxidase 1

increases expression

ISO

epoxiconazole results in increased expression of DUOX1 mRNA

NCBI chr15:45,129,994...45,165,574
Ensembl chr15:45,129,468...45,165,576

G

dual oxidase maturation factor 1

decreases expression

ISO

epoxiconazole results in decreased expression of DUOXA1 mRNA

NCBI chr15:45,117,366...45,129,879
Ensembl chr15:45,117,364...45,130,611

G

dual specificity phosphatase 1

decreases expression

ISO

epoxiconazole results in decreased expression of DUSP1 mRNA

NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,766,992...172,771,198

G

dual specificity phosphatase 10

decreases expression

ISO

epoxiconazole results in decreased expression of DUSP10 mRNA

NCBI chr 1:221,701,424...221,742,089
Ensembl chr 1:221,700,669...221,742,089

G

dual specificity phosphatase 11

increases expression

ISO

epoxiconazole results in increased expression of DUSP11 mRNA

NCBI chr 2:73,762,213...73,780,149
Ensembl chr 2:73,761,782...73,780,173

G

dual specificity phosphatase 15

increases expression

ISO

epoxiconazole results in increased expression of DUSP15 mRNA

NCBI chr20:31,845,593...31,870,664
Ensembl chr20:31,847,637...31,870,664

G

dual specificity phosphatase 3

increases expression

ISO

epoxiconazole results in increased expression of DUSP3 mRNA

NCBI chr17:43,766,125...43,778,977
Ensembl chr17:43,766,121...43,779,000

G

dual specificity phosphatase 6

increases expression

ISO

epoxiconazole results in increased expression of DUSP6 mRNA

NCBI chr12:89,347,235...89,352,501
Ensembl chr12:89,347,235...89,352,501

G

dynein cytoplasmic 2 heavy chain 1

decreases expression

ISO

epoxiconazole results in decreased expression of DYNC2H1 mRNA

NCBI chr11:103,109,426...103,479,863
Ensembl chr11:103,109,410...103,479,863

G

dynein 2 intermediate chain 1

increases expression

ISO

epoxiconazole results in increased expression of DYNC2I1 mRNA

NCBI chr 7:158,839,245...158,958,698
Ensembl chr 7:158,856,558...158,956,747

G

dynein light chain LC8-type 2

decreases expression

ISO

epoxiconazole results in decreased expression of DYNLL2 mRNA

NCBI chr17:58,083,419...58,095,542
Ensembl chr17:58,082,863...58,095,542

G

dynein light chain roadblock-type 1

increases expression

ISO

epoxiconazole results in increased expression of DYNLRB1 mRNA

NCBI chr20:34,515,602...34,540,958
Ensembl chr20:34,516,379...34,540,958

G

dysferlin

increases expression

ISO

epoxiconazole results in increased expression of DYSF mRNA

NCBI chr 2:71,453,561...71,686,763
Ensembl chr 2:71,453,561...71,686,763

G

dystrotelin

increases expression

ISO

epoxiconazole results in increased expression of DYTN mRNA

NCBI chr 2:206,651,621...206,718,396
Ensembl chr 2:206,651,621...206,721,570

G

DAZ interacting zinc finger protein 3

decreases expression

ISO

epoxiconazole results in decreased expression of DZIP3 mRNA

NCBI chr 3:108,589,510...108,694,840
Ensembl chr 3:108,589,480...108,694,846

G

E2F transcription factor 8

affects expression

ISO

epoxiconazole affects the expression of E2F8 mRNA

NCBI chr11:19,224,063...19,241,655
Ensembl chr11:19,224,063...19,241,684

G

E4F transcription factor 1

decreases expression

ISO

epoxiconazole results in decreased expression of E4F1 mRNA

NCBI chr16:2,223,591...2,235,742
Ensembl chr16:2,223,440...2,235,743

G

EBP cholestenol delta-isomerase

decreases expression

ISO

epoxiconazole results in decreased expression of EBP mRNA

NCBI chr X:48,521,808...48,528,716
Ensembl chr X:48,521,089...48,528,716

G

endothelin converting enzyme 1

decreases expression

ISO

epoxiconazole results in decreased expression of ECE1 mRNA

NCBI chr 1:21,217,250...21,345,504
Ensembl chr 1:21,217,247...21,345,572

G

enoyl-CoA hydratase domain containing 2

decreases expression

ISO

epoxiconazole results in decreased expression of ECHDC2 mRNA

NCBI chr 1:52,895,910...52,921,774
Ensembl chr 1:52,895,910...52,927,212

G

enoyl-CoA delta isomerase 2

increases expression

ISO

epoxiconazole results in increased expression of ECI2 mRNA

NCBI chr 6:4,115,706...4,135,575
Ensembl chr 6:4,115,685...4,135,597

G

ectodysplasin A2 receptor

decreases expression

ISO

epoxiconazole results in decreased expression of EDA2R mRNA

NCBI chr X:66,595,637...66,639,269
Ensembl chr X:66,594,384...66,639,298

G

ectodysplasin A receptor

increases expression

ISO

epoxiconazole results in increased expression of EDAR mRNA

NCBI chr 2:108,894,471...108,989,220
Ensembl chr 2:108,894,471...108,989,372

G

eukaryotic translation elongation factor 2

decreases expression

ISO

epoxiconazole results in decreased expression of EEF2 mRNA

NCBI chr19:3,976,056...3,985,463
Ensembl chr19:3,976,044...3,985,479

G

eukaryotic elongation factor, selenocysteine-tRNA specific

decreases expression

ISO

epoxiconazole results in decreased expression of EEFSEC mRNA

NCBI chr 3:128,153,481...128,426,223
Ensembl chr 3:128,153,433...128,409,356

G

estrogen-induced osteoclastogenesis regulator 1

decreases expression

ISO

epoxiconazole results in decreased expression of EEIG1 mRNA

NCBI chr 9:127,940,582...127,980,989
Ensembl chr 9:127,940,582...127,981,068

G

EF-hand calcium binding domain 11

decreases expression

ISO

epoxiconazole results in decreased expression of EFCAB11 mRNA

NCBI chr14:89,794,669...89,954,777
Ensembl chr14:89,794,669...89,954,777

G

EF-hand calcium binding domain 7

increases expression

ISO

epoxiconazole results in increased expression of EFCAB7 mRNA

NCBI chr 1:63,523,525...63,585,370
Ensembl chr 1:63,523,372...63,572,693

G

EGF containing fibulin extracellular matrix protein 1

increases expression

ISO

epoxiconazole results in increased expression of EFEMP1 mRNA

NCBI chr 2:55,865,967...55,923,782
Ensembl chr 2:55,865,962...55,924,271

G

EF-hand domain family member D2

affects expression

ISO

epoxiconazole affects the expression of EFHD2 mRNA

NCBI chr 1:15,409,888...15,430,339
Ensembl chr 1:15,409,849...15,430,339

G

ephrin A1

increases expression

ISO

epoxiconazole results in increased expression of EFNA1 mRNA

NCBI chr 1:155,127,876...155,134,899
Ensembl chr 1:155,127,876...155,134,899

G

epidermal growth factor

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGF mRNA

NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766

G

epidermal growth factor receptor

multiple interactions
decreases expression

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGFR mRNA
epoxiconazole results in decreased expression of EGFR mRNA

PMID:25607892 PMID:35436446

NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,018,820...55,211,628

G

egl-9 family hypoxia inducible factor 2

decreases expression

ISO

epoxiconazole results in decreased expression of EGLN2 mRNA

NCBI chr19:40,799,191...40,808,434
Ensembl chr19:40,798,996...40,808,444

G

egl-9 family hypoxia inducible factor 3

decreases expression

ISO

epoxiconazole results in decreased expression of EGLN3 mRNA

NCBI chr14:33,924,227...33,951,074
Ensembl chr14:33,924,227...34,462,774

G

early growth response 1

decreases expression
increases expression

ISO

epoxiconazole results in decreased expression of EGR1 mRNA
epoxiconazole results in increased expression of EGR1 mRNA

PMID:28454766 PMID:35436446

NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303

G

EH domain binding protein 1

increases expression

ISO

epoxiconazole results in increased expression of EHBP1 mRNA

NCBI chr 2:62,673,878...63,046,487
Ensembl chr 2:62,673,851...63,046,487

G

EH domain containing 1

decreases expression

ISO

epoxiconazole results in decreased expression of EHD1 mRNA

PMID:28454766 PMID:35436446

NCBI chr11:64,851,642...64,879,693
Ensembl chr11:64,851,642...64,888,372

G

EH domain containing 3

decreases expression

ISO

epoxiconazole results in decreased expression of EHD3 mRNA

NCBI chr 2:31,234,152...31,269,451
Ensembl chr 2:31,233,961...31,269,451

G

enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of EHHADH mRNA

NCBI chr 3:185,190,624...185,254,049
Ensembl chr 3:185,190,624...185,281,990

G

euchromatic histone lysine methyltransferase 2

decreases expression

ISO

epoxiconazole results in decreased expression of EHMT2 mRNA

NCBI chr 6:31,879,759...31,897,698
Ensembl chr 6:31,879,758...31,897,723

G

eukaryotic translation initiation factor 1B

increases expression

ISO

epoxiconazole results in increased expression of EIF1B mRNA

NCBI chr 3:40,309,707...40,312,424
Ensembl chr 3:40,309,707...40,312,424

G

eukaryotic translation initiation factor 2 alpha kinase 2

decreases expression

ISO

epoxiconazole results in decreased expression of EIF2AK2 mRNA

NCBI chr 2:37,099,210...37,156,980
Ensembl chr 2:37,099,210...37,157,688

G

eukaryotic translation initiation factor 2 alpha kinase 3

increases expression
multiple interactions

ISO

epoxiconazole results in increased expression of EIF2AK3 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of EIF2AK3 mRNA

NCBI chr 2:88,556,741...88,628,145
Ensembl chr 2:88,556,741...88,691,518

G

eukaryotic translation initiation factor 2B subunit alpha

decreases expression

ISO

epoxiconazole results in decreased expression of EIF2B1 mRNA

NCBI chr12:123,620,406...123,633,686
Ensembl chr12:123,620,406...123,633,766

G

eukaryotic translation initiation factor 2B subunit beta

decreases expression

ISO

epoxiconazole results in decreased expression of EIF2B2 mRNA

NCBI chr14:75,002,921...75,012,366
Ensembl chr14:75,002,894...75,012,366

G

eukaryotic translation initiation factor 2D

decreases expression

ISO

epoxiconazole results in decreased expression of EIF2D mRNA

NCBI chr 1:206,569,146...206,612,465
Ensembl chr 1:206,571,292...206,612,514

G

eukaryotic translation initiation factor 2 subunit beta

increases expression

ISO

epoxiconazole results in increased expression of EIF2S2 mRNA

NCBI chr20:34,088,309...34,112,243
Ensembl chr20:34,088,309...34,112,279

G

eukaryotic translation initiation factor 2 subunit gamma

increases expression

ISO

epoxiconazole results in increased expression of EIF2S3X mRNA

NCBI chr X:24,054,956...24,078,810
Ensembl chr X:24,054,911...24,078,810

G

eukaryotic translation initiation factor 2 subunit gamma B

increases expression

ISO

epoxiconazole results in increased expression of EIF2S3Y mRNA

NCBI chr12:10,505,890...10,523,135
Ensembl chr12:10,505,602...10,523,135

G

eukaryotic translation initiation factor 3 subunit I

decreases expression

ISO

epoxiconazole results in decreased expression of EIF3I mRNA

NCBI chr 1:32,222,407...32,236,170
Ensembl chr 1:32,221,077...32,245,397

G

eukaryotic translation initiation factor 3 subunit M

increases expression

ISO

epoxiconazole results in increased expression of EIF3M mRNA

NCBI chr11:32,583,831...32,606,264
Ensembl chr11:32,583,785...32,606,264

G

eukaryotic translation initiation factor 4A1

decreases expression

ISO

epoxiconazole results in decreased expression of EIF4A1 mRNA

NCBI chr17:7,572,825...7,579,006
Ensembl chr17:7,572,760...7,579,006

G

eukaryotic translation initiation factor 4B

decreases expression

ISO

epoxiconazole results in decreased expression of EIF4B mRNA

NCBI chr12:53,006,456...53,042,215
Ensembl chr12:53,006,279...53,042,230

G

eukaryotic translation initiation factor 4E binding protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of EIF4EBP1 mRNA

NCBI chr 8:38,030,534...38,060,365
Ensembl chr 8:38,030,512...38,060,365

G

eukaryotic translation initiation factor 4 gamma 1

decreases expression

ISO

epoxiconazole results in decreased expression of EIF4G1 mRNA

NCBI chr 3:184,314,606...184,335,358
Ensembl chr 3:184,314,490...184,335,358

G

eukaryotic translation initiation factor 4 gamma 2

decreases expression

ISO

epoxiconazole results in decreased expression of EIF4G2 mRNA

NCBI chr11:10,797,046...10,808,926
Ensembl chr11:10,797,050...10,808,940

G

eukaryotic translation initiation factor 4 gamma 3

increases expression

ISO

epoxiconazole results in increased expression of EIF4G3 mRNA

NCBI chr 1:20,806,292...21,176,897
Ensembl chr 1:20,806,292...21,177,285

G

eukaryotic translation initiation factor 4H

decreases expression

ISO

epoxiconazole results in decreased expression of EIF4H mRNA

NCBI chr 7:74,174,356...74,197,096
Ensembl chr 7:74,174,231...74,197,122

G

eukaryotic translation initiation factor 6

decreases expression

ISO

epoxiconazole results in decreased expression of EIF6 mRNA

NCBI chr20:35,278,906...35,284,772
Ensembl chr20:35,278,906...35,284,985

G

ELAV like RNA binding protein 4

increases expression

ISO

epoxiconazole results in increased expression of ELAVL4 mRNA

NCBI chr 1:50,048,055...50,203,772
Ensembl chr 1:50,024,029...50,203,772

G

E74 like ETS transcription factor 1

increases expression

ISO

epoxiconazole results in increased expression of ELF1 mRNA

NCBI chr13:40,931,919...41,061,386
Ensembl chr13:40,931,242...41,061,440

G

E74 like ETS transcription factor 2

decreases expression

ISO

epoxiconazole results in decreased expression of ELF2 mRNA

NCBI chr 4:139,057,220...139,177,915
Ensembl chr 4:139,028,112...139,177,224

G

elongation factor for RNA polymerase II

decreases expression

ISO

epoxiconazole results in decreased expression of ELL mRNA

NCBI chr19:18,442,663...18,522,070
Ensembl chr19:18,442,663...18,522,116

G

engulfment and cell motility 1

decreases expression

ISO

epoxiconazole results in decreased expression of ELMO1 mRNA

NCBI chr 7:36,852,906...37,449,326
Ensembl chr 7:36,852,906...37,449,223

G

engulfment and cell motility 3

decreases expression

ISO

epoxiconazole results in decreased expression of ELMO3 mRNA

NCBI chr16:67,199,131...67,204,004
Ensembl chr16:67,199,111...67,204,029

G

ELMO domain containing 3

affects expression

ISO

epoxiconazole affects the expression of ELMOD3 mRNA

NCBI chr 2:85,354,769...85,391,748
Ensembl chr 2:85,354,394...85,391,752

G

elongin C

increases expression

ISO

epoxiconazole results in increased expression of ELOC mRNA

NCBI chr 8:73,945,119...73,972,287
Ensembl chr 8:73,939,169...73,972,307

G

ELOVL fatty acid elongase 1

increases expression

ISO

epoxiconazole results in increased expression of ELOVL1 mRNA

NCBI chr 1:43,363,401...43,368,011
Ensembl chr 1:43,363,396...43,368,075

G

ELOVL fatty acid elongase 3

increases expression

ISO

epoxiconazole results in increased expression of ELOVL3 mRNA

NCBI chr10:102,224,767...102,229,589
Ensembl chr10:102,226,299...102,229,589

G

ELOVL fatty acid elongase 6

decreases expression

ISO

epoxiconazole results in decreased expression of ELOVL6 mRNA

NCBI chr 4:110,045,846...110,199,202
Ensembl chr 4:110,045,846...110,199,199

G

ER membrane protein complex subunit 1

decreases expression

ISO

epoxiconazole results in decreased expression of EMC1 mRNA

NCBI chr 1:19,215,660...19,251,524
Ensembl chr 1:19,215,660...19,251,552

G

EMAP like 5

decreases expression

ISO

epoxiconazole results in decreased expression of EML5 mRNA

NCBI chr14:88,612,431...88,792,953
Ensembl chr14:88,612,240...88,792,994

G

epithelial membrane protein 2

increases expression

ISO

epoxiconazole results in increased expression of EMP2 mRNA

NCBI chr16:10,528,422...10,580,598
Ensembl chr16:10,528,422...10,580,689

G

epithelial membrane protein 3 (MAM blood group)

decreases expression

ISO

epoxiconazole results in decreased expression of EMP3 mRNA

NCBI chr19:48,325,552...48,330,553
Ensembl chr19:48,321,310...48,330,560

G

empty spiracles homeobox 2

affects expression

ISO

epoxiconazole affects the expression of EMX2 mRNA

NCBI chr10:117,542,746...117,549,546
Ensembl chr10:117,542,445...117,549,546

G

ectodermal-neural cortex 1

increases expression

ISO

epoxiconazole results in increased expression of ENC1 mRNA

NCBI chr 5:74,627,409...74,640,728
Ensembl chr 5:74,627,406...74,641,424

G

endoglin

decreases expression

ISO

epoxiconazole results in decreased expression of ENG mRNA

NCBI chr 9:127,815,016...127,854,658
Ensembl chr 9:127,811,130...127,855,232

G

energy homeostasis associated

decreases expression

ISO

epoxiconazole results in decreased expression of ENHO mRNA

NCBI chr 9:34,521,043...34,522,990
Ensembl chr 9:34,521,043...34,523,174

G

glutamyl aminopeptidase

decreases expression

ISO

epoxiconazole results in decreased expression of ENPEP mRNA

NCBI chr 4:110,476,155...110,565,285
Ensembl chr 4:110,365,733...110,565,285

G

ectonucleoside triphosphate diphosphohydrolase 5 (inactive)

decreases expression
increases expression

ISO

epoxiconazole results in decreased expression of ENTPD5 mRNA
epoxiconazole results in increased expression of ENTPD5 mRNA

PMID:22334560 PMID:35436446

NCBI chr14:73,955,329...74,019,288
Ensembl chr14:73,958,010...74,019,399

G

endosomal transmembrane epsin interactor 1

increases expression

ISO

epoxiconazole results in increased expression of ENTREP1 mRNA

NCBI chr 9:69,324,567...69,392,456
Ensembl chr 9:69,324,567...69,392,592

G

endothelium and lymphocyte associated ASCH domain 1

decreases expression

ISO

epoxiconazole results in decreased expression of EOLA1 mRNA

NCBI chr X:149,540,601...149,555,345
Ensembl chr X:149,536,605...149,550,510

G

E1A binding protein p300

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of EP300 mRNA

NCBI chr22:41,092,592...41,180,077
Ensembl chr22:41,091,816...41,180,077

G

E1A binding protein p400

decreases expression

ISO

epoxiconazole results in decreased expression of EP400 mRNA

NCBI chr12:131,949,942...132,080,460
Ensembl chr12:131,949,931...132,080,460

G

endothelial PAS domain protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of EPAS1 mRNA

NCBI chr 2:46,297,407...46,386,697
Ensembl chr 2:46,293,667...46,386,697

G

erythrocyte membrane protein band 4.1 like 4B

increases expression

ISO

epoxiconazole results in increased expression of EPB41L4B mRNA

NCBI chr 9:109,171,974...109,321,059
Ensembl chr 9:109,171,463...109,321,067

G

erythrocyte membrane protein band 4.1 like 5

decreases expression

ISO

epoxiconazole results in decreased expression of EPB41L5 mRNA

NCBI chr 2:120,013,077...120,179,119
Ensembl chr 2:120,013,066...120,179,119

G

ectopic P-granules 5 autophagy tethering factor

decreases expression

ISO

epoxiconazole results in decreased expression of EPG5 mRNA

NCBI chr18:45,800,581...45,967,329
Ensembl chr18:45,800,581...45,967,340

G

epithelial mitogen

affects expression

ISO

epoxiconazole affects the expression of EPGN mRNA

NCBI chr 4:74,308,470...74,316,789
Ensembl chr 4:74,308,470...74,316,789

G

EPH receptor A2

increases expression

ISO

epoxiconazole results in increased expression of EPHA2 mRNA

NCBI chr 1:16,124,337...16,156,069
Ensembl chr 1:16,124,337...16,156,069

G

EPH receptor A6

decreases expression

ISO

epoxiconazole results in decreased expression of EPHA6 mRNA

NCBI chr 3:96,814,594...97,761,532
Ensembl chr 3:96,814,581...97,761,532

G

EPH receptor A7

decreases expression

ISO

epoxiconazole results in decreased expression of EPHA7 mRNA

NCBI chr 6:93,240,020...93,419,559
Ensembl chr 6:93,240,020...93,419,687

G

EPH receptor B4

decreases expression

ISO

epoxiconazole results in decreased expression of EPHB4 mRNA

NCBI chr 7:100,802,565...100,827,523
Ensembl chr 7:100,802,563...100,827,555

G

EPH receptor B6

increases expression

ISO

epoxiconazole results in increased expression of EPHB6 mRNA

NCBI chr 7:142,855,076...142,871,093
Ensembl chr 7:142,854,930...142,871,094

G

epoxide hydrolase 1

increases expression
multiple interactions
decreases expression

ISO

epoxiconazole results in increased expression of EPHX1 mRNA
[cyproconazole co-treated with epoxiconazole] results in increased expression of EPHX1 mRNA
epoxiconazole results in decreased expression of EPHX1 mRNA

PMID:22334560 PMID:25182419 PMID:29038839 PMID:35436446

NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,095...225,845,567

G

epoxide hydrolase 2

decreases expression

ISO

epoxiconazole results in decreased expression of EPHX2 mRNA

NCBI chr 8:27,491,143...27,548,626
Ensembl chr 8:27,490,775...27,548,992

G

epsin 1

decreases expression

ISO

epoxiconazole results in decreased expression of EPN1 mRNA

NCBI chr19:55,675,226...55,709,533
Ensembl chr19:55,675,109...55,709,858

G

epidermal growth factor receptor pathway substrate 15 like 1

decreases expression

ISO

epoxiconazole results in decreased expression of EPS15L1 mRNA

NCBI chr19:16,355,247...16,472,012
Ensembl chr19:16,355,225...16,472,085

G

EPS8 signaling adaptor L1

increases expression

ISO

epoxiconazole results in increased expression of EPS8L1 mRNA

NCBI chr19:55,075,869...55,087,923
Ensembl chr19:55,072,020...55,090,124

G

EPS8 signaling adaptor L2

affects expression

ISO

epoxiconazole affects the expression of EPS8L2 mRNA

NCBI chr11:706,231...727,727
Ensembl chr11:694,438...727,729

G

Era like 12S mitochondrial rRNA chaperone 1

decreases expression

ISO

epoxiconazole results in decreased expression of ERAL1 mRNA

NCBI chr17:28,855,016...28,861,061
Ensembl chr17:28,855,009...28,861,067

G

erb-b2 receptor tyrosine kinase 2

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of ERBB2 mRNA

NCBI chr17:39,688,094...39,728,658
Ensembl chr17:39,687,914...39,730,426

G

erb-b2 receptor tyrosine kinase 3

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ERBB3 mRNA

NCBI chr12:56,080,108...56,103,505
Ensembl chr12:56,076,799...56,103,505

G

erb-b2 receptor tyrosine kinase 4

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ERBB4 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of ERBB4 mRNA

NCBI chr 2:211,375,717...212,538,802
Ensembl chr 2:211,375,717...212,538,841

G

ELKS/RAB6-interacting/CAST family member 1

decreases expression

ISO

epoxiconazole results in decreased expression of ERC1 mRNA

NCBI chr12:989,959...1,495,933
Ensembl chr12:989,998...1,495,933

G

ERCC excision repair 1, endonuclease non-catalytic subunit

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ERCC1 mRNA

NCBI chr19:45,407,334...45,451,547
Ensembl chr19:45,407,333...45,478,867

G

ERCC excision repair 3, TFIIH core complex helicase subunit

decreases expression

ISO

epoxiconazole results in decreased expression of ERCC3 mRNA

NCBI chr 2:127,257,290...127,294,144
Ensembl chr 2:127,257,285...127,294,188

G

ETS2 repressor factor

affects expression

ISO

epoxiconazole affects the expression of ERF mRNA

NCBI chr19:42,247,569...42,255,128
Ensembl chr19:42,247,569...42,255,131

G

ER lipid raft associated 1

decreases expression

ISO

epoxiconazole results in decreased expression of ERLIN1 mRNA

NCBI chr10:100,150,094...100,186,029
Ensembl chr10:100,150,094...100,186,033

G

endoplasmic reticulum metallopeptidase 1

decreases expression

ISO

epoxiconazole results in decreased expression of ERMP1 mRNA

NCBI chr 9:5,784,572...5,867,091
Ensembl chr 9:5,749,832...5,879,537

G

endoplasmic reticulum to nucleus signaling 1

decreases expression

ISO

epoxiconazole results in decreased expression of ERN1 mRNA

NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819

G

endoplasmic reticulum protein 27

increases expression

ISO

epoxiconazole results in increased expression of ERP27 mRNA

NCBI chr12:14,914,039...14,938,537
Ensembl chr12:14,914,039...14,938,537

G

establishment of sister chromatid cohesion N-acetyltransferase 1

decreases expression

ISO

epoxiconazole results in decreased expression of ESCO1 mRNA

NCBI chr18:21,529,284...21,600,704
Ensembl chr18:21,529,041...21,600,966

G

espin like

increases expression

ISO

epoxiconazole results in increased expression of ESPNL mRNA

NCBI chr 2:238,100,340...238,133,287
Ensembl chr 2:238,100,340...238,133,287

G

estrogen receptor 1

decreases expression

ISO

epoxiconazole results in decreased expression of ESR1 mRNA

NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,651,284...152,129,619

G

epithelial splicing regulatory protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of ESRP2 mRNA

NCBI chr16:68,229,033...68,236,127
Ensembl chr16:68,229,033...68,238,102

G

estrogen related receptor gamma

decreases expression

ISO

epoxiconazole results in decreased expression of ESRRG mRNA

NCBI chr 1:216,503,246...217,137,702
Ensembl chr 1:216,503,246...217,137,755

G

extended synaptotagmin 1

decreases expression

ISO

epoxiconazole results in decreased expression of ESYT1 mRNA

NCBI chr12:56,128,267...56,144,674
Ensembl chr12:56,118,250...56,144,674

G

embryonic testis differentiation homolog B

increases expression

ISO

epoxiconazole results in increased expression of ETD mRNA

NCBI chr X:135,118,955...135,120,526
Ensembl chr X:135,118,955...135,120,526

G

electron transfer flavoprotein subunit alpha

decreases expression

ISO

epoxiconazole results in decreased expression of ETFA mRNA

NCBI chr15:76,215,353...76,311,469
Ensembl chr15:76,188,555...76,311,730

G

electron transfer flavoprotein dehydrogenase

affects expression

ISO

epoxiconazole affects the expression of ETFDH mRNA

NCBI chr 4:158,672,296...158,709,623
Ensembl chr 4:158,671,968...158,710,758

G

electron transfer flavoprotein regulatory factor 1

increases expression

ISO

epoxiconazole results in increased expression of ETFRF1 mRNA

NCBI chr12:25,195,237...25,205,143
Ensembl chr12:25,194,775...25,209,645

G

ETHE1 persulfide dioxygenase

increases expression

ISO

epoxiconazole results in increased expression of ETHE1 mRNA

NCBI chr19:43,506,719...43,527,201
Ensembl chr19:43,506,719...43,527,257

G

ethanolamine kinase 2

decreases expression

ISO

epoxiconazole results in decreased expression of ETNK2 mRNA

NCBI chr 1:204,131,062...204,152,044
Ensembl chr 1:204,131,062...204,152,044

G

ethanolamine-phosphate phospho-lyase

decreases expression

ISO

epoxiconazole results in decreased expression of ETNPPL mRNA

NCBI chr 4:108,742,053...108,763,053
Ensembl chr 4:108,741,969...108,763,228

G

ETS proto-oncogene 2, transcription factor

decreases expression

ISO

epoxiconazole results in decreased expression of ETS2 mRNA

NCBI chr21:38,805,183...38,824,955
Ensembl chr21:38,805,115...38,824,956

G

ETS variant transcription factor 3

decreases expression

ISO

epoxiconazole results in decreased expression of ETV3 mRNA

NCBI chr 1:157,121,191...157,138,395
Ensembl chr 1:157,121,191...157,138,474

G

ETS variant transcription factor 5

decreases expression

ISO

epoxiconazole results in decreased expression of ETV5 mRNA

NCBI chr 3:186,046,314...186,109,089
Ensembl chr 3:186,046,314...186,110,318

G

ETS variant transcription factor 6

decreases expression

ISO

epoxiconazole results in decreased expression of ETV6 mRNA

NCBI chr12:11,649,674...11,895,377
Ensembl chr12:11,649,623...11,895,386

G

ecotropic viral integration site 5

increases expression

ISO

epoxiconazole results in increased expression of EVI5 mRNA

NCBI chr 1:92,508,696...92,792,410
Ensembl chr 1:92,508,696...92,792,416

G

exocyst complex component 1

decreases expression

ISO

epoxiconazole results in decreased expression of EXOC1 mRNA

NCBI chr 4:55,853,648...55,905,086
Ensembl chr 4:55,853,628...55,905,096

G

exocyst complex component 8

increases expression

ISO

epoxiconazole results in increased expression of EXOC8 mRNA

NCBI chr 1:231,332,753...231,337,852
Ensembl chr 1:231,332,753...231,337,852

G

exosome component 4

decreases expression

ISO

epoxiconazole results in decreased expression of EXOSC4 mRNA

NCBI chr 8:144,064,056...144,080,648
Ensembl chr 8:144,078,621...144,081,244

G

exosome component 8

increases expression

ISO

epoxiconazole results in increased expression of EXOSC8 mRNA

NCBI chr13:37,000,786...37,009,614
Ensembl chr13:36,998,816...37,025,881

G

exosome component 9

decreases expression

ISO

epoxiconazole results in decreased expression of EXOSC9 mRNA

NCBI chr 4:121,801,323...121,817,021
Ensembl chr 4:121,801,318...121,817,021

G

exostosin like glycosyltransferase 3

decreases expression

ISO

epoxiconazole results in decreased expression of EXTL3 mRNA

NCBI chr 8:28,607,736...28,756,562
Ensembl chr 8:28,600,469...28,756,561

G

coagulation factor X

increases expression

ISO

epoxiconazole results in increased expression of F10 mRNA

NCBI chr13:113,122,799...113,149,529
Ensembl chr13:113,122,788...113,149,531

G

coagulation factor II thrombin receptor

decreases expression

ISO

epoxiconazole results in decreased expression of F2R mRNA

NCBI chr 5:76,716,126...76,735,770
Ensembl chr 5:76,716,126...76,735,770

G

coagulation factor V

decreases expression

ISO

epoxiconazole results in decreased expression of F5 mRNA

NCBI chr 1:169,511,951...169,586,481
Ensembl chr 1:169,511,951...169,586,588

G

coagulation factor VII

decreases expression

ISO

epoxiconazole results in decreased expression of F7 mRNA

NCBI chr13:113,105,791...113,120,685
Ensembl chr13:113,105,762...113,120,685

G

coagulation factor VIII associated 2

increases expression

ISO

epoxiconazole results in increased expression of F8A mRNA

NCBI chr X:155,382,095...155,383,801
Ensembl chr X:155,382,095...155,383,801

G

coagulation factor IX

decreases expression

ISO

epoxiconazole results in decreased expression of F9 mRNA

NCBI chr X:139,530,739...139,563,459
Ensembl chr X:139,530,739...139,563,459

G

fatty acid amide hydrolase

decreases expression

ISO

epoxiconazole results in decreased expression of FAAH mRNA

NCBI chr 1:46,394,317...46,413,845
Ensembl chr 1:46,394,265...46,415,754

G

fatty acid binding protein 2

increases expression

ISO

epoxiconazole results in increased expression of FABP2 mRNA

NCBI chr 4:119,317,250...119,322,138
Ensembl chr 4:119,317,250...119,322,138

G

fatty acid binding protein 4

increases expression

ISO

epoxiconazole results in increased expression of FABP4 mRNA

NCBI chr 8:81,478,419...81,483,233
Ensembl chr 8:81,477,651...81,483,239

G

fatty acid binding protein 5

affects expression

ISO

epoxiconazole affects the expression of FABP5 mRNA

NCBI chr 8:81,280,536...81,284,775
Ensembl chr 8:81,280,535...81,284,777

G

fatty acid desaturase 2

decreases expression

ISO

epoxiconazole results in decreased expression of FADS2 mRNA

NCBI chr11:61,816,203...61,867,354
Ensembl chr11:61,792,980...61,867,354

G

fatty acid desaturase 6

decreases expression

ISO

epoxiconazole results in decreased expression of FADS6 mRNA

NCBI chr17:74,874,787...74,893,633
Ensembl chr17:74,877,295...74,893,781

G

fumarylacetoacetate hydrolase

decreases expression

ISO

epoxiconazole results in decreased expression of FAH mRNA

NCBI chr15:80,152,789...80,186,949
Ensembl chr15:80,152,292...80,186,990

G

fumarylacetoacetate hydrolase domain containing 2A

increases expression

ISO

epoxiconazole results in increased expression of FAHD2A mRNA

NCBI chr 2:95,402,708...95,421,656
Ensembl chr 2:95,402,691...95,416,616

G

family with sequence similarity 110 member D

decreases expression

ISO

epoxiconazole results in decreased expression of FAM110D mRNA

NCBI chr 1:26,159,079...26,163,962
Ensembl chr 1:26,159,047...26,163,962

G

family with sequence similarity 114 member A1

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of FAM114A1 mRNA
epoxiconazole results in decreased expression of FAM114A1 mRNA

PMID:22334560 PMID:35436446

NCBI chr 4:38,867,806...38,945,739
Ensembl chr 4:38,867,677...38,945,740

G

family with sequence similarity 114 member A2

decreases expression

ISO

epoxiconazole results in decreased expression of FAM114A2 mRNA

NCBI chr 5:153,990,148...154,038,910
Ensembl chr 5:153,990,148...154,038,936

G

family with sequence similarity 118 member A

decreases expression

ISO

epoxiconazole results in decreased expression of FAM118A mRNA

NCBI chr22:45,308,960...45,341,955
Ensembl chr22:45,308,968...45,342,824

G

family with sequence similarity 120 member B

decreases expression

ISO

epoxiconazole results in decreased expression of FAM120B mRNA

NCBI chr 6:170,290,703...170,407,067
Ensembl chr 6:170,290,703...170,407,067

G

family with sequence similarity 135 member A

increases expression

ISO

epoxiconazole results in increased expression of FAM135A mRNA

NCBI chr 6:70,413,508...70,561,174
Ensembl chr 6:70,412,941...70,561,608

G

family with sequence similarity 13 member A

decreases expression

ISO

epoxiconazole results in decreased expression of FAM13A mRNA

NCBI chr 4:88,725,960...89,057,185
Ensembl chr 4:88,725,955...89,111,398

G

family with sequence similarity 149 member A

increases expression

ISO

epoxiconazole results in increased expression of FAM149A mRNA

NCBI chr 4:186,104,704...186,175,337
Ensembl chr 4:186,104,419...186,175,337

G

family with sequence similarity 162 member A

increases expression

ISO

epoxiconazole results in increased expression of FAM162A mRNA

NCBI chr 3:122,384,182...122,412,334
Ensembl chr 3:122,384,161...122,412,334

G

family with sequence similarity 168 member A

decreases expression

ISO

epoxiconazole results in decreased expression of FAM168A mRNA

NCBI chr11:73,400,487...73,598,112
Ensembl chr11:73,400,487...73,598,189

G

family with sequence similarity 169 member A

increases expression

ISO

epoxiconazole results in increased expression of FAM169A mRNA

NCBI chr 5:74,777,574...74,866,966
Ensembl chr 5:74,777,574...74,867,022

G

family with sequence similarity 171 member A1

decreases expression

ISO

epoxiconazole results in decreased expression of FAM171A1 mRNA

NCBI chr10:15,211,643...15,374,554
Ensembl chr10:15,211,643...15,371,289

G

family with sequence similarity 171 member B

decreases expression

ISO

epoxiconazole results in decreased expression of FAM171B mRNA

NCBI chr 2:186,694,060...186,765,959
Ensembl chr 2:186,694,019...186,765,959

G

family with sequence similarity 174 member A

increases expression

ISO

epoxiconazole results in increased expression of FAM174A mRNA

NCBI chr 5:100,535,374...100,586,741
Ensembl chr 5:100,535,338...100,586,741

G

family with sequence similarity 180 member A

decreases expression

ISO

epoxiconazole results in decreased expression of FAM180A mRNA

NCBI chr 7:135,729,592...135,748,813
Ensembl chr 7:135,728,348...135,748,813

G

FAM20B glycosaminoglycan xylosylkinase

decreases expression

ISO

epoxiconazole results in decreased expression of FAM20B mRNA

NCBI chr 1:179,017,334...179,076,567
Ensembl chr 1:179,025,804...179,076,567

G

family with sequence similarity 222 member A

decreases expression

ISO

epoxiconazole results in decreased expression of FAM222A mRNA

NCBI chr12:109,713,825...109,770,495
Ensembl chr12:109,713,825...109,770,495

G

family with sequence similarity 227 member B

increases expression

ISO

epoxiconazole results in increased expression of FAM227B mRNA

NCBI chr15:49,326,970...49,620,818
Ensembl chr15:49,326,962...49,620,929

G

family with sequence similarity 234 member A

decreases expression

ISO

epoxiconazole results in decreased expression of FAM234A mRNA

NCBI chr16:234,821...269,963
Ensembl chr16:234,521...272,183

G

family with sequence similarity 240 member A

increases expression

ISO

epoxiconazole results in increased expression of FAM240A mRNA

NCBI chr 3:46,612,525...46,626,543
Ensembl chr 3:46,612,525...46,626,543

G

FAM3 metabolism regulating signaling molecule A

decreases expression

ISO

epoxiconazole results in decreased expression of FAM3A mRNA

NCBI chr X:154,506,171...154,516,232
Ensembl chr X:154,506,159...154,516,882

G

FAM3 metabolism regulating signaling molecule C

decreases expression

ISO

epoxiconazole results in decreased expression of FAM3C mRNA

NCBI chr 7:121,348,878...121,396,396
Ensembl chr 7:121,347,792...121,398,471

G

family with sequence similarity 47 member E

decreases expression

ISO

epoxiconazole results in decreased expression of FAM47E mRNA

NCBI chr 4:76,214,040...76,283,783
Ensembl chr 4:76,214,040...76,284,294

G

family with sequence similarity 50 member B

decreases expression

ISO

epoxiconazole results in decreased expression of FAM50B mRNA

NCBI chr 6:3,831,894...3,851,317
Ensembl chr 6:3,849,373...3,851,320

G

family with sequence similarity 53 member B

decreases expression

ISO

epoxiconazole results in decreased expression of FAM53B mRNA

NCBI chr10:124,619,292...124,744,378
Ensembl chr10:124,619,292...124,744,475

G

family with sequence similarity 72 member A

decreases expression

ISO

epoxiconazole results in decreased expression of FAM72A mRNA

NCBI chr 1:206,186,179...206,205,773
Ensembl chr 1:206,186,179...206,204,414

G

family with sequence similarity 78 member B

increases expression

ISO

epoxiconazole results in increased expression of FAM78B mRNA

NCBI chr 1:166,055,918...166,167,001
Ensembl chr 1:166,057,426...166,167,001

G

family with sequence similarity 98 member A

decreases expression

ISO

epoxiconazole results in decreased expression of FAM98A mRNA

NCBI chr 2:33,583,660...33,599,299
Ensembl chr 2:33,532,744...33,599,347

G

FA complementation group C

decreases expression

ISO

epoxiconazole results in decreased expression of FANCC mRNA

NCBI chr 9:95,099,054...95,317,709
Ensembl chr 9:95,099,054...95,426,796

G

FANCD2 opposite strand

increases expression

ISO

epoxiconazole results in increased expression of FANCD2OS mRNA

NCBI chr 3:10,081,320...10,108,457
Ensembl chr 3:10,081,317...10,108,255

G

FA complementation group L

decreases expression

ISO

epoxiconazole results in decreased expression of FANCL mRNA

NCBI chr 2:58,159,243...58,241,380
Ensembl chr 2:58,159,243...58,241,410

G

FA complementation group M

decreases expression

ISO

epoxiconazole results in decreased expression of FANCM mRNA

NCBI chr14:45,135,930...45,200,890
Ensembl chr14:45,135,909...45,200,890

G

FERM, ARH/RhoGEF and pleckstrin domain protein 1

increases expression

ISO

epoxiconazole results in increased expression of FARP1 mRNA

NCBI chr13:98,142,589...98,455,176
Ensembl chr13:98,142,165...98,455,176

G

phenylalanyl-tRNA synthetase subunit alpha

affects expression

ISO

epoxiconazole affects the expression of FARSA mRNA

NCBI chr19:12,922,479...12,933,711
Ensembl chr19:12,922,276...12,934,037

G

Fas cell surface death receptor

multiple interactions
increases expression

ISO

[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of FAS mRNA
epoxiconazole results in increased expression of FAS mRNA

PMID:29038839 PMID:35436446

NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605

G

fatty acid synthase

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of FASN mRNA
epoxiconazole results in decreased expression of FASN mRNA

PMID:29038839 PMID:35436446

NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294

G

FAST kinase domains 1

decreases expression

ISO

epoxiconazole results in decreased expression of FASTKD1 mRNA

NCBI chr 2:169,528,508...169,573,865
Ensembl chr 2:169,528,508...169,573,912

G

FAT atypical cadherin 1

decreases expression

ISO

epoxiconazole results in decreased expression of FAT1 mRNA

NCBI chr 4:186,587,794...186,726,696
Ensembl chr 4:186,587,791...186,726,722

G

FAT atypical cadherin 4

decreases expression

ISO

epoxiconazole results in decreased expression of FAT4 mRNA

NCBI chr 4:125,314,955...125,492,932
Ensembl chr 4:125,314,918...125,492,932

G

FAU ubiquitin like and ribosomal protein S30 fusion

increases expression

ISO

epoxiconazole results in increased expression of FAU mRNA

NCBI chr11:65,120,630...65,122,134
Ensembl chr11:65,120,626...65,122,221

G

Fas binding factor 1

affects expression

ISO

epoxiconazole affects the expression of FBF1 mRNA

NCBI chr17:75,909,574...75,941,042
Ensembl chr17:75,909,574...75,941,140

G

F-box DNA helicase 1

decreases expression

ISO

epoxiconazole results in decreased expression of FBH1 mRNA

NCBI chr10:5,889,572...5,937,593
Ensembl chr10:5,890,203...5,937,594

G

fibulin 5

decreases expression

ISO

epoxiconazole results in decreased expression of FBLN5 mRNA

NCBI chr14:91,869,411...91,947,694
Ensembl chr14:91,869,410...91,948,064

G

fructose-bisphosphatase 2

increases expression

ISO

epoxiconazole results in increased expression of FBP2 mRNA

NCBI chr 9:94,558,720...94,593,824
Ensembl chr 9:94,558,720...94,593,824

G

F-box and leucine rich repeat protein 15

decreases expression

ISO

epoxiconazole results in decreased expression of FBXL15 mRNA

NCBI chr10:102,420,836...102,423,136
Ensembl chr10:102,418,520...102,423,142

G

F-box and leucine rich repeat protein 3

increases expression

ISO

epoxiconazole results in increased expression of FBXL3 mRNA

NCBI chr13:77,005,260...77,027,159
Ensembl chr13:76,992,598...77,027,195

G

F-box protein 27

increases expression

ISO

epoxiconazole results in increased expression of FBXO27 mRNA

NCBI chr19:39,005,842...39,032,549
Ensembl chr19:38,990,714...39,033,773

G

F-box protein 43

decreases expression

ISO

epoxiconazole results in decreased expression of FBXO43 mRNA

NCBI chr 8:100,133,351...100,150,569
Ensembl chr 8:100,133,351...100,145,817

G

F-box protein 44

decreases expression

ISO

epoxiconazole results in decreased expression of FBXO44 mRNA

NCBI chr 1:11,654,407...11,663,327
Ensembl chr 1:11,650,618...11,663,327

G

F-box and WD repeat domain containing 10

decreases expression

ISO

epoxiconazole results in decreased expression of FBXW10 mRNA

NCBI chr17:18,744,054...18,779,349
Ensembl chr17:18,744,026...18,779,349

G

F-box and WD repeat domain containing 5

decreases expression

ISO

epoxiconazole results in decreased expression of FBXW5 mRNA

NCBI chr 9:136,940,435...136,944,738
Ensembl chr 9:136,940,435...136,944,762

G

F-box and WD repeat domain containing 9

decreases expression

ISO

epoxiconazole results in decreased expression of FBXW9 mRNA

NCBI chr19:12,688,916...12,696,631
Ensembl chr19:12,688,053...12,696,649

G

FCF1 rRNA-processing protein

increases expression

ISO

epoxiconazole results in increased expression of FCF1 mRNA

NCBI chr14:74,713,144...74,738,620
Ensembl chr14:74,713,144...74,738,620

G

Fc gamma receptor IIb

decreases expression

ISO

epoxiconazole results in decreased expression of FCGR2B mRNA

NCBI chr 1:161,647,243...161,678,654
Ensembl chr 1:161,662,803...161,679,490

G

Fc gamma receptor and transporter

decreases expression

ISO

epoxiconazole results in decreased expression of FCGRT mRNA

NCBI chr19:49,512,661...49,526,428
Ensembl chr19:49,506,806...49,526,917

G

FCH and double SH3 domains 1

increases expression

ISO

epoxiconazole results in increased expression of FCHSD1 mRNA

NCBI chr 5:141,639,302...141,651,418
Ensembl chr 5:141,639,302...141,651,430

G

farnesyl-diphosphate farnesyltransferase 1

increases expression

EXP

epoxiconazole results in increased expression of FDFT1 mRNA

NCBI chr 8:11,795,582...11,839,298
Ensembl chr 8:11,795,570...11,839,500

G

farnesyl diphosphate synthase

decreases expression

ISO

epoxiconazole results in decreased expression of FDPS mRNA

NCBI chr 1:155,308,866...155,320,665
Ensembl chr 1:155,304,786...155,320,666

G

fem-1 homolog A

decreases expression

ISO

epoxiconazole results in decreased expression of FEM1A mRNA

NCBI chr19:4,791,734...4,801,273
Ensembl chr19:4,791,734...4,801,273

G

fer-1 like family member 4 (pseudogene)

increases expression

ISO

epoxiconazole results in increased expression of FER1L4 mRNA

NCBI chr20:35,558,737...35,607,562
Ensembl chr20:35,558,866...35,607,494

G

fer-1 like family member 6

increases expression

ISO

epoxiconazole results in increased expression of FER1L6 mRNA

NCBI chr 8:123,851,987...124,120,061
Ensembl chr 8:123,851,987...124,120,061

G

fasciculation and elongation protein zeta 2

increases expression

ISO

epoxiconazole results in increased expression of FEZ2 mRNA

NCBI chr 2:36,552,258...36,598,168
Ensembl chr 2:36,531,805...36,646,087

G

fibroblast growth factor 1

decreases expression

ISO

epoxiconazole results in decreased expression of FGF1 mRNA

PMID:22334560 PMID:35436446

NCBI chr 5:142,592,178...142,698,070
Ensembl chr 5:142,592,166...142,698,070

G

fibroblast growth factor 18

increases expression

ISO

epoxiconazole results in increased expression of FGF18 mRNA

NCBI chr 5:171,419,647...171,457,626
Ensembl chr 5:171,419,645...171,457,626

G

fibroblast growth factor 21

decreases expression

ISO

epoxiconazole results in decreased expression of FGF21 mRNA

NCBI chr19:48,755,524...48,758,330
Ensembl chr19:48,755,524...48,758,333

G

fibroblast growth factor receptor 4

increases expression

ISO

epoxiconazole results in increased expression of FGFR4 mRNA

NCBI chr 5:177,086,915...177,098,144
Ensembl chr 5:177,086,456...177,098,151

G

fibroblast growth factor receptor like 1

decreases expression

ISO

epoxiconazole results in decreased expression of FGFRL1 mRNA

NCBI chr 4:1,010,212...1,026,898
Ensembl chr 4:1,008,649...1,026,901

G

FGGY carbohydrate kinase domain containing

decreases expression

ISO

epoxiconazole results in decreased expression of FGGY mRNA

NCBI chr 1:59,296,378...59,762,730
Ensembl chr 1:59,295,910...59,810,647

G

fibrinogen like 1

decreases expression

ISO

epoxiconazole results in decreased expression of FGL1 mRNA

NCBI chr 8:17,864,389...17,895,538
Ensembl chr 8:17,863,528...17,910,378

G

fumarate hydratase

increases expression

ISO

epoxiconazole results in increased expression of FH1 mRNA

NCBI chr 1:241,497,603...241,519,755
Ensembl chr 1:241,497,511...241,519,799

G

four and a half LIM domains 1

increases expression

ISO

epoxiconazole results in increased expression of FHL1 mRNA

NCBI chr X:136,146,702...136,211,359
Ensembl chr X:136,146,702...136,211,359

G

fidgetin, microtubule severing factor

increases expression

ISO

epoxiconazole results in increased expression of FIGN mRNA

NCBI chr 2:163,602,611...163,736,008
Ensembl chr 2:163,593,396...163,736,012

G

fission, mitochondrial 1

decreases expression

ISO

epoxiconazole results in decreased expression of FIS1 mRNA

NCBI chr 7:101,239,472...101,245,081
Ensembl chr 7:101,239,458...101,252,316

G

fat storage inducing transmembrane protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of FITM2 mRNA

NCBI chr20:44,302,840...44,311,202
Ensembl chr20:44,302,840...44,311,202

G

FKBP prolyl isomerase 10

increases expression

ISO

epoxiconazole results in increased expression of FKBP10 mRNA

NCBI chr17:41,813,004...41,823,213
Ensembl chr17:41,812,680...41,823,221

G

FKBP prolyl isomerase 14

increases expression

ISO

epoxiconazole results in increased expression of FKBP14 mRNA

NCBI chr 7:30,005,923...30,026,702
Ensembl chr 7:30,010,587...30,026,702

G

FKBP prolyl isomerase 2

affects expression

ISO

epoxiconazole affects the expression of FKBP2 mRNA

NCBI chr11:64,241,095...64,244,135
Ensembl chr11:64,241,003...64,244,132

G

FKBP prolyl isomerase 3

increases expression

ISO

epoxiconazole results in increased expression of FKBP3 mRNA

NCBI chr14:45,115,599...45,134,481
Ensembl chr14:45,115,599...45,135,319

G

FKBP prolyl isomerase 4

decreases expression

ISO

epoxiconazole results in decreased expression of FKBP4 mRNA

NCBI chr12:2,794,970...2,805,423
Ensembl chr12:2,794,290...2,805,423

G

FKBP prolyl isomerase 5

affects expression

ISO

epoxiconazole affects the expression of FKBP5 mRNA

NCBI chr 6:35,573,590...35,728,583
Ensembl chr 6:35,572,945...35,728,622

G

FKBP prolyl isomerase 7

decreases expression

ISO

epoxiconazole results in decreased expression of FKBP7 mRNA

NCBI chr 2:178,463,664...178,478,600
Ensembl chr 2:178,463,664...178,478,600

G

FKBP prolyl isomerase 8

decreases expression

ISO

epoxiconazole results in decreased expression of FKBP8 mRNA

NCBI chr19:18,531,763...18,543,573
Ensembl chr19:18,531,751...18,544,264

G

fukutin

decreases expression

ISO

epoxiconazole results in decreased expression of FKTN mRNA

NCBI chr 9:105,558,130...105,641,118
Ensembl chr 9:105,558,122...105,653,820

G

FLII actin remodeling protein

decreases expression

ISO

epoxiconazole results in decreased expression of FLII mRNA

NCBI chr17:18,244,815...18,259,022
Ensembl chr17:18,244,782...18,258,772

G

filamin A

decreases expression

ISO

epoxiconazole results in decreased expression of FLNA mRNA

NCBI chr X:154,348,531...154,374,634
Ensembl chr X:154,348,524...154,374,638

G

fibronectin leucine rich transmembrane protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of FLRT1 mRNA

NCBI chr11:64,035,931...64,119,171
Ensembl chr11:64,035,931...64,119,173

G

fibronectin leucine rich transmembrane protein 2

increases expression

ISO

epoxiconazole results in increased expression of FLRT2 mRNA

NCBI chr14:85,530,144...85,654,428
Ensembl chr14:85,530,017...85,654,428

G

FLVCR choline and putative heme transporter 2

increases expression

ISO

epoxiconazole results in increased expression of FLVCR2 mRNA

NCBI chr14:75,578,620...75,648,167
Ensembl chr14:75,578,594...75,663,214

G

FLYWCH-type zinc finger 1

decreases expression

ISO

epoxiconazole results in decreased expression of FLYWCH1 mRNA

NCBI chr16:2,911,931...2,951,208
Ensembl chr16:2,911,599...2,951,208

G

formation of mitochondrial complex V assembly factor 1 homolog

increases expression

ISO

epoxiconazole results in increased expression of FMC1 mRNA

NCBI chr 7:139,340,472...139,346,328
Ensembl chr 7:139,339,457...139,346,328

G

flavin containing dimethylaniline monoxygenase 3

decreases expression

ISO

epoxiconazole results in decreased expression of FMO3 mRNA

NCBI chr 1:171,090,905...171,117,819
Ensembl chr 1:171,085,113...171,118,675

G

flavin containing dimethylaniline monoxygenase 4

decreases expression

ISO

epoxiconazole results in decreased expression of FMO4 mRNA

NCBI chr 1:171,314,183...171,342,084
Ensembl chr 1:171,314,091...171,343,741

G

flavin containing dimethylaniline monoxygenase 5

decreases expression

ISO

epoxiconazole results in decreased expression of FMO5 mRNA

NCBI chr 1:147,184,305...147,227,284
Ensembl chr 1:147,175,351...147,243,050

G

fragile X messenger ribonucleoprotein 1

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of FMR1 mRNA

NCBI chr X:147,911,919...147,951,125
Ensembl chr X:147,911,858...147,951,125

G

fructosamine 3 kinase related protein

decreases expression

ISO

epoxiconazole results in decreased expression of FN3KRP mRNA

NCBI chr17:82,716,706...82,728,013
Ensembl chr17:82,716,706...82,730,328

G

folliculin interacting protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of FNIP2 mRNA

NCBI chr 4:158,769,026...158,908,050
Ensembl chr 4:158,769,026...158,908,050

G

Fos proto-oncogene, AP-1 transcription factor subunit

increases expression

ISO

epoxiconazole results in increased expression of FOS mRNA

NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190

G

FosB proto-oncogene, AP-1 transcription factor subunit

increases expression

ISO

epoxiconazole results in increased expression of FOSB mRNA

NCBI chr19:45,467,996...45,475,179
Ensembl chr19:45,467,995...45,475,179

G

forkhead box A1

decreases expression

ISO

epoxiconazole results in decreased expression of FOXA1 mRNA

NCBI chr14:37,589,552...37,595,249
Ensembl chr14:37,589,552...37,596,059

G

forkhead box A2

decreases expression

ISO

epoxiconazole results in decreased expression of FOXA2 mRNA

NCBI chr20:22,580,998...22,585,490
Ensembl chr20:22,580,998...22,585,455

G

forkhead box A3

increases expression

ISO

epoxiconazole results in increased expression of FOXA3 mRNA

NCBI chr19:45,864,326...45,873,797
Ensembl chr19:45,863,989...45,873,798

G

forkhead box G1

decreases expression

ISO

epoxiconazole results in decreased expression of FOXG1 mRNA

NCBI chr14:28,766,787...28,770,277
Ensembl chr14:28,764,329...28,770,277

G

forkhead box I3

increases expression

ISO

epoxiconazole results in increased expression of FOXI3 mRNA

NCBI chr 2:88,446,787...88,452,693
Ensembl chr 2:88,446,787...88,452,693

G

forkhead box K1

decreases expression

ISO

epoxiconazole results in decreased expression of FOXK1 mRNA

NCBI chr 7:4,682,295...4,771,442
Ensembl chr 7:4,682,295...4,771,442

G

forkhead box O1

decreases expression

ISO

epoxiconazole results in decreased expression of FOXO1 mRNA

NCBI chr13:40,555,667...40,666,641
Ensembl chr13:40,555,667...40,667,612

G

forkhead box O3

decreases expression

ISO

epoxiconazole results in decreased expression of FOXO3 mRNA

NCBI chr 6:108,559,825...108,684,774
Ensembl chr 6:108,559,652...108,684,774

G

forkhead box P2

decreases expression

ISO

epoxiconazole results in decreased expression of FOXP2 mRNA

NCBI chr 7:114,086,327...114,693,765
Ensembl chr 7:114,086,317...114,693,772

G

forkhead box Q1

decreases expression

ISO

epoxiconazole results in decreased expression of FOXQ1 mRNA

NCBI chr 6:1,312,098...1,314,758
Ensembl chr 6:1,312,098...1,314,758

G

forkhead box R2

increases expression

ISO

epoxiconazole results in increased expression of FOXR2 mRNA

NCBI chr X:55,623,400...55,626,192
Ensembl chr X:55,623,400...55,626,192

G

FAD dependent oxidoreductase domain containing 1

decreases expression

ISO

epoxiconazole results in decreased expression of FOXRED1 mRNA

NCBI chr11:126,269,154...126,278,126
Ensembl chr11:126,269,024...126,278,132

G

formyl peptide receptor 1

increases expression

ISO

epoxiconazole results in increased expression of FPR1 mRNA

NCBI chr19:51,745,172...51,751,878
Ensembl chr19:51,745,172...51,804,115

G

FSHD region gene 1

increases expression

ISO

epoxiconazole results in increased expression of FRG1 mRNA

NCBI chr 4:189,940,872...189,963,192
Ensembl chr 4:189,940,842...189,963,207

G

FERM domain containing 4B

decreases expression

ISO

epoxiconazole results in decreased expression of FRMD4B mRNA

NCBI chr 3:69,168,782...69,542,586
Ensembl chr 3:69,168,782...69,542,583

G

FERM domain containing 5

increases expression

ISO

epoxiconazole results in increased expression of FRMD5 mRNA

NCBI chr15:43,870,764...44,199,473
Ensembl chr15:43,870,761...44,195,271

G

FERM and PDZ domain containing 3

decreases expression

ISO

epoxiconazole results in decreased expression of FRMPD3 mRNA

NCBI chr X:107,449,652...107,605,251
Ensembl chr X:107,449,652...107,605,255

G

follistatin

affects expression

ISO

epoxiconazole affects the expression of FST mRNA

NCBI chr 5:53,480,629...53,487,134
Ensembl chr 5:53,480,210...53,487,134

G

formimidoyltransferase cyclodeaminase

decreases expression

ISO

epoxiconazole results in decreased expression of FTCD mRNA

NCBI chr21:46,136,262...46,155,579
Ensembl chr21:46,136,083...46,155,581

G

FTO alpha-ketoglutarate dependent dioxygenase

decreases expression

ISO

epoxiconazole results in decreased expression of FTO mRNA

NCBI chr16:53,703,963...54,121,941
Ensembl chr16:53,701,692...54,158,512

G

FtsJ RNA 2'-O-methyltransferase 3

decreases expression

ISO

epoxiconazole results in decreased expression of FTSJ3 mRNA

NCBI chr17:63,819,433...63,827,663
Ensembl chr17:63,819,433...63,830,012

G

fucosyltransferase 11

decreases expression

ISO

epoxiconazole results in decreased expression of POFUT4 mRNA

NCBI chr10:73,772,276...73,780,254
Ensembl chr10:73,772,276...73,780,251

G

frataxin

increases expression

ISO

epoxiconazole results in increased expression of FXN mRNA

NCBI chr 9:69,035,752...69,079,076
Ensembl chr 9:69,035,750...69,079,076

G

FXYD domain containing ion transport regulator 7

increases expression

ISO

epoxiconazole results in increased expression of FXYD7 mRNA

NCBI chr19:35,143,255...35,154,302
Ensembl chr19:35,143,148...35,154,302

G

FYN proto-oncogene, Src family tyrosine kinase

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of FYN mRNA

NCBI chr 6:111,660,332...111,873,452
Ensembl chr 6:111,660,332...111,873,475

G

frizzled class receptor 3

increases expression

ISO

epoxiconazole results in increased expression of FZD3 mRNA

NCBI chr 8:28,494,212...28,574,258
Ensembl chr 8:28,494,205...28,574,267

G

frizzled class receptor 4

decreases expression

ISO

epoxiconazole results in decreased expression of FZD4 mRNA

NCBI chr11:86,945,679...86,955,395
Ensembl chr11:86,945,679...86,955,395

G

frizzled class receptor 5

increases expression

ISO

epoxiconazole results in increased expression of FZD5 mRNA

NCBI chr 2:207,762,598...207,769,906
Ensembl chr 2:207,762,598...207,769,914

G

frizzled class receptor 6

increases expression

ISO

epoxiconazole results in increased expression of FZD6 mRNA

NCBI chr 8:103,298,494...103,332,866
Ensembl chr 8:103,298,433...103,332,866

G

frizzled class receptor 7

increases expression

ISO

epoxiconazole results in increased expression of FZD7 mRNA

NCBI chr 2:202,033,855...202,038,441
Ensembl chr 2:202,033,855...202,038,441

G

frizzled class receptor 8

decreases expression

ISO

epoxiconazole results in decreased expression of FZD8 mRNA

NCBI chr10:35,638,247...35,642,296
Ensembl chr10:35,638,247...35,642,296

G

fizzy and cell division cycle 20 related 1

decreases expression

ISO

epoxiconazole results in decreased expression of FZR1 mRNA

NCBI chr19:3,506,311...3,538,334
Ensembl chr19:3,506,277...3,538,334

G

G0/G1 switch 2

increases expression

ISO

epoxiconazole results in increased expression of G0S2 mRNA

NCBI chr 1:209,675,412...209,676,390
Ensembl chr 1:209,675,412...209,676,390

G

G3BP stress granule assembly factor 2

increases expression

ISO

epoxiconazole results in increased expression of G3BP2 mRNA

NCBI chr 4:75,642,786...75,724,437
Ensembl chr 4:75,641,849...75,726,301

G

glucose-6-phosphatase catalytic subunit 1

decreases expression

EXP
ISO

epoxiconazole results in decreased expression of G6PC1 mRNA

PMID:32194361 PMID:35436446

NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438

G

glucose-6-phosphatase catalytic subunit 3

decreases expression

ISO

epoxiconazole results in decreased expression of G6PC3 mRNA

NCBI chr17:44,070,673...44,076,344
Ensembl chr17:44,070,620...44,082,151

G

alpha glucosidase

decreases expression

ISO

epoxiconazole results in decreased expression of GAA mRNA

NCBI chr17:80,101,581...80,119,881
Ensembl chr17:80,101,533...80,119,881

G

GRB2 associated binding protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of GAB1 mRNA

NCBI chr 4:143,336,876...143,474,565
Ensembl chr 4:143,336,402...143,474,565

G

gamma-aminobutyric acid type B receptor subunit 2

decreases expression

ISO

epoxiconazole results in decreased expression of GABBR2 mRNA

NCBI chr 9:98,288,109...98,708,935
Ensembl chr 9:98,288,096...98,709,739

G

gamma-aminobutyric acid type A receptor subunit alpha1

increases expression

ISO

epoxiconazole results in increased expression of GABRA1 mRNA

NCBI chr 5:161,847,191...161,899,971
Ensembl chr 5:161,847,063...161,899,981

G

gamma-aminobutyric acid type A receptor subunit alpha2

increases expression

ISO

epoxiconazole results in increased expression of GABRA2 mRNA

NCBI chr 4:46,243,548...46,390,300
Ensembl chr 4:46,243,548...46,475,230

G

gamma-aminobutyric acid type A receptor subunit alpha4

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GABRA4 mRNA

NCBI chr 4:46,918,900...46,993,581
Ensembl chr 4:46,918,900...46,993,581

G

gamma-aminobutyric acid type A receptor subunit beta1

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GABRB1 mRNA

NCBI chr 4:46,993,647...47,426,447
Ensembl chr 4:46,993,723...47,426,447

G

growth arrest and DNA damage inducible beta

increases expression
affects expression

ISO

epoxiconazole results in increased expression of GADD45B mRNA
epoxiconazole affects the expression of GADD45B mRNA

PMID:22334560 PMID:23970803 PMID:35436446

NCBI chr19:2,476,127...2,478,257
Ensembl chr19:2,476,122...2,478,805

G

growth arrest and DNA damage inducible gamma

decreases expression

ISO

epoxiconazole results in decreased expression of GADD45G mRNA

NCBI chr 9:89,605,012...89,606,555
Ensembl chr 9:89,605,012...89,606,555

G

galactose-3-O-sulfotransferase 1

increases expression

ISO

epoxiconazole results in increased expression of GAL3ST1 mRNA

NCBI chr22:30,554,635...30,574,665
Ensembl chr22:30,554,632...30,576,210

G

galactose-3-O-sulfotransferase 2

increases expression

ISO

epoxiconazole results in increased expression of GAL3ST2 mRNA

NCBI chr 2:241,776,822...241,804,287
Ensembl chr 2:241,776,822...241,804,287

G

galactose mutarotase

decreases expression

ISO

epoxiconazole results in decreased expression of GALM mRNA

NCBI chr 2:38,666,114...38,734,765
Ensembl chr 2:38,666,081...38,741,237

G

galactosamine (N-acetyl)-6-sulfatase

decreases expression

ISO

epoxiconazole results in decreased expression of GALNS mRNA

NCBI chr16:88,813,734...88,856,947
Ensembl chr16:88,813,733...88,856,970

G

polypeptide N-acetylgalactosaminyltransferase 11

decreases expression

ISO

epoxiconazole results in decreased expression of GALNT11 mRNA

NCBI chr 7:152,025,674...152,122,340
Ensembl chr 7:152,025,626...152,122,347

G

polypeptide N-acetylgalactosaminyltransferase 18

increases expression

ISO

epoxiconazole results in increased expression of GALNT18 mRNA

NCBI chr11:11,270,877...11,622,005
Ensembl chr11:11,270,864...11,622,431

G

polypeptide N-acetylgalactosaminyltransferase 4

decreases expression

ISO

epoxiconazole results in decreased expression of GALNT4 mRNA

NCBI chr12:89,519,412...89,524,796
Ensembl chr12:89,519,412...89,524,796

G

polypeptide N-acetylgalactosaminyltransferase 9

decreases expression

ISO

epoxiconazole results in decreased expression of GALNT9 mRNA

NCBI chr12:132,196,372...132,329,589
Ensembl chr12:132,196,372...132,329,598

G

guanidinoacetate N-methyltransferase

decreases expression

ISO

epoxiconazole results in decreased expression of GAMT mRNA

NCBI chr19:1,397,026...1,401,542
Ensembl chr19:1,397,026...1,401,570

G

glucosidase II alpha subunit

decreases expression

ISO

epoxiconazole results in decreased expression of GANAB mRNA

NCBI chr11:62,624,829...62,646,613
Ensembl chr11:62,624,824...62,646,726

G

growth arrest specific 2 like 3

increases expression

ISO

epoxiconazole results in increased expression of GAS2L3 mRNA

NCBI chr12:100,573,684...100,628,288
Ensembl chr12:100,573,681...100,628,288

G

growth arrest specific 8

decreases expression

ISO

epoxiconazole results in decreased expression of GAS8 mRNA

NCBI chr16:90,019,633...90,044,960
Ensembl chr16:90,019,629...90,044,975

G

golgi associated kinase 1A

increases expression

ISO

epoxiconazole results in increased expression of GASK1A mRNA

NCBI chr 3:42,979,311...43,057,715
Ensembl chr 3:42,979,087...43,067,898

G

GATA zinc finger domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of GATAD1 mRNA

NCBI chr 7:92,447,482...92,495,769
Ensembl chr 7:92,447,482...92,460,075

G

GATA zinc finger domain containing 2B

increases expression

ISO

epoxiconazole results in increased expression of GATAD2B mRNA

NCBI chr 1:153,804,725...153,922,972
Ensembl chr 1:153,789,030...153,923,360

G

guanylate binding protein family member 6

decreases expression

ISO

epoxiconazole results in decreased expression of GBP9 mRNA

NCBI chr 1:89,364,059...89,388,160
Ensembl chr 1:89,363,895...89,388,160

G

guanylate binding protein 7

decreases expression

ISO

epoxiconazole results in decreased expression of GBP7 mRNA

NCBI chr 1:89,131,742...89,176,003
Ensembl chr 1:89,131,742...89,176,062

G

GTP cyclohydrolase 1

increases expression

ISO

epoxiconazole results in increased expression of GCH1 mRNA

NCBI chr14:54,842,017...54,902,826
Ensembl chr14:54,842,008...54,903,280

G

GTP cyclohydrolase I feedback regulator

increases expression

ISO

epoxiconazole results in increased expression of GCHFR mRNA

NCBI chr15:40,764,068...40,767,708
Ensembl chr15:40,764,068...40,767,708

G

glucokinase

decreases expression

ISO

epoxiconazole results in decreased expression of GCK mRNA

NCBI chr 7:44,143,213...44,189,439
Ensembl chr 7:44,143,213...44,198,170

G

glutamate-cysteine ligase catalytic subunit

increases expression

ISO

epoxiconazole results in increased expression of GCLC mRNA

NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970

G

glucosaminyl (N-acetyl) transferase 2 (I blood group)

decreases expression

ISO

epoxiconazole results in decreased expression of GCNT2 mRNA

NCBI chr 6:10,521,351...10,629,368
Ensembl chr 6:10,492,223...10,629,368

G

glycerophosphodiester phosphodiesterase 1

decreases expression

ISO

epoxiconazole results in decreased expression of GDE1 mRNA

NCBI chr16:19,501,693...19,522,098
Ensembl chr16:19,501,693...19,522,123

G

growth differentiation factor 10

affects expression

ISO

epoxiconazole affects the expression of GDF10 mRNA

NCBI chr10:47,300,197...47,313,577
Ensembl chr10:47,300,171...47,313,577

G

growth differentiation factor 15

decreases expression

ISO

epoxiconazole results in decreased expression of GDF15 mRNA

NCBI chr19:18,386,158...18,389,176
Ensembl chr19:18,374,731...18,389,176

G

growth differentiation factor 9

increases expression

ISO

epoxiconazole results in increased expression of GDF9 mRNA

NCBI chr 5:132,861,185...132,866,651
Ensembl chr 5:132,861,181...132,866,884

G

glial cell derived neurotrophic factor

decreases expression
multiple interactions

ISO

epoxiconazole results in decreased expression of GDNF mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GDNF mRNA

PMID:25607892 PMID:35436446

NCBI chr 5:37,812,677...37,840,041
Ensembl chr 5:37,812,677...37,840,041

G

GDP-D-glucose phosphorylase 1

increases expression

ISO

epoxiconazole results in increased expression of GDPGP1 mRNA

NCBI chr15:90,234,209...90,245,811
Ensembl chr15:90,233,471...90,245,811

G

gem nuclear organelle associated protein 5

decreases expression

ISO

epoxiconazole results in decreased expression of GEMIN5 mRNA

NCBI chr 5:154,887,411...154,938,211
Ensembl chr 5:154,887,411...154,938,211

G

growth factor, augmenter of liver regeneration

increases expression

ISO

epoxiconazole results in increased expression of GFER mRNA

NCBI chr16:1,984,193...1,987,749
Ensembl chr16:1,984,193...1,987,749

G

glutamine-fructose-6-phosphate transaminase 2

decreases expression

ISO

epoxiconazole results in decreased expression of GFPT2 mRNA

NCBI chr 5:180,300,698...180,353,336
Ensembl chr 5:180,300,682...180,353,339

G

GDNF family receptor alpha 1

decreases expression

ISO

epoxiconazole results in decreased expression of GFRA1 mRNA

NCBI chr10:116,056,925...116,274,705
Ensembl chr10:116,056,925...116,276,803

G

gamma-glutamyl carboxylase

decreases expression

ISO

epoxiconazole results in decreased expression of GGCX mRNA

NCBI chr 2:85,544,720...85,561,493
Ensembl chr 2:85,544,720...85,561,819

G

growth hormone receptor

decreases expression

ISO

epoxiconazole results in decreased expression of GHR mRNA

NCBI chr 5:42,423,439...42,721,878
Ensembl chr 5:42,423,439...42,721,878

G

GRB10 interacting GYF protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of GIGYF2 mRNA

NCBI chr 2:232,697,331...232,860,605
Ensembl chr 2:232,697,259...232,860,605

G

GIMAP family P-loop NTPase domain containing 1

decreases expression

ISO

epoxiconazole results in decreased expression of GIMD1 mRNA

NCBI chr 4:106,357,392...106,368,778
Ensembl chr 4:106,357,392...106,368,778

G

GINS complex subunit 1

decreases expression

ISO

epoxiconazole results in decreased expression of GINS1 mRNA

NCBI chr20:25,407,673...25,448,563
Ensembl chr20:25,391,008...25,452,700

G

GIPC PDZ domain containing family member 2

increases expression

ISO

epoxiconazole results in increased expression of GIPC2 mRNA

NCBI chr 1:78,044,970...78,138,444
Ensembl chr 1:77,979,542...78,138,448

G

GIT ArfGAP 1

decreases expression

ISO

epoxiconazole results in decreased expression of GIT1 mRNA

NCBI chr17:29,573,475...29,589,648
Ensembl chr17:29,573,475...29,594,054

G

gap junction protein alpha 6, pseudogene

increases expression

ISO

epoxiconazole results in increased expression of GJA6 mRNA

NCBI chr X:18,534,866...18,535,789
Ensembl chr X:18,535,079...18,536,120

G

gap junction protein gamma 3

increases expression

ISO

epoxiconazole results in increased expression of GJC3 mRNA

NCBI chr 7:99,923,266...99,930,747
Ensembl chr 7:99,923,266...99,929,620

G

glycerol kinase

increases expression

ISO

epoxiconazole results in increased expression of GK mRNA

NCBI chr X:30,653,423...30,731,462
Ensembl chr X:30,653,359...30,731,462

G

galactosidase beta 1 like

decreases expression

ISO

epoxiconazole results in decreased expression of GLB1L mRNA

NCBI chr 2:219,236,598...219,245,444
Ensembl chr 2:219,236,598...219,245,478

G

glycine decarboxylase

affects expression

ISO

epoxiconazole affects the expression of GLDC mRNA

NCBI chr 9:6,532,467...6,645,729
Ensembl chr 9:6,532,467...6,645,729

G

GLE1 RNA export mediator

increases expression

ISO

epoxiconazole results in increased expression of GLE1 mRNA

NCBI chr 9:128,504,692...128,542,288
Ensembl chr 9:128,504,655...128,543,874

G

GLI family zinc finger 3

decreases expression

ISO

epoxiconazole results in decreased expression of GLI3 mRNA

NCBI chr 7:41,960,949...42,264,268
Ensembl chr 7:41,960,949...42,264,265

G

glycosylated lysosomal membrane protein

decreases expression

ISO

epoxiconazole results in decreased expression of GLMP mRNA

NCBI chr 1:156,292,688...156,295,679
Ensembl chr 1:156,290,089...156,295,689

G

glycine receptor alpha 3

increases expression

ISO

epoxiconazole results in increased expression of GLRA3 mRNA

NCBI chr 4:174,636,920...174,829,247
Ensembl chr 4:174,636,920...174,829,247

G

glutaredoxin

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of GLRX mRNA
epoxiconazole results in decreased expression of GLRX mRNA

PMID:22334560 PMID:35436446

NCBI chr 5:95,813,849...95,822,726
Ensembl chr 5:95,751,319...95,822,734

G

glutaredoxin 5

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of GLRX5 mRNA
epoxiconazole results in decreased expression of GLRX5 mRNA

PMID:22334560 PMID:35436446

NCBI chr14:95,535,050...95,544,714
Ensembl chr14:95,533,503...95,544,724

G

glutaminase

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GLS mRNA

NCBI chr 2:190,880,821...190,965,552
Ensembl chr 2:190,880,821...190,965,552

G

glutaminase 2

decreases expression

ISO

epoxiconazole results in decreased expression of GLS2 mRNA

NCBI chr12:56,470,952...56,488,161
Ensembl chr12:56,470,945...56,488,414

G

glycolipid transfer protein domain containing 2

decreases expression

ISO

epoxiconazole results in decreased expression of GLTPD2 mRNA

NCBI chr17:4,788,964...4,790,589
Ensembl chr17:4,788,964...4,790,589

G

glutamate dehydrogenase 1

decreases expression

ISO

epoxiconazole results in decreased expression of GLUD1 mRNA

NCBI chr10:87,050,202...87,094,843
Ensembl chr10:87,050,202...87,095,049

G

glycosylation dependent cell adhesion molecule 1 (pseudogene)

increases expression

ISO

epoxiconazole results in increased expression of GLYCAM1 mRNA

NCBI chr12:54,608,187...54,610,462
Ensembl chr12:54,608,187...54,610,462
Ensembl chr12:54,608,187...54,610,462

G

glycerate kinase

decreases expression

ISO

epoxiconazole results in decreased expression of GLYCTK mRNA

NCBI chr 3:52,287,828...52,295,257
Ensembl chr 3:52,286,945...52,295,273

G

GDP-mannose 4,6-dehydratase

increases expression

ISO

epoxiconazole results in increased expression of GMDS mRNA

NCBI chr 6:1,623,806...2,245,605
Ensembl chr 6:1,623,793...2,245,702

G

glucocorticoid modulatory element binding protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of GMEB1 mRNA

NCBI chr 1:28,668,229...28,719,353
Ensembl chr 1:28,668,280...28,719,353

G

glia maturation factor gamma

increases expression

ISO

epoxiconazole results in increased expression of GMFG mRNA

NCBI chr19:39,328,359...39,336,043
Ensembl chr19:39,328,353...39,342,372

G

geminin DNA replication inhibitor

affects expression

ISO

epoxiconazole affects the expression of GMNN mRNA

NCBI chr 6:24,774,937...24,786,099
Ensembl chr 6:24,774,892...24,786,103

G

GDP-mannose pyrophosphorylase A

decreases expression

ISO

epoxiconazole results in decreased expression of GMPPA mRNA

NCBI chr 2:219,498,891...219,506,989
Ensembl chr 2:219,498,618...219,513,898

G

G protein subunit alpha 12

decreases expression

ISO

epoxiconazole results in decreased expression of GNA12 mRNA

NCBI chr 7:2,728,105...2,844,308
Ensembl chr 7:2,721,822...2,870,786

G

G protein subunit alpha L

decreases expression

ISO

epoxiconazole results in decreased expression of GNAL mRNA

NCBI chr18:11,689,264...11,885,685
Ensembl chr18:11,689,264...11,885,685

G

G protein subunit alpha o1

increases expression

ISO

epoxiconazole results in increased expression of GNAO1 mRNA

NCBI chr16:56,191,489...56,357,444
Ensembl chr16:56,189,660...56,357,444

G

GNAS complex locus

decreases expression

ISO

epoxiconazole results in decreased expression of GNAS mRNA

NCBI chr20:58,839,748...58,911,192
Ensembl chr20:58,839,718...58,911,192

G

G protein subunit alpha z

decreases expression

ISO

epoxiconazole results in decreased expression of GNAZ mRNA

NCBI chr22:23,070,519...23,125,032
Ensembl chr22:23,070,325...23,125,036

G

G protein subunit gamma 5

increases expression

ISO

epoxiconazole results in increased expression of GNG5 mRNA

NCBI chr 1:84,498,325...84,506,581
Ensembl chr 1:84,498,284...84,507,237

G

G protein nucleolar 3 like

decreases expression

ISO

epoxiconazole results in decreased expression of GNL3L mRNA

NCBI chr X:54,530,219...54,645,854
Ensembl chr X:54,529,900...54,621,565

G

glucosamine-6-phosphate deaminase 2

increases expression

ISO

epoxiconazole results in increased expression of GNPDA2 mRNA

NCBI chr 4:44,701,795...44,726,556
Ensembl chr 4:44,682,200...44,726,588

G

golgin A1

increases expression

ISO

epoxiconazole results in increased expression of GOLGA1 mRNA

NCBI chr 9:124,878,275...124,948,043
Ensembl chr 9:124,878,275...124,948,492

G

golgin A3

decreases expression

ISO

epoxiconazole results in decreased expression of GOLGA3 mRNA

NCBI chr12:132,768,914...132,829,081
Ensembl chr12:132,768,902...132,829,143

G

golgin A5

increases expression

ISO

epoxiconazole results in increased expression of GOLGA5 mRNA

NCBI chr14:92,794,305...92,839,947
Ensembl chr14:92,794,230...92,839,963

G

golgin A6 family like 9

increases expression

ISO

epoxiconazole results in increased expression of CCDC202 mRNA

NCBI chr15:82,415,923...82,439,153
Ensembl chr15:82,429,816...82,439,153

G

gon-4 like

decreases expression

ISO

epoxiconazole results in decreased expression of GON4L mRNA

NCBI chr 1:155,745,112...155,859,431
Ensembl chr 1:155,749,659...155,859,400

G

golgi reassembly stacking protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of GORASP1 mRNA

NCBI chr 3:39,096,599...39,107,627
Ensembl chr 3:39,095,222...39,108,369

G

glutamic-oxaloacetic transaminase 1

decreases expression

ISO

epoxiconazole results in decreased expression of GOT1 mRNA

NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,671

G

glycoprotein V platelet

increases expression

ISO

epoxiconazole results in increased expression of GP5 mRNA

NCBI chr 3:194,394,821...194,399,266
Ensembl chr 3:194,394,821...194,399,266

G

glycosylphosphatidylinositol anchor attachment 1

decreases expression

ISO

epoxiconazole results in decreased expression of GPAA1 mRNA

NCBI chr 8:144,082,634...144,086,216
Ensembl chr 8:144,082,337...144,093,149

G

glycerol-3-phosphate acyltransferase, mitochondrial

decreases expression

ISO

epoxiconazole results in decreased expression of GPAM mRNA

NCBI chr10:112,149,865...112,227,677
Ensembl chr10:112,149,865...112,215,416

G

G-patch domain containing 11

decreases expression

ISO

epoxiconazole results in decreased expression of GPATCH11 mRNA

NCBI chr 2:37,084,518...37,099,244
Ensembl chr 2:37,084,482...37,099,244

G

G-patch domain containing 2 like

increases expression

ISO

epoxiconazole results in increased expression of GPATCH2L mRNA

NCBI chr14:76,151,922...76,235,555
Ensembl chr14:76,151,916...76,254,342

G

G-patch domain containing 4 (gene/pseudogene)

affects expression

ISO

epoxiconazole affects the expression of GPATCH4 mRNA

NCBI chr 1:156,594,301...156,601,479
Ensembl chr 1:156,594,301...156,601,496

G

glypican 1

decreases expression
increases expression

ISO

epoxiconazole results in decreased expression of GPC1 mRNA
epoxiconazole results in increased expression of GPC1 mRNA

PMID:28454766 PMID:35436446

NCBI chr 2:240,435,663...240,468,076
Ensembl chr 2:240,435,636...240,468,076

G

glypican 5

increases expression

ISO

epoxiconazole results in increased expression of GPC5 mRNA

NCBI chr13:91,398,621...92,867,237
Ensembl chr13:91,398,621...92,873,682

G

glycerophosphocholine phosphodiesterase 1

decreases expression

ISO

epoxiconazole results in decreased expression of GPCPD1 mRNA

NCBI chr20:5,544,439...5,611,006
Ensembl chr20:5,544,404...5,611,045

G

glycerol-3-phosphate dehydrogenase 1

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of GPD1 mRNA
epoxiconazole results in decreased expression of GPD1 mRNA

PMID:29038839 PMID:35436446

NCBI chr12:50,104,008...50,111,313
Ensembl chr12:50,103,982...50,111,316

G

glucose-6-phosphate isomerase

decreases expression

ISO

epoxiconazole results in decreased expression of GPI1 mRNA

NCBI chr19:34,359,718...34,402,413
Ensembl chr19:34,359,480...34,402,413

G

GPN-loop GTPase 1

decreases expression

ISO

epoxiconazole results in decreased expression of GPN1 mRNA

NCBI chr 2:27,628,247...27,651,511
Ensembl chr 2:27,628,247...27,651,511

G

glycoprotein nmb

decreases expression

ISO

epoxiconazole results in decreased expression of GPNMB mRNA

NCBI chr 7:23,246,775...23,275,108
Ensembl chr 7:23,235,967...23,275,108

G

G protein-coupled receptor 108

decreases expression

ISO

epoxiconazole results in decreased expression of GPR108 mRNA

NCBI chr19:6,729,914...6,737,580
Ensembl chr19:6,729,914...6,737,606

G

G protein-coupled receptor 137B

decreases expression

ISO

epoxiconazole results in decreased expression of GPR137B mRNA

NCBI chr 1:236,142,539...236,208,907
Ensembl chr 1:236,142,148...236,221,865

G

G protein-coupled receptor 139

increases expression

ISO

epoxiconazole results in increased expression of GPR139 mRNA

NCBI chr16:20,028,239...20,073,890
Ensembl chr16:20,028,239...20,073,890

G

G protein-coupled receptor 141B, pseudogene

increases expression

ISO

epoxiconazole results in increased expression of GPR141B mRNA

NCBI chr 7:37,796,193...37,796,876
Ensembl chr 7:37,796,058...37,796,888

G

G protein-coupled receptor 155

decreases expression

ISO

epoxiconazole results in decreased expression of GPR155 mRNA

NCBI chr 2:174,431,571...174,487,029
Ensembl chr 2:174,431,571...174,487,150

G

G protein-coupled receptor 161

increases expression

ISO

epoxiconazole results in increased expression of GPR161 mRNA

NCBI chr 1:168,079,542...168,137,667
Ensembl chr 1:168,079,542...168,137,685

G

G protein-coupled receptor 171

decreases expression

ISO

epoxiconazole results in decreased expression of GPR171 mRNA

NCBI chr 3:151,197,754...151,203,216
Ensembl chr 3:151,197,832...151,203,216

G

G protein-coupled receptor 19

decreases expression

ISO

epoxiconazole results in decreased expression of GPR19 mRNA

NCBI chr12:12,660,890...12,717,246
Ensembl chr12:12,660,047...12,696,705

G

G protein-coupled receptor 33

increases expression

ISO

epoxiconazole results in increased expression of GPR33 mRNA

NCBI chr14:31,482,875...31,488,039
Ensembl chr14:31,482,875...31,488,039

G

G protein-coupled receptor 55

decreases expression

ISO

epoxiconazole results in decreased expression of GPR55 mRNA

NCBI chr 2:230,907,328...230,961,201
Ensembl chr 2:230,907,318...230,961,066

G

G protein-coupled receptor 65

increases expression

ISO

epoxiconazole results in increased expression of GPR65 mRNA

NCBI chr14:88,005,135...88,014,811
Ensembl chr14:88,005,135...88,014,811

G

G protein-coupled receptor 82

increases expression

ISO

epoxiconazole results in increased expression of GPR82 mRNA

NCBI chr X:41,724,181...41,730,130
Ensembl chr X:41,724,181...41,730,130

G

G protein-coupled receptor class C group 5 member C

decreases expression

ISO

epoxiconazole results in decreased expression of GPRC5C mRNA

NCBI chr17:74,432,088...74,451,658
Ensembl chr17:74,424,851...74,451,653

G

G protein-coupled receptor class C group 5 member D

increases expression

ISO

epoxiconazole results in increased expression of GPRC5D mRNA

NCBI chr12:12,940,575...12,952,170
Ensembl chr12:12,940,575...12,952,170

G

glutamic--pyruvic transaminase 2

decreases expression

ISO

epoxiconazole results in decreased expression of GPT2 mRNA

NCBI chr16:46,884,362...46,931,289
Ensembl chr16:46,882,857...46,931,298

G

glutathione peroxidase 2

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole] results in increased expression of GPX2 mRNA

NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746

G

glutathione peroxidase 4

increases expression

ISO

epoxiconazole results in increased expression of GPX4 mRNA

NCBI chr19:1,103,994...1,106,779
Ensembl chr19:1,103,982...1,106,791

G

GRAM domain containing 2A

increases expression

ISO

epoxiconazole results in increased expression of GRAMD2A mRNA

NCBI chr15:72,159,806...72,197,787
Ensembl chr15:72,159,806...72,197,830

G

growth factor receptor bound protein 14

increases expression

ISO

epoxiconazole results in increased expression of GRB14 mRNA

NCBI chr 2:164,492,417...164,621,482
Ensembl chr 2:164,492,417...164,622,472

G

gremlin 1, DAN family BMP antagonist

increases expression

ISO

epoxiconazole results in increased expression of GREM1 mRNA

NCBI chr15:32,718,004...32,745,106
Ensembl chr15:32,716,998...32,745,106

G

gremlin 2, DAN family BMP antagonist

decreases expression

ISO

epoxiconazole results in decreased expression of GREM2 mRNA

NCBI chr 1:240,489,573...240,612,155
Ensembl chr 1:240,489,573...240,612,155

G

glyoxylate and hydroxypyruvate reductase

decreases expression

ISO

epoxiconazole results in decreased expression of GRHPR mRNA

NCBI chr 9:37,422,435...37,439,494
Ensembl chr 9:37,422,664...37,437,259

G

glutamate ionotropic receptor AMPA type subunit 2

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIA2 mRNA

NCBI chr 4:157,220,120...157,366,075
Ensembl chr 4:157,204,182...157,387,146

G

glutamate ionotropic receptor AMPA type subunit 3

decreases expression

ISO

epoxiconazole results in decreased expression of GRIA3 mRNA

NCBI chr X:123,184,278...123,490,915
Ensembl chr X:123,184,023...123,490,915

G

glutamate ionotropic receptor AMPA type subunit 4

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIA4 mRNA

NCBI chr11:105,609,994...105,982,090
Ensembl chr11:105,609,535...105,982,090

G

glutamate ionotropic receptor kainate type subunit 1

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIK1 mRNA

NCBI chr21:29,536,933...29,939,996
Ensembl chr21:29,536,933...29,940,033

G

glutamate ionotropic receptor kainate type subunit 2

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIK2 mRNA

NCBI chr 6:101,393,708...102,070,083
Ensembl chr 6:100,962,701...102,081,622

G

glutamate ionotropic receptor NMDA type subunit 1

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIN1 mRNA

NCBI chr 9:137,139,154...137,168,756
Ensembl chr 9:137,138,346...137,168,756

G

glutamate ionotropic receptor NMDA type subunit 2B

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIN2B mRNA

NCBI chr12:13,537,337...13,982,134
Ensembl chr12:13,437,942...13,982,002

G

glutamate receptor interacting protein 1

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIP1 mRNA

NCBI chr12:66,347,431...67,069,338
Ensembl chr12:66,347,431...67,069,162

G

glutamate receptor interacting protein 2

increases expression

ISO

epoxiconazole results in increased expression of GRIP2 mRNA

NCBI chr 3:14,489,107...14,603,017
Ensembl chr 3:14,489,107...14,556,075

G

GRIP1 associated protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of GRIPAP1 mRNA

NCBI chr X:48,973,723...49,002,264
Ensembl chr X:48,973,719...49,002,265

G

G protein-coupled receptor kinase 1

increases expression

ISO

epoxiconazole results in increased expression of GRK1 mRNA

NCBI chr13:113,648,199...113,737,736
Ensembl chr13:113,667,219...113,737,736

G

G protein-coupled receptor kinase 5

increases expression

ISO

epoxiconazole results in increased expression of GRK5 mRNA

NCBI chr10:119,207,571...119,459,745
Ensembl chr10:119,207,543...119,459,745

G

glutamate metabotropic receptor 1

increases expression

ISO

epoxiconazole results in increased expression of GRM1 mRNA

NCBI chr 6:146,027,707...146,437,601
Ensembl chr 6:146,027,646...146,437,601

G

glutamate metabotropic receptor 2

decreases expression

ISO

epoxiconazole results in decreased expression of GRM2 mRNA

NCBI chr 3:51,707,068...51,718,613
Ensembl chr 3:51,707,061...51,718,616

G

glutamate metabotropic receptor 7

increases expression

ISO

epoxiconazole results in increased expression of GRM7 mRNA

NCBI chr 3:6,861,115...7,741,533
Ensembl chr 3:6,770,001...7,741,533

G

granulin precursor

decreases expression

ISO

epoxiconazole results in decreased expression of GRN mRNA

PMID:22334560 PMID:35436446

NCBI chr17:44,345,302...44,353,106
Ensembl chr17:44,345,108...44,353,106

G

goosecoid homeobox 2

increases expression

ISO

epoxiconazole results in increased expression of GSC2 mRNA

NCBI chr22:19,146,993...19,150,292
Ensembl chr22:19,146,993...19,150,292

G

glutathione-disulfide reductase

increases expression

ISO

epoxiconazole results in increased expression of GSR mRNA

NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,064...30,727,975

G

glutathione S-transferase alpha 3

increases expression

ISO

epoxiconazole results in increased expression of GSTA2 mRNA

PMID:22334560 PMID:35436446

NCBI chr 6:52,896,646...52,909,698
Ensembl chr 6:52,896,639...52,909,701

G

glutathione S-transferase alpha 5

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of GSTA5 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of GSTA5 mRNA

NCBI chr 6:52,831,692...52,846,245
Ensembl chr 6:52,831,655...52,840,843

G

glutathione S-transferase mu 1

increases expression

ISO

epoxiconazole results in increased expression of GSTM1 mRNA

PMID:22334560 PMID:25182419

NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,340...109,709,039

G

glutathione S-transferase mu 2

increases expression

ISO

epoxiconazole results in increased expression of GSTM2 mRNA

PMID:22334560 PMID:25182419

NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,667,348...109,709,551

G

glutathione S-transferase mu 3

decreases expression
increases expression

ISO

epoxiconazole results in decreased expression of GSTM3 mRNA
epoxiconazole results in increased expression of GSTM3 mRNA

PMID:22334560 PMID:23970803 PMID:35436446

NCBI chr 1:109,733,937...109,741,038
Ensembl chr 1:109,733,932...109,741,038

G

glutathione S-transferase mu 4

increases expression

ISO

epoxiconazole results in increased expression of GSTM4 mRNA

NCBI chr 1:109,656,099...109,667,727
Ensembl chr 1:109,656,099...109,665,496

G

glutathione S-transferase pi 1

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of GSTP1 mRNA
epoxiconazole results in decreased expression of GSTP1 mRNA

PMID:25182419 PMID:35436446

NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,658...67,586,659

G

glutathione S-transferase theta 1

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of GSTT1 mRNA
epoxiconazole results in decreased expression of GSTT1 mRNA

PMID:22334560 PMID:35436446

G

glutathione S-transferase theta 2B

decreases expression

ISO

epoxiconazole results in decreased expression of GSTT2 mRNA

NCBI chr22:23,957,414...23,961,206
Ensembl chr22:23,957,414...23,961,197

G

glutathione S-transferase theta 3, pseudogene

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of GSTT3 mRNA
epoxiconazole results in decreased expression of GSTT3 mRNA

PMID:22334560 PMID:23970803 PMID:35436446

G

general transcription factor IIB

increases expression

ISO

epoxiconazole results in increased expression of GTF2B mRNA

NCBI chr 1:88,852,633...88,891,567
Ensembl chr 1:88,852,633...88,891,944

G

general transcription factor IIH subunit 3

decreases expression

ISO

epoxiconazole results in decreased expression of GTF2H3 mRNA

NCBI chr12:123,633,829...123,662,604
Ensembl chr12:123,633,739...123,662,604

G

general transcription factor IIH subunit 4

decreases expression

ISO

epoxiconazole results in decreased expression of GTF2H4 mRNA

NCBI chr 6:30,908,207...30,914,106
Ensembl chr 6:30,907,522...30,914,119

G

GTF2I repeat domain containing 1

affects expression

ISO

epoxiconazole affects the expression of GTF2IRD1 mRNA

NCBI chr 7:74,453,906...74,602,605
Ensembl chr 7:74,452,463...74,602,619

G

GTP binding protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of GTPBP1 mRNA

NCBI chr22:38,705,944...38,743,115
Ensembl chr22:38,705,742...38,738,299

G

GTP binding protein 4

decreases expression

ISO

epoxiconazole results in decreased expression of GTPBP4 mRNA

NCBI chr10:988,434...1,019,932
Ensembl chr10:988,418...1,019,932

G

GTP binding protein 8

decreases expression

ISO

epoxiconazole results in decreased expression of GTPBP8 mRNA

NCBI chr 3:112,990,984...113,001,969
Ensembl chr 3:112,990,978...113,015,060

G

G2 and S-phase expressed 1

decreases expression

ISO

epoxiconazole results in decreased expression of GTSE1 mRNA

NCBI chr22:46,296,870...46,330,810
Ensembl chr22:46,296,870...46,330,810

G

guanylyl cyclase domain containing 1

decreases expression

ISO

epoxiconazole results in decreased expression of GUCD1 mRNA

NCBI chr22:24,540,438...24,555,894
Ensembl chr22:24,540,423...24,555,935

G

gulonolactone (L-) oxidase, pseudogene

decreases expression

ISO

epoxiconazole results in decreased expression of GULO mRNA

NCBI chr 8:27,577,611...27,589,073
Ensembl chr 8:27,560,274...27,589,073

G

GULP PTB domain containing engulfment adaptor 1

increases expression

ISO

epoxiconazole results in increased expression of GULP1 mRNA

NCBI chr 2:188,291,874...188,595,926
Ensembl chr 2:188,291,105...188,595,943

G

glycophorin A (MNS blood group)

increases expression

ISO

epoxiconazole results in increased expression of GYPA mRNA

NCBI chr 4:144,109,303...144,140,718
Ensembl chr 4:144,109,303...144,140,751

G

glycogen synthase 2

affects expression

ISO

epoxiconazole affects the expression of GYS2 mRNA

NCBI chr12:21,532,577...21,604,847
Ensembl chr12:21,536,107...21,604,917

G

granzyme A

decreases expression

ISO

epoxiconazole results in decreased expression of GZMA mRNA

NCBI chr 5:55,102,646...55,110,252
Ensembl chr 5:55,102,646...55,110,252

G

H1.7 linker histone

decreases expression

ISO

epoxiconazole results in decreased expression of H1F7 mRNA

NCBI chr12:48,328,980...48,330,279
Ensembl chr12:48,328,980...48,330,279

G

H1.8 linker histone

increases expression

ISO

epoxiconazole results in increased expression of H1F8 mRNA

NCBI chr 3:129,543,175...129,551,467
Ensembl chr 3:129,543,175...129,551,467

G

H2B clustered histone 11

increases expression

ISO

epoxiconazole results in increased expression of H2BC11 mRNA

NCBI chr 6:27,132,316...27,132,795
Ensembl chr 6:27,122,657...27,132,795

G

H2B clustered histone 12

increases expression

ISO

epoxiconazole results in increased expression of H2BC12 mRNA

NCBI chr 6:27,138,293...27,146,858
Ensembl chr 6:27,137,298...27,146,857

G

H2B clustered histone 5

decreases expression
affects expression

ISO

epoxiconazole results in decreased expression of H2BC21 mRNA
epoxiconazole affects the expression of H2BC21 mRNA

PMID:22334560 PMID:35436446

NCBI chr 6:26,158,121...26,171,349
Ensembl chr 6:26,158,122...26,171,349

G

H2B clustered histone 9

increases expression

ISO

epoxiconazole results in increased expression of H2BC9 mRNA

NCBI chr 6:26,251,614...26,252,075
Ensembl chr 6:26,251,614...26,252,075

G

H3.3 histone A

increases expression

ISO

epoxiconazole results in increased expression of H3F3A mRNA

NCBI chr 1:226,061,831...226,072,019
Ensembl chr 1:226,061,571...226,073,206

G

hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase

decreases expression

ISO

epoxiconazole results in decreased expression of H6PD mRNA

NCBI chr 1:9,234,774...9,271,337
Ensembl chr 1:9,234,774...9,271,337

G

3-hydroxyanthranilate 3,4-dioxygenase

decreases expression

ISO

epoxiconazole results in decreased expression of HAAO mRNA

NCBI chr 2:42,767,089...42,792,583
Ensembl chr 2:42,765,709...42,792,941

G

3-hydroxyacyl-CoA dehydratase 1

increases expression

ISO

epoxiconazole results in increased expression of HACD1 mRNA

NCBI chr10:17,589,032...17,617,374
Ensembl chr10:17,588,316...17,617,430

G

2-hydroxyacyl-CoA lyase 1

affects expression

ISO

epoxiconazole affects the expression of HACL1 mRNA

NCBI chr 3:15,560,699...15,601,569
Ensembl chr 3:15,560,582...15,601,883

G

hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole] results in increased expression of HADHA mRNA

NCBI chr 2:26,190,635...26,244,632
Ensembl chr 2:26,190,635...26,245,044

G

hydroxyacylglutathione hydrolase like

decreases expression

ISO

epoxiconazole results in decreased expression of HAGHL mRNA

NCBI chr16:727,106...729,715
Ensembl chr16:726,494...735,525

G

histidine ammonia-lyase

decreases expression

ISO

epoxiconazole results in decreased expression of HAL mRNA

NCBI chr12:95,972,662...95,996,344
Ensembl chr12:95,972,662...95,996,365

G

hydroxyacid oxidase 1

decreases expression

ISO

epoxiconazole results in decreased expression of HAO1 mRNA

NCBI chr20:7,882,985...7,940,458
Ensembl chr20:7,882,985...7,940,520

G

hydroxyacid oxidase 2

decreases expression

ISO

epoxiconazole results in decreased expression of HAO2 mRNA

NCBI chr 1:119,368,785...119,394,130
Ensembl chr 1:119,368,727...119,394,258

G

hyaluronan synthase 1

decreases expression

ISO

epoxiconazole results in decreased expression of HAS1 mRNA

NCBI chr19:51,713,112...51,723,991
Ensembl chr19:51,713,112...51,723,991

G

histone acetyltransferase 1

increases expression

ISO

epoxiconazole results in increased expression of HAT1 mRNA

NCBI chr 2:171,922,461...171,983,686
Ensembl chr 2:171,922,429...171,986,153

G

hepatitis A virus cellular receptor 2

increases expression

ISO

epoxiconazole results in increased expression of HAVCR2 mRNA

NCBI chr 5:157,085,832...157,109,044
Ensembl chr 5:157,085,422...157,142,869

G

host cell factor C1

decreases expression

ISO

epoxiconazole results in decreased expression of HCFC1 mRNA

NCBI chr X:153,947,557...153,971,818
Ensembl chr X:153,946,434...153,972,427

G

host cell factor C1 regulator 1

decreases expression

ISO

epoxiconazole results in decreased expression of HCFC1R1 mRNA

NCBI chr16:3,022,620...3,024,286
Ensembl chr16:3,022,625...3,024,286

G

histone deacetylase 11

decreases expression

ISO

epoxiconazole results in decreased expression of HDAC11 mRNA

NCBI chr 3:13,480,306...13,506,416
Ensembl chr 3:13,479,724...13,506,424

G

histone deacetylase 3

increases expression

ISO

epoxiconazole results in increased expression of HDAC3 mRNA

NCBI chr 5:141,620,881...141,636,849
Ensembl chr 5:141,620,778...141,636,867

G

histone deacetylase 8

decreases expression

ISO

epoxiconazole results in decreased expression of HDAC8 mRNA

NCBI chr X:72,329,516...72,572,843
Ensembl chr X:72,329,516...72,573,101

G

HD domain containing 3

increases expression

ISO

epoxiconazole results in increased expression of HDDC3 mRNA

NCBI chr15:90,929,968...90,932,569
Ensembl chr15:90,929,968...90,935,196

G

HDGF like 3

increases expression

ISO

epoxiconazole results in increased expression of HDGFL3 mRNA

NCBI chr15:83,112,738...83,207,823
Ensembl chr15:83,112,738...83,208,424

G

HEAT repeat containing 5B

decreases expression

ISO

epoxiconazole results in decreased expression of HEATR5B mRNA

NCBI chr 2:36,980,895...37,084,372
Ensembl chr 2:36,968,383...37,084,398

G

heme binding protein 1

increases expression

ISO

epoxiconazole results in increased expression of HEBP1 mRNA

NCBI chr12:12,974,870...13,000,265
Ensembl chr12:12,974,867...13,000,275

G

HECT domain E3 ubiquitin protein ligase 1

decreases expression

ISO

epoxiconazole results in decreased expression of HECTD1 mRNA

NCBI chr14:31,100,117...31,207,793
Ensembl chr14:31,100,115...31,208,381

G

HECT domain E3 ubiquitin protein ligase 2

decreases expression

ISO

epoxiconazole results in decreased expression of HECTD2 mRNA

NCBI chr10:91,409,235...91,514,820
Ensembl chr10:91,409,280...91,514,829

G

HECT domain E3 ubiquitin protein ligase 3

decreases expression

ISO

epoxiconazole results in decreased expression of HECTD3 mRNA

NCBI chr 1:45,002,548...45,011,324
Ensembl chr 1:45,002,540...45,011,369

G

HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2

decreases expression

ISO

epoxiconazole results in decreased expression of HECW2 mRNA

NCBI chr 2:196,194,072...196,593,554
Ensembl chr 2:196,189,099...196,593,684

G

helicase, POLQ like

decreases expression

ISO

epoxiconazole results in decreased expression of HELQ mRNA

NCBI chr 4:83,407,346...83,455,883
Ensembl chr 4:83,407,343...83,455,855

G

HemK methyltransferase family member 1

increases expression

ISO

epoxiconazole results in increased expression of HEMK1 mRNA

NCBI chr 3:50,569,180...50,596,166
Ensembl chr 3:50,567,895...50,596,168

G

hephaestin like 1

increases expression

ISO

epoxiconazole results in increased expression of HEPHL1 mRNA

NCBI chr11:94,021,354...94,114,208
Ensembl chr11:94,021,354...94,114,208

G

HECT and RLD domain containing E3 ubiquitin protein ligase 2

decreases expression

ISO

epoxiconazole results in decreased expression of HERC2 mRNA

NCBI chr15:28,111,040...28,322,179
Ensembl chr15:28,111,040...28,322,179

G

HECT and RLD domain containing E3 ubiquitin protein ligase 3

increases expression

ISO

epoxiconazole results in increased expression of HERC3 mRNA

NCBI chr 4:88,523,843...88,708,539
Ensembl chr 4:88,523,810...88,708,450
Ensembl chr 4:88,523,810...88,708,450

G

homocysteine inducible ER protein with ubiquitin like domain 1

multiple interactions
decreases expression

ISO

[cyproconazole co-treated with epoxiconazole] results in increased expression of HERPUD1 mRNA
epoxiconazole results in decreased expression of HERPUD1 mRNA

PMID:29038839 PMID:35436446

NCBI chr16:56,932,142...56,944,864
Ensembl chr16:56,930,815...56,944,864

G

hes family bHLH transcription factor 6

multiple interactions
decreases expression

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of HES6 mRNA
epoxiconazole results in decreased expression of HES6 mRNA

PMID:25607892 PMID:35436446

NCBI chr 2:238,238,267...238,240,038
Ensembl chr 2:238,238,267...238,240,662

G

hepatocyte growth factor-regulated tyrosine kinase substrate

decreases expression

ISO

epoxiconazole results in decreased expression of HGS mRNA

NCBI chr17:81,684,011...81,702,121
Ensembl chr17:81,683,326...81,703,138

G

hematopoietically expressed homeobox

decreases expression

ISO

epoxiconazole results in decreased expression of HHEX mRNA

NCBI chr10:92,689,955...92,695,647
Ensembl chr10:92,689,903...92,695,647

G

hedgehog interacting protein

decreases expression

ISO

epoxiconazole results in decreased expression of HHIP mRNA

NCBI chr 4:144,646,156...144,745,271
Ensembl chr 4:144,646,156...144,745,271

G

HIG1 hypoxia inducible domain family member 1A

increases expression

ISO

epoxiconazole results in increased expression of HIGD1A mRNA

NCBI chr 3:42,782,908...42,804,490
Ensembl chr 3:42,782,908...42,804,527

G

HIG1 hypoxia inducible domain family member 1C

increases expression

ISO

epoxiconazole results in increased expression of HIGD1C mRNA

NCBI chr12:50,931,110...50,972,592
Ensembl chr12:50,952,538...50,970,607

G

heat shock protein nuclear import factor hikeshi

affects expression

ISO

epoxiconazole affects the expression of HIKESHI mRNA

NCBI chr11:86,302,240...86,345,943
Ensembl chr11:86,302,181...86,345,943

G

histidine triad nucleotide binding protein 2

increases expression

ISO

epoxiconazole results in increased expression of HINT2 mRNA

NCBI chr 9:35,812,960...35,815,479
Ensembl chr 9:35,812,960...35,815,354

G

huntingtin interacting protein 1 related

increases expression

ISO

epoxiconazole results in increased expression of HIP1R mRNA

NCBI chr12:122,834,748...122,862,961
Ensembl chr12:122,834,453...122,862,961

G

hemojuvelin BMP co-receptor

affects expression

ISO

epoxiconazole affects the expression of HJV mRNA

NCBI chr 1:146,017,470...146,021,735
Ensembl chr 1:146,017,468...146,036,746

G

major histocompatibility complex, class I, A

decreases expression

ISO

epoxiconazole results in decreased expression of H2-Q1 mRNA

NCBI chr 6:29,942,532...29,945,870
Ensembl chr 6:29,941,260...29,949,572

G

major histocompatibility complex, class II, DM alpha

decreases expression

ISO

epoxiconazole results in decreased expression of H2-DMA mRNA

NCBI chr 6:32,948,618...32,953,097
Ensembl chr 6:32,948,613...32,969,094

G

major histocompatibility complex, class II, DM beta

affects expression

ISO

epoxiconazole affects the expression of H2-DMB1 mRNA

NCBI chr 6:32,934,636...32,941,028
Ensembl chr 6:32,934,629...32,941,054

G

major histocompatibility complex, class II, DR beta 1

increases expression

ISO

epoxiconazole results in increased expression of H2-EB1 mRNA

NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848

G

major histocompatibility complex, class I, G

decreases expression

ISO

epoxiconazole results in decreased expression of H2-M3 mRNA

NCBI chr 6:29,826,474...29,831,021
Ensembl chr 6:29,826,967...29,831,125

G

holocarboxylase synthetase

increases expression

ISO

epoxiconazole results in increased expression of HLCS mRNA

NCBI chr21:36,748,625...36,990,211
Ensembl chr21:36,748,626...36,990,236

G

HLF transcription factor, PAR bZIP family member

affects expression

ISO

epoxiconazole affects the expression of HLF mRNA

NCBI chr17:55,264,960...55,325,187
Ensembl chr17:55,264,960...55,325,187

G

helicase like transcription factor

increases expression

ISO

epoxiconazole results in increased expression of HLTF mRNA

NCBI chr 3:149,030,063...149,086,533
Ensembl chr 3:149,030,122...149,086,554

G

histocompatibility minor 13

decreases expression

ISO

epoxiconazole results in decreased expression of H13 mRNA

NCBI chr20:31,514,442...31,569,543
Ensembl chr20:31,514,370...31,577,923

G

high mobility group box 2

decreases expression

ISO

epoxiconazole results in decreased expression of HMGB2 mRNA

NCBI chr 4:173,331,376...173,334,358
Ensembl chr 4:173,331,376...173,334,456

G

3-hydroxy-3-methylglutaryl-CoA reductase

decreases expression

ISO

epoxiconazole results in decreased expression of HMGCR mRNA

NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,241

G

3-hydroxy-3-methylglutaryl-CoA synthase 1

decreases expression

ISO

epoxiconazole results in decreased expression of HMGCS1 mRNA

NCBI chr 5:43,287,470...43,313,412
Ensembl chr 5:43,287,470...43,313,512

G

high mobility group nucleosome binding domain 1

increases expression

ISO

epoxiconazole results in increased expression of HMGN1 mRNA

NCBI chr21:39,342,315...39,349,088
Ensembl chr21:39,342,315...39,349,653

G

heme oxygenase 1

decreases expression

ISO

epoxiconazole results in decreased expression of HMOX1 mRNA

NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214

G

HNF1 homeobox A

decreases expression

ISO

epoxiconazole results in decreased expression of HNF1A mRNA

NCBI chr12:120,978,543...121,002,512
Ensembl chr12:120,978,543...121,002,512

G

hepatocyte nuclear factor 4 alpha

decreases expression

ISO

epoxiconazole results in decreased expression of HNF4A mRNA

NCBI chr20:44,355,699...44,434,596
Ensembl chr20:44,355,699...44,432,845

G

homer scaffold protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of HOMER2 mRNA

NCBI chr15:82,834,661...82,986,157
Ensembl chr15:82,834,664...82,986,153

G

homeobox and leucine zipper encoding

affects expression

ISO

epoxiconazole affects the expression of HOMEZ mRNA

NCBI chr14:23,272,422...23,286,132
Ensembl chr14:23,272,422...23,299,796

G

hook microtubule tethering protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of HOOK2 mRNA

NCBI chr19:12,763,003...12,792,350
Ensembl chr19:12,762,640...12,872,740

G

HORMA domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of HORMAD1 mRNA

NCBI chr 1:150,698,060...150,720,895
Ensembl chr 1:150,698,060...150,720,895

G

homeobox A13

decreases expression

ISO

epoxiconazole results in decreased expression of HOXA13 mRNA

NCBI chr 7:27,194,364...27,200,091
Ensembl chr 7:27,193,503...27,200,091

G

homeobox C10

increases expression

ISO

epoxiconazole results in increased expression of HOXC10 mRNA

NCBI chr12:53,985,146...53,990,279
Ensembl chr12:53,985,065...53,990,279

G

hippocalcin like 1

decreases expression

ISO

epoxiconazole results in decreased expression of HPCAL1 mRNA

NCBI chr 2:10,302,904...10,427,604
Ensembl chr 2:10,301,356...10,427,835

G

hypoxanthine phosphoribosyltransferase 1

increases expression

ISO

epoxiconazole results in increased expression of HPRT1 mRNA

NCBI chr X:134,460,165...134,500,668
Ensembl chr X:134,460,155...134,520,513

G

HPS5 biogenesis of lysosomal organelles complex 2 subunit 2

decreases expression

ISO

epoxiconazole results in decreased expression of HPS5 mRNA

NCBI chr11:18,278,670...18,322,174
Ensembl chr11:18,278,668...18,322,523

G

HRas proto-oncogene, GTPase

decreases expression

ISO

epoxiconazole results in decreased expression of HRAS mRNA

NCBI chr11:532,242...535,576
Ensembl chr11:532,242...537,343

G

histamine receptor H1

increases expression

ISO

epoxiconazole results in increased expression of HRH1 mRNA

NCBI chr 3:11,137,238...11,263,557
Ensembl chr 3:11,137,093...11,263,557

G

heparan sulfate-glucosamine 3-sulfotransferase 1

increases expression

ISO

epoxiconazole results in increased expression of HS3ST1 mRNA

NCBI chr 4:11,393,150...11,434,327
Ensembl chr 4:11,393,150...11,429,564

G

heparan sulfate-glucosamine 3-sulfotransferase 3A1

increases expression

ISO

epoxiconazole results in increased expression of HS3ST3A1 mRNA

NCBI chr17:13,494,032...13,601,929
Ensembl chr17:13,494,032...13,601,929

G

heparan sulfate-glucosamine 3-sulfotransferase 3B1

decreases expression

ISO

epoxiconazole results in decreased expression of HS3ST3B1 mRNA

NCBI chr17:14,301,081...14,349,404
Ensembl chr17:14,301,081...14,349,404

G

heparan sulfate 6-O-sulfotransferase 1

decreases expression

ISO

epoxiconazole results in decreased expression of HS6ST1 mRNA

NCBI chr 2:128,265,480...128,318,868
Ensembl chr 2:128,236,716...128,318,868

G

heat shock factor binding protein 1 like 1

decreases expression

ISO

epoxiconazole results in decreased expression of HSBP1L1 mRNA

NCBI chr18:79,964,643...79,970,822
Ensembl chr18:79,964,582...79,970,823

G

hydroxysteroid 17-beta dehydrogenase 1

increases expression

ISO

epoxiconazole results in increased expression of HSD17B1 mRNA

NCBI chr17:42,552,923...42,555,214
Ensembl chr17:42,552,922...42,555,214

G

hydroxysteroid 17-beta dehydrogenase 12

increases expression

EXP

epoxiconazole results in increased expression of HSD17B12 mRNA

NCBI chr11:43,556,721...43,856,615
Ensembl chr11:43,680,509...43,857,741

G

hydroxysteroid 17-beta dehydrogenase 14

increases expression

ISO

epoxiconazole results in increased expression of HSD17B14 mRNA

NCBI chr19:48,813,018...48,836,491
Ensembl chr19:48,813,014...48,837,064

G

hydroxysteroid 17-beta dehydrogenase 2

increases expression

ISO

epoxiconazole results in increased expression of HSD17B2 mRNA

NCBI chr16:82,035,253...82,098,534
Ensembl chr16:82,034,988...82,098,534

G

hydroxysteroid 17-beta dehydrogenase 6

increases expression
decreases expression

ISO
EXP

epoxiconazole results in increased expression of HSD17B6 mRNA
epoxiconazole results in decreased expression of HSD17B6 mRNA

PMID:34182286 PMID:35436446

NCBI chr12:56,763,324...56,787,790
Ensembl chr12:56,751,817...56,788,409

G

hydroxysteroid 17-beta dehydrogenase 7

increases expression

EXP

epoxiconazole results in increased expression of HSD17B7 mRNA

NCBI chr 1:162,790,702...162,812,823
Ensembl chr 1:162,790,702...162,812,823

G

hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1

decreases expression

ISO

epoxiconazole results in decreased expression of HSD3B2 mRNA

NCBI chr 1:119,507,203...119,515,058
Ensembl chr 1:119,507,198...119,515,054

G

hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7

increases expression

ISO

epoxiconazole results in increased expression of HSD3B7 mRNA

NCBI chr16:30,985,207...30,989,147
Ensembl chr16:30,985,143...30,989,154

G

heat shock transcription factor 1

decreases expression

ISO

epoxiconazole results in decreased expression of HSF1 mRNA

NCBI chr 8:144,291,604...144,314,720
Ensembl chr 8:144,291,529...144,314,727

G

heat shock protein 90 alpha family class A member 1

decreases expression

ISO

epoxiconazole results in decreased expression of HSP90AA1 mRNA

NCBI chr14:102,080,742...102,139,749
Ensembl chr14:102,080,738...102,139,699

G

heat shock protein family A (Hsp70) member 13

increases expression

ISO

epoxiconazole results in increased expression of HSPA13 mRNA

NCBI chr21:14,371,115...14,383,146
Ensembl chr21:14,371,115...14,383,484

G

heat shock protein family A (Hsp70) member 4 like

decreases expression

ISO

epoxiconazole results in decreased expression of HSPA4L mRNA

NCBI chr 4:127,781,796...127,840,733
Ensembl chr 4:127,781,821...127,840,733

G

heat shock protein family A (Hsp70) member 5

decreases expression

ISO

epoxiconazole results in decreased expression of HSPA5 mRNA

NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382

G

heat shock protein family B (small) member 6

decreases expression

ISO

epoxiconazole results in decreased expression of HSPB6 mRNA

NCBI chr19:35,754,566...35,757,029
Ensembl chr19:35,754,566...35,758,079

G

heat shock protein family B (small) member 7

increases expression

ISO

epoxiconazole results in increased expression of HSPB7 mRNA

NCBI chr 1:16,014,029...16,019,594
Ensembl chr 1:16,014,028...16,020,597

G

heat shock protein family B (small) member 8

increases expression
multiple interactions

ISO

epoxiconazole results in increased expression of HSPB8 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of HSPB8 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of HSPB8 mRNA

NCBI chr12:119,178,931...119,194,746
Ensembl chr12:119,171,555...119,224,855

G

hyaluronidase 2

decreases expression

ISO

epoxiconazole results in decreased expression of HYAL2 mRNA

NCBI chr 3:50,317,808...50,322,745
Ensembl chr 3:50,315,845...50,324,687

G

hydroxylysine kinase

decreases expression

ISO

epoxiconazole results in decreased expression of HYKK mRNA

NCBI chr15:78,507,577...78,537,373
Ensembl chr15:78,507,564...78,537,372

G

hypoxia up-regulated 1

decreases expression

ISO

epoxiconazole results in decreased expression of HYOU1 mRNA

NCBI chr11:119,044,188...119,057,205
Ensembl chr11:119,044,185...119,057,252

G

isoleucyl-tRNA synthetase 1

decreases expression

ISO

epoxiconazole results in decreased expression of IARS1 mRNA

NCBI chr 9:92,210,207...92,293,697
Ensembl chr 9:92,210,207...92,293,854

G

iron-sulfur cluster assembly factor IBA57

decreases expression

ISO

epoxiconazole results in decreased expression of IBA57 mRNA

NCBI chr 1:228,165,804...228,182,257
Ensembl chr 1:228,165,777...228,182,257

G

islet cell autoantigen 1

decreases expression

ISO

epoxiconazole results in decreased expression of ICA1 mRNA

NCBI chr 7:8,113,184...8,262,555
Ensembl chr 7:8,113,181...8,262,687

G

interactor of little elongation complex ELL subunit 2

decreases expression

ISO

epoxiconazole results in decreased expression of ICE2 mRNA

NCBI chr15:60,419,609...60,479,142
Ensembl chr15:60,419,608...60,479,160

G

inhibitor of DNA binding 1

decreases expression

ISO

epoxiconazole results in decreased expression of ID1 mRNA

NCBI chr20:31,605,289...31,606,510
Ensembl chr20:31,573,014...31,606,515

G

inhibitor of DNA binding 2

increases expression

ISO

epoxiconazole results in increased expression of ID2 mRNA

NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461

G

isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta

decreases expression

ISO

epoxiconazole results in decreased expression of IDH3B mRNA

NCBI chr20:2,658,395...2,664,216
Ensembl chr20:2,658,393...2,664,219

G

isopentenyl-diphosphate delta isomerase 1

decreases expression

ISO

epoxiconazole results in decreased expression of IDI1 mRNA

NCBI chr10:1,039,152...1,056,704
Ensembl chr10:1,039,152...1,049,119

G

IFI30 lysosomal thiol reductase

decreases expression

ISO

epoxiconazole results in decreased expression of IFI30 mRNA

NCBI chr19:18,173,813...18,178,117
Ensembl chr19:18,173,162...18,178,121

G

interferon induced protein 44

decreases expression

ISO

epoxiconazole results in decreased expression of IFI44 mRNA

NCBI chr 1:78,649,789...78,664,078
Ensembl chr 1:78,647,078...78,664,412

G

interferon induced protein with tetratricopeptide repeats 3

increases expression

ISO

epoxiconazole results in increased expression of IFIT3 mRNA

NCBI chr10:89,327,997...89,340,968
Ensembl chr10:89,327,307...89,377,473

G

interferon alpha 1

increases expression

ISO

epoxiconazole results in increased expression of IFNA1 mRNA

NCBI chr 9:21,440,439...21,441,316
Ensembl chr 9:21,440,439...21,441,316

G

interferon alpha and beta receptor subunit 2

increases expression

ISO

epoxiconazole results in increased expression of IFNAR2 mRNA

NCBI chr21:33,229,938...33,265,664
Ensembl chr21:33,205,282...33,265,675

G

interferon epsilon

increases expression

ISO

epoxiconazole results in increased expression of IFNE mRNA

NCBI chr 9:21,480,839...21,482,313
Ensembl chr 9:21,480,839...21,482,313

G

interferon gamma

decreases expression

ISO

epoxiconazole results in decreased expression of IFNG mRNA

NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740

G

interferon lambda receptor 1

increases expression

ISO

epoxiconazole results in increased expression of IFNLR1 mRNA

NCBI chr 1:24,154,168...24,187,289
Ensembl chr 1:24,154,168...24,187,959

G

interferon related developmental regulator 1

decreases expression

ISO

epoxiconazole results in decreased expression of IFRD1 mRNA

NCBI chr 7:112,423,174...112,477,203
Ensembl chr 7:112,422,887...112,481,017

G

intraflagellar transport 122

decreases expression

ISO

epoxiconazole results in decreased expression of IFT122 mRNA

NCBI chr 3:129,440,224...129,520,507
Ensembl chr 3:129,429,607...129,520,510

G

intraflagellar transport 172

decreases expression

ISO

epoxiconazole results in decreased expression of IFT172 mRNA

NCBI chr 2:27,444,377...27,489,743
Ensembl chr 2:27,444,377...27,489,836

G

intraflagellar transport 25

increases expression

ISO

epoxiconazole results in increased expression of IFT25 mRNA

NCBI chr 1:53,911,576...53,946,305
Ensembl chr 1:53,916,574...53,946,588

G

intraflagellar transport 27

increases expression

ISO

epoxiconazole results in increased expression of IFT27 mRNA

NCBI chr22:36,758,211...36,776,119
Ensembl chr22:36,758,202...36,776,309

G

intraflagellar transport 74

decreases expression

ISO

epoxiconazole results in decreased expression of IFT74 mRNA

NCBI chr 9:26,947,110...27,066,134
Ensembl chr 9:26,947,039...27,066,134

G

intraflagellar transport 81

increases expression

ISO

epoxiconazole results in increased expression of IFT81 mRNA

NCBI chr12:110,124,357...110,218,793
Ensembl chr12:110,124,335...110,218,795

G

insulin like growth factor 1

decreases expression

ISO

epoxiconazole results in decreased expression of IGF1 mRNA

NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744

G

insulin like growth factor 2 mRNA binding protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of IGF2BP2 mRNA

NCBI chr 3:185,643,130...185,825,042
Ensembl chr 3:185,643,130...185,825,061

G

insulin like growth factor 2 receptor

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of IGF2R mRNA

NCBI chr 6:159,969,082...160,111,504
Ensembl chr 6:159,969,082...160,113,507

G

insulin like growth factor binding protein acid labile subunit

decreases expression

ISO

epoxiconazole results in decreased expression of IGFALS mRNA

PMID:22334560 PMID:35436446

NCBI chr16:1,790,413...1,794,908
Ensembl chr16:1,790,413...1,794,971

G

insulin like growth factor binding protein 1

increases expression

ISO

epoxiconazole results in increased expression of IGFBP1 mRNA

NCBI chr 7:45,888,488...45,893,660
Ensembl chr 7:45,888,360...45,893,660

G

immunoglobulin superfamily member 1

increases expression

ISO

epoxiconazole results in increased expression of IGSF1 mRNA

NCBI chr X:131,273,506...131,289,457
Ensembl chr X:131,273,506...131,578,899

G

immunoglobulin superfamily member 11

increases expression

ISO

epoxiconazole results in increased expression of IGSF11 mRNA

NCBI chr 3:118,900,557...119,146,020
Ensembl chr 3:118,900,557...119,146,068

G

IKBKB interacting protein

increases expression

ISO

epoxiconazole results in increased expression of IKBIP mRNA

NCBI chr12:98,613,404...98,644,788
Ensembl chr12:98,613,405...98,645,113

G

inhibitor of nuclear factor kappa B kinase subunit epsilon

increases expression

ISO

epoxiconazole results in increased expression of IKBKE mRNA

PMID:22334560 PMID:23970803

NCBI chr 1:206,470,476...206,496,889
Ensembl chr 1:206,470,332...206,496,891

G

inhibitor of nuclear factor kappa B kinase regulatory subunit gamma

decreases expression

ISO

epoxiconazole results in decreased expression of IKBKG mRNA

NCBI chr X:154,541,238...154,565,046
Ensembl chr X:154,541,179...154,565,047

G

interleukin 13 receptor subunit alpha 2

increases expression

ISO

epoxiconazole results in increased expression of IL13RA2 mRNA

NCBI chr X:115,003,982...115,017,616
Ensembl chr X:115,003,975...115,019,977

G

interleukin 15

decreases expression

ISO

epoxiconazole results in decreased expression of IL15 mRNA

NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,237...141,735,276

G

interleukin 17 receptor B

decreases expression

ISO

epoxiconazole results in decreased expression of IL17RB mRNA

NCBI chr 3:53,846,568...53,865,794
Ensembl chr 3:53,845,783...53,866,045

G

interleukin 17 receptor C

decreases expression

ISO

epoxiconazole results in decreased expression of IL17RC mRNA

NCBI chr 3:9,917,098...9,933,621
Ensembl chr 3:9,917,040...9,933,630

G

interleukin 18

increases expression

ISO

epoxiconazole results in increased expression of IL18 mRNA

NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,251...112,164,106

G

interleukin 1 beta

affects expression

ISO

epoxiconazole affects the expression of IL1B mRNA

NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816

G

interleukin 1 receptor accessory protein

decreases expression

ISO

epoxiconazole results in decreased expression of IL1RAP mRNA

NCBI chr 3:190,514,085...190,659,750
Ensembl chr 3:190,514,051...190,659,750

G

interleukin 1 receptor accessory protein like 1

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of IL1RAPL1 mRNA

NCBI chr X:28,587,446...29,956,718
Ensembl chr X:28,587,446...29,956,718

G

interleukin 1 receptor accessory protein like 2

increases expression

ISO

epoxiconazole results in increased expression of IL1RAPL2 mRNA

NCBI chr X:104,566,199...105,767,829
Ensembl chr X:104,566,199...105,767,829

G

interleukin 1 receptor like 2

increases expression

ISO

epoxiconazole results in increased expression of IL1RL2 mRNA

NCBI chr 2:102,186,973...102,243,086
Ensembl chr 2:102,186,980...102,240,002

G

interleukin 1 receptor antagonist

decreases expression

ISO

epoxiconazole results in decreased expression of IL1RN mRNA

NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016

G

interleukin 22 receptor subunit alpha 1

increases expression

ISO

epoxiconazole results in increased expression of IL22RA1 mRNA

NCBI chr 1:24,119,771...24,143,140
Ensembl chr 1:24,119,771...24,143,165

G

interleukin 31

increases expression

ISO

epoxiconazole results in increased expression of IL31 mRNA

NCBI chr12:122,172,029...122,174,221
Ensembl chr12:122,172,029...122,174,221

G

interleukin 33

decreases expression

ISO

epoxiconazole results in decreased expression of IL33 mRNA

NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,136...6,257,983

G

interleukin 34

increases expression

ISO

epoxiconazole results in increased expression of IL34 mRNA

NCBI chr16:70,579,899...70,660,682
Ensembl chr16:70,579,878...70,661,556

G

interleukin 6 receptor

affects expression

ISO

epoxiconazole affects the expression of IL6RA mRNA

NCBI chr 1:154,405,343...154,469,450
Ensembl chr 1:154,405,193...154,469,450

G

ilvB acetolactate synthase like

decreases expression

ISO

epoxiconazole results in decreased expression of ILVBL mRNA

NCBI chr19:15,114,987...15,125,786
Ensembl chr19:15,114,976...15,125,792

G

inner mitochondrial membrane peptidase subunit 1

increases expression

ISO

epoxiconazole results in increased expression of IMMP1L mRNA

NCBI chr11:31,432,401...31,509,622
Ensembl chr11:31,432,399...31,509,645

G

impact RWD domain protein

increases expression

ISO

epoxiconazole results in increased expression of IMPACT mRNA

NCBI chr18:24,426,670...24,453,531
Ensembl chr18:24,426,634...24,453,531

G

inosine monophosphate dehydrogenase 2

decreases expression

ISO

epoxiconazole results in decreased expression of IMPDH2 mRNA

NCBI chr 3:49,024,325...49,029,398
Ensembl chr 3:49,024,321...49,029,452

G

interphotoreceptor matrix proteoglycan 2

increases expression

ISO

epoxiconazole results in increased expression of IMPG2 mRNA

NCBI chr 3:101,222,546...101,320,575
Ensembl chr 3:101,222,546...101,320,575

G

inverted formin 2

decreases expression

ISO

epoxiconazole results in decreased expression of INF2 mRNA

NCBI chr14:104,681,133...104,722,535
Ensembl chr14:104,681,146...104,722,535

G

inhibin subunit beta A

decreases expression

ISO

epoxiconazole results in decreased expression of INHBA mRNA

NCBI chr 7:41,685,114...41,705,406
Ensembl chr 7:41,667,168...41,705,834

G

inhibin subunit beta C

decreases expression

ISO

epoxiconazole results in decreased expression of INHBC mRNA

NCBI chr12:57,434,784...57,452,062
Ensembl chr12:57,434,784...57,452,062

G

inhibin subunit beta E

affects expression

ISO

epoxiconazole affects the expression of INHBE mRNA

NCBI chr12:57,455,307...57,458,025
Ensembl chr12:57,452,323...57,459,280

G

indolethylamine N-methyltransferase

affects expression

ISO

epoxiconazole affects the expression of INMT mRNA

NCBI chr 7:30,752,135...30,757,602
Ensembl chr 7:30,697,985...30,757,602

G

inositol polyphosphate-5-phosphatase K

decreases expression

ISO

epoxiconazole results in decreased expression of INPP5K mRNA

NCBI chr17:1,494,577...1,516,612
Ensembl chr17:1,494,575...1,516,742

G

INSC spindle orientation adaptor protein

decreases expression

ISO

epoxiconazole results in decreased expression of INSC mRNA

NCBI chr11:15,111,416...15,269,676
Ensembl chr11:15,112,424...15,247,208

G

insulin induced gene 1

decreases expression

ISO

epoxiconazole results in decreased expression of INSIG1 mRNA

NCBI chr 7:155,297,878...155,310,235
Ensembl chr 7:155,296,731...155,311,963

G

insulin induced gene 2

increases expression

ISO

epoxiconazole results in increased expression of INSIG2 mRNA

NCBI chr 2:118,088,471...118,110,997
Ensembl chr 2:118,088,137...118,112,313

G

insulin receptor related receptor

increases expression

ISO

epoxiconazole results in increased expression of INSRR mRNA

NCBI chr 1:156,840,063...156,859,117
Ensembl chr 1:156,840,063...156,859,117

G

integrator complex subunit 15

decreases expression

ISO

epoxiconazole results in decreased expression of INTS15 mRNA

NCBI chr 7:6,590,021...6,608,726
Ensembl chr 7:6,589,978...6,608,726

G

integrator complex subunit 3

decreases expression

ISO

epoxiconazole results in decreased expression of INTS3 mRNA

NCBI chr 1:153,728,050...153,774,808
Ensembl chr 1:153,728,050...153,774,808

G

integrator complex subunit 7

decreases expression

ISO

epoxiconazole results in decreased expression of INTS7 mRNA

NCBI chr 1:211,940,403...212,035,557
Ensembl chr 1:211,940,399...212,035,557

G

integrator complex subunit 9

decreases expression

ISO

epoxiconazole results in decreased expression of INTS9 mRNA

NCBI chr 8:28,767,661...28,889,969
Ensembl chr 8:28,767,661...28,890,242

G

importin 11

increases expression

ISO

epoxiconazole results in increased expression of IPO11 mRNA

NCBI chr 5:62,412,763...62,628,582
Ensembl chr 5:62,403,518...62,629,949

G

intracisternal A particle-promoted polypeptide

decreases expression

ISO

epoxiconazole results in decreased expression of IPP mRNA

NCBI chr 1:45,694,324...45,750,653
Ensembl chr 1:45,694,324...45,750,653

G

IQ motif containing B1

increases expression

ISO

epoxiconazole results in increased expression of IQCB1 mRNA

NCBI chr 3:121,769,761...121,835,060
Ensembl chr 3:121,769,399...121,835,093

G

IQ motif containing E

increases expression

ISO

epoxiconazole results in increased expression of IQCE mRNA

NCBI chr 7:2,558,979...2,614,728
Ensembl chr 7:2,558,972...2,614,733

G

IQ motif containing F6

decreases expression

ISO

epoxiconazole results in decreased expression of IQCF6 mRNA

NCBI chr 3:51,778,563...51,779,237
Ensembl chr 3:51,778,561...51,779,241

G

inositol 1,4,5-triphosphate receptor associated 2

decreases expression

ISO

epoxiconazole results in decreased expression of IRAG2 mRNA

NCBI chr12:24,997,575...25,108,335
Ensembl chr12:25,004,342...25,108,489

G

interferon regulatory factor 1

increases expression

ISO

epoxiconazole results in increased expression of IRF1 mRNA

NCBI chr 5:132,481,609...132,490,773
Ensembl chr 5:132,440,440...132,508,719

G

interferon regulatory factor 2 binding protein 2

increases expression

ISO

epoxiconazole results in increased expression of IRF2BP2 mRNA

NCBI chr 1:234,604,269...234,610,178
Ensembl chr 1:234,602,300...234,610,178

G

interferon regulatory factor 7

decreases expression

ISO

epoxiconazole results in decreased expression of IRF7 mRNA

NCBI chr11:612,555...615,950
Ensembl chr11:612,551...615,983

G

immunity related GTPase Q

increases expression

ISO

epoxiconazole results in increased expression of IRGQ mRNA

NCBI chr19:43,584,367...43,596,134
Ensembl chr19:43,584,367...43,596,145

G

insulin receptor substrate 2

increases expression

ISO

epoxiconazole results in increased expression of IRS2 mRNA

NCBI chr13:109,752,695...109,786,583
Ensembl chr13:109,752,695...109,786,583

G

iroquois homeobox 3

increases expression

ISO

epoxiconazole results in increased expression of IRX3 mRNA

NCBI chr16:54,283,304...54,286,787
Ensembl chr16:54,283,304...54,286,787

G

iroquois homeobox 6

increases expression

ISO

epoxiconazole results in increased expression of IRX6 mRNA

NCBI chr16:55,324,203...55,330,756
Ensembl chr16:55,323,974...55,330,757

G

intestine specific homeobox

increases expression

ISO

epoxiconazole results in increased expression of ISX mRNA

NCBI chr22:35,066,158...35,087,387
Ensembl chr22:35,066,136...35,087,392

G

inositol-3-phosphate synthase 1

decreases expression

ISO

epoxiconazole results in decreased expression of ISYNA1 mRNA

NCBI chr19:18,434,388...18,438,133
Ensembl chr19:18,434,388...18,438,178

G

integrin subunit alpha 2b

increases expression

ISO

epoxiconazole results in increased expression of ITGA2B mRNA

NCBI chr17:44,372,181...44,389,649
Ensembl chr17:44,372,177...44,389,649

G

integrin subunit alpha 8

increases expression

ISO

epoxiconazole results in increased expression of ITGA8 mRNA

NCBI chr10:15,513,954...15,719,922
Ensembl chr10:15,513,954...15,719,936

G

integrin subunit alpha 9

decreases expression

ISO

epoxiconazole results in decreased expression of ITGA9 mRNA

NCBI chr 3:37,452,141...37,823,507
Ensembl chr 3:37,452,090...37,823,507

G

integrin subunit alpha E

increases expression

ISO

epoxiconazole results in increased expression of ITGAE mRNA

NCBI chr17:3,714,628...3,801,188
Ensembl chr17:3,714,628...3,801,193

G

integrin subunit alpha X

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole] results in increased expression of ITGAX mRNA

NCBI chr16:31,355,176...31,382,999
Ensembl chr16:31,355,134...31,382,999

G

integrin subunit beta 1 binding protein 1

increases expression

ISO

epoxiconazole results in increased expression of ITGB1BP1 mRNA

NCBI chr 2:9,403,475...9,423,569
Ensembl chr 2:9,403,475...9,423,891

G

integrin subunit beta 2

decreases expression

ISO

epoxiconazole results in decreased expression of ITGB2 mRNA

NCBI chr21:44,885,953...44,928,815
Ensembl chr21:44,885,948...44,932,079

G

inter-alpha-trypsin inhibitor heavy chain 1

decreases expression

ISO

epoxiconazole results in decreased expression of ITIH1 mRNA

NCBI chr 3:52,777,599...52,792,068
Ensembl chr 3:52,777,567...52,792,068

G

inter-alpha-trypsin inhibitor heavy chain 2

decreases expression

ISO

epoxiconazole results in decreased expression of ITIH2 mRNA

NCBI chr10:7,703,316...7,749,520
Ensembl chr10:7,699,386...7,758,675

G

inter-alpha-trypsin inhibitor heavy chain 3

decreases expression

ISO

epoxiconazole results in decreased expression of ITIH3 mRNA

NCBI chr 3:52,794,796...52,808,797
Ensembl chr 3:52,794,450...52,809,881

G

inter-alpha-trypsin inhibitor heavy chain 5

decreases expression

ISO

epoxiconazole results in decreased expression of ITIH5 mRNA

NCBI chr10:7,559,270...7,666,966
Ensembl chr10:7,559,270...7,667,021

G

integral membrane protein 2C

increases expression

ISO

epoxiconazole results in increased expression of ITM2C mRNA

NCBI chr 2:230,864,185...230,879,254
Ensembl chr 2:230,864,639...230,879,248

G

inositol 1,4,5-trisphosphate receptor type 1

decreases expression

ISO

epoxiconazole results in decreased expression of ITPR1 mRNA

NCBI chr 3:4,493,348...4,847,506
Ensembl chr 3:4,493,345...4,847,506

G

inositol 1,4,5-trisphosphate receptor type 2

decreases expression

ISO

epoxiconazole results in decreased expression of ITPR2 mRNA

NCBI chr12:26,335,352...26,833,194
Ensembl chr12:26,335,352...26,833,194

G

ITPRIP like 1

decreases expression

ISO

epoxiconazole results in decreased expression of ITPRIPL1 mRNA

NCBI chr 2:96,325,317...96,330,507
Ensembl chr 2:96,324,977...96,330,517

G

ITPRIP like 2

decreases expression

ISO

epoxiconazole results in decreased expression of ITPRIPL2 mRNA

NCBI chr16:19,113,964...19,121,629
Ensembl chr16:19,113,932...19,121,629

G

isovaleryl-CoA dehydrogenase

decreases expression

ISO

epoxiconazole results in decreased expression of IVD mRNA

NCBI chr15:40,405,795...40,435,947
Ensembl chr15:40,405,485...40,435,947

G

involucrin

increases expression

ISO

epoxiconazole results in increased expression of IVL mRNA

NCBI chr 1:152,908,546...152,911,886
Ensembl chr 1:152,908,546...152,911,886

G

influenza virus NS1A binding protein

decreases expression

ISO

epoxiconazole results in decreased expression of IVNS1ABP mRNA

NCBI chr 1:185,296,388...185,317,243
Ensembl chr 1:185,292,931...185,317,780

G

jade family PHD finger 1

decreases expression

ISO

epoxiconazole results in decreased expression of JADE1 mRNA

NCBI chr 4:128,809,700...128,875,224
Ensembl chr 4:128,809,576...128,875,224

G

jagunal homolog 1

decreases expression

ISO

epoxiconazole results in decreased expression of JAGN1 mRNA

NCBI chr 3:9,890,610...9,894,349
Ensembl chr 3:9,890,574...9,894,349

G

junctional adhesion molecule 3

decreases expression

ISO

epoxiconazole results in decreased expression of JAM3 mRNA

NCBI chr11:134,069,072...134,152,001
Ensembl chr11:134,068,998...134,152,001

G

junctional cadherin 5 associated

decreases expression

ISO

epoxiconazole results in decreased expression of JCAD mRNA

NCBI chr10:30,012,803...30,115,494
Ensembl chr10:30,012,803...30,115,494

G

JRK like

increases expression

ISO

epoxiconazole results in increased expression of JRKL mRNA

NCBI chr11:96,390,013...96,393,561
Ensembl chr11:96,389,989...96,507,574

G

Jun proto-oncogene, AP-1 transcription factor subunit

affects expression

ISO

epoxiconazole affects the expression of JUN mRNA

NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048

G

JunB proto-oncogene, AP-1 transcription factor subunit

increases expression

ISO

epoxiconazole results in increased expression of JUNB mRNA

NCBI chr19:12,791,486...12,793,315
Ensembl chr19:12,791,486...12,793,315

G

junction plakoglobin

decreases expression

ISO

epoxiconazole results in decreased expression of JUP mRNA

NCBI chr17:41,754,609...41,786,711
Ensembl chr17:41,750,887...41,786,931

G

KN motif and ankyrin repeat domains 1

increases expression

ISO

epoxiconazole results in increased expression of KANK1 mRNA

NCBI chr 9:470,295...746,103
Ensembl chr 9:470,291...746,105

G

KAT8 regulatory NSL complex subunit 1

decreases expression

ISO

epoxiconazole results in decreased expression of KANSL1 mRNA

NCBI chr17:46,029,916...46,225,367
Ensembl chr17:46,029,916...46,225,389

G

KAT8 regulatory NSL complex subunit 3

decreases expression

ISO

epoxiconazole results in decreased expression of KANSL3 mRNA

NCBI chr 2:96,580,494...96,638,312
Ensembl chr 2:96,593,170...96,642,787

G

KASH domain containing 5

decreases expression

ISO

epoxiconazole results in decreased expression of KASH5 mRNA

NCBI chr19:49,388,249...49,417,990
Ensembl chr19:49,388,219...49,417,990

G

lysine acetyltransferase 8

increases expression

ISO

epoxiconazole results in increased expression of KAT8 mRNA

NCBI chr16:31,117,664...31,131,393
Ensembl chr16:31,114,489...31,131,393

G

kelch repeat and BTB domain containing 8

decreases expression

ISO

epoxiconazole results in decreased expression of KBTBD8 mRNA

NCBI chr 3:66,998,307...67,011,210
Ensembl chr 3:66,998,307...67,011,210

G

potassium channel modulatory factor 1

decreases expression

ISO

epoxiconazole results in decreased expression of KCMF1 mRNA

NCBI chr 2:84,971,161...85,059,472
Ensembl chr 2:84,970,644...85,059,472

G

potassium voltage-gated channel subfamily A regulatory beta subunit 1

increases expression

ISO

epoxiconazole results in increased expression of KCNAB1 mRNA

NCBI chr 3:156,118,211...156,539,138
Ensembl chr 3:156,037,701...156,538,756

G

potassium voltage-gated channel subfamily A regulatory beta subunit 2

increases expression

ISO

epoxiconazole results in increased expression of KCNAB2 mRNA

NCBI chr 1:5,992,676...6,101,180
Ensembl chr 1:5,990,927...6,101,193

G

potassium voltage-gated channel subfamily H member 3

increases expression

ISO

epoxiconazole results in increased expression of KCNH3 mRNA

NCBI chr12:49,539,030...49,558,337
Ensembl chr12:49,539,028...49,558,337

G

potassium voltage-gated channel subfamily H member 8

decreases expression

ISO

epoxiconazole results in decreased expression of KCNH8 mRNA

NCBI chr 3:19,148,510...19,535,642
Ensembl chr 3:19,148,102...19,535,642

G

potassium inwardly rectifying channel subfamily J member 13

increases expression

ISO

epoxiconazole results in increased expression of KCNJ13 mRNA

NCBI chr 2:232,765,802...232,776,565
Ensembl chr 2:232,765,802...232,776,565

G

potassium inwardly rectifying channel subfamily J member 5

decreases expression

ISO

epoxiconazole results in decreased expression of KCNJ5 mRNA

NCBI chr11:128,891,356...128,921,163
Ensembl chr11:128,890,453...128,921,163

G

potassium two pore domain channel subfamily K member 1

increases expression

ISO

epoxiconazole results in increased expression of KCNK1 mRNA

NCBI chr 1:233,614,106...233,672,514
Ensembl chr 1:233,614,106...233,672,514

G

potassium two pore domain channel subfamily K member 5

decreases expression

ISO

epoxiconazole results in decreased expression of KCNK5 mRNA

NCBI chr 6:39,188,971...39,229,475
Ensembl chr 6:39,188,128...39,229,559

G

potassium calcium-activated channel subfamily M alpha 1

increases expression

ISO

epoxiconazole results in increased expression of KCNMA1 mRNA

NCBI chr10:76,869,602...77,637,808
Ensembl chr10:76,869,601...77,638,369

G

potassium voltage-gated channel subfamily Q member 1

increases expression

ISO

epoxiconazole results in increased expression of KCNQ1 mRNA

NCBI chr11:2,445,008...2,849,105
Ensembl chr11:2,444,654...2,849,105

G

potassium sodium-activated channel subfamily T member 2

decreases expression

ISO

epoxiconazole results in decreased expression of KCNT2 mRNA

NCBI chr 1:196,225,779...196,608,440
Ensembl chr 1:196,225,779...196,609,225

G

potassium voltage-gated channel modifier subfamily V member 2

decreases expression

ISO

epoxiconazole results in decreased expression of KCNV2 mRNA

NCBI chr 9:2,717,510...2,730,037
Ensembl chr 9:2,717,510...2,730,037

G

potassium channel tetramerization domain containing 17

decreases expression

ISO

epoxiconazole results in decreased expression of KCTD17 mRNA

NCBI chr22:37,051,742...37,063,390
Ensembl chr22:37,051,739...37,063,390

G

potassium channel tetramerization domain containing 20

decreases expression

ISO

epoxiconazole results in decreased expression of KCTD20 mRNA

NCBI chr 6:36,443,000...36,491,141
Ensembl chr 6:36,442,767...36,491,143

G

potassium channel tetramerization domain containing 21

increases expression

ISO

epoxiconazole results in increased expression of KCTD21 mRNA

NCBI chr11:78,171,249...78,188,626
Ensembl chr11:78,171,245...78,188,644

G

lysine demethylase 3B

affects expression

ISO

epoxiconazole affects the expression of KDM3B mRNA

NCBI chr 5:138,352,685...138,437,027
Ensembl chr 5:138,352,681...138,437,028

G

lysine demethylase 6B

decreases expression

ISO

epoxiconazole results in decreased expression of KDM6B mRNA

NCBI chr17:7,834,217...7,854,796
Ensembl chr17:7,834,193...7,854,796

G

KH domain containing 3 like, subcortical maternal complex member

increases expression

ISO

epoxiconazole results in increased expression of KHDC3 mRNA

NCBI chr 6:73,362,658...73,364,171
Ensembl chr 6:73,362,658...73,364,171

G

KIAA0232

decreases expression

ISO

epoxiconazole results in decreased expression of D5ERTD579E mRNA

NCBI chr 4:6,782,727...6,884,164
Ensembl chr 4:6,781,375...6,884,170

G

KICSTOR subunit 2

decreases expression

ISO

epoxiconazole results in decreased expression of KICS2 mRNA

NCBI chr12:64,186,316...64,222,296
Ensembl chr12:64,186,226...64,222,296

G

kinesin family member 18B

increases expression

ISO

epoxiconazole results in increased expression of KIF18B mRNA

NCBI chr17:44,924,711...44,947,773
Ensembl chr17:44,924,707...44,947,776

G

kinesin family member 1B

increases expression

ISO

epoxiconazole results in increased expression of KIF1B mRNA

NCBI chr 1:10,210,570...10,381,603
Ensembl chr 1:10,210,533...10,381,606

G

kinesin family member 4A

increases expression

ISO

epoxiconazole results in increased expression of KIF4 mRNA

NCBI chr X:70,290,104...70,420,886
Ensembl chr X:70,290,067...70,420,886

G

kinesin family binding protein

decreases expression

ISO

epoxiconazole results in decreased expression of KIFBP mRNA

NCBI chr10:68,988,803...69,016,982
Ensembl chr10:68,988,803...69,043,544

G

kirre like nephrin family adhesion molecule 2

increases expression

ISO

epoxiconazole results in increased expression of KIRREL2 mRNA

NCBI chr19:35,851,399...35,867,136
Ensembl chr19:35,851,369...35,867,145

G

KIT ligand

decreases expression

ISO

epoxiconazole results in decreased expression of KITL mRNA

NCBI chr12:88,492,793...88,580,471
Ensembl chr12:88,492,789...88,580,851

G

kizuna centrosomal protein

increases expression

ISO

epoxiconazole results in increased expression of KIZ mRNA

NCBI chr20:21,125,975...21,246,622
Ensembl chr20:21,125,975...21,246,622

G

KLF transcription factor 10

decreases expression

ISO

epoxiconazole results in decreased expression of KLF10 mRNA

NCBI chr 8:102,648,784...102,655,725
Ensembl chr 8:102,648,783...102,655,728

G

KLF transcription factor 11

increases expression

ISO

epoxiconazole results in increased expression of KLF11 mRNA

NCBI chr 2:10,043,550...10,054,836
Ensembl chr 2:10,042,849...10,054,836

G

KLF transcription factor 13

decreases expression

ISO

epoxiconazole results in decreased expression of KLF13 mRNA

NCBI chr15:31,326,835...31,435,665
Ensembl chr15:31,326,706...31,435,665

G

KLF transcription factor 15

decreases expression

ISO

epoxiconazole results in decreased expression of KLF15 mRNA

NCBI chr 3:126,288,125...126,357,408
Ensembl chr 3:126,342,635...126,357,458

G

KLF transcription factor 3

decreases expression

ISO

epoxiconazole results in decreased expression of KLF3 mRNA

NCBI chr 4:38,664,199...38,701,517
Ensembl chr 4:38,664,032...38,701,517

G

kelch domain containing 3

decreases expression

ISO

epoxiconazole results in decreased expression of KLHDC3 mRNA

NCBI chr 6:43,014,249...43,021,294
Ensembl chr 6:43,014,103...43,021,298

G

kelch like family member 14

increases expression

ISO

epoxiconazole results in increased expression of KLHL14 mRNA

NCBI chr18:32,672,673...32,773,023
Ensembl chr18:32,672,601...32,773,023

G

kelch like family member 2

decreases expression

ISO

epoxiconazole results in decreased expression of KLHL2 mRNA

NCBI chr 4:165,207,561...165,323,156
Ensembl chr 4:165,207,561...165,323,156

G

kelch like family member 21

decreases expression

ISO

epoxiconazole results in decreased expression of KLHL21 mRNA

NCBI chr 1:6,590,724...6,602,869
Ensembl chr 1:6,590,724...6,614,607

G

kallikrein 1

decreases expression

ISO

epoxiconazole results in decreased expression of KLK1 mRNA

NCBI chr19:50,819,146...50,823,787
Ensembl chr19:50,819,146...50,823,787

G

kallikrein related peptidase 14

increases expression

ISO

epoxiconazole results in increased expression of KLK14 mRNA

NCBI chr19:51,077,494...51,084,210
Ensembl chr19:51,077,317...51,086,530

G

killer cell lectin like receptor B1

increases expression

ISO

epoxiconazole results in increased expression of KLRB1A mRNA

NCBI chr12:9,594,551...9,607,916
Ensembl chr12:9,594,551...9,607,916

G

lysine methyltransferase 2B

decreases expression

ISO

epoxiconazole results in decreased expression of KMT2B mRNA

NCBI chr19:35,718,003...35,738,878
Ensembl chr19:35,717,973...35,738,880

G

lysine methyltransferase 5A

increases expression

ISO

epoxiconazole results in increased expression of KMT5A mRNA

NCBI chr12:123,384,132...123,409,353
Ensembl chr12:123,384,132...123,409,353

G

karyopherin subunit alpha 2

decreases expression

ISO

epoxiconazole results in decreased expression of KPNA2 mRNA

NCBI chr17:68,035,735...68,046,854
Ensembl chr17:68,035,636...68,047,364

G

karyopherin subunit alpha 4

increases expression

ISO

epoxiconazole results in increased expression of KPNA4 mRNA

NCBI chr 3:160,495,007...160,565,571
Ensembl chr 3:160,495,007...160,565,587

G

keratin 18

increases expression

ISO

epoxiconazole results in increased expression of KRT18 mRNA

NCBI chr12:52,948,855...52,952,906
Ensembl chr12:52,945,688...52,952,911

G

keratin 20

increases expression

ISO

epoxiconazole results in increased expression of KRT20 mRNA

NCBI chr17:40,875,889...40,885,242
Ensembl chr17:40,874,934...40,885,243

G

keratin 23

decreases expression

ISO

epoxiconazole results in decreased expression of KRT23 mRNA

NCBI chr17:40,922,700...40,937,646
Ensembl chr17:40,922,700...40,937,646

G

keratin 33B

increases expression

ISO

epoxiconazole results in increased expression of KRT33B mRNA

NCBI chr17:41,363,498...41,369,813
Ensembl chr17:41,363,498...41,369,813

G

keratin 40

increases expression

ISO

epoxiconazole results in increased expression of KRT40 mRNA

NCBI chr17:40,977,715...40,987,135
Ensembl chr17:40,977,715...40,987,135

G

keratin 72

increases expression

ISO

epoxiconazole results in increased expression of KRT72 mRNA

NCBI chr12:52,585,589...52,602,953
Ensembl chr12:52,585,589...52,601,538

G

keratin 8

increases expression

ISO

epoxiconazole results in increased expression of KRT8 mRNA

NCBI chr12:52,897,191...52,949,860
Ensembl chr12:52,897,182...52,949,954

G

keratin 80

decreases expression

ISO

epoxiconazole results in decreased expression of KRT80 mRNA

NCBI chr12:52,168,996...52,192,014
Ensembl chr12:52,168,996...52,192,014

G

keratin 90, pseudogene

increases expression

ISO

epoxiconazole results in increased expression of KRT90 mRNA

NCBI chr12:52,413,861...52,419,240
Ensembl chr12:52,411,742...52,421,867

G

keratin associated protein 17-1

increases expression

ISO

epoxiconazole results in increased expression of KRTAP17-1 mRNA

NCBI chr17:41,314,912...41,315,710
Ensembl chr17:41,314,912...41,315,710

G

keratin associated protein 26-1

affects expression

ISO

epoxiconazole affects the expression of KRTAP26-1 mRNA

NCBI chr21:30,319,124...30,320,315
Ensembl chr21:30,319,124...30,320,315

G

keratin associated protein 3-2

affects expression

ISO

epoxiconazole affects the expression of KRTAP3-2 mRNA

NCBI chr17:40,999,193...40,999,906
Ensembl chr17:40,999,193...40,999,906

G

keratin associated protein 3-3

affects expression

ISO

epoxiconazole affects the expression of KRTAP3-3 mRNA

NCBI chr17:40,993,430...40,994,164
Ensembl chr17:40,993,430...40,994,164

G

keratin associated protein 5-1

increases expression

ISO

epoxiconazole results in increased expression of KRTAP5-1 mRNA

NCBI chr11:1,584,342...1,585,283
Ensembl chr11:1,584,342...1,585,283

G

keratin associated protein 5-4

increases expression

ISO

epoxiconazole results in increased expression of KRTAP5-4 mRNA

NCBI chr11:1,620,958...1,622,138
Ensembl chr11:1,620,958...1,622,138

G

keratin associated protein 6-3

increases expression

ISO

epoxiconazole results in increased expression of KRTAP6-3 mRNA

NCBI chr21:30,592,440...30,593,055
Ensembl chr21:30,592,440...30,593,055

G

keratin associated protein 9-1

affects expression

ISO

epoxiconazole affects the expression of KRTAP9-5 mRNA

NCBI chr17:41,189,887...41,190,639
Ensembl chr17:41,189,887...41,190,639

G

keratin associated protein 9-6

increases expression

ISO

epoxiconazole results in increased expression of KRTAP9-3 mRNA

NCBI chr17:41,265,378...41,265,860
Ensembl chr17:41,265,378...41,265,860

G

kynurenine aminotransferase 1

decreases expression

ISO

epoxiconazole results in decreased expression of KYAT1 mRNA

NCBI chr 9:128,832,942...128,882,523
Ensembl chr 9:128,819,663...128,881,931
Ensembl chr 9:128,819,663...128,881,931

G

kynureninase

decreases expression

ISO

epoxiconazole results in decreased expression of KYNU mRNA

NCBI chr 2:142,877,664...143,055,833
Ensembl chr 2:142,877,613...143,055,833

G

L1 cell adhesion molecule

increases expression

ISO

epoxiconazole results in increased expression of L1CAM mRNA

NCBI chr X:153,861,514...153,886,173
Ensembl chr X:153,861,511...153,886,204

G

L3MBTL histone methyl-lysine binding protein 1

increases expression

ISO

epoxiconazole results in increased expression of L3MBTL1 mRNA

NCBI chr20:43,507,697...43,550,954
Ensembl chr20:43,489,442...43,550,954

G

laccase domain containing 1

decreases expression

ISO

epoxiconazole results in decreased expression of LACC1 mRNA

NCBI chr13:43,879,178...43,893,932
Ensembl chr13:43,878,917...43,895,091

G

lactamase beta 2

decreases expression

ISO

epoxiconazole results in decreased expression of LACTB2 mRNA

NCBI chr 8:70,637,266...70,669,185
Ensembl chr 8:70,631,109...70,669,185

G

lymphocyte activating 3

increases expression

ISO

epoxiconazole results in increased expression of LAG3 mRNA

NCBI chr12:6,772,520...6,778,455
Ensembl chr12:6,772,360...6,778,455

G

laminin subunit alpha 1

increases expression

ISO

epoxiconazole results in increased expression of LAMA1 mRNA

NCBI chr18:6,941,742...7,117,797
Ensembl chr18:6,941,742...7,117,859

G

laminin subunit alpha 2

increases expression

ISO

epoxiconazole results in increased expression of LAMA2 mRNA

NCBI chr 6:128,883,138...129,516,566
Ensembl chr 6:128,883,138...129,516,566

G

laminin subunit alpha 3

decreases expression

ISO

epoxiconazole results in decreased expression of LAMA3 mRNA

NCBI chr18:23,689,453...23,955,066
Ensembl chr18:23,689,453...23,956,222

G

laminin subunit beta 2

increases expression

ISO

epoxiconazole results in increased expression of LAMB2 mRNA

NCBI chr 3:49,121,114...49,133,050
Ensembl chr 3:49,121,113...49,133,118

G

laminin subunit beta 3

decreases expression

ISO

epoxiconazole results in decreased expression of LAMB3 mRNA

NCBI chr 1:209,614,870...209,652,425
Ensembl chr 1:209,614,870...209,653,106

G

laminin subunit gamma 1

decreases expression

ISO

epoxiconazole results in decreased expression of LAMC1 mRNA

NCBI chr 1:183,023,420...183,145,592
Ensembl chr 1:183,023,420...183,145,592

G

LanC like glutathione S-transferase 1

decreases expression

ISO

epoxiconazole results in decreased expression of LANCL1 mRNA

NCBI chr 2:210,431,251...210,477,584
Ensembl chr 2:210,427,131...210,477,652

G

La ribonucleoprotein 1B

increases expression

ISO

epoxiconazole results in increased expression of LARP1B mRNA

NCBI chr 4:128,060,789...128,222,926
Ensembl chr 4:128,060,801...128,222,931

G

LAS1 like ribosome biogenesis factor

decreases expression

ISO

epoxiconazole results in decreased expression of LAS1L mRNA

NCBI chr X:65,512,582...65,534,787
Ensembl chr X:65,438,549...65,534,818

G

LIM and SH3 protein 1

increases expression

ISO

epoxiconazole results in increased expression of LASP1 mRNA

NCBI chr17:38,870,058...38,921,770
Ensembl chr17:38,869,185...38,921,771

G

large tumor suppressor kinase 2

decreases expression

ISO

epoxiconazole results in decreased expression of LATS2 mRNA

NCBI chr13:20,973,036...21,061,586
Ensembl chr13:20,973,029...21,061,603

G

lipopolysaccharide binding protein

decreases expression

ISO

epoxiconazole results in decreased expression of LBP mRNA

NCBI chr20:38,346,482...38,377,013
Ensembl chr20:38,346,482...38,377,511

G

late cornified envelope 1F

increases expression

ISO

epoxiconazole results in increased expression of LCE1F mRNA

NCBI chr 1:152,775,140...152,777,024
Ensembl chr 1:152,775,140...152,777,024

G

late cornified envelope 3E

increases expression

ISO

epoxiconazole results in increased expression of LCE3A mRNA

NCBI chr 1:152,565,654...152,566,780
Ensembl chr 1:152,565,654...152,566,780

G

lipocalin 2

increases expression

ISO

epoxiconazole results in increased expression of LCN2 mRNA

NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453

G

ligand dependent nuclear receptor corepressor

decreases expression

ISO

epoxiconazole results in decreased expression of LCOR mRNA

NCBI chr10:96,832,298...96,995,956
Ensembl chr10:96,831,803...96,995,956

G

LIM domain binding 3

increases expression

ISO

epoxiconazole results in increased expression of LDB3 mRNA

NCBI chr10:86,666,788...86,736,072
Ensembl chr10:86,666,664...86,736,159

G

lactate dehydrogenase A

decreases expression

ISO

epoxiconazole results in decreased expression of LDHA mRNA

NCBI chr11:18,394,563...18,408,425
Ensembl chr11:18,394,347...18,408,425

G

lactate dehydrogenase D

decreases expression

ISO

epoxiconazole results in decreased expression of LDHD mRNA

NCBI chr16:75,111,864...75,116,780
Ensembl chr16:75,111,855...75,116,782

G

low density lipoprotein receptor

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of LDLR mRNA
epoxiconazole results in decreased expression of LDLR mRNA

PMID:28454766 PMID:35436446

NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,830

G

low density lipoprotein receptor class A domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of LDLRAD1 mRNA

NCBI chr 1:54,007,298...54,018,186
Ensembl chr 1:54,007,298...54,018,194

G

low density lipoprotein receptor adaptor protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of LDLRAP1 mRNA

NCBI chr 1:25,543,606...25,590,400
Ensembl chr 1:25,543,573...25,591,200

G

leukocyte receptor cluster member 8

decreases expression

ISO

epoxiconazole results in decreased expression of LENG8 mRNA

NCBI chr19:54,449,199...54,462,016
Ensembl chr19:54,449,157...54,462,022

G

leptin receptor

decreases expression

ISO

epoxiconazole results in decreased expression of LEPR mRNA

NCBI chr 1:65,420,652...65,641,559
Ensembl chr 1:65,420,652...65,641,559

G

LETM1 domain containing 1

decreases expression

ISO

epoxiconazole results in decreased expression of LETMD1 mRNA

NCBI chr12:51,048,220...51,068,958
Ensembl chr12:51,047,962...51,060,426

G

galectin 3 binding protein

decreases expression

ISO

epoxiconazole results in decreased expression of LGALS3BP mRNA

NCBI chr17:78,971,255...78,979,923
Ensembl chr17:78,971,238...78,979,962

G

galectin like

increases expression

ISO

epoxiconazole results in increased expression of LGALSL mRNA

NCBI chr 2:64,454,162...64,461,381
Ensembl chr 2:64,453,969...64,461,381

G

phospholysine phosphohistidine inorganic pyrophosphate phosphatase

decreases expression

ISO

epoxiconazole results in decreased expression of LHPP mRNA

NCBI chr10:124,461,823...124,614,141
Ensembl chr10:124,461,792...124,617,888

G

LIM homeobox 3

increases expression

ISO

epoxiconazole results in increased expression of LHX3 mRNA

NCBI chr 9:136,196,250...136,205,128
Ensembl chr 9:136,196,250...136,205,128

G

DNA ligase 3

increases expression

ISO

epoxiconazole results in increased expression of LIG3 mRNA

NCBI chr17:34,980,512...35,010,872
Ensembl chr17:34,980,462...35,009,743

G

LIM domain and actin binding 1

decreases expression

ISO

epoxiconazole results in decreased expression of LIMA1 mRNA

NCBI chr12:50,175,788...50,283,520
Ensembl chr12:50,175,788...50,283,524

G

LIM zinc finger domain containing 2

decreases expression

ISO

epoxiconazole results in decreased expression of LIMS2 mRNA

NCBI chr 2:127,638,426...127,681,786
Ensembl chr 2:127,638,381...127,681,786

G

long intergenic non-protein coding RNA, p53 induced transcript

decreases expression

ISO

epoxiconazole results in decreased expression of LNCPINT mRNA

NCBI chr 7:130,877,562...131,109,925
Ensembl chr 7:130,791,264...131,110,176

G

lipase G, endothelial type

decreases expression

ISO

epoxiconazole results in decreased expression of LIPG mRNA

NCBI chr18:49,561,479...49,599,185
Ensembl chr18:49,560,699...49,599,185

G

lipoyl(octanoyl) transferase 2

decreases expression

ISO

epoxiconazole results in decreased expression of LIPT2 mRNA

NCBI chr11:74,490,519...74,493,724
Ensembl chr11:74,490,519...74,493,724

G

lipopolysaccharide induced TNF factor

increases expression

ISO

epoxiconazole results in increased expression of LITAF mRNA

NCBI chr16:11,547,722...11,640,317
Ensembl chr16:11,546,875...11,636,395

G

LLGL scribble cell polarity complex component 2

decreases expression

ISO

epoxiconazole results in decreased expression of LLGL2 mRNA

NCBI chr17:75,525,002...75,575,209
Ensembl chr17:75,525,080...75,575,215

G

lectin, mannose binding 2

decreases expression

ISO

epoxiconazole results in decreased expression of LMAN2 mRNA

NCBI chr 5:177,331,567...177,351,668
Ensembl chr 5:177,315,805...177,351,840

G

lipase maturation factor 1

decreases expression

ISO

epoxiconazole results in decreased expression of LMF1 mRNA

NCBI chr16:853,634...981,613
Ensembl chr16:853,634...981,318

G

lamin tail domain containing 2

affects expression

ISO

epoxiconazole affects the expression of LMNTD2 mRNA

NCBI chr11:554,850...560,738
Ensembl chr11:554,850...560,738

G

LIM domain 7

decreases expression

ISO

epoxiconazole results in decreased expression of LMO7 mRNA

NCBI chr13:75,620,434...75,859,870
Ensembl chr13:75,620,434...75,859,870

G

ligand of numb-protein X 1

decreases expression

ISO

epoxiconazole results in decreased expression of LNX1 mRNA

NCBI chr 4:53,459,301...53,652,477
Ensembl chr 4:53,459,301...53,701,405

G

ligand of numb-protein X 2

increases expression

ISO

epoxiconazole results in increased expression of LNX2 mRNA

NCBI chr13:27,545,913...27,621,107
Ensembl chr13:27,545,911...27,621,344

G

LON peptidase N-terminal domain and ring finger 1

affects expression

ISO

epoxiconazole affects the expression of LONRF1 mRNA

NCBI chr 8:12,721,906...12,755,526
Ensembl chr 8:12,721,906...12,756,073

G

LON peptidase N-terminal domain and ring finger 2

increases expression

ISO

epoxiconazole results in increased expression of LONRF2 mRNA

NCBI chr 2:100,271,875...100,322,501
Ensembl chr 2:100,271,875...100,322,501

G

LON peptidase N-terminal domain and ring finger 3

decreases expression

ISO

epoxiconazole results in decreased expression of LONRF3 mRNA

PMID:22334560 PMID:23970803 PMID:35436446

NCBI chr X:118,974,614...119,018,355
Ensembl chr X:118,974,614...119,022,925

G

lysyl oxidase like 3

decreases expression

ISO

epoxiconazole results in decreased expression of LOXL3 mRNA

NCBI chr 2:74,532,258...74,555,702
Ensembl chr 2:74,532,258...74,555,718

G

lysyl oxidase like 4

increases expression

ISO

epoxiconazole results in increased expression of LOXL4 mRNA

NCBI chr10:98,247,690...98,268,194
Ensembl chr10:98,247,690...98,268,650

G

lysophosphatidic acid receptor 6

increases expression

ISO

epoxiconazole results in increased expression of LPAR6 mRNA

NCBI chr13:48,389,571...48,444,669
Ensembl chr13:48,389,567...48,444,704

G

lipin 1

decreases expression

ISO

epoxiconazole results in decreased expression of LPIN1 mRNA

NCBI chr 2:11,677,544...11,827,409
Ensembl chr 2:11,677,544...11,827,409

G

lipin 2

decreases expression

ISO

epoxiconazole results in decreased expression of LPIN2 mRNA

NCBI chr18:2,916,994...3,013,144
Ensembl chr18:2,885,296...3,013,345

G

lactoperoxidase

increases expression

ISO

epoxiconazole results in increased expression of LPO mRNA

NCBI chr17:58,238,584...58,268,518
Ensembl chr17:58,218,548...58,268,518

G

LIM domain containing preferred translocation partner in lipoma

decreases expression

ISO

epoxiconazole results in decreased expression of LPP mRNA

NCBI chr 3:188,153,021...188,890,671
Ensembl chr 3:188,152,994...188,890,671

G

lecithin retinol acyltransferase

decreases expression

ISO

epoxiconazole results in decreased expression of LRAT mRNA

NCBI chr 4:154,740,838...154,753,120
Ensembl chr 4:154,626,945...154,753,120

G

leucine rich alpha-2-glycoprotein 1

affects expression

ISO

epoxiconazole affects the expression of LRG1 mRNA

NCBI chr19:4,536,402...4,540,036
Ensembl chr19:4,536,402...4,540,067

G

leucine rich repeat, Ig-like and transmembrane domains 1

affects expression

ISO

epoxiconazole affects the expression of LRIT1 mRNA

NCBI chr10:84,231,520...84,241,546
Ensembl chr10:84,231,520...84,241,546

G

leucine rich repeat, Ig-like and transmembrane domains 2

decreases expression

ISO

epoxiconazole results in decreased expression of LRIT2 mRNA

NCBI chr10:84,220,485...84,225,589
Ensembl chr10:84,220,571...84,225,544

G

LDL receptor related protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of LRP1 mRNA

NCBI chr12:57,128,483...57,213,361
Ensembl chr12:57,128,483...57,213,361

G

LDL receptor related protein 3

decreases expression

ISO

epoxiconazole results in decreased expression of LRP3 mRNA

NCBI chr19:33,194,330...33,208,864
Ensembl chr19:33,177,603...33,208,864

G

LDL receptor related protein 4

affects expression

ISO

epoxiconazole affects the expression of LRP4 mRNA

NCBI chr11:46,856,717...46,918,550
Ensembl chr11:46,856,717...46,918,642

G

LDL receptor related protein 5

increases expression

ISO

epoxiconazole results in increased expression of LRP5 mRNA

NCBI chr11:68,298,412...68,449,275
Ensembl chr11:68,312,447...68,449,275

G

leucine rich pentatricopeptide repeat containing

decreases expression

ISO

epoxiconazole results in decreased expression of LRPPRC mRNA

NCBI chr 2:43,886,224...43,996,265
Ensembl chr 2:43,886,224...43,996,226

G

leucine rich repeat containing 18

increases expression

ISO

epoxiconazole results in increased expression of LRRC18 mRNA

NCBI chr10:48,909,480...48,939,840
Ensembl chr10:48,909,480...48,939,840

G

leucine rich repeat containing 28

decreases expression

ISO

epoxiconazole results in decreased expression of LRRC28 mRNA

NCBI chr15:99,251,481...99,390,729
Ensembl chr15:99,250,937...99,390,729

G

leucine rich repeat containing 3

decreases expression

ISO

epoxiconazole results in decreased expression of LRRC3 mRNA

PMID:22334560 PMID:35436446

NCBI chr21:44,455,510...44,462,196
Ensembl chr21:44,455,490...44,462,196

G

leucine rich repeat containing 39

decreases expression

ISO

epoxiconazole results in decreased expression of LRRC39 mRNA

NCBI chr 1:100,148,448...100,179,667
Ensembl chr 1:100,148,424...100,178,267

G

leucine rich repeat containing 47

increases expression

ISO

epoxiconazole results in increased expression of LRRC47 mRNA

NCBI chr 1:3,778,559...3,796,498
Ensembl chr 1:3,778,559...3,796,511

G

leucine rich repeat containing 59

decreases expression

ISO

epoxiconazole results in decreased expression of LRRC59 mRNA

NCBI chr17:50,381,238...50,397,523
Ensembl chr17:50,375,059...50,398,227

G

leucine rich repeat containing 66

decreases expression

ISO

epoxiconazole results in decreased expression of LRRC66 mRNA

NCBI chr 4:51,993,652...52,020,363
Ensembl chr 4:51,993,614...52,020,363

G

leucine rich repeat containing 7

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of LRRC7 mRNA

NCBI chr 1:69,567,922...70,144,364
Ensembl chr 1:69,567,922...70,151,945

G

leucine rich repeat containing 8 VRAC subunit C

decreases expression

ISO

epoxiconazole results in decreased expression of LRRC8C mRNA

NCBI chr 1:89,615,824...89,719,533
Ensembl chr 1:89,632,707...89,769,903

G

leucine rich repeat containing 8 VRAC subunit D

decreases expression

ISO

epoxiconazole results in decreased expression of LRRC8D mRNA

NCBI chr 1:89,821,032...89,936,611
Ensembl chr 1:89,820,978...89,936,611

G

leucine rich repeat containing 9

increases expression

ISO

epoxiconazole results in increased expression of LRRC9 mRNA

NCBI chr14:59,919,713...60,066,817
Ensembl chr14:59,919,713...60,066,817

G

leucine rich repeat and sterile alpha motif containing 1

increases expression

ISO

epoxiconazole results in increased expression of LRSAM1 mRNA

NCBI chr 9:127,451,486...127,503,501
Ensembl chr 9:127,451,469...127,503,503

G

LSM11, U7 small nuclear RNA associated

increases expression

ISO

epoxiconazole results in increased expression of LSM11 mRNA

NCBI chr 5:157,743,712...157,760,709
Ensembl chr 5:157,743,712...157,760,709

G

LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated

increases expression

ISO

epoxiconazole results in increased expression of LSM3 mRNA

NCBI chr 3:14,178,817...14,201,122
Ensembl chr 3:14,178,801...14,201,122

G

LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated

increases expression

ISO

epoxiconazole results in increased expression of LSM6 mRNA

NCBI chr 4:146,175,718...146,191,535
Ensembl chr 4:146,175,685...146,204,436

G

lanosterol synthase

multiple interactions
decreases expression
increases expression

ISO
EXP

[cyproconazole co-treated with epoxiconazole] results in increased expression of LSS mRNA
epoxiconazole results in decreased expression of LSS mRNA
epoxiconazole results in increased expression of LSS mRNA

PMID:29038839 PMID:34182286 PMID:35436446

NCBI chr21:46,188,446...46,228,774
Ensembl chr21:46,188,141...46,228,840

G

latent transforming growth factor beta binding protein 4

decreases expression

ISO

epoxiconazole results in decreased expression of LTBP4 mRNA

NCBI chr19:40,593,166...40,629,820
Ensembl chr19:40,592,883...40,629,821

G

lactotransferrin

increases expression

ISO

epoxiconazole results in increased expression of LTF mRNA

NCBI chr 3:46,435,645...46,485,234
Ensembl chr 3:46,435,645...46,485,234

G

LUC7 like 3 pre-mRNA splicing factor

decreases expression

ISO

epoxiconazole results in decreased expression of LUC7L3 mRNA

NCBI chr17:50,719,603...50,756,219
Ensembl chr17:50,719,565...50,756,219

G

lumican

decreases expression

ISO

epoxiconazole results in decreased expression of LUM mRNA

NCBI chr12:91,102,629...91,111,494
Ensembl chr12:91,102,629...91,111,512

G

lymphocyte antigen 6 family member D

increases expression

ISO

epoxiconazole results in increased expression of LY6D mRNA

NCBI chr 8:142,784,882...142,786,539
Ensembl chr 8:142,784,882...142,786,539

G

lymphocyte antigen 6 family member G5C

decreases expression

ISO

epoxiconazole results in decreased expression of LY6G5C mRNA

NCBI chr 6:31,676,684...31,681,067
Ensembl chr 6:31,676,684...31,684,040

G

lymphocyte antigen 86

affects expression

ISO

epoxiconazole affects the expression of LY86 mRNA

NCBI chr 6:6,588,720...6,654,982
Ensembl chr 6:6,588,108...6,654,983

G

lymphocyte antigen 96

increases expression

ISO

epoxiconazole results in increased expression of LY96 mRNA

NCBI chr 8:73,991,392...74,099,857
Ensembl chr 8:73,991,392...74,029,079

G

LY6/PLAUR domain containing 1

decreases expression

ISO

epoxiconazole results in decreased expression of LYPD1 mRNA

NCBI chr 2:132,643,286...132,671,526
Ensembl chr 2:132,643,286...132,671,579

G

lysophospholipase 1

increases expression

ISO

epoxiconazole results in increased expression of LYPLA1 mRNA

NCBI chr 8:54,042,987...54,101,947
Ensembl chr 8:54,046,367...54,102,017

G

lysophospholipase like 1

increases expression

ISO

epoxiconazole results in increased expression of LYPLAL1 mRNA

NCBI chr 1:219,173,878...219,445,496
Ensembl chr 1:219,173,853...219,220,700

G

LYR motif containing 1

increases expression

ISO

epoxiconazole results in increased expression of LYRM1 mRNA

NCBI chr16:20,899,882...20,925,006
Ensembl chr16:20,899,821...20,925,011

G

LYR motif containing 4

decreases expression

ISO

epoxiconazole results in decreased expression of LYRM4 mRNA

NCBI chr 6:5,031,753...5,260,950
Ensembl chr 6:5,102,595...5,260,950

G

LysM domain containing 1

decreases expression

ISO

epoxiconazole results in decreased expression of LYSMD1 mRNA

NCBI chr 1:151,148,496...151,165,902
Ensembl chr 1:151,159,748...151,165,948

G

lymphatic vessel endothelial hyaluronan receptor 1

decreases expression

ISO

epoxiconazole results in decreased expression of LYVE1 mRNA

NCBI chr11:10,556,966...10,568,665
Ensembl chr11:10,556,966...10,611,689

G

mab-21 like 4

increases expression

ISO

epoxiconazole results in increased expression of MAB21L4 mRNA

NCBI chr 2:240,886,048...240,896,839
Ensembl chr 2:240,886,048...240,896,893

G

macoilin 1

decreases expression

ISO

epoxiconazole results in decreased expression of MACO1 mRNA

NCBI chr 1:25,430,897...25,500,209
Ensembl chr 1:25,430,853...25,500,209

G

mono-ADP ribosylhydrolase 2

affects expression

ISO

epoxiconazole affects the expression of MACROD2 mRNA

NCBI chr20:13,995,516...16,053,197
Ensembl chr20:13,995,369...16,053,197

G

MAD2L1 binding protein

decreases expression

ISO

epoxiconazole results in decreased expression of MAD2L1BP mRNA

NCBI chr 6:43,629,540...43,640,941
Ensembl chr 6:43,629,494...43,640,955

G

mitotic arrest deficient 2 like 2

increases expression

ISO

epoxiconazole results in increased expression of MAD2L2 mRNA

NCBI chr 1:11,674,480...11,691,830
Ensembl chr 1:11,657,230...11,692,605

G

macrophage erythroblast attacher, E3 ubiquitin ligase

increases expression

ISO

epoxiconazole results in increased expression of MAEA mRNA

NCBI chr 4:1,289,891...1,340,137
Ensembl chr 4:1,289,876...1,340,147

G

MAF bZIP transcription factor

increases expression

ISO

epoxiconazole results in increased expression of MAF mRNA

NCBI chr16:79,202,622...79,600,737
Ensembl chr16:79,585,843...79,600,737

G

MAF bZIP transcription factor B

decreases expression

ISO

epoxiconazole results in decreased expression of MAFB mRNA

NCBI chr20:40,685,848...40,689,236
Ensembl chr20:40,685,848...40,689,236

G

MAGE family member A1

increases expression

ISO

epoxiconazole results in increased expression of MAGEA1 mRNA

NCBI chr X:153,179,284...153,183,880
Ensembl chr X:153,179,284...153,183,880

G

MAGE family member E2

increases expression

ISO

epoxiconazole results in increased expression of MAGEE2 mRNA

NCBI chr X:75,782,987...75,785,254
Ensembl chr X:75,782,987...75,785,254

G

membrane associated guanylate kinase, WW and PDZ domain containing 2

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of MAGI2 mRNA

NCBI chr 7:78,017,055...79,453,667
Ensembl chr 7:78,017,055...79,453,667

G

mago homolog, exon junction complex subunit

increases expression

ISO

epoxiconazole results in increased expression of MAGOH mRNA

NCBI chr 1:53,226,900...53,238,518
Ensembl chr 1:53,226,890...53,238,621

G

magnesium transporter 1

increases expression

ISO

epoxiconazole results in increased expression of MAGT1 mRNA

NCBI chr X:77,825,747...77,895,568
Ensembl chr X:77,825,747...77,899,271

G

mal, T cell differentiation protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of MAL2 mRNA

NCBI chr 8:119,208,363...119,245,673
Ensembl chr 8:119,165,034...119,249,903

G

mitochondrial assembly of ribosomal large subunit 1

increases expression

ISO

epoxiconazole results in increased expression of MALSU1 mRNA

NCBI chr 7:23,299,339...23,311,729
Ensembl chr 7:23,298,739...23,311,729

G

mastermind like transcriptional coactivator 3

decreases expression

ISO

epoxiconazole results in decreased expression of MAML3 mRNA

NCBI chr 4:139,716,753...140,154,184
Ensembl chr 4:139,716,753...140,154,212

G

mannosidase alpha class 2B member 1

decreases expression

ISO

epoxiconazole results in decreased expression of MAN2B1 mRNA

NCBI chr19:12,646,512...12,666,742
Ensembl chr19:12,643,831...12,666,762

G

mannosidase beta

decreases expression
multiple interactions

ISO

epoxiconazole results in decreased expression of MANBA mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MANBA mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of MANBA mRNA

PMID:29038839 PMID:35436446

NCBI chr 4:102,630,770...102,760,968
Ensembl chr 4:102,630,770...102,760,999

G

MANSC domain containing 4

increases expression

ISO

epoxiconazole results in increased expression of MANSC4 mRNA

NCBI chr12:27,762,427...27,780,236
Ensembl chr12:27,762,427...27,780,236

G

microtubule associated protein 1 light chain 3 alpha

increases expression

ISO

epoxiconazole results in increased expression of MAP1LC3A mRNA

NCBI chr20:34,546,844...34,560,345
Ensembl chr20:34,546,838...34,560,357

G

mitogen-activated protein kinase kinase 2

decreases expression

ISO

epoxiconazole results in decreased expression of MAP2K2 mRNA

NCBI chr19:4,090,321...4,124,122
Ensembl chr19:4,090,317...4,124,216

G

mitogen-activated protein kinase kinase 3

increases expression

ISO

epoxiconazole results in increased expression of MAP2K3 mRNA

NCBI chr17:21,284,711...21,315,240
Ensembl chr17:21,284,672...21,315,240

G

mitogen-activated protein kinase kinase 6

decreases expression

ISO

epoxiconazole results in decreased expression of MAP2K6 mRNA

NCBI chr17:69,414,697...69,553,865
Ensembl chr17:69,414,683...69,553,865

G

mitogen-activated protein kinase kinase 7

decreases expression

ISO

epoxiconazole results in decreased expression of MAP2K7 mRNA

NCBI chr19:7,903,877...7,914,478
Ensembl chr19:7,903,843...7,914,480

G

mitogen-activated protein kinase kinase kinase 1

increases expression

ISO

epoxiconazole results in increased expression of MAP3K1 mRNA

NCBI chr 5:56,815,549...56,896,152
Ensembl chr 5:56,815,538...56,896,152

G

mitogen-activated protein kinase kinase kinase 10

decreases expression

ISO

epoxiconazole results in decreased expression of MAP3K10 mRNA

NCBI chr19:40,191,426...40,215,575
Ensembl chr19:40,191,426...40,215,578

G

mitogen-activated protein kinase kinase kinase 9

increases expression

ISO

epoxiconazole results in increased expression of MAP3K9 mRNA

NCBI chr14:70,722,526...70,809,513
Ensembl chr14:70,722,526...70,809,545

G

mitogen-activated protein kinase kinase kinase kinase 1

decreases expression

ISO

epoxiconazole results in decreased expression of MAP4K1 mRNA

NCBI chr19:38,587,641...38,617,953
Ensembl chr19:38,587,641...38,619,161

G

mitogen-activated protein kinase kinase kinase kinase 4

increases expression

ISO

epoxiconazole results in increased expression of MAP4K4 mRNA

NCBI chr 2:101,697,707...101,894,690
Ensembl chr 2:101,696,850...101,894,690

G

microtubule associated protein 6

increases expression

ISO

epoxiconazole results in increased expression of MAP6 mRNA

NCBI chr11:75,586,918...75,669,038
Ensembl chr11:75,586,916...75,669,038

G

MAP6 domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of MAP6D1 mRNA

NCBI chr 3:183,815,922...183,825,577
Ensembl chr 3:183,815,884...183,825,594

G

microtubule associated protein 7

decreases expression

ISO

epoxiconazole results in decreased expression of MAP7 mRNA

NCBI chr 6:136,342,734...136,550,422
Ensembl chr 6:136,342,281...136,550,819

G

MAP7 domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of MAP7D1 mRNA

NCBI chr 1:36,156,160...36,180,849
Ensembl chr 1:36,155,579...36,180,849

G

mitogen-activated protein kinase 1 interacting protein 1 like

decreases expression

ISO

epoxiconazole results in decreased expression of MAPK1IP1L mRNA

NCBI chr14:55,051,647...55,070,194
Ensembl chr14:55,051,647...55,070,194

G

mitogen-activated protein kinase 6

decreases expression

ISO

epoxiconazole results in decreased expression of MAPK6 mRNA

NCBI chr15:51,971,825...52,067,375
Ensembl chr15:51,952,106...52,067,375

G

mitogen-activated protein kinase 8

decreases expression

ISO

epoxiconazole results in decreased expression of MAPK8 mRNA

NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360

G

MAPK activated protein kinase 2

increases expression

ISO

epoxiconazole results in increased expression of MAPKAPK2 mRNA

NCBI chr 1:206,684,905...206,734,281
Ensembl chr 1:206,684,886...206,734,284

G

microtubule associated protein RP/EB family member 2

decreases expression

ISO

epoxiconazole results in decreased expression of MAPRE2 mRNA

NCBI chr18:34,977,027...35,143,470
Ensembl chr18:34,976,928...35,143,470

G

membrane associated ring-CH-type finger 8

decreases expression

ISO

epoxiconazole results in decreased expression of MARCHF8 mRNA

NCBI chr10:45,454,585...45,594,907
Ensembl chr10:45,454,585...45,594,931

G

methionyl-tRNA synthetase 2, mitochondrial

decreases expression

ISO

epoxiconazole results in decreased expression of MARS2 mRNA

NCBI chr 2:197,705,369...197,708,395
Ensembl chr 2:197,705,369...197,708,395

G

MARVEL domain containing 1

affects expression

ISO

epoxiconazole affects the expression of MARVELD1 mRNA

NCBI chr10:97,713,730...97,718,150
Ensembl chr10:97,713,173...97,718,150

G

MARVEL domain containing 2

increases expression

ISO

epoxiconazole results in increased expression of MARVELD2 mRNA

NCBI chr 5:69,415,116...69,444,330
Ensembl chr 5:69,415,065...69,444,330

G

MAS1 proto-oncogene like, G protein-coupled receptor

increases expression

ISO

epoxiconazole results in increased expression of MRGPRH mRNA

NCBI chr 6:29,486,697...29,487,956
Ensembl chr 6:29,486,697...29,487,956

G

microtubule associated serine/threonine kinase family member 4

increases expression

ISO

epoxiconazole results in increased expression of MAST4 mRNA

NCBI chr 5:66,596,393...67,169,593
Ensembl chr 5:66,596,380...67,169,593

G

methionine adenosyltransferase 2A

decreases expression

ISO

epoxiconazole results in decreased expression of MAT2A mRNA

NCBI chr 2:85,539,168...85,545,281
Ensembl chr 2:85,539,165...85,545,281

G

MAU2 sister chromatid cohesion factor

decreases expression

ISO

epoxiconazole results in decreased expression of MAU2 mRNA

NCBI chr19:19,320,829...19,358,754
Ensembl chr19:19,320,811...19,358,754

G

mitochondrial antiviral signaling protein

decreases expression

ISO

epoxiconazole results in decreased expression of MAVS mRNA

NCBI chr20:3,846,834...3,876,118
Ensembl chr20:3,842,694...3,876,123

G

Mab-21 domain containing 2

affects expression

ISO

epoxiconazole affects the expression of MB21D2 mRNA

NCBI chr 3:192,796,815...192,917,856
Ensembl chr 3:192,796,815...192,917,856

G

methyl-CpG binding domain protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of MBD1 mRNA

NCBI chr18:50,266,885...50,281,767
Ensembl chr18:50,266,746...50,281,846

G

methyl-CpG binding domain protein 3

decreases expression

ISO

epoxiconazole results in decreased expression of MBD3 mRNA

NCBI chr19:1,573,596...1,592,865
Ensembl chr19:1,573,596...1,592,869

G

mannose binding lectin 1, pseudogene

affects expression

ISO

epoxiconazole affects the expression of MBL1 mRNA

NCBI chr10:79,920,178...79,923,119
Ensembl chr10:79,920,327...79,923,032
Ensembl chr10:79,920,327...79,923,032

G

muscleblind like splicing regulator 2

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of MBNL2 mRNA
epoxiconazole results in decreased expression of MBNL2 mRNA

PMID:22334560 PMID:35436446

NCBI chr13:97,141,834...97,394,120
Ensembl chr13:97,221,434...97,394,121

G

muscleblind like splicing regulator 3

decreases expression

ISO

epoxiconazole results in decreased expression of MBNL3 mRNA

NCBI chr X:132,369,320...132,490,035
Ensembl chr X:132,369,320...132,489,978

G

melanin concentrating hormone receptor 1

decreases expression

ISO

epoxiconazole results in decreased expression of MCHR1 mRNA

NCBI chr22:40,679,484...40,682,812
Ensembl chr22:40,679,273...40,682,812

G

minichromosome maintenance 10 replication initiation factor

decreases expression

ISO

epoxiconazole results in decreased expression of MCM10 mRNA

NCBI chr10:13,161,558...13,211,110
Ensembl chr10:13,161,554...13,211,110

G

mucolipin TRP cation channel 1

decreases expression

ISO

epoxiconazole results in decreased expression of MCOLN1 mRNA

NCBI chr19:7,522,624...7,534,009
Ensembl chr19:7,522,611...7,534,009

G

MAPK regulated corepressor interacting protein 1

increases expression

ISO

epoxiconazole results in increased expression of MCRIP1 mRNA

NCBI chr17:81,822,361...81,833,291
Ensembl chr17:81,821,790...81,833,302

G

MAPK regulated corepressor interacting protein 2

increases expression

ISO

epoxiconazole results in increased expression of MCRIP2 mRNA

NCBI chr16:641,828...648,474
Ensembl chr16:636,817...648,474

G

MyoD family inhibitor domain containing 2

increases expression

ISO

epoxiconazole results in increased expression of MDFIC2 mRNA

NCBI chr 3:70,194,479...70,312,638
Ensembl chr 3:70,194,479...70,312,638

G

MAM domain containing glycosylphosphatidylinositol anchor 1

affects expression

ISO

epoxiconazole affects the expression of MDGA1 mRNA

NCBI chr 6:37,630,679...37,697,883
Ensembl chr 6:37,630,679...37,699,306

G

MAM domain containing glycosylphosphatidylinositol anchor 2

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of MDGA2 mRNA

NCBI chr14:46,839,623...47,675,605
Ensembl chr14:46,840,092...47,675,605

G

MDM2 proto-oncogene

multiple interactions
increases expression

ISO

[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MDM2 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of MDM2 mRNA
epoxiconazole results in increased expression of MDM2 mRNA

NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,175...68,845,544

G

male-enhanced antigen 1

decreases expression

ISO

epoxiconazole results in decreased expression of MEA1 mRNA

NCBI chr 6:43,011,143...43,016,886
Ensembl chr 6:43,011,143...43,016,868

G

methyl-CpG binding protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of MECP2 mRNA

NCBI chr X:154,021,573...154,097,717
Ensembl chr X:154,021,573...154,137,103

G

mediator complex subunit 15

decreases expression

ISO

epoxiconazole results in decreased expression of MED15 mRNA

NCBI chr22:20,507,610...20,587,619
Ensembl chr22:20,495,913...20,587,632

G

mediator complex subunit 16

decreases expression

ISO

epoxiconazole results in decreased expression of MED16 mRNA

NCBI chr19:867,963...893,187
Ensembl chr19:867,630...893,218

G

mediator complex subunit 19

decreases expression

ISO

epoxiconazole results in decreased expression of MED19 mRNA

NCBI chr11:57,703,709...57,712,215
Ensembl chr11:57,703,710...57,712,259

G

mediator complex subunit 21

increases expression

ISO

epoxiconazole results in increased expression of MED21 mRNA

NCBI chr12:27,022,558...27,038,951
Ensembl chr12:27,022,546...27,066,343

G

mediator complex subunit 25

decreases expression

ISO

epoxiconazole results in decreased expression of MED25 mRNA

NCBI chr19:49,818,289...49,840,384
Ensembl chr19:49,818,277...49,840,383

G

mediator complex subunit 27

decreases expression

ISO

epoxiconazole results in decreased expression of MED27 mRNA

NCBI chr 9:131,860,112...132,079,867
Ensembl chr 9:131,852,928...132,079,875

G

mediator complex subunit 31

decreases expression

ISO

epoxiconazole results in decreased expression of MED31 mRNA

NCBI chr17:6,643,311...6,651,605
Ensembl chr17:6,643,311...6,651,634

G

mediator complex subunit 4

decreases expression

ISO

epoxiconazole results in decreased expression of MED4 mRNA

NCBI chr13:48,075,724...48,095,104
Ensembl chr13:48,053,323...48,095,131

G

mediator complex subunit 6

increases expression

ISO

epoxiconazole results in increased expression of MED6 mRNA

NCBI chr14:70,583,221...70,600,655
Ensembl chr14:70,581,257...70,600,690

G

meiosis/spermiogenesis associated 1

increases expression

ISO

epoxiconazole results in increased expression of MEIG1 mRNA

PMID:22334560 PMID:23970803

NCBI chr10:14,954,228...14,988,050
Ensembl chr10:14,954,194...14,988,050

G

meiosis specific with OB-fold

increases expression

ISO

epoxiconazole results in increased expression of MEIOB mRNA

NCBI chr16:1,833,986...1,872,164
Ensembl chr16:1,833,986...1,884,294

G

menin 1

decreases expression

ISO

epoxiconazole results in decreased expression of MEN1 mRNA

NCBI chr11:64,803,516...64,811,294
Ensembl chr11:64,803,510...64,811,294

G

methylphosphate capping enzyme

affects expression

ISO

epoxiconazole affects the expression of MEPCE mRNA

NCBI chr 7:100,428,790...100,434,118
Ensembl chr 7:100,428,322...100,434,126

G

MER proto-oncogene, tyrosine kinase

decreases expression

ISO

epoxiconazole results in decreased expression of MERTK mRNA

NCBI chr 2:111,898,607...112,029,561
Ensembl chr 2:111,898,607...112,029,561

G

mesoderm development LRP chaperone

increases expression

ISO

epoxiconazole results in increased expression of MESD mRNA

NCBI chr15:80,946,289...80,989,819
Ensembl chr15:80,946,289...80,989,834

G

methyltransferase 1, tRNA methylguanosine

decreases expression

ISO

epoxiconazole results in decreased expression of METTL1 mRNA

NCBI chr12:57,768,471...57,772,105
Ensembl chr12:57,768,471...57,772,131

G

methyltransferase like 27

decreases expression

ISO

epoxiconazole results in decreased expression of METTL27 mRNA

NCBI chr 7:73,834,590...73,842,516
Ensembl chr 7:73,834,012...73,842,539

G

methyltransferase 2A, tRNA N3-cytidine

decreases expression

ISO

epoxiconazole results in decreased expression of METTL2 mRNA

NCBI chr17:62,423,897...62,453,385
Ensembl chr17:62,423,875...62,453,385

G

methyltransferase 5, N6-adenosine

increases expression

ISO

epoxiconazole results in increased expression of METTL5 mRNA

NCBI chr 2:169,811,757...169,824,905
Ensembl chr 2:169,810,081...169,824,931

G

methyltransferase 8, tRNA N3-cytidine

decreases expression

ISO

epoxiconazole results in decreased expression of METTL8 mRNA

NCBI chr 2:171,315,746...171,434,772
Ensembl chr 2:171,315,746...171,434,802

G

methyltransferase 9, His-X-His N1(pi)-histidine

increases expression

ISO

epoxiconazole results in increased expression of METTL9 mRNA

NCBI chr16:21,597,208...21,657,471
Ensembl chr16:21,597,218...21,657,471

G

milk fat globule EGF and factor V/VIII domain containing

decreases expression

ISO

epoxiconazole results in decreased expression of MFGE8 mRNA

NCBI chr15:88,898,683...88,913,379
Ensembl chr15:88,898,683...88,913,468

G

mitofusin 2

decreases expression

ISO

epoxiconazole results in decreased expression of MFN2 mRNA

NCBI chr 1:11,980,444...12,013,508
Ensembl chr 1:11,980,181...12,015,211

G

major facilitator superfamily domain containing 10

increases expression

ISO

epoxiconazole results in increased expression of MFSD10 mRNA

NCBI chr 4:2,930,567...2,934,825
Ensembl chr 4:2,930,559...2,935,462

G

major facilitator superfamily domain containing 11

increases expression

ISO

epoxiconazole results in increased expression of MFSD11 mRNA

NCBI chr17:76,736,634...76,803,805
Ensembl chr17:76,735,865...76,781,449

G

MFSD2 lysolipid transporter A, lysophospholipid

decreases expression

ISO

epoxiconazole results in decreased expression of MFSD2A mRNA

NCBI chr 1:39,955,145...39,969,956
Ensembl chr 1:39,955,112...39,969,968

G

major facilitator superfamily domain containing 3

decreases expression

ISO

epoxiconazole results in decreased expression of MFSD3 mRNA

NCBI chr 8:144,509,070...144,511,213
Ensembl chr 8:144,509,070...144,511,213

G

major facilitator superfamily domain containing 6

decreases expression

ISO

epoxiconazole results in decreased expression of MFSD6 mRNA

NCBI chr 2:190,407,576...190,502,314
Ensembl chr 2:190,408,355...190,509,205

G

alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase

decreases expression

ISO

epoxiconazole results in decreased expression of MGAT2 mRNA

NCBI chr14:49,620,799...49,623,481
Ensembl chr14:49,620,799...49,623,481

G

alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A

increases expression

ISO

epoxiconazole results in increased expression of MGAT4A mRNA

NCBI chr 2:98,619,106...98,731,132
Ensembl chr 2:98,619,106...98,732,639

G

MGAT4 family member E, pseudogene

increases expression

ISO

epoxiconazole results in increased expression of MGAT4E mRNA

NCBI chr 1:202,820,257...202,827,225
Ensembl chr 1:202,825,186...202,826,320
Ensembl chr 1:202,825,186...202,826,320

G

monoglyceride lipase

decreases expression

ISO

epoxiconazole results in decreased expression of MGLL mRNA

NCBI chr 3:127,689,066...127,823,185
Ensembl chr 3:127,689,062...128,052,190

G

mahogunin ring finger 1

decreases expression

ISO

epoxiconazole results in decreased expression of MGRN1 mRNA

NCBI chr16:4,624,826...4,690,972
Ensembl chr16:4,616,493...4,690,977

G

MIA SH3 domain ER export factor 2

decreases expression

ISO

epoxiconazole results in decreased expression of MIA2 mRNA

NCBI chr14:39,233,915...39,388,522
Ensembl chr14:39,230,231...39,388,513

G

microtubule associated monooxygenase, calponin and LIM domain containing 2

increases expression

ISO

epoxiconazole results in increased expression of MICAL2 mRNA

NCBI chr11:12,110,590...12,362,140
Ensembl chr11:12,094,008...12,362,140

G

MICAL like 1

increases expression

ISO

epoxiconazole results in increased expression of MICALL1 mRNA

NCBI chr22:37,906,297...37,942,822
Ensembl chr22:37,905,657...37,942,822

G

MID1 interacting protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of MID1IP1 mRNA

NCBI chr X:38,801,459...38,806,532
Ensembl chr X:38,801,417...38,806,537

G

mitotic deacetylase associated SANT domain protein

decreases expression

ISO

epoxiconazole results in decreased expression of MIDEAS mRNA

NCBI chr14:73,715,122...73,790,285
Ensembl chr14:73,715,122...73,790,285

G

midnolin

decreases expression

ISO

epoxiconazole results in decreased expression of MIDN mRNA

NCBI chr19:1,248,583...1,259,143
Ensembl chr19:1,248,331...1,259,145

G

mitochondrial elongation factor 1

decreases expression

ISO

epoxiconazole results in decreased expression of MIEF1 mRNA

NCBI chr22:39,500,100...39,518,132
Ensembl chr22:39,499,432...39,518,132

G

macrophage migration inhibitory factor

affects expression

ISO

epoxiconazole affects the expression of MIF mRNA

NCBI chr22:23,894,383...23,895,223
Ensembl chr22:23,894,372...23,895,227

G

mitoguardin 2

decreases expression

ISO

epoxiconazole results in decreased expression of MIGA2 mRNA

NCBI chr 9:129,036,626...129,072,082
Ensembl chr 9:129,036,614...129,072,087

G

membrane integral NOTCH2 associated receptor 2

increases expression

ISO

epoxiconazole results in increased expression of MINAR2 mRNA

NCBI chr 5:129,748,094...129,766,732
Ensembl chr 5:129,748,094...129,766,732

G

MINDY lysine 48 deubiquitinase 3

decreases expression

ISO

epoxiconazole results in decreased expression of MINDY3 mRNA

NCBI chr10:15,778,174...15,860,507
Ensembl chr10:15,778,170...15,860,528

G

MINDY lysine 48 deubiquitinase 4

decreases expression

ISO

epoxiconazole results in decreased expression of MINDY4 mRNA

NCBI chr 7:30,771,417...30,892,387
Ensembl chr 7:30,771,417...30,892,387

G

multiple inositol-polyphosphate phosphatase 1

decreases expression

ISO

epoxiconazole results in decreased expression of MINPP1 mRNA

NCBI chr10:87,504,893...87,553,461
Ensembl chr10:87,504,875...87,553,461

G

MIS12 kinetochore complex component

decreases expression

ISO

epoxiconazole results in decreased expression of MIS12 mRNA

NCBI chr17:5,486,374...5,490,811
Ensembl chr17:5,486,285...5,490,816

G

marker of proliferation Ki-67

increases expression

ISO

epoxiconazole results in increased expression of MKI67 protein

NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,448

G

MKKS centrosomal shuttling protein

increases expression

ISO

epoxiconazole results in increased expression of MKKS mRNA

NCBI chr20:10,401,009...10,434,222
Ensembl chr20:10,401,009...10,434,222

G

MAPK interacting serine/threonine kinase 1

decreases expression

ISO

epoxiconazole results in decreased expression of MKNK1 mRNA

NCBI chr 1:46,557,407...46,604,268
Ensembl chr 1:46,557,407...46,616,843

G

MAPK interacting serine/threonine kinase 2

decreases expression

ISO

epoxiconazole results in decreased expression of MKNK2 mRNA

NCBI chr19:2,037,471...2,051,244
Ensembl chr19:2,037,465...2,061,220

G

MKRN2 opposite strand

decreases expression

ISO

epoxiconazole results in decreased expression of MKRN2OS mRNA

NCBI chr 3:12,539,776...12,560,999
Ensembl chr 3:12,514,934...12,561,059

G

malectin

increases expression

ISO

epoxiconazole results in increased expression of MLEC mRNA

NCBI chr12:120,687,149...120,701,859
Ensembl chr12:120,687,125...120,704,282

G

MLLT3 super elongation complex subunit

decreases expression

ISO

epoxiconazole results in decreased expression of MLLT3 mRNA

NCBI chr 9:20,341,669...20,622,499
Ensembl chr 9:20,341,669...20,622,499

G

MAX dimerization protein MLX

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MLX mRNA

NCBI chr17:42,567,100...42,573,203
Ensembl chr17:42,567,072...42,573,239

G

metabolism of cobalamin associated C

decreases expression

ISO

epoxiconazole results in decreased expression of MMACHC mRNA

NCBI chr 1:45,500,300...45,513,382
Ensembl chr 1:45,500,300...45,513,382

G

monocyte to macrophage differentiation associated 2

decreases expression

ISO

epoxiconazole results in decreased expression of MMD2 mRNA

NCBI chr 7:4,892,245...4,959,187
Ensembl chr 7:4,905,989...4,959,212

G

matrix metallopeptidase 13

increases expression

ISO

epoxiconazole results in increased expression of MMP13 mRNA

NCBI chr11:102,942,995...102,955,732
Ensembl chr11:102,942,995...102,955,732

G

matrix metallopeptidase 15

decreases expression

ISO

epoxiconazole results in decreased expression of MMP15 mRNA

NCBI chr16:58,025,754...58,046,901
Ensembl chr16:58,025,606...58,046,901

G

matrix metallopeptidase 3

decreases expression

ISO

epoxiconazole results in decreased expression of MMP3 mRNA

NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609

G

myeloid cell nuclear differentiation antigen

increases expression

ISO

epoxiconazole results in increased expression of IFI211 mRNA

NCBI chr 1:158,831,351...158,849,502
Ensembl chr 1:158,831,332...158,849,506

G

MAX network transcriptional repressor

decreases expression

ISO

epoxiconazole results in decreased expression of MNT mRNA

NCBI chr17:2,384,073...2,401,060
Ensembl chr17:2,384,073...2,401,142

G

MOB family member 4, phocein

increases expression

ISO

epoxiconazole results in increased expression of MOB4 mRNA

NCBI chr 2:197,515,554...197,553,699
Ensembl chr 2:197,515,571...197,553,699

G

molybdenum cofactor sulfurase

increases expression

ISO

epoxiconazole results in increased expression of MOCOS mRNA

NCBI chr18:36,187,497...36,272,157
Ensembl chr18:36,186,894...36,272,157

G

molybdenum cofactor synthesis 1

decreases expression

ISO

epoxiconazole results in decreased expression of MOCS1 mRNA

NCBI chr 6:39,904,170...39,934,462
Ensembl chr 6:39,899,578...39,934,551

G

monoacylglycerol O-acyltransferase 1

decreases expression

ISO

epoxiconazole results in decreased expression of MOGAT1 mRNA

NCBI chr 2:222,671,658...222,709,930
Ensembl chr 2:222,671,658...222,709,930

G

MORC family CW-type zinc finger 3

increases expression

ISO

epoxiconazole results in increased expression of MORC3 mRNA

NCBI chr21:36,320,197...36,376,632
Ensembl chr21:36,320,189...36,386,148

G

MORN repeat containing 2

increases expression

ISO

epoxiconazole results in increased expression of MORN2 mRNA

NCBI chr 2:38,875,976...38,882,709
Ensembl chr 2:38,875,976...38,882,709

G

MORN repeat containing 3

decreases expression

ISO

epoxiconazole results in decreased expression of MORN3 mRNA

NCBI chr12:121,648,742...121,672,644
Ensembl chr12:121,648,742...121,672,649

G

Mov10 RNA helicase

decreases expression

ISO

epoxiconazole results in decreased expression of MOV10 mRNA

NCBI chr 1:112,674,439...112,700,739
Ensembl chr 1:112,673,141...112,702,383

G

monooxygenase DBH like 1

increases expression

ISO

epoxiconazole results in increased expression of MOXD1 mRNA

NCBI chr 6:132,296,055...132,401,475
Ensembl chr 6:132,296,055...132,401,556

G

macrophage expressed 1

decreases expression

ISO

epoxiconazole results in decreased expression of MPEG1 mRNA

NCBI chr11:59,208,510...59,212,927
Ensembl chr11:59,208,510...59,213,474

G

MAGUK p55 scaffold protein 4

decreases expression

ISO

epoxiconazole results in decreased expression of MPP4 mRNA

NCBI chr 2:201,644,874...201,698,644
Ensembl chr 2:201,644,870...201,698,694

G

metallophosphoesterase 1

decreases expression

ISO

epoxiconazole results in decreased expression of MPPE1 mRNA

NCBI chr18:11,882,622...11,908,317
Ensembl chr18:11,882,622...11,909,180

G

metallophosphoesterase domain containing 2

increases expression

ISO

epoxiconazole results in increased expression of MPPED2 mRNA

NCBI chr11:30,384,079...30,586,990
Ensembl chr11:30,384,493...30,586,927

G

myosin phosphatase Rho interacting protein

decreases expression

ISO

epoxiconazole results in decreased expression of MPRIP mRNA

NCBI chr17:17,042,457...17,192,643
Ensembl chr17:17,042,457...17,217,679

G

mucosal pentraxin 1 (pseudogene)

increases expression

ISO

epoxiconazole results in increased expression of MPTX1 mRNA

NCBI chr 1:159,276,507...159,277,182
Ensembl chr 1:159,268,623...159,277,111

G

MPV17 mitochondrial inner membrane protein like

decreases expression

ISO

epoxiconazole results in decreased expression of MPV17L mRNA

NCBI chr16:15,395,754...15,413,271
Ensembl chr16:15,395,754...15,413,271

G

myelin protein zero like 2

decreases expression

ISO

epoxiconazole results in decreased expression of MPZL2 mRNA

NCBI chr11:118,253,416...118,264,297
Ensembl chr11:118,253,416...118,264,536

G

major histocompatibility complex, class I-related

decreases expression

ISO

epoxiconazole results in decreased expression of MR1 mRNA

NCBI chr 1:181,033,387...181,061,938
Ensembl chr 1:181,033,374...181,061,938

G

MRE11 homolog, double strand break repair nuclease

decreases expression

ISO

epoxiconazole results in decreased expression of MRE11A mRNA

NCBI chr11:94,415,570...94,512,412
Ensembl chr11:94,415,570...94,493,889

G

melanoregulin

affects expression

ISO

epoxiconazole affects the expression of MREG mRNA

NCBI chr 2:215,939,308...216,034,096
Ensembl chr 2:215,942,584...216,034,096

G

MRG domain binding protein

decreases expression

ISO

epoxiconazole results in decreased expression of MRGBP mRNA

NCBI chr20:62,796,473...62,801,729
Ensembl chr20:62,796,473...62,801,729

G

MAS related GPR family member E

increases expression

ISO

epoxiconazole results in increased expression of MRGPRE mRNA

NCBI chr11:3,225,030...3,232,417
Ensembl chr11:3,225,030...3,232,417

G

methylthioribose-1-phosphate isomerase 1

decreases expression

ISO

epoxiconazole results in decreased expression of MRI1 mRNA

NCBI chr19:13,764,522...13,774,282
Ensembl chr19:13,764,522...13,774,282

G

maestro

increases expression

ISO

epoxiconazole results in increased expression of MRO mRNA

NCBI chr18:50,795,130...50,825,380
Ensembl chr18:50,795,120...50,825,449

G

maestro heat like repeat family member 2A

increases expression

ISO

epoxiconazole results in increased expression of MROH2A mRNA

NCBI chr 2:233,775,724...233,833,418
Ensembl chr 2:233,775,679...233,833,423

G

maestro heat like repeat family member 6

increases expression

ISO

epoxiconazole results in increased expression of MROH6 mRNA

NCBI chr 8:143,566,192...143,572,772
Ensembl chr 8:143,566,192...143,572,772

G

mitochondrial ribosomal protein L19

decreases expression

ISO

epoxiconazole results in decreased expression of MRPL19 mRNA

NCBI chr 2:75,646,783...75,662,206
Ensembl chr 2:75,646,783...75,690,851

G

mitochondrial ribosomal protein L22

increases expression

ISO

epoxiconazole results in increased expression of MRPL22 mRNA

NCBI chr 5:154,941,073...154,969,411
Ensembl chr 5:154,941,073...154,969,411

G

mitochondrial ribosomal protein L23

decreases expression

ISO

epoxiconazole results in decreased expression of MRPL23 mRNA

NCBI chr11:1,947,332...2,014,944
Ensembl chr11:1,947,278...1,986,375

G

mitochondrial ribosomal protein L24

affects expression

ISO

epoxiconazole affects the expression of MRPL24 mRNA

NCBI chr 1:156,737,303...156,742,716
Ensembl chr 1:156,737,294...156,741,590

G

mitochondrial ribosomal protein L27

decreases expression

ISO

epoxiconazole results in decreased expression of MRPL27 mRNA

NCBI chr17:50,367,867...50,373,184
Ensembl chr17:50,367,857...50,373,207

G

mitochondrial ribosomal protein L33

increases expression

ISO

epoxiconazole results in increased expression of MRPL33 mRNA

NCBI chr 2:27,771,719...27,779,733
Ensembl chr 2:27,771,717...27,988,087

G

mitochondrial ribosomal protein L34

decreases expression

ISO

epoxiconazole results in decreased expression of MRPL34 mRNA

NCBI chr19:17,292,573...17,306,843
Ensembl chr19:17,292,609...17,306,843

G

mitochondrial ribosomal protein L37

increases expression

ISO

epoxiconazole results in increased expression of MRPL37 mRNA

NCBI chr 1:54,200,167...54,225,489
Ensembl chr 1:54,184,041...54,225,464

G

mitochondrial ribosomal protein L38

decreases expression

ISO

epoxiconazole results in decreased expression of MRPL38 mRNA

NCBI chr17:75,898,644...75,904,884
Ensembl chr17:75,898,643...75,905,093

G

mitochondrial ribosomal protein L42

increases expression

ISO

epoxiconazole results in increased expression of MRPL42 mRNA

NCBI chr12:93,467,514...93,516,214
Ensembl chr12:93,467,490...93,516,214

G

mitochondrial ribosomal protein L46

increases expression

ISO

epoxiconazole results in increased expression of MRPL46 mRNA

NCBI chr15:88,459,478...88,467,388
Ensembl chr15:88,459,468...88,467,420

G

mitochondrial ribosomal protein L52

increases expression

ISO

epoxiconazole results in increased expression of MRPL52 mRNA

NCBI chr14:22,829,887...22,835,037
Ensembl chr14:22,829,875...22,835,037

G

mitochondrial ribosomal protein L54

increases expression

ISO

epoxiconazole results in increased expression of MRPL54 mRNA

NCBI chr19:3,762,682...3,767,565
Ensembl chr19:3,762,672...3,768,575

G

mitochondrial ribosomal protein L55

increases expression

ISO

epoxiconazole results in increased expression of MRPL55 mRNA

NCBI chr 1:228,106,685...228,109,299
Ensembl chr 1:228,105,949...228,109,358

G

mitochondrial ribosomal protein S14

increases expression

ISO

epoxiconazole results in increased expression of MRPS14 mRNA

NCBI chr 1:175,012,958...175,023,425
Ensembl chr 1:175,010,789...175,023,432

G

mitochondrial ribosomal protein S16

increases expression

ISO

epoxiconazole results in increased expression of MRPS16 mRNA

NCBI chr10:73,248,849...73,252,644
Ensembl chr10:73,248,843...73,252,693

G

mitochondrial ribosomal protein S18B

multiple interactions
increases expression

ISO

[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MRPS18B mRNA
epoxiconazole results in increased expression of MRPS18B mRNA

PMID:29038839 PMID:35436446

NCBI chr 6:30,617,840...30,626,392
Ensembl chr 6:30,617,823...30,626,398

G

mitochondrial ribosomal protein S18C

decreases expression

ISO

epoxiconazole results in decreased expression of MRPS18C mRNA

NCBI chr 4:83,456,058...83,462,298
Ensembl chr 4:83,455,932...83,470,428

G

mitochondrial ribosomal protein S21

increases expression

ISO

epoxiconazole results in increased expression of MRPS21 mRNA

NCBI chr 1:150,293,861...150,308,979
Ensembl chr 1:150,293,854...150,308,981

G

mitochondrial ribosomal protein S25

decreases expression

ISO

epoxiconazole results in decreased expression of MRPS25 mRNA

NCBI chr 3:15,042,251...15,065,315
Ensembl chr 3:15,009,611...15,065,339

G

mitochondrial ribosomal protein S27

decreases expression

ISO

epoxiconazole results in decreased expression of MRPS27 mRNA

NCBI chr 5:72,219,403...72,320,240
Ensembl chr 5:72,214,953...72,321,717

G

mitochondrial ribosomal protein S33

increases expression

ISO

epoxiconazole results in increased expression of MRPS33 mRNA

NCBI chr 7:141,002,610...141,014,952
Ensembl chr 7:141,002,610...141,015,228

G

myocardin related transcription factor B

decreases expression

ISO

epoxiconazole results in decreased expression of MRTFB mRNA

NCBI chr16:13,994,774...14,266,779
Ensembl chr16:14,071,058...14,266,778

G

membrane spanning 4-domains A4A

increases expression

ISO

epoxiconazole results in increased expression of MS4A4A mRNA

NCBI chr11:60,280,666...60,308,970
Ensembl chr11:60,185,657...60,318,080

G

methylsterol monooxygenase 1

multiple interactions
decreases expression
increases expression

ISO
EXP

[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MSMO1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of MSMO1 mRNA
epoxiconazole results in decreased expression of MSMO1 mRNA
epoxiconazole results in increased expression of MSMO1 mRNA

PMID:29038839 PMID:34182286 PMID:35436446

NCBI chr 4:165,327,669...165,343,164
Ensembl chr 4:165,327,667...165,343,180

G

macrophage scavenger receptor 1

increases expression

ISO

epoxiconazole results in increased expression of MSR1 mRNA

NCBI chr 8:16,107,881...16,192,651
Ensembl chr 8:16,107,878...16,567,490

G

metallothionein 1X

decreases expression

ISO

epoxiconazole results in decreased expression of MT1 mRNA

NCBI chr16:56,682,470...56,684,196
Ensembl chr16:56,682,468...56,684,196

G

metallothionein 2A

increases expression

ISO

epoxiconazole results in increased expression of MT2 mRNA

NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497

G

methylthioadenosine phosphorylase

decreases expression

ISO

epoxiconazole results in decreased expression of MTAP mRNA

NCBI chr 9:21,802,636...21,941,115
Ensembl chr 9:21,802,636...21,937,651

G

mitochondrial amidoxime reducing component 2

increases expression

ISO

epoxiconazole results in increased expression of MTARC2 mRNA

NCBI chr 1:220,748,322...220,784,815
Ensembl chr 1:220,748,122...220,784,824

G

mitochondrial carrier 1

increases expression

ISO

epoxiconazole results in increased expression of MTCH1 mRNA

NCBI chr 6:36,968,135...36,986,551
Ensembl chr 6:36,965,807...36,986,298

G

mitochondrial transcription termination factor 1

affects expression

ISO

epoxiconazole affects the expression of MTERF1B mRNA

NCBI chr 7:91,870,929...91,880,702
Ensembl chr 7:91,692,008...91,880,727

G

metal response element binding transcription factor 2

decreases expression

ISO

epoxiconazole results in decreased expression of MTF2 mRNA

NCBI chr 1:93,079,283...93,139,076
Ensembl chr 1:93,079,235...93,139,079

G

mitochondrial methionyl-tRNA formyltransferase

increases expression

ISO

epoxiconazole results in increased expression of MTFMT mRNA

NCBI chr15:65,001,512...65,029,639
Ensembl chr15:65,001,512...65,029,643

G

mitochondrial fission regulator 1

decreases expression

ISO

epoxiconazole results in decreased expression of MTFR1 mRNA

NCBI chr 8:65,643,889...65,778,598
Ensembl chr 8:65,644,684...65,771,261

G

mitochondrial fission regulator 2

decreases expression

ISO

epoxiconazole results in decreased expression of MTFR2 mRNA

NCBI chr 6:136,231,034...136,250,311
Ensembl chr 6:136,231,024...136,250,571

G

methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like

decreases expression

ISO

epoxiconazole results in decreased expression of MTHFD1L mRNA

NCBI chr 6:150,865,702...151,101,887
Ensembl chr 6:150,865,679...151,101,887

G

methylenetetrahydrofolate reductase

increases expression

ISO

epoxiconazole results in increased expression of MTHFR mRNA

NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455

G

mitoregulin

increases expression

ISO

epoxiconazole results in increased expression of MTLN mRNA

NCBI chr 2:110,211,529...110,212,547
Ensembl chr 2:110,211,529...110,245,420

G

myotubularin related protein 4

decreases expression

ISO

epoxiconazole results in decreased expression of MTMR4 mRNA

NCBI chr17:58,489,537...58,519,047
Ensembl chr17:58,489,529...58,517,905

G

melatonin receptor 1A

affects expression

ISO

epoxiconazole affects the expression of MTNR1A mRNA

NCBI chr 4:186,533,655...186,555,567
Ensembl chr 4:186,526,792...186,555,567

G

mechanistic target of rapamycin kinase

decreases expression

ISO

epoxiconazole results in decreased expression of MTOR mRNA

NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,531...11,262,556

G

MTSS I-BAR domain containing 1

decreases expression

ISO

epoxiconazole results in decreased expression of MTSS1 mRNA

NCBI chr 8:124,550,784...124,728,473
Ensembl chr 8:124,550,776...124,728,775

G

microtubule associated scaffold protein 2

increases expression

ISO

epoxiconazole results in increased expression of MTUS2 mRNA

NCBI chr13:28,819,963...29,505,947
Ensembl chr13:28,820,021...29,505,947

G

mucin 13, cell surface associated

increases expression

ISO

epoxiconazole results in increased expression of MUC13 mRNA

NCBI chr 3:124,905,442...124,934,751
Ensembl chr 3:124,905,440...124,953,819

G

mucin 5B, oligomeric mucus/gel-forming

decreases expression

ISO

epoxiconazole results in decreased expression of MUC5B mRNA

NCBI chr11:1,223,066...1,262,172
Ensembl chr11:1,223,066...1,262,172

G

mucin like 3

increases expression

ISO

epoxiconazole results in increased expression of MUCL3 mRNA

NCBI chr 6:30,940,973...30,954,221
Ensembl chr 6:30,940,973...30,954,221

G

musculoskeletal, embryonic nuclear protein 1

increases expression

ISO

epoxiconazole results in increased expression of MUSTN1 mRNA

NCBI chr 3:52,833,121...52,835,019
Ensembl chr 3:52,833,114...52,835,019

G

multivesicular body subunit 12B

increases expression

ISO

epoxiconazole results in increased expression of MVB12B mRNA

NCBI chr 9:126,326,829...126,507,040
Ensembl chr 9:126,326,815...126,507,041

G

major vault protein

decreases expression

ISO

epoxiconazole results in decreased expression of MVP mRNA

NCBI chr16:29,820,394...29,848,039
Ensembl chr16:29,820,394...29,848,039

G

myosin binding protein C1

increases expression

ISO

epoxiconazole results in increased expression of MYBPC1 mRNA

NCBI chr12:101,594,971...101,695,841
Ensembl chr12:101,568,353...101,686,181

G

MYC proto-oncogene, bHLH transcription factor

decreases expression

ISO

epoxiconazole results in decreased expression of MYC mRNA

NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951

G

MYC binding protein

increases expression

ISO

epoxiconazole results in increased expression of MYCBP mRNA

NCBI chr 1:38,862,490...38,873,378
Ensembl chr 1:38,862,493...38,873,378

G

MYD88 innate immune signal transduction adaptor

decreases expression

ISO

epoxiconazole results in decreased expression of MYD88 mRNA

NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024

G

myosin heavy chain 8

decreases expression

ISO

epoxiconazole results in decreased expression of MYH8 mRNA

NCBI chr17:10,390,322...10,421,950
Ensembl chr17:10,390,322...10,421,950

G

myosin light chain 2

decreases expression

ISO

epoxiconazole results in decreased expression of MYL2 mRNA

NCBI chr12:110,910,845...110,921,449
Ensembl chr12:110,909,996...111,052,434

G

myosin light chain 6

increases expression

ISO

epoxiconazole results in increased expression of MYL6 mRNA

NCBI chr12:56,158,359...56,161,579
Ensembl chr12:56,158,345...56,163,496

G

myosin X

decreases expression

ISO

epoxiconazole results in decreased expression of MYO10 mRNA

NCBI chr 5:16,661,907...16,936,288
Ensembl chr 5:16,661,907...16,936,288

G

myosin IB

decreases expression

ISO

epoxiconazole results in decreased expression of MYO1B mRNA

NCBI chr 2:191,245,404...191,425,386
Ensembl chr 2:191,245,064...191,425,820

G

myosin IC

decreases expression

ISO

epoxiconazole results in decreased expression of MYO1C mRNA

NCBI chr17:1,464,186...1,492,686
Ensembl chr17:1,464,186...1,492,698

G

myosin IXA

decreases expression

ISO

epoxiconazole results in decreased expression of MYO9A mRNA

NCBI chr15:71,822,291...72,118,600
Ensembl chr15:71,822,291...72,118,577

G

myocilin opposite strand

increases expression

ISO

epoxiconazole results in increased expression of MYOCOS mRNA

NCBI chr 1:171,600,872...171,626,888
Ensembl chr 1:171,600,621...171,638,799

G

myotilin

increases expression

ISO

epoxiconazole results in increased expression of MYOT mRNA

NCBI chr 5:137,867,860...137,887,851
Ensembl chr 5:137,867,858...137,887,851

G

NEDD4 binding protein 2 like 1

increases expression

ISO

epoxiconazole results in increased expression of N4BP2L1 mRNA

NCBI chr13:32,400,723...32,429,615
Ensembl chr13:32,400,723...32,428,311

G

N-alpha-acetyltransferase 25, NatB auxiliary subunit

decreases expression

ISO

epoxiconazole results in decreased expression of NAA25 mRNA

NCBI chr12:112,026,689...112,108,783
Ensembl chr12:112,026,689...112,109,434

G

N-alpha-acetyltransferase 38, NatC auxiliary subunit

decreases expression

ISO

epoxiconazole results in decreased expression of NAA38 mRNA

NCBI chr17:7,856,685...7,885,420
Ensembl chr17:7,856,685...7,885,238

G

N-alpha-acetyltransferase 40, NatD catalytic subunit

increases expression

ISO

epoxiconazole results in increased expression of NAA40 mRNA

NCBI chr11:63,939,002...63,957,319
Ensembl chr11:63,938,669...63,957,319

G

N-alpha-acetyltransferase 60, NatF catalytic subunit

decreases expression

ISO

epoxiconazole results in decreased expression of NAA60 mRNA

NCBI chr16:3,443,611...3,486,963
Ensembl chr16:3,443,649...3,486,954

G

N-acylethanolamine acid amidase

decreases expression

ISO

epoxiconazole results in decreased expression of NAAA mRNA

NCBI chr 4:75,910,655...75,941,013
Ensembl chr 4:75,910,655...75,941,013

G

NGFI-A binding protein 2

increases expression

ISO

epoxiconazole results in increased expression of NAB2 mRNA

NCBI chr12:57,089,114...57,095,476
Ensembl chr12:57,089,014...57,095,476

G

nucleic acid binding protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of NABP1 mRNA

NCBI chr 2:191,678,136...191,686,943
Ensembl chr 2:191,678,068...191,741,097

G

nascent polypeptide associated complex subunit alpha

increases expression

ISO

epoxiconazole results in increased expression of NACA mRNA

NCBI chr12:56,712,427...56,725,299
Ensembl chr12:56,712,305...56,731,628

G

NACC family member 2

decreases expression

ISO

epoxiconazole results in decreased expression of NACC2 mRNA

NCBI chr 9:136,006,537...136,095,289
Ensembl chr 9:136,006,537...136,095,289

G

NAD kinase

decreases expression

ISO

epoxiconazole results in decreased expression of NADK mRNA

NCBI chr 1:1,751,232...1,780,514
Ensembl chr 1:1,751,232...1,780,544

G

N-acetylglucosamine kinase

increases expression

ISO

epoxiconazole results in increased expression of NAGK mRNA

NCBI chr 2:71,068,296...71,079,808
Ensembl chr 2:71,064,344...71,079,808

G

N-acetyl-alpha-glucosaminidase

decreases expression

ISO

epoxiconazole results in decreased expression of NAGLU mRNA

NCBI chr17:42,536,241...42,544,449
Ensembl chr17:42,536,241...42,544,449

G

N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase

decreases expression

ISO

epoxiconazole results in decreased expression of NAGPA mRNA

NCBI chr16:5,024,844...5,033,935
Ensembl chr16:5,024,756...5,034,141

G

nicotinamide phosphoribosyltransferase

affects expression

ISO

epoxiconazole affects the expression of NAMPT mRNA

NCBI chr 7:106,248,298...106,285,888
Ensembl chr 7:106,248,298...106,291,225

G

nanos C2HC-type zinc finger 3

increases expression

ISO

epoxiconazole results in increased expression of NANOS3 mRNA

NCBI chr19:13,862,036...13,880,757
Ensembl chr19:13,862,063...13,880,757

G

nucleosome assembly protein 1 like 4

decreases expression

ISO

epoxiconazole results in decreased expression of NAP1L4 mRNA

NCBI chr11:2,944,437...2,992,329
Ensembl chr11:2,944,429...2,992,386

G

nicotinate phosphoribosyltransferase

decreases expression

ISO

epoxiconazole results in decreased expression of NAPRT mRNA

PMID:22334560 PMID:35436446

NCBI chr 8:143,572,874...143,578,330
Ensembl chr 8:143,574,782...143,578,649

G

nuclear prelamin A recognition factor

decreases expression

ISO

epoxiconazole results in decreased expression of NARF mRNA

NCBI chr17:82,458,198...82,490,537
Ensembl chr17:82,458,180...82,490,537

G

N-acetyltransferase 8 (putative)

decreases expression

ISO

epoxiconazole results in decreased expression of NAT8 mRNA

PMID:22334560 PMID:35436446

NCBI chr 2:73,640,723...73,642,422
Ensembl chr 2:73,640,723...73,643,229

G

neuron navigator 2

affects expression

ISO

epoxiconazole affects the expression of NAV2 mRNA

NCBI chr11:19,345,236...20,121,601
Ensembl chr11:19,350,724...20,121,601

G

NBR1 autophagy cargo receptor

decreases expression

ISO

epoxiconazole results in decreased expression of NBR1 mRNA

NCBI chr17:43,170,409...43,211,688
Ensembl chr17:43,170,317...43,211,689

G

nuclear cap binding protein subunit 2

decreases expression

ISO

epoxiconazole results in decreased expression of NCBP2 mRNA

NCBI chr 3:196,935,406...196,942,528
Ensembl chr 3:196,935,402...196,942,594

G

neutral cholesterol ester hydrolase 1

affects expression

ISO

epoxiconazole affects the expression of NCEH1 mRNA

NCBI chr 3:172,630,249...172,711,067
Ensembl chr 3:172,630,249...172,711,218

G

nuclear receptor coactivator 5

increases expression

ISO

epoxiconazole results in increased expression of NCOA5 mRNA

NCBI chr20:46,060,991...46,089,962
Ensembl chr20:46,060,985...46,089,962

G

nicastrin

decreases expression

ISO

epoxiconazole results in decreased expression of NCSTN mRNA

NCBI chr 1:160,343,383...160,358,949
Ensembl chr 1:160,343,294...160,358,957

G

nudE neurodevelopment protein 1 like 1

affects expression

ISO

epoxiconazole affects the expression of NDEL1 mRNA

NCBI chr17:8,413,131...8,474,328
Ensembl chr17:8,408,528...8,490,411

G

N-myc downstream regulated 1

increases expression

ISO

epoxiconazole results in increased expression of NDRG1 mRNA

PMID:22334560 PMID:23970803 PMID:35436446

NCBI chr 8:133,237,175...133,297,252
Ensembl chr 8:133,237,175...133,302,022

G

NDRG family member 4

increases expression

ISO

epoxiconazole results in increased expression of NDRG4 mRNA

NCBI chr16:58,463,715...58,515,387
Ensembl chr16:58,462,846...58,513,628

G

N-deacetylase and N-sulfotransferase 1

decreases expression

ISO

epoxiconazole results in decreased expression of NDST1 mRNA

PMID:22334560 PMID:35436446

NCBI chr 5:150,497,779...150,558,211
Ensembl chr 5:150,485,648...150,558,211

G

NADH:ubiquinone oxidoreductase subunit A1

increases expression

ISO

epoxiconazole results in increased expression of NDUFA1 mRNA

NCBI chr X:119,871,832...119,876,662
Ensembl chr X:119,871,796...119,876,689

G

NADH:ubiquinone oxidoreductase subunit A11

increases expression

ISO

epoxiconazole results in increased expression of NDUFA11 mRNA

NCBI chr19:5,891,229...5,903,790
Ensembl chr19:5,891,207...5,904,006

G

NADH:ubiquinone oxidoreductase subunit A2

increases expression

ISO

epoxiconazole results in increased expression of NDUFA2 mRNA

NCBI chr 5:140,645,285...140,647,630
Ensembl chr 5:140,638,740...140,647,771

G

NADH:ubiquinone oxidoreductase subunit A3

increases expression

ISO

epoxiconazole results in increased expression of NDUFA3 mRNA

NCBI chr19:54,102,855...54,107,568
Ensembl chr19:54,102,728...54,109,257

G

NDUFA4 mitochondrial complex associated

increases expression

ISO

epoxiconazole results in increased expression of NDUFA4 mRNA

NCBI chr 7:10,931,943...10,940,153
Ensembl chr 7:10,931,943...10,940,531

G

NADH:ubiquinone oxidoreductase subunit A6

increases expression

ISO

epoxiconazole results in increased expression of NDUFA6 mRNA

NCBI chr22:42,085,526...42,090,772
Ensembl chr22:42,085,526...42,090,884

G

NADH:ubiquinone oxidoreductase subunit A7

increases expression

ISO

epoxiconazole results in increased expression of NDUFA7 mRNA

NCBI chr19:8,308,595...8,321,375
Ensembl chr19:8,308,768...8,321,382

G

NADH:ubiquinone oxidoreductase complex assembly factor 2

increases expression

ISO

epoxiconazole results in increased expression of NDUFAF2 mRNA

NCBI chr 5:60,945,205...61,153,026
Ensembl chr 5:60,945,177...61,154,531

G

NADH:ubiquinone oxidoreductase complex assembly factor 3

decreases expression

ISO

epoxiconazole results in decreased expression of NDUFAF3 mRNA

NCBI chr 3:49,020,452...49,023,495
Ensembl chr 3:49,020,459...49,023,495

G

NADH:ubiquinone oxidoreductase complex assembly factor 4

decreases expression

ISO

epoxiconazole results in decreased expression of NDUFAF4 mRNA

NCBI chr 6:96,889,315...96,897,891
Ensembl chr 6:96,889,313...96,897,894

G

NADH:ubiquinone oxidoreductase subunit B10

increases expression

ISO

epoxiconazole results in increased expression of NDUFB10 mRNA

NCBI chr16:1,959,538...1,961,975
Ensembl chr16:1,959,508...1,962,021

G

NADH:ubiquinone oxidoreductase subunit B11

increases expression

ISO

epoxiconazole results in increased expression of NDUFB11 mRNA

NCBI chr X:47,142,216...47,145,491
Ensembl chr X:47,142,071...47,145,466

G

NADH:ubiquinone oxidoreductase subunit B2

increases expression

ISO

epoxiconazole results in increased expression of NDUFB2 mRNA

NCBI chr 7:140,696,708...140,706,643
Ensembl chr 7:140,690,777...140,723,923

G

NADH:ubiquinone oxidoreductase subunit B4

increases expression

ISO

epoxiconazole results in increased expression of NDUFB4 mRNA

NCBI chr 3:120,596,336...120,602,507
Ensembl chr 3:120,596,303...120,602,507

G

NADH:ubiquinone oxidoreductase subunit B6

increases expression

ISO

epoxiconazole results in increased expression of NDUFB6 mRNA

NCBI chr 9:32,553,001...32,573,159
Ensembl chr 9:32,553,001...32,573,184

G

NADH:ubiquinone oxidoreductase subunit B7

increases expression

ISO

epoxiconazole results in increased expression of NDUFB7 mRNA

NCBI chr19:14,566,078...14,572,066
Ensembl chr19:14,566,078...14,572,066

G

NADH:ubiquinone oxidoreductase subunit C1

increases expression

ISO

epoxiconazole results in increased expression of NDUFC1 mRNA

NCBI chr 4:139,289,917...139,302,551
Ensembl chr 4:139,266,880...139,302,564

G

NADH:ubiquinone oxidoreductase subunit C2

increases expression

ISO

epoxiconazole results in increased expression of NDUFC2 mRNA

NCBI chr11:78,068,297...78,079,862
Ensembl chr11:78,068,297...78,081,871

G

NADH:ubiquinone oxidoreductase core subunit S2

increases expression

ISO

epoxiconazole results in increased expression of NDUFS2 mRNA

NCBI chr 1:161,197,417...161,214,395
Ensembl chr 1:161,197,104...161,214,723

G

NADH:ubiquinone oxidoreductase subunit S5

increases expression

ISO

epoxiconazole results in increased expression of NDUFS5 mRNA

NCBI chr 1:39,026,350...39,034,615
Ensembl chr 1:39,026,318...39,034,636

G

NADH:ubiquinone oxidoreductase core subunit S7

decreases expression

ISO

epoxiconazole results in decreased expression of NDUFS7 mRNA

NCBI chr19:1,383,907...1,395,584
Ensembl chr19:1,383,527...1,395,590

G

NADH:ubiquinone oxidoreductase subunit V3

affects expression

ISO

epoxiconazole affects the expression of NDUFV3 mRNA

NCBI chr21:42,893,309...42,913,299
Ensembl chr21:42,879,644...42,913,304

G

nebulette

increases expression

ISO

epoxiconazole results in increased expression of NEBL mRNA

PMID:22334560 PMID:23970803 PMID:35436446

NCBI chr10:20,779,973...21,293,050
Ensembl chr10:20,779,973...21,293,011

G

nectin cell adhesion molecule 2

decreases expression

ISO

epoxiconazole results in decreased expression of NECTIN2 mRNA

NCBI chr19:44,846,297...44,889,223
Ensembl chr19:44,846,175...44,889,228

G

nectin cell adhesion molecule 4

increases expression

ISO

epoxiconazole results in increased expression of NECTIN4 mRNA

NCBI chr 1:161,070,998...161,089,558
Ensembl chr 1:161,070,988...161,090,045

G

NEDD4 like E3 ubiquitin protein ligase

affects expression

ISO

epoxiconazole affects the expression of NEDD4L mRNA

NCBI chr18:58,044,226...58,401,540
Ensembl chr18:58,044,050...58,401,540

G

NIMA related kinase 9

decreases expression

ISO

epoxiconazole results in decreased expression of NEK9 mRNA

NCBI chr14:75,079,353...75,127,202
Ensembl chr14:75,079,353...75,127,344

G

nephrocan, pseudogene

increases expression

ISO

epoxiconazole results in increased expression of NEPN mRNA

NCBI chr 6:117,602,928...117,645,087
Ensembl chr 6:117,633,706...117,645,087

G

neuroepithelial cell transforming 1

increases expression

ISO

epoxiconazole results in increased expression of NET1 mRNA

NCBI chr10:5,412,557...5,459,056
Ensembl chr10:5,412,557...5,459,056

G

neuraminidase 4

increases expression

ISO

epoxiconazole results in increased expression of NEU4 mRNA

NCBI chr 2:241,809,193...241,817,413
Ensembl chr 2:241,808,982...241,817,415

G

neuronal differentiation 2

increases expression

ISO

epoxiconazole results in increased expression of NEUROD2 mRNA

NCBI chr17:39,603,768...39,607,920
Ensembl chr17:39,603,536...39,609,777

G

neurofibromin 1

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NF1 mRNA

NCBI chr17:31,094,977...31,377,675
Ensembl chr17:31,094,927...31,382,116

G

neurofascin

decreases expression

ISO

epoxiconazole results in decreased expression of NFASC mRNA

NCBI chr 1:204,828,652...205,022,822
Ensembl chr 1:204,828,651...205,022,822

G

NFE2 like bZIP transcription factor 2

increases activity

ISO

epoxiconazole results in increased activity of NFE2L2 protein

NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756

G

nuclear factor I A

decreases expression

ISO

epoxiconazole results in decreased expression of NFIA mRNA

NCBI chr 1:61,077,227...61,462,788
Ensembl chr 1:60,865,259...61,462,788

G

nuclear factor I B

decreases expression

ISO

epoxiconazole results in decreased expression of NFIB mRNA

NCBI chr 9:14,081,843...14,532,077
Ensembl chr 9:14,081,843...14,398,983

G

nuclear factor, interleukin 3 regulated

increases expression

ISO

epoxiconazole results in increased expression of NFIL3 mRNA

NCBI chr 9:91,409,045...91,483,497
Ensembl chr 9:91,408,748...91,425,066

G

nuclear factor I X

decreases expression

ISO

epoxiconazole results in decreased expression of NFIX mRNA

NCBI chr19:12,995,475...13,098,796
Ensembl chr19:12,995,475...13,098,796

G

NFKB inhibitor alpha

decreases expression

ISO

epoxiconazole results in decreased expression of NFKBIA mRNA

NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749

G

NFS1 cysteine desulfurase

decreases expression

ISO

epoxiconazole results in decreased expression of NFS1 mRNA

NCBI chr20:35,668,052...35,699,352
Ensembl chr20:35,668,052...35,699,373

G

NFU1 iron-sulfur cluster scaffold

increases expression

ISO

epoxiconazole results in increased expression of NFU1 mRNA

NCBI chr 2:69,395,750...69,439,567
Ensembl chr 2:69,396,113...69,437,657

G

nuclear transcription factor Y subunit gamma

decreases expression

ISO

epoxiconazole results in decreased expression of NFYC mRNA

NCBI chr 1:40,691,704...40,771,603
Ensembl chr 1:40,691,570...40,771,606

G

neuronal guanine nucleotide exchange factor

decreases expression

ISO

epoxiconazole results in decreased expression of NGEF mRNA

NCBI chr 2:232,878,701...233,013,256
Ensembl chr 2:232,878,686...233,013,263

G

NHERF family PDZ scaffold protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of NHERF1 mRNA

NCBI chr17:74,748,628...74,769,353
Ensembl chr17:74,748,619...74,769,360

G

NHERF family PDZ scaffold protein 2

increases expression

ISO

epoxiconazole results in increased expression of NHERF2 mRNA

NCBI chr16:2,026,902...2,039,026
Ensembl chr16:2,025,356...2,039,026

G

NHL repeat containing 2

increases expression

ISO

epoxiconazole results in increased expression of NHLRC2 mRNA

NCBI chr10:113,854,661...113,917,194
Ensembl chr10:113,854,475...113,917,194

G

NHS like 1

affects expression

ISO

epoxiconazole affects the expression of NHSL1 mRNA

NCBI chr 6:138,422,043...138,693,212
Ensembl chr 6:138,422,043...138,693,253

G

nidogen 1

decreases expression

ISO

epoxiconazole results in decreased expression of NID1 mRNA

NCBI chr 1:235,975,830...236,065,090
Ensembl chr 1:235,975,830...236,065,202

G

NIPA like domain containing 1

affects expression

ISO

epoxiconazole affects the expression of NIPAL1 mRNA

NCBI chr 4:48,016,772...48,040,173
Ensembl chr 4:47,914,142...48,040,173

G

NIPBL cohesin loading factor

increases expression

ISO

epoxiconazole results in increased expression of NIPBL mRNA

NCBI chr 5:36,876,769...37,066,413
Ensembl chr 5:36,876,769...37,066,413

G

nipsnap homolog 1

decreases expression

ISO

epoxiconazole results in decreased expression of NIPSNAP1 mRNA

NCBI chr22:29,554,808...29,581,113
Ensembl chr22:29,554,808...29,581,327

G

nipsnap homolog 2

increases expression

ISO

epoxiconazole results in increased expression of NIPSNAP2 mRNA

NCBI chr 7:55,964,585...56,000,179
Ensembl chr 7:55,951,793...56,000,181

G

nipsnap homolog 3A

decreases expression

ISO

epoxiconazole results in decreased expression of NIPSNAP3A mRNA

NCBI chr 9:104,747,683...104,760,120
Ensembl chr 9:104,747,683...104,760,138

G

sodium/potassium transporting ATPase interacting 1

increases expression

ISO

epoxiconazole results in increased expression of NKAIN1 mRNA

NCBI chr 1:31,179,745...31,239,887
Ensembl chr 1:31,179,344...31,239,966

G

NFKB inhibitor interacting Ras like 2

increases expression

ISO

epoxiconazole results in increased expression of NKIRAS2 mRNA

NCBI chr17:42,017,576...42,025,641
Ensembl chr17:42,011,382...42,025,644

G

NFKB repressing factor

increases expression

ISO

epoxiconazole results in increased expression of NKRF mRNA

NCBI chr X:119,588,337...119,606,424
Ensembl chr X:119,588,337...119,606,443

G

natural killer cell triggering receptor

decreases expression

ISO

epoxiconazole results in decreased expression of NKTR mRNA

NCBI chr 3:42,600,612...42,648,735
Ensembl chr 3:42,600,471...42,648,738

G

NK6 homeobox 3

decreases expression

ISO

epoxiconazole results in decreased expression of NKX6-3 mRNA

NCBI chr 8:41,645,177...41,650,817
Ensembl chr 8:41,645,177...41,650,817

G

neuroligin 1

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NLGN1 mRNA

NCBI chr 3:173,395,952...174,294,372
Ensembl chr 3:173,396,284...174,294,372

G

NLR family pyrin domain containing 6

decreases expression

ISO

epoxiconazole results in decreased expression of NLRP6 mRNA

NCBI chr11:278,407...285,388
Ensembl chr11:278,407...285,388

G

N-myc and STAT interactor

increases expression

ISO

epoxiconazole results in increased expression of NMI mRNA

NCBI chr 2:151,270,470...151,289,668
Ensembl chr 2:151,270,467...151,289,908

G

nicotinamide riboside kinase 1

decreases expression

ISO

epoxiconazole results in decreased expression of NMRK1 mRNA

NCBI chr 9:75,060,577...75,088,155
Ensembl chr 9:75,060,573...75,088,306

G

nicotinamide N-methyltransferase

increases expression

ISO

epoxiconazole results in increased expression of NNMT mRNA

NCBI chr11:114,257,806...114,313,536
Ensembl chr11:114,257,765...114,314,329

G

NOC3 like DNA replication regulator

decreases expression

ISO

epoxiconazole results in decreased expression of NOC3L mRNA

NCBI chr10:94,314,907...94,362,939
Ensembl chr10:94,333,226...94,362,982

G

nucleolar complex associated 4 homolog

decreases expression

ISO

epoxiconazole results in decreased expression of NOC4L mRNA

NCBI chr12:132,144,457...132,152,468
Ensembl chr12:132,144,425...132,152,473

G

nocturnin

decreases expression

ISO

epoxiconazole results in decreased expression of NOCT mRNA

NCBI chr 4:139,015,781...139,045,939
Ensembl chr 4:139,015,772...139,045,939

G

nucleolar protein 12

increases expression

ISO

epoxiconazole results in increased expression of NOL12 mRNA

NCBI chr22:37,686,343...37,693,474
Ensembl chr22:37,681,673...37,693,476

G

nucleolar protein 4

increases expression

ISO

epoxiconazole results in increased expression of NOL4 mRNA

NCBI chr18:33,851,100...34,224,913
Ensembl chr18:33,851,100...34,224,952

G

nucleolar protein 4 like

increases expression

ISO

epoxiconazole results in increased expression of NOL4L mRNA

NCBI chr20:32,443,059...32,585,333
Ensembl chr20:32,443,059...32,585,333

G

nucleolar protein 6

decreases expression

ISO

epoxiconazole results in decreased expression of NOL6 mRNA

NCBI chr 9:33,461,353...33,473,924
Ensembl chr 9:33,461,353...33,473,930

G

nucleolar and coiled-body phosphoprotein 1

decreases expression

ISO

epoxiconazole results in decreased expression of NOLC1 mRNA

NCBI chr10:102,152,389...102,163,870
Ensembl chr10:102,152,175...102,163,875

G

NOP10 ribonucleoprotein

increases expression

ISO

epoxiconazole results in increased expression of NOP10 mRNA

NCBI chr15:34,341,719...34,343,136
Ensembl chr15:34,339,159...34,343,180

G

NOP2 nucleolar protein

decreases expression

ISO

epoxiconazole results in decreased expression of NOP2 mRNA

NCBI chr12:6,556,871...6,568,291
Ensembl chr12:6,556,863...6,568,691

G

nitric oxide synthase 1 adaptor protein

decreases expression

ISO

epoxiconazole results in decreased expression of NOS1AP mRNA

NCBI chr 1:162,069,691...162,370,475
Ensembl chr 1:162,069,691...162,370,475

G

nitric oxide synthase interacting protein

increases expression

ISO

epoxiconazole results in increased expression of NOSIP mRNA

NCBI chr19:49,555,468...49,580,556
Ensembl chr19:49,555,468...49,592,927

G

nitric oxide synthase trafficking

affects expression

ISO

epoxiconazole affects the expression of NOSTRIN mRNA

NCBI chr 2:168,786,539...168,865,514
Ensembl chr 2:168,786,539...168,866,787

G

notch receptor 1

increases expression

ISO

epoxiconazole results in increased expression of NOTCH1 mRNA

NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048

G

notch receptor 2

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of NOTCH2 mRNA

NCBI chr 1:119,911,553...120,069,662
Ensembl chr 1:119,911,553...120,100,779

G

notch receptor 3

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NOTCH3 mRNA

NCBI chr19:15,159,038...15,200,995
Ensembl chr19:15,159,038...15,200,996

G

notch receptor 4

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NOTCH4 mRNA

NCBI chr 6:32,194,843...32,224,067
Ensembl chr 6:32,194,843...32,224,111

G

NADPH oxidase 1

increases expression

ISO

epoxiconazole results in increased expression of NOX1 mRNA

NCBI chr X:100,843,324...100,874,359
Ensembl chr X:100,843,324...100,874,464

G

NADPH oxidase 3

increases expression

ISO

epoxiconazole results in increased expression of NOX3 mRNA

NCBI chr 6:155,395,368...155,455,839
Ensembl chr 6:155,395,368...155,455,839

G

NADP dependent oxidoreductase domain containing 1

decreases expression

ISO

epoxiconazole results in decreased expression of NOXRED1 mRNA

NCBI chr14:77,394,021...77,426,013
Ensembl chr14:77,394,021...77,423,523

G

neuronal PAS domain protein 2

increases expression

ISO

epoxiconazole results in increased expression of NPAS2 mRNA

NCBI chr 2:100,818,723...100,996,829
Ensembl chr 2:100,820,091...100,996,829

G

NPC intracellular cholesterol transporter 1

decreases expression

ISO

epoxiconazole results in decreased expression of NPC1 mRNA

NCBI chr18:23,506,184...23,586,506
Ensembl chr18:23,506,184...23,586,969

G

NPL4 homolog, ubiquitin recognition factor

increases expression
multiple interactions

ISO

epoxiconazole results in increased expression of NPLOC4 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of NPLOC4 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of NPLOC4 mRNA

NCBI chr17:81,556,885...81,637,112
Ensembl chr17:81,556,887...81,648,465

G

natriuretic peptide receptor 2

decreases expression

ISO

epoxiconazole results in decreased expression of NPR2 mRNA

NCBI chr 9:35,791,591...35,809,731
Ensembl chr 9:35,791,003...35,809,732

G

neuropeptide VF precursor

increases expression

ISO

epoxiconazole results in increased expression of NPVF mRNA

NCBI chr 7:25,224,570...25,228,486
Ensembl chr 7:25,224,570...25,228,486

G

neuropeptide Y receptor Y1

increases expression

ISO

epoxiconazole results in increased expression of NPY1R mRNA

NCBI chr 4:163,323,962...163,344,689
Ensembl chr 4:163,323,962...163,344,852

G

neuropeptide Y receptor Y2

increases expression

ISO

epoxiconazole results in increased expression of NPY2R mRNA

NCBI chr 4:155,173,723...155,217,076
Ensembl chr 4:155,208,636...155,217,078

G

NAD(P)H quinone dehydrogenase 1

increases expression
multiple interactions

ISO

epoxiconazole results in increased expression of NQO1 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of NQO1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of NQO1 mRNA

PMID:25182419 PMID:29038839

NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668

G

nuclear receptor subfamily 1 group D member 1

increases expression

ISO

epoxiconazole results in increased expression of NR1D1 mRNA

NCBI chr17:40,092,793...40,100,589
Ensembl chr17:40,092,793...40,100,589

G

nuclear receptor subfamily 1 group H member 3

decreases expression

ISO

epoxiconazole results in decreased expression of NR1H3 mRNA

NCBI chr11:47,248,300...47,269,033
Ensembl chr11:47,248,300...47,269,070

G

nuclear receptor subfamily 1 group H member 4

decreases expression

ISO

epoxiconazole results in decreased expression of NR1H4 mRNA

NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414

G

nuclear receptor subfamily 1 group H member 5, pseudogene

decreases expression

ISO

epoxiconazole results in decreased expression of NR1H5 mRNA

NCBI chr 1:114,834,456...114,851,544
Ensembl chr 1:114,837,227...114,851,453

G

nuclear receptor subfamily 1 group I member 2

decreases expression

ISO

epoxiconazole results in decreased expression of NR1I2 mRNA

NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487

G

nuclear receptor subfamily 1 group I member 3

affects expression
decreases expression

ISO

epoxiconazole affects the expression of NR1I3 mRNA
epoxiconazole results in decreased expression of NR1I3 mRNA

PMID:25949234 PMID:35436446

NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,262

G

nuclear receptor subfamily 2 group F member 1

decreases expression

ISO

epoxiconazole results in decreased expression of NR2F1 mRNA

NCBI chr 5:93,583,222...93,594,611
Ensembl chr 5:93,583,222...93,594,611

G

nuclear receptor subfamily 2 group F member 2

decreases expression

ISO

epoxiconazole results in decreased expression of NR2F2 mRNA

NCBI chr15:96,326,046...96,340,263
Ensembl chr15:96,325,797...96,340,263

G

nuclear receptor subfamily 2 group F member 6

increases expression

ISO

epoxiconazole results in increased expression of NR2F6 mRNA

NCBI chr19:17,231,883...17,245,919
Ensembl chr19:17,231,883...17,245,919

G

nuclear receptor subfamily 4 group A member 1

affects expression

ISO

epoxiconazole affects the expression of NR4A1 mRNA

NCBI chr12:52,022,832...52,059,503
Ensembl chr12:52,022,832...52,059,509

G

nuclear receptor subfamily 4 group A member 2

increases expression

ISO

epoxiconazole results in increased expression of NR4A2 mRNA

NCBI chr 2:156,324,437...156,332,721
Ensembl chr 2:156,324,432...156,342,348

G

nuclear receptor subfamily 4 group A member 3

increases expression

ISO

epoxiconazole results in increased expression of NR4A3 mRNA

NCBI chr 9:99,821,885...99,866,891
Ensembl chr 9:99,821,855...99,866,891

G

neurotrophin receptor associated death domain, pseudogene

increases expression

ISO

epoxiconazole results in increased expression of NRADD mRNA

NCBI chr 3:47,011,542...47,013,467
Ensembl chr 3:47,011,542...47,013,146

G

nebulin related anchoring protein

increases expression

ISO

epoxiconazole results in increased expression of NRAP mRNA

NCBI chr10:113,588,714...113,664,041
Ensembl chr10:113,588,714...113,664,121

G

nuclear receptor binding protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of NRBP2 mRNA

NCBI chr 8:143,829,776...143,840,973
Ensembl chr 8:143,833,583...143,840,973

G

neuronal cell adhesion molecule

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRCAM mRNA

NCBI chr 7:108,147,649...108,456,720
Ensembl chr 7:108,147,623...108,456,717

G

NRDE-2, necessary for RNA interference, domain containing

increases expression

ISO

epoxiconazole results in increased expression of NRDE2 mRNA

NCBI chr14:90,267,860...90,331,941
Ensembl chr14:90,267,860...90,331,981

G

neuronal regeneration related protein

decreases expression

ISO

epoxiconazole results in decreased expression of NREP mRNA

NCBI chr 5:111,728,802...111,976,932
Ensembl chr 5:111,662,621...111,997,464

G

neuregulin 1

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRG1 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRG1 mRNA

NCBI chr 8:31,639,245...32,774,046
Ensembl chr 8:31,639,222...32,855,666

G

neuregulin 2

increases expression

ISO

epoxiconazole results in increased expression of NRG2 mRNA

NCBI chr 5:139,846,781...140,043,299
Ensembl chr 5:139,846,779...140,043,299

G

neuregulin 4

decreases expression

ISO

epoxiconazole results in decreased expression of NRG4 mRNA

NCBI chr15:75,935,393...76,060,240
Ensembl chr15:75,935,969...76,059,795

G

neurexin 1

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRXN1 mRNA

NCBI chr 2:49,918,503...51,032,132
Ensembl chr 2:49,918,503...51,225,575

G

neurexin 2

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRXN2 mRNA

NCBI chr11:64,606,174...64,723,197
Ensembl chr11:64,606,174...64,723,197

G

neurexin 3

decreases expression

ISO

epoxiconazole results in decreased expression of NRXN3 mRNA

NCBI chr14:78,170,373...79,868,291
Ensembl chr14:78,170,373...79,868,291

G

nuclear receptor binding SET domain protein 3

increases expression

ISO

epoxiconazole results in increased expression of NSD3 mRNA

NCBI chr 8:38,269,704...38,382,271
Ensembl chr 8:38,269,704...38,382,279

G

NAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL

increases expression

EXP

epoxiconazole results in increased expression of NSDHL mRNA

NCBI chr X:152,831,063...152,869,729
Ensembl chr X:152,830,967...152,869,729

G

N-ethylmaleimide sensitive factor, vesicle fusing ATPase

decreases expression

ISO

epoxiconazole results in decreased expression of NSF mRNA

NCBI chr17:46,590,669...46,757,464
Ensembl chr17:46,590,669...46,757,679

G

NSFL1 cofactor

increases expression

ISO

epoxiconazole results in increased expression of NSFL1C mRNA

NCBI chr20:1,442,166...1,466,849
Ensembl chr20:1,442,162...1,473,842

G

NSL1 component of MIS12 kinetochore complex

increases expression

ISO

epoxiconazole results in increased expression of NSL1 mRNA

PMID:22334560 PMID:23970803

NCBI chr 1:212,726,153...212,791,777
Ensembl chr 1:212,726,153...212,791,783

G

NOP2/Sun RNA methyltransferase 2

affects expression

ISO

epoxiconazole affects the expression of NSUN2 mRNA

NCBI chr 5:6,599,239...6,633,044
Ensembl chr 5:6,599,237...6,633,304

G

NOP2/Sun RNA methyltransferase 4

decreases expression

ISO

epoxiconazole results in decreased expression of NSUN4 mRNA

NCBI chr 1:46,340,807...46,385,199
Ensembl chr 1:46,340,719...46,369,218

G

5'-nucleotidase, cytosolic IB

affects expression

ISO

epoxiconazole affects the expression of NT5C1B mRNA

NCBI chr 2:18,562,871...18,589,569
Ensembl chr 2:18,562,871...18,589,572

G

5'-nucleotidase, cytosolic II

decreases expression

ISO

epoxiconazole results in decreased expression of NT5C2 mRNA

NCBI chr10:103,088,017...103,193,272
Ensembl chr10:103,087,141...103,277,605

G

5'-nucleotidase, cytosolic IIIA

decreases expression

ISO

epoxiconazole results in decreased expression of NT5C3 mRNA

NCBI chr 7:33,014,113...33,062,776
Ensembl chr 7:33,014,113...33,062,824

G

5'-nucleotidase, cytosolic IIIB

decreases expression

ISO

epoxiconazole results in decreased expression of NT5C3B mRNA

NCBI chr17:41,825,057...41,836,232
Ensembl chr17:41,825,057...41,836,260

G

5'-nucleotidase domain containing 3

decreases expression

ISO

epoxiconazole results in decreased expression of NT5DC3 mRNA

NCBI chr12:103,746,315...103,841,234
Ensembl chr12:103,770,453...103,841,260

G

5',3'-nucleotidase, mitochondrial

decreases expression

ISO

epoxiconazole results in decreased expression of NT5M mRNA

NCBI chr17:17,303,373...17,347,663
Ensembl chr17:17,303,331...17,347,663

G

nucleoside-triphosphatase, cancer-related

increases expression

ISO

epoxiconazole results in increased expression of NTPCR mRNA

NCBI chr 1:232,950,611...232,983,882
Ensembl chr 1:232,950,564...232,983,882

G

neurotrophic receptor tyrosine kinase 2

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NTRK2 mRNA

NCBI chr 9:84,668,522...85,027,054
Ensembl chr 9:84,668,375...85,095,751

G

negative regulator of ubiquitin like proteins 1

decreases expression

ISO

epoxiconazole results in decreased expression of NUB1 mRNA

NCBI chr 7:151,341,812...151,378,449
Ensembl chr 7:151,341,708...151,378,461

G

NudC domain containing 3

decreases expression

ISO

epoxiconazole results in decreased expression of NUDCD3 mRNA

NCBI chr 7:44,379,119...44,490,658
Ensembl chr 7:44,379,119...44,490,690

G

nudix hydrolase 1

decreases expression

ISO

epoxiconazole results in decreased expression of NUDT1 mRNA

NCBI chr 7:2,242,226...2,251,145
Ensembl chr 7:2,242,203...2,251,824

G

nudix hydrolase 12

decreases expression

ISO

epoxiconazole results in decreased expression of NUDT12 mRNA

NCBI chr 5:103,548,855...103,562,789
Ensembl chr 5:103,548,855...103,562,806

G

nudix hydrolase 14

decreases expression

ISO

epoxiconazole results in decreased expression of NUDT14 mRNA

NCBI chr14:105,172,939...105,181,312
Ensembl chr14:105,172,937...105,181,323

G

nudix hydrolase 2

increases expression

ISO

epoxiconazole results in increased expression of NUDT2 mRNA

NCBI chr 9:34,329,569...34,343,699
Ensembl chr 9:34,329,506...34,343,713

G

nudix hydrolase 22

decreases expression

ISO

epoxiconazole results in decreased expression of NUDT22 mRNA

NCBI chr11:64,226,258...64,230,269
Ensembl chr11:64,225,941...64,230,686

G

nudix hydrolase 3

increases expression

ISO

epoxiconazole results in increased expression of NUDT3 mRNA

NCBI chr 6:34,279,679...34,392,669
Ensembl chr 6:34,279,679...34,392,677

G

nudix hydrolase 7

affects expression

ISO

epoxiconazole affects the expression of NUDT7 mRNA

NCBI chr16:77,722,514...77,742,260
Ensembl chr16:77,722,485...77,742,260

G

nucleoporin 133

decreases expression

ISO

epoxiconazole results in decreased expression of NUP133 mRNA

NCBI chr 1:229,440,259...229,508,341
Ensembl chr 1:229,440,259...229,508,356

G

nucleoporin 205

decreases expression

ISO

epoxiconazole results in decreased expression of NUP205 mRNA

NCBI chr 7:135,557,917...135,648,753
Ensembl chr 7:135,557,726...135,648,757

G

nucleoporin 93

increases expression

ISO

epoxiconazole results in increased expression of NUP93 mRNA

NCBI chr16:56,730,129...56,850,286
Ensembl chr16:56,730,095...56,850,286

G

NACHT and WD repeat domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of NWD1 mRNA

NCBI chr19:16,719,847...16,817,963
Ensembl chr19:16,719,847...16,817,963

G

neurexophilin and PC-esterase domain family member 2

increases expression

ISO

epoxiconazole results in increased expression of NXPE2 mRNA

NCBI chr11:114,464,276...114,813,702
Ensembl chr11:114,678,527...114,707,069

G

neurexophilin and PC-esterase domain family member 4

increases expression

ISO

epoxiconazole results in increased expression of NXPE4 mRNA

NCBI chr11:114,570,591...114,678,250
Ensembl chr11:114,570,591...114,598,282

G

neurexophilin 1

increases expression

ISO

epoxiconazole results in increased expression of NXPH1 mRNA

NCBI chr 7:8,433,609...8,752,961
Ensembl chr 7:8,433,609...8,752,961

G

nuclear transport factor 2 like export factor 1

increases expression

ISO

epoxiconazole results in increased expression of NXT1 mRNA

NCBI chr20:23,350,791...23,354,771
Ensembl chr20:23,350,767...23,354,771

G

2'-5'-oligoadenylate synthetase 1

increases expression

ISO

epoxiconazole results in increased expression of OAS1G mRNA

NCBI chr12:112,906,962...112,933,219
Ensembl chr12:112,905,856...112,933,219

G

2'-5'-oligoadenylate synthetase like

increases expression

ISO

epoxiconazole results in increased expression of OASL1 mRNA

NCBI chr12:121,017,761...121,039,246
Ensembl chr12:121,017,763...121,039,246

G

ornithine aminotransferase

increases expression

ISO

epoxiconazole results in increased expression of OAT mRNA

NCBI chr10:124,397,303...124,418,923
Ensembl chr10:124,397,298...124,419,760

G

odorant binding protein 2A

decreases expression

ISO

epoxiconazole results in decreased expression of OBP2A mRNA

PMID:22334560 PMID:23970803

NCBI chr 9:135,546,126...135,549,969
Ensembl chr 9:135,545,504...135,549,969

G

odorant binding protein 2B

increases expression

ISO

epoxiconazole results in increased expression of OBP2B mRNA

NCBI chr 9:133,205,279...133,223,255
Ensembl chr 9:133,205,277...133,209,250

G

OCIA domain containing 2

decreases expression

ISO

epoxiconazole results in decreased expression of OCIAD2 mRNA

NCBI chr 4:48,885,019...48,906,828
Ensembl chr 4:48,885,019...48,906,937

G

occludin

increases expression

ISO

epoxiconazole results in increased expression of OCLN mRNA

NCBI chr 5:69,492,547...69,558,104
Ensembl chr 5:69,492,184...69,558,104

G

outer dynein arm docking complex subunit 4

decreases expression

ISO

epoxiconazole results in decreased expression of ODAD4 mRNA

NCBI chr17:41,930,617...41,966,503
Ensembl chr17:41,930,617...41,966,503

G

outer dense fiber of sperm tails 4

decreases expression

ISO

epoxiconazole results in decreased expression of ODF4 mRNA

NCBI chr17:8,339,840...8,346,046
Ensembl chr17:8,339,840...8,346,048

G

O-GlcNAcase

decreases expression

ISO

epoxiconazole results in decreased expression of OGA mRNA

NCBI chr10:101,784,450...101,818,444
Ensembl chr10:101,784,443...101,818,620

G

oxoglutarate dehydrogenase

decreases expression

ISO

epoxiconazole results in decreased expression of OGDH mRNA

NCBI chr 7:44,606,627...44,709,066
Ensembl chr 7:44,606,549...44,709,070

G

2-oxoglutarate and iron dependent oxygenase domain containing 1

decreases expression

ISO

epoxiconazole results in decreased expression of OGFOD1 mRNA

NCBI chr16:56,451,524...56,479,104
Ensembl chr16:56,451,508...56,479,104

G

2-oxoglutarate and iron dependent oxygenase domain containing 3

decreases expression

ISO

epoxiconazole results in decreased expression of OGFOD3 mRNA

NCBI chr17:82,389,210...82,418,586
Ensembl chr17:82,389,210...82,418,637

G

opioid growth factor receptor like 1

increases expression

ISO

epoxiconazole results in increased expression of OGFRL1 mRNA

NCBI chr 6:71,288,811...71,309,059
Ensembl chr 6:71,288,811...71,309,059

G

osteoglycin

decreases expression

ISO

epoxiconazole results in decreased expression of OGN mRNA

NCBI chr 9:92,383,268...92,404,699
Ensembl chr 9:92,383,268...92,406,734

G

oncoprotein induced transcript 3

decreases expression

ISO

epoxiconazole results in decreased expression of OIT3 mRNA

NCBI chr10:72,893,739...72,933,036
Ensembl chr10:72,893,573...72,933,036

G

olfactomedin like 3

decreases expression

ISO

epoxiconazole results in decreased expression of OLFML3 mRNA

NCBI chr 1:113,979,474...113,982,253
Ensembl chr 1:113,979,024...114,035,572

G

OMA1 zinc metallopeptidase

decreases expression

ISO

epoxiconazole results in decreased expression of OMA1 mRNA

NCBI chr 1:58,480,719...58,546,726
Ensembl chr 1:58,415,384...58,546,838

G

osteomodulin

increases expression

ISO

epoxiconazole results in increased expression of OMD mRNA

NCBI chr 9:92,412,380...92,424,471
Ensembl chr 9:92,412,380...92,424,471

G

one cut homeobox 1

decreases expression

ISO

epoxiconazole results in decreased expression of ONECUT1 mRNA

NCBI chr15:52,755,053...52,790,336
Ensembl chr15:52,755,053...52,791,078

G

oocyte secreted protein 2

increases expression

ISO

epoxiconazole results in increased expression of OOSP2 mRNA

NCBI chr11:60,040,409...60,048,044
Ensembl chr11:60,040,409...60,048,044

G

5-oxoprolinase, ATP-hydrolysing

decreases expression

ISO

epoxiconazole results in decreased expression of OPLAH mRNA

NCBI chr 8:144,050,322...144,063,961
Ensembl chr 8:144,051,265...144,064,091

G

opioid receptor mu 1

increases expression

ISO

epoxiconazole results in increased expression of OPRM1 mRNA

NCBI chr 6:154,010,496...154,246,867
Ensembl chr 6:154,010,496...154,246,867

G

olfactory receptor family 10 subfamily G member 7

increases expression

ISO

epoxiconazole results in increased expression of OR10G7 mRNA

NCBI chr11:124,036,013...124,041,325
Ensembl chr11:124,036,013...124,041,325

G

olfactory receptor family 10 subfamily G member 9

increases expression

ISO

epoxiconazole results in increased expression of OR10G9 mRNA

NCBI chr11:124,023,013...124,023,948
Ensembl chr11:124,023,013...124,023,948

G

olfactory receptor family 12 subfamily D member 3

increases expression

ISO

epoxiconazole results in increased expression of OR12D17 mRNA

NCBI chr 6:29,373,423...29,375,291
Ensembl chr 6:29,373,423...29,375,291

G

olfactory receptor family 1 subfamily N member 1

increases expression

ISO

epoxiconazole results in increased expression of OR1N1 mRNA

NCBI chr 9:122,526,358...122,527,293
Ensembl chr 9:122,526,358...122,527,293

G

olfactory receptor family 2 subfamily AG member 2

increases expression

ISO

epoxiconazole results in increased expression of OR2AG2B mRNA

NCBI chr11:6,765,626...6,771,976
Ensembl chr11:6,765,626...6,771,976

G

olfactory receptor family 2 subfamily AJ member 1

decreases expression

ISO

epoxiconazole results in decreased expression of OR2AJ4 mRNA

NCBI chr 1:247,924,889...247,935,339
Ensembl chr 1:247,924,889...247,935,339

G

olfactory receptor family 2 subfamily B member 2

increases expression

ISO

epoxiconazole results in increased expression of OR2B2 mRNA

NCBI chr 6:27,911,185...27,912,396
Ensembl chr 6:27,911,185...27,912,396

G

olfactory receptor family 2 subfamily G member 6

increases expression

ISO

epoxiconazole results in increased expression of OR2Y13 mRNA

NCBI chr 1:248,508,073...248,527,337
Ensembl chr 1:248,508,073...248,527,337

G

olfactory receptor family 3 subfamily A member 4 pseudogene

increases expression

ISO

epoxiconazole results in increased expression of OR3A4 mRNA

NCBI chr17:3,310,245...3,311,446
Ensembl chr17:3,310,311...3,311,216

G

olfactory receptor family 4 subfamily A member 47

increases expression

ISO

epoxiconazole results in increased expression of OR4A47 mRNA

NCBI chr11:48,488,793...48,489,722
Ensembl chr11:48,488,793...48,489,722

G

olfactory receptor family 4 subfamily C member 45 (gene/pseudogene)

increases expression

ISO

epoxiconazole results in increased expression of OR4C52 mRNA

NCBI chr11:50,032,874...50,033,794
Ensembl chr11:50,032,874...50,033,794

G

olfactory receptor family 4 subfamily C member 46

increases expression

ISO

epoxiconazole results in increased expression of OR4C10 mRNA

NCBI chr11:54,603,069...54,603,998
Ensembl chr11:54,603,069...54,603,998

G

olfactory receptor family 51 subfamily B member 2

decreases expression

ISO

epoxiconazole results in decreased expression of OR51B17 mRNA

NCBI chr11:5,323,359...5,324,297
Ensembl chr11:5,323,359...5,324,297

G

olfactory receptor family 51 subfamily I member 1

increases expression

ISO

epoxiconazole results in increased expression of OR51I1 mRNA

NCBI chr11:5,440,570...5,441,514
Ensembl chr11:5,440,570...5,441,514

G

olfactory receptor family 52 subfamily A member 5

increases expression

ISO

epoxiconazole results in increased expression of OR52A5B mRNA

NCBI chr11:5,128,776...5,138,356
Ensembl chr11:5,128,776...5,138,356

G

olfactory receptor family 52 subfamily B member 4

increases expression

ISO

epoxiconazole results in increased expression of OR52B4 mRNA

NCBI chr11:4,367,263...4,368,386
Ensembl chr11:4,367,263...4,368,386

G

olfactory receptor family 56 subfamily B member 1

decreases expression

ISO

epoxiconazole results in decreased expression of OR56B1 mRNA

NCBI chr11:5,736,448...5,738,523
Ensembl chr11:5,736,448...5,738,523

G

olfactory receptor family 56 subfamily B member 4

increases expression

ISO

epoxiconazole results in increased expression of OR56B34 mRNA

NCBI chr11:6,107,684...6,108,835
Ensembl chr11:6,107,684...6,108,835

G

olfactory receptor family 5 subfamily B member 2

increases expression

ISO

epoxiconazole results in increased expression of OR5B99 mRNA

NCBI chr11:58,421,238...58,428,121
Ensembl chr11:58,421,238...58,428,121

G

olfactory receptor family 5 subfamily B member 3

increases expression

ISO

epoxiconazole results in increased expression of OR5B3 mRNA

NCBI chr11:58,402,464...58,406,874
Ensembl chr11:58,402,464...58,406,874

G

olfactory receptor family 5 subfamily D member 16

increases expression

ISO

epoxiconazole results in increased expression of OR5D16 mRNA

NCBI chr11:55,838,752...55,839,738
Ensembl chr11:55,838,752...55,839,738

G

olfactory receptor family 5 subfamily D member 18

increases expression

ISO

epoxiconazole results in increased expression of OR5D18 mRNA

NCBI chr11:55,819,630...55,820,571
Ensembl chr11:55,819,630...55,820,571

G

olfactory receptor family 5 subfamily G member 5 pseudogene

decreases expression

ISO

epoxiconazole results in decreased expression of OR5G25 mRNA

NCBI chr11:56,801,859...56,802,794
Ensembl chr11:56,801,856...56,802,794

G

olfactory receptor family 5 subfamily K member 3

increases expression

ISO

epoxiconazole results in increased expression of OR5K3 mRNA

NCBI chr 3:98,390,666...98,391,631
Ensembl chr 3:98,390,666...98,391,631

G

olfactory receptor family 5 subfamily M member 10

decreases expression
increases expression

ISO

epoxiconazole results in decreased expression of OR5M10 mRNA
epoxiconazole results in increased expression of OR5M10B mRNA

NCBI chr11:56,576,774...56,577,721
Ensembl chr11:56,576,774...56,577,721

G

olfactory receptor family 5 subfamily M member 8

increases expression

ISO

epoxiconazole results in increased expression of OR5M8 mRNA

NCBI chr11:56,490,435...56,491,370
Ensembl chr11:56,490,435...56,491,370

G

olfactory receptor family 5 subfamily T member 2

decreases expression

ISO

epoxiconazole results in decreased expression of OR5T7 mRNA

NCBI chr11:56,231,282...56,234,255
Ensembl chr11:56,231,282...56,234,255

G

olfactory receptor family 5 subfamily W member 2

increases expression

ISO

epoxiconazole results in increased expression of OR5W8 mRNA

NCBI chr11:55,913,650...55,914,582
Ensembl chr11:55,913,650...55,914,582

G

olfactory receptor family 6 subfamily B member 1

decreases expression

ISO

epoxiconazole results in decreased expression of OR6B1 mRNA

NCBI chr 7:144,000,320...144,008,793
Ensembl chr 7:144,000,320...144,008,793

G

olfactory receptor family 6 subfamily C member 6

increases expression

ISO

epoxiconazole results in increased expression of OR6C6 mRNA

NCBI chr12:55,293,988...55,296,569
Ensembl chr12:55,293,988...55,296,569

G

olfactory receptor family 7 subfamily G member 2

decreases expression

ISO

epoxiconazole results in decreased expression of OR7G27 mRNA

NCBI chr19:9,100,407...9,107,475
Ensembl chr19:9,100,407...9,107,475

G

olfactory receptor family 8 subfamily K member 3 (gene/pseudogene)

affects expression
decreases expression

ISO

epoxiconazole affects the expression of OR8K40 mRNA
epoxiconazole results in decreased expression of OR8K3 mRNA

NCBI chr11:56,315,144...56,320,639
Ensembl chr11:56,315,144...56,320,639

G

olfactory receptor family 9 subfamily Q member 1

increases expression

ISO

epoxiconazole results in increased expression of OR9Q1 mRNA

NCBI chr11:58,023,881...58,181,616
Ensembl chr11:58,023,881...58,181,616

G

ORAI calcium release-activated calcium modulator 1

increases expression

ISO

epoxiconazole results in increased expression of ORAI1 mRNA

NCBI chr12:121,626,530...121,643,109
Ensembl chr12:121,626,509...121,643,109

G

origin recognition complex subunit 2

affects expression

ISO

epoxiconazole affects the expression of ORC2 mRNA

NCBI chr 2:200,908,977...200,963,660
Ensembl chr 2:200,908,973...200,963,702

G

orosomucoid 1

increases expression

ISO

epoxiconazole results in increased expression of ORM1 mRNA

NCBI chr 9:114,323,098...114,326,479
Ensembl chr 9:114,323,025...114,326,479

G

orosomucoid 2

decreases expression
increases expression

ISO

epoxiconazole results in decreased expression of ORM2 mRNA
epoxiconazole results in increased expression of ORM2 mRNA

PMID:22334560 PMID:35436446

NCBI chr 9:114,329,869...114,333,251
Ensembl chr 9:114,329,788...114,333,254

G

oxysterol binding protein

increases expression

ISO

epoxiconazole results in increased expression of OSBP mRNA

NCBI chr11:59,574,398...59,615,774
Ensembl chr11:59,574,398...59,615,781

G

oxysterol binding protein like 2

decreases expression

ISO

epoxiconazole results in decreased expression of OSBPL2 mRNA

NCBI chr20:62,228,243...62,236,301
Ensembl chr20:62,231,922...62,296,213

G

oxysterol binding protein like 8

decreases expression

ISO

epoxiconazole results in decreased expression of OSBPL8 mRNA

NCBI chr12:76,351,797...76,559,771
Ensembl chr12:76,351,797...76,559,809

G

oxidative stress induced growth inhibitor 1

increases expression

ISO

epoxiconazole results in increased expression of OSGIN1 mRNA

NCBI chr16:83,953,240...83,966,332
Ensembl chr16:83,931,311...83,966,333

G

oligosaccharyltransferase complex subunit 4, non-catalytic

increases expression

ISO

epoxiconazole results in increased expression of OST4 mRNA

PMID:22334560 PMID:35436446

NCBI chr 2:27,070,472...27,071,654
Ensembl chr 2:27,070,470...27,071,685

G

oligosaccharyltransferase complex non-catalytic subunit

increases expression

ISO

epoxiconazole results in increased expression of OSTC mRNA

NCBI chr 4:108,650,599...108,667,820
Ensembl chr 4:108,650,585...108,667,820

G

OTU deubiquitinase, ubiquitin aldehyde binding 1

decreases expression

ISO

epoxiconazole results in decreased expression of OTUB1 mRNA

NCBI chr11:63,986,438...63,998,412
Ensembl chr11:63,985,853...64,001,811

G

OTU deubiquitinase with linear linkage specificity like

increases expression

ISO

epoxiconazole results in increased expression of OTULINL mRNA

NCBI chr 5:14,581,792...14,616,180
Ensembl chr 5:14,581,792...14,616,180

G

OXA1L mitochondrial inner membrane protein

decreases expression

ISO

epoxiconazole results in decreased expression of OXA1L mRNA

NCBI chr14:22,766,688...22,773,042
Ensembl chr14:22,766,522...22,773,042

G

oxidoreductase NAD binding domain containing 1

decreases expression

ISO

epoxiconazole results in decreased expression of OXNAD1 mRNA

NCBI chr 3:16,265,212...16,352,095
Ensembl chr 3:16,265,160...16,350,299

G

oxidation resistance 1

increases expression

ISO

epoxiconazole results in increased expression of OXR1 mRNA

NCBI chr 8:106,270,178...106,752,694
Ensembl chr 8:106,270,144...106,752,694

G

oxidative stress responsive kinase 1

decreases expression

ISO

epoxiconazole results in decreased expression of OXSR1 mRNA

NCBI chr 3:38,164,063...38,255,484
Ensembl chr 3:38,165,089...38,255,484

G

purinergic receptor P2X 4

decreases expression
increases expression

ISO

epoxiconazole results in decreased expression of P2RX4 mRNA
epoxiconazole results in increased expression of P2RX4 mRNA

PMID:22334560 PMID:35436446

NCBI chr12:121,210,129...121,234,106
Ensembl chr12:121,210,065...121,234,112

G

purinergic receptor P2X 5

increases expression

ISO

epoxiconazole results in increased expression of P2RX5 mRNA

NCBI chr17:3,673,227...3,723,835
Ensembl chr17:3,672,199...3,696,398

G

purinergic receptor P2X 6

increases expression

ISO

epoxiconazole results in increased expression of P2RX6 mRNA

NCBI chr22:21,009,799...21,028,008
Ensembl chr22:21,009,808...21,028,013

G

purinergic receptor P2Y2

decreases expression

ISO

epoxiconazole results in decreased expression of P2RY2 mRNA

NCBI chr11:73,218,281...73,242,427
Ensembl chr11:73,216,664...73,242,427

G

pyrimidinergic receptor P2Y4

decreases expression

ISO

epoxiconazole results in decreased expression of P2RY4 mRNA

NCBI chr X:70,258,166...70,260,204
Ensembl chr X:70,258,166...70,260,204

G

prolyl 4-hydroxylase subunit alpha 1

decreases expression

ISO

epoxiconazole results in decreased expression of P4HA1 mRNA

NCBI chr10:73,007,217...73,096,866
Ensembl chr10:73,005,811...73,096,983

G

PP2A Aalpha (PPP2R1A) and B55A (PPP2R2A) interacting phosphatase regulator 1

increases expression

ISO

epoxiconazole results in increased expression of PABIR1 mRNA

NCBI chr 9:68,780,065...68,785,566
Ensembl chr 9:68,780,065...68,785,566

G

poly(A) binding protein cytoplasmic 1 like

increases expression

ISO

epoxiconazole results in increased expression of PABPC1L mRNA

NCBI chr20:44,910,060...44,939,316
Ensembl chr20:44,910,060...44,959,035

G

poly(A) binding protein cytoplasmic 3

increases expression

ISO

epoxiconazole results in increased expression of PABPC6 mRNA

NCBI chr13:25,096,136...25,099,254
Ensembl chr13:25,096,136...25,099,254

G

poly(A) binding protein cytoplasmic 4 like

increases expression

ISO

epoxiconazole results in increased expression of PABPC4L mRNA

NCBI chr 4:133,948,459...134,201,901
Ensembl chr 4:134,196,333...134,201,885

G

phosphofurin acidic cluster sorting protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of PACS1 mRNA

NCBI chr11:66,070,272...66,244,744
Ensembl chr11:66,070,272...66,244,744

G

platelet activating factor acetylhydrolase 2

decreases expression

ISO

epoxiconazole results in decreased expression of PAFAH2 mRNA

NCBI chr 1:25,959,767...25,998,063
Ensembl chr 1:25,959,767...25,999,206

G

poly(A) binding protein interacting protein 1

increases expression

ISO

epoxiconazole results in increased expression of PAIP1 mRNA

NCBI chr 5:43,526,267...43,557,411
Ensembl chr 5:43,526,267...43,557,758

G

p21 (RAC1) activated kinase 2

increases expression

ISO

epoxiconazole results in increased expression of PAK2 mRNA

NCBI chr 3:196,739,857...196,832,647
Ensembl chr 3:196,739,743...196,832,647

G

polyamine oxidase

decreases expression

ISO

epoxiconazole results in decreased expression of PAOX mRNA

NCBI chr10:133,379,262...133,391,694
Ensembl chr10:133,379,246...133,392,078

G

3'-phosphoadenosine 5'-phosphosulfate synthase 2

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of PAPSS2 mRNA
epoxiconazole results in decreased expression of PAPSS2 mRNA

PMID:22334560 PMID:23970803 PMID:35436446

NCBI chr10:87,659,878...87,747,705
Ensembl chr10:87,659,613...87,747,708

G

progestin and adipoQ receptor family member 7

decreases expression

ISO

epoxiconazole results in decreased expression of PAQR7 mRNA

NCBI chr 1:25,861,484...25,875,708
Ensembl chr 1:25,861,484...25,875,874

G

progestin and adipoQ receptor family member 9

increases expression

ISO

epoxiconazole results in increased expression of PAQR9 mRNA

NCBI chr 3:142,949,164...142,964,008
Ensembl chr 3:142,949,164...142,964,022

G

poly(ADP-ribose) polymerase family member 16

decreases expression

ISO

epoxiconazole results in decreased expression of PARP16 mRNA

NCBI chr15:65,230,917...65,286,883
Ensembl chr15:65,234,460...65,300,618

G

poly(ADP-ribose) polymerase family member 9

decreases expression

ISO

epoxiconazole results in decreased expression of PARP9 mRNA

NCBI chr 3:122,527,924...122,564,784
Ensembl chr 3:122,527,910...122,565,478

G

PAS domain containing serine/threonine kinase

increases expression

ISO

epoxiconazole results in increased expression of PASK mRNA

NCBI chr 2:241,106,099...241,150,347
Ensembl chr 2:241,106,099...241,150,852

G

pro-apoptotic WT1 regulator

increases expression

ISO

epoxiconazole results in increased expression of PAWR mRNA

NCBI chr12:79,584,879...79,690,964
Ensembl chr12:79,574,979...79,690,964

G

polysaccharide biosynthesis domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of PBDC1 mRNA

NCBI chr X:76,173,062...76,178,314
Ensembl chr X:76,173,034...76,178,755

G

phenazine biosynthesis like protein domain containing

decreases expression

ISO

epoxiconazole results in decreased expression of PBLD1 mRNA

NCBI chr10:68,282,660...68,332,928
Ensembl chr10:68,282,657...68,334,114

G

pyruvate carboxylase

decreases expression

ISO

epoxiconazole results in decreased expression of PCX mRNA

PMID:22334560 PMID:35436446

NCBI chr11:66,848,420...66,958,383
Ensembl chr11:66,848,208...66,958,524

G

propionyl-CoA carboxylase subunit beta

decreases expression

ISO

epoxiconazole results in decreased expression of PCCB mRNA

NCBI chr 3:136,250,340...136,330,169
Ensembl chr 3:136,250,314...136,337,896

G

protocadherin 1

increases expression

ISO

epoxiconazole results in increased expression of PCDH1 mRNA

NCBI chr 5:141,853,090...141,878,410
Ensembl chr 5:141,853,090...141,879,246

G

polycomb group ring finger 5

decreases expression

ISO

epoxiconazole results in decreased expression of PCGF5 mRNA

NCBI chr10:91,156,219...91,284,337
Ensembl chr10:91,162,339...91,284,337

G

phosphorylated CTD interacting factor 1

decreases expression

ISO

epoxiconazole results in decreased expression of PCIF1 mRNA

NCBI chr20:45,934,683...45,948,020
Ensembl chr20:45,934,678...45,948,023

G

piccolo presynaptic cytomatrix protein

increases expression

ISO

epoxiconazole results in increased expression of PCLO mRNA

NCBI chr 7:82,754,012...83,162,884
Ensembl chr 7:82,754,012...83,162,930

G

protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1

decreases expression

ISO

epoxiconazole results in decreased expression of PCMTD1 mRNA

NCBI chr 8:51,817,575...51,899,186
Ensembl chr 8:51,817,575...51,900,042

G

pecanex 1

affects expression

ISO

epoxiconazole affects the expression of PCNX1 mRNA

NCBI chr14:70,907,459...71,115,382
Ensembl chr14:70,907,405...71,115,382

G

procollagen C-endopeptidase enhancer

affects expression

ISO

epoxiconazole affects the expression of PCOLCE mRNA

NCBI chr 7:100,602,363...100,608,175
Ensembl chr 7:100,602,334...100,608,175

G

Purkinje cell protein 4

increases expression

ISO

epoxiconazole results in increased expression of PCP4 mRNA

NCBI chr21:39,867,438...39,929,392
Ensembl chr21:39,867,438...39,929,397

G

proprotein convertase subtilisin/kexin type 1

increases expression

ISO

epoxiconazole results in increased expression of PCSK1 mRNA

NCBI chr 5:96,390,333...96,433,248
Ensembl chr 5:96,390,333...96,434,143

G

proprotein convertase subtilisin/kexin type 2

increases expression

ISO

epoxiconazole results in increased expression of PCSK2 mRNA

NCBI chr20:17,226,107...17,484,578
Ensembl chr20:17,226,107...17,484,578

G

proprotein convertase subtilisin/kexin type 7

affects expression

ISO

epoxiconazole affects the expression of PCSK7 mRNA

NCBI chr11:117,204,337...117,232,073
Ensembl chr11:117,204,337...117,232,528

G

proprotein convertase subtilisin/kexin type 9

decreases expression

ISO

epoxiconazole results in decreased expression of PCSK9 mRNA

NCBI chr 1:55,039,548...55,064,852
Ensembl chr 1:55,039,445...55,064,852

G

prenylcysteine oxidase 1

decreases expression

ISO

epoxiconazole results in decreased expression of PCYOX1 mRNA

NCBI chr 2:70,257,915...70,281,185
Ensembl chr 2:70,257,386...70,281,185

G

phosphate cytidylyltransferase 1A, choline

decreases expression

ISO

epoxiconazole results in decreased expression of PCYT1A mRNA

NCBI chr 3:196,234,368...196,287,726
Ensembl chr 3:196,214,222...196,287,957

G

programmed cell death 10

increases expression

ISO

epoxiconazole results in increased expression of PDCD10 mRNA

NCBI chr 3:167,683,298...167,734,892
Ensembl chr 3:167,683,298...167,735,039

G

programmed cell death 11

decreases expression

ISO

epoxiconazole results in decreased expression of PDCD11 mRNA

NCBI chr10:103,396,626...103,446,294
Ensembl chr10:103,396,626...103,446,297

G

programmed cell death 2

decreases expression

ISO

epoxiconazole results in decreased expression of PDCD2 mRNA

NCBI chr 6:170,575,295...170,584,637
Ensembl chr 6:170,575,295...170,584,692

G

programmed cell death 5

increases expression

ISO

epoxiconazole results in increased expression of PDCD5 mRNA

NCBI chr19:32,581,190...32,587,453
Ensembl chr19:32,581,188...32,587,453

G

programmed cell death 6

decreases expression

ISO

epoxiconazole results in decreased expression of PDCD6 mRNA

NCBI chr 5:271,646...314,974
Ensembl chr 5:271,621...314,974

G

phosducin like 2

decreases expression

ISO

epoxiconazole results in decreased expression of PDCL2 mRNA

NCBI chr 4:55,556,519...55,592,245
Ensembl chr 4:55,556,519...55,592,245

G

phosphodiesterase 10A

increases expression

ISO

epoxiconazole results in increased expression of PDE10A mRNA

NCBI chr 6:165,327,289...165,988,052
Ensembl chr 6:165,327,287...165,988,117

G

phosphodiesterase 3B

increases expression

ISO

epoxiconazole results in increased expression of PDE3B mRNA

NCBI chr11:14,643,804...14,899,321
Ensembl chr11:14,643,663...14,874,614

G

phosphodiesterase 7B

decreases expression

ISO

epoxiconazole results in decreased expression of PDE7B mRNA

NCBI chr 6:135,851,701...136,195,574
Ensembl chr 6:135,851,701...136,195,574

G

phosphodiesterase 9A

affects expression

ISO

epoxiconazole affects the expression of PDE9A mRNA

NCBI chr21:42,653,621...42,775,509
Ensembl chr21:42,653,591...42,775,513

G

platelet derived growth factor subunit A

decreases expression

ISO

epoxiconazole results in decreased expression of PDGFA mRNA

NCBI chr 7:497,258...520,700
Ensembl chr 7:497,258...520,695

G

platelet derived growth factor C

increases expression

ISO

epoxiconazole results in increased expression of PDGFC mRNA

NCBI chr 4:156,760,454...156,971,799
Ensembl chr 4:156,760,454...156,971,799

G

platelet derived growth factor receptor like

affects expression

ISO

epoxiconazole affects the expression of PDGFRL mRNA

NCBI chr 8:17,576,433...17,643,144
Ensembl chr 8:17,576,433...17,644,071

G

pyruvate dehydrogenase E1 subunit alpha 1

decreases expression

ISO

epoxiconazole results in decreased expression of PDHA1 mRNA

NCBI chr X:19,343,927...19,361,718
Ensembl chr X:19,343,893...19,361,718

G

pyruvate dehydrogenase kinase 2

affects expression

ISO

epoxiconazole affects the expression of PDK2 mRNA

NCBI chr17:50,094,737...50,112,152
Ensembl chr17:50,094,737...50,112,152

G

pyruvate dehydrogenase kinase 3

decreases expression

ISO

epoxiconazole results in decreased expression of PDK3 mRNA

NCBI chr X:24,465,286...24,550,466
Ensembl chr X:24,465,244...24,550,466

G

pyruvate dehydrogenase kinase 4

increases expression

ISO

epoxiconazole results in increased expression of PDK4 mRNA

NCBI chr 7:95,583,499...95,596,516
Ensembl chr 7:95,583,497...95,597,638

G

PDZ and LIM domain 3

decreases expression

ISO

epoxiconazole results in decreased expression of PDLIM3 mRNA

NCBI chr 4:185,500,660...185,535,507
Ensembl chr 4:185,500,660...185,535,507

G

pyridoxal kinase

decreases expression

ISO

epoxiconazole results in decreased expression of PDXK mRNA

NCBI chr21:43,737,000...43,738,097
Ensembl chr21:43,719,094...43,762,307

G

PDZK1 interacting protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of PDZK1IP1 mRNA

NCBI chr 1:47,183,582...47,190,036
Ensembl chr 1:47,183,582...47,191,398

G

platelet endothelial aggregation receptor 1

decreases expression

ISO

epoxiconazole results in decreased expression of PEAR1 mRNA

NCBI chr 1:156,893,718...156,916,429
Ensembl chr 1:156,893,666...156,916,432

G

plasmanylethanolamine desaturase 1

decreases expression

ISO

epoxiconazole results in decreased expression of PEDS1 mRNA

NCBI chr20:50,118,254...50,153,723
Ensembl chr20:50,118,254...50,153,754

G

paternally expressed 10

increases expression

ISO

epoxiconazole results in increased expression of PEG10 mRNA

NCBI chr 7:94,656,325...94,669,695
Ensembl chr 7:94,656,325...94,669,695

G

pellino E3 ubiquitin protein ligase 1

decreases expression

ISO

epoxiconazole results in decreased expression of PELI1 mRNA

NCBI chr 2:64,092,652...64,144,420
Ensembl chr 2:64,092,652...64,144,420

G

pellino E3 ubiquitin protein ligase family member 3

increases expression

ISO

epoxiconazole results in increased expression of PELI3 mRNA

NCBI chr11:66,466,327...66,477,337
Ensembl chr11:66,466,303...66,478,998

G

peptidase D

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of PEPD mRNA
epoxiconazole results in decreased expression of PEPD mRNA

PMID:22334560 PMID:35436446

NCBI chr19:33,386,950...33,521,791
Ensembl chr19:33,386,950...33,521,823

G

period circadian regulator 1

affects expression

ISO

epoxiconazole affects the expression of PER1 mRNA

NCBI chr17:8,140,472...8,152,404
Ensembl chr17:8,140,467...8,156,506

G

period circadian regulator 2

affects expression

ISO

epoxiconazole affects the expression of PER2 mRNA

NCBI chr 2:238,244,044...238,300,065
Ensembl chr 2:238,244,044...238,290,102

G

period circadian regulator 3

affects expression

ISO

epoxiconazole affects the expression of PER3 mRNA

NCBI chr 1:7,784,291...7,845,177
Ensembl chr 1:7,784,291...7,845,181

G

peroxisomal biogenesis factor 1

increases expression

ISO

epoxiconazole results in increased expression of PEX1 mRNA

NCBI chr 7:92,487,025...92,528,520
Ensembl chr 7:92,487,020...92,528,640

G

peroxisomal biogenesis factor 11 alpha

decreases expression

ISO

epoxiconazole results in decreased expression of PEX11A mRNA

NCBI chr15:89,681,535...89,690,754
Ensembl chr15:89,677,764...89,690,783

G

peroxisomal biogenesis factor 12

decreases expression

ISO

epoxiconazole results in decreased expression of PEX12 mRNA

NCBI chr17:35,574,795...35,578,571
Ensembl chr17:35,574,795...35,578,863

G

peroxisomal biogenesis factor 26

decreases expression

ISO

epoxiconazole results in decreased expression of PEX26 mRNA

NCBI chr22:18,077,990...18,105,396
Ensembl chr22:18,077,923...18,105,396

G

prefoldin subunit 1

increases expression

ISO

epoxiconazole results in increased expression of PFDN1 mRNA

NCBI chr 5:140,245,035...140,303,101
Ensembl chr 5:140,245,035...140,303,113

G

prefoldin subunit 5

increases expression

ISO

epoxiconazole results in increased expression of PFDN5 mRNA

NCBI chr12:53,295,542...53,299,450
Ensembl chr12:53,295,291...53,299,452

G

prefoldin subunit 6

decreases expression

ISO

epoxiconazole results in decreased expression of PFDN6 mRNA

NCBI chr 6:33,289,197...33,290,934
Ensembl chr 6:33,288,680...33,298,401

G

6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1

decreases expression

ISO

epoxiconazole results in decreased expression of PFKFB1 mRNA

NCBI chr X:54,932,961...54,998,789
Ensembl chr X:54,931,434...54,998,534

G

6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3

affects expression

ISO

epoxiconazole affects the expression of PFKFB3 mRNA

NCBI chr10:6,144,921...6,326,637
Ensembl chr10:6,144,928...6,254,644

G

phosphofructokinase, muscle

increases expression

ISO

epoxiconazole results in increased expression of PFKM mRNA

NCBI chr12:48,105,353...48,146,404
Ensembl chr12:48,105,139...48,150,704

G

profilin 1

decreases expression

ISO

epoxiconazole results in decreased expression of PFN1 mRNA

NCBI chr17:4,945,652...4,948,530
Ensembl chr17:4,945,652...4,950,517

G

profilin 2

increases expression

ISO

epoxiconazole results in increased expression of PFN2 mRNA

NCBI chr 3:149,964,904...149,970,895
Ensembl chr 3:149,964,904...150,050,788

G

phosphoglycerate mutase 1

decreases expression

ISO

epoxiconazole results in decreased expression of PGAM1 mRNA

NCBI chr10:97,426,191...97,433,444
Ensembl chr10:97,426,124...97,433,444

G

post-GPI attachment to proteins 2

increases expression

ISO

epoxiconazole results in increased expression of PGAP2 mRNA

NCBI chr11:3,797,720...3,826,371
Ensembl chr11:3,797,724...3,826,371

G

post-GPI attachment to proteins phospholipase 3

decreases expression

ISO

epoxiconazole results in decreased expression of PGAP3 mRNA

NCBI chr17:39,671,122...39,688,057
Ensembl chr17:39,671,122...39,696,797

G

post-GPI attachment to proteins GalNAc transferase 4

increases expression

ISO

epoxiconazole results in increased expression of PGAP4 mRNA

NCBI chr 9:101,473,170...101,533,686
Ensembl chr 9:101,473,170...101,533,537

G

piggyBac transposable element derived 1

increases expression

ISO

epoxiconazole results in increased expression of PGBD1 mRNA

NCBI chr 6:28,281,572...28,302,549
Ensembl chr 6:28,281,493...28,303,691

G

protein-glucosylgalactosylhydroxylysine glucosidase

decreases expression

ISO

epoxiconazole results in decreased expression of PGGHG mRNA

NCBI chr11:289,126...296,107
Ensembl chr11:289,095...296,107

G

peptidoglycan recognition protein 4

increases expression

ISO

epoxiconazole results in increased expression of PGLYRP4 mRNA

NCBI chr 1:153,330,120...153,348,841
Ensembl chr 1:153,330,120...153,348,841

G

phosphoglucomutase 3

decreases expression

ISO

epoxiconazole results in decreased expression of PGM3 mRNA

NCBI chr 6:83,148,705...83,193,900
Ensembl chr 6:83,147,324...83,194,005

G

phosphoglucomutase 5

increases expression

ISO

epoxiconazole results in increased expression of PGM5 mRNA

NCBI chr 9:68,356,611...68,531,061
Ensembl chr 9:68,328,308...68,535,009

G

progesterone receptor

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of PGR mRNA

NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813

G

phosphatidylglycerophosphate synthase 1

increases expression

ISO

epoxiconazole results in increased expression of PGS1 mRNA

NCBI chr17:78,378,649...78,424,659
Ensembl chr17:78,378,637...78,425,114

G

polyhomeotic homolog 1

increases expression

ISO

epoxiconazole results in increased expression of PHC1 mRNA

NCBI chr12:8,913,843...8,941,467
Ensembl chr12:8,913,827...8,942,938

G

PHD finger protein 23

decreases expression

ISO

epoxiconazole results in decreased expression of PHF23 mRNA

NCBI chr17:7,235,038...7,240,828
Ensembl chr17:7,235,029...7,239,722

G

pleckstrin homology like domain family A member 1

affects expression

ISO

epoxiconazole affects the expression of PHLDA1 mRNA

NCBI chr12:76,025,447...76,031,776
Ensembl chr12:76,025,447...76,031,776

G

phosphohistidine phosphatase 1

increases expression

ISO

epoxiconazole results in increased expression of PHPT1 mRNA

NCBI chr 9:136,849,409...136,851,024
Ensembl chr 9:136,848,724...136,851,039

G

phytanoyl-CoA dioxygenase domain containing 1

decreases expression

ISO

epoxiconazole results in decreased expression of PHYHD1 mRNA

NCBI chr 9:128,920,982...128,942,041
Ensembl chr 9:128,920,966...128,942,042

G

phytanoyl-CoA 2-hydroxylase interacting protein

increases expression

ISO

epoxiconazole results in increased expression of PHYHIP mRNA

NCBI chr 8:22,219,703...22,232,099
Ensembl chr 8:22,219,703...22,232,101

G

5-phosphohydroxy-L-lysine phospho-lyase

decreases expression

ISO

epoxiconazole results in decreased expression of PHYKPL mRNA

NCBI chr 5:178,207,144...178,232,822
Ensembl chr 5:178,207,144...178,233,208

G

phosphatidylinositol 4-kinase type 2 alpha

increases expression

ISO

epoxiconazole results in increased expression of PI4K2A mRNA

NCBI chr10:97,640,671...97,676,434
Ensembl chr10:97,640,671...97,676,757

G

protein inhibitor of activated STAT 4

decreases expression

ISO

epoxiconazole results in decreased expression of PIAS4 mRNA

NCBI chr19:4,007,736...4,039,386
Ensembl chr19:4,007,695...4,039,386

G

phosphotyrosine interaction domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of PID1 mRNA

NCBI chr 2:229,023,973...229,271,287
Ensembl chr 2:228,850,526...229,271,867

G

piercer of microtubule wall 1

increases expression

ISO

epoxiconazole results in increased expression of PIERCE1 mRNA

NCBI chr 9:135,495,181...135,499,869
Ensembl chr 9:135,495,180...135,501,734

G

phosphatidylinositol glycan anchor biosynthesis class B

decreases expression

ISO

epoxiconazole results in decreased expression of PIGB mRNA

NCBI chr15:55,319,222...55,355,648
Ensembl chr15:55,318,960...55,355,648

G

phosphatidylinositol glycan anchor biosynthesis class C

decreases expression

ISO

epoxiconazole results in decreased expression of PIGC mRNA

NCBI chr 1:172,441,457...172,444,069
Ensembl chr 1:172,370,189...172,444,148

G

phosphatidylinositol glycan anchor biosynthesis class L

decreases expression

ISO

epoxiconazole results in decreased expression of PIGL mRNA

NCBI chr17:16,217,210...16,326,411
Ensembl chr17:16,217,191...16,351,797

G

phosphatidylinositol glycan anchor biosynthesis class M

decreases expression

ISO

epoxiconazole results in decreased expression of PIGM mRNA

NCBI chr 1:160,024,953...160,031,990
Ensembl chr 1:160,024,953...160,031,990

G

phosphatidylinositol glycan anchor biosynthesis class N

decreases expression

ISO

epoxiconazole results in decreased expression of PIGN mRNA

NCBI chr18:62,017,615...62,187,056
Ensembl chr18:61,905,255...62,187,118

G

phosphatidylinositol glycan anchor biosynthesis class P

affects expression

ISO

epoxiconazole affects the expression of PIGP mRNA

NCBI chr21:37,065,364...37,073,071
Ensembl chr21:37,062,846...37,073,318

G

phosphatidylinositol glycan anchor biosynthesis class Q

decreases expression

ISO

epoxiconazole results in decreased expression of PIGQ mRNA

NCBI chr16:569,968...584,109
Ensembl chr16:566,995...584,120

G

phosphatidylinositol glycan anchor biosynthesis class W

decreases expression

ISO

epoxiconazole results in decreased expression of PIGW mRNA

NCBI chr17:36,534,987...36,539,303
Ensembl chr17:36,534,987...36,539,310

G

phosphatidylinositol glycan anchor biosynthesis class X

decreases expression

ISO

epoxiconazole results in decreased expression of PIGX mRNA

NCBI chr 3:196,712,377...196,736,007
Ensembl chr 3:196,639,775...196,736,007

G

PIH1 domain containing 1

decreases expression

ISO

epoxiconazole results in decreased expression of PIH1D1 mRNA

NCBI chr19:49,446,298...49,451,814
Ensembl chr19:49,446,291...49,453,537

G

phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma

affects expression

ISO

epoxiconazole affects the expression of PIK3C2G mRNA

NCBI chr12:18,242,961...18,726,817
Ensembl chr12:18,242,960...18,648,416

G

phosphoinositide-3-kinase regulatory subunit 4

decreases expression

ISO

epoxiconazole results in decreased expression of PIK3R4 mRNA

NCBI chr 3:130,678,934...130,746,829
Ensembl chr 3:130,678,934...130,746,829

G

Pim-1 proto-oncogene, serine/threonine kinase

increases expression

ISO

epoxiconazole results in increased expression of PIM1 mRNA

NCBI chr 6:37,170,152...37,175,428
Ensembl chr 6:37,170,152...37,175,428

G

Pim-3 proto-oncogene, serine/threonine kinase

affects expression

ISO

epoxiconazole affects the expression of PIM3 mRNA

NCBI chr22:49,960,772...49,964,072
Ensembl chr22:49,960,463...49,964,075

G

peptidylprolyl cis/trans isomerase, NIMA-interacting 1

decreases expression

ISO

epoxiconazole results in decreased expression of PIN1 mRNA

NCBI chr19:9,835,318...9,849,689
Ensembl chr19:9,835,257...9,849,690

G

phosphatidylinositol-5-phosphate 4-kinase type 2 beta

decreases expression

ISO

epoxiconazole results in decreased expression of PIP4K2B mRNA

NCBI chr17:38,765,691...38,799,556
Ensembl chr17:38,765,691...38,800,126

G

phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2

increases expression

ISO

epoxiconazole results in increased expression of PIP4P2 mRNA

NCBI chr 8:90,993,802...91,040,859
Ensembl chr 8:90,990,482...91,041,007

G

phosphatidylinositol-4-phosphate 5-kinase type 1 beta

increases expression

ISO

epoxiconazole results in increased expression of PIP5K1B mRNA

NCBI chr 9:68,705,240...69,009,176
Ensembl chr 9:68,705,190...69,009,191

G

pipecolic acid and sarcosine oxidase

decreases expression

ISO

epoxiconazole results in decreased expression of PIPOX mRNA

PMID:22334560 PMID:35436446

NCBI chr17:29,043,141...29,057,216
Ensembl chr17:28,950,513...29,057,583

G

phosphatidylserine decarboxylase

decreases expression

ISO

epoxiconazole results in decreased expression of PISD mRNA

NCBI chr22:31,618,491...31,662,564
Ensembl chr22:31,618,489...31,662,239

G

phosphatidylinositol transfer protein cytoplasmic 1

decreases expression

ISO

epoxiconazole results in decreased expression of PITPNC1 mRNA

NCBI chr17:67,377,281...67,697,256
Ensembl chr17:67,377,281...67,697,256

G

phosphatidylinositol transfer protein membrane associated 2

decreases expression

ISO

epoxiconazole results in decreased expression of PITPNM2 mRNA

NCBI chr12:122,983,480...123,151,848
Ensembl chr12:122,983,480...123,151,142

G

polycystin 1 like 1, transient receptor potential channel interacting

increases expression

ISO

epoxiconazole results in increased expression of PKD1L1 mRNA

NCBI chr 7:47,774,614...47,960,906
Ensembl chr 7:47,740,202...47,948,466

G

cAMP-dependent protein kinase inhibitor gamma

decreases expression

ISO

epoxiconazole results in decreased expression of PKIG mRNA

NCBI chr20:44,531,875...44,619,037
Ensembl chr20:44,531,762...44,624,247

G

pyruvate kinase L/R

decreases expression

ISO

epoxiconazole results in decreased expression of PKLR mRNA

NCBI chr 1:155,289,293...155,308,654
Ensembl chr 1:155,289,293...155,301,438

G

protein kinase N2

increases expression

ISO

epoxiconazole results in increased expression of PKN2 mRNA

NCBI chr 1:88,684,273...88,836,255
Ensembl chr 1:88,684,222...88,836,255

G

protein kinase N3

decreases expression

ISO

epoxiconazole results in decreased expression of PKN3 mRNA

NCBI chr 9:128,702,503...128,720,916
Ensembl chr 9:128,702,499...128,720,924

G

plakophilin 1

increases expression

ISO

epoxiconazole results in increased expression of PKP1 mRNA

NCBI chr 1:201,283,506...201,332,989
Ensembl chr 1:201,283,452...201,332,993

G

phospholipase A2 group XIIA

increases expression

ISO

epoxiconazole results in increased expression of PLA2G12A mRNA

NCBI chr 4:109,709,989...109,730,070
Ensembl chr 4:109,709,989...109,730,070

G

phospholipase A2 group IIE

increases expression

ISO

epoxiconazole results in increased expression of PLA2G2E mRNA

NCBI chr 1:19,920,009...19,923,617
Ensembl chr 1:19,920,009...19,923,617

G

phospholipase A2 group IVC

decreases expression

ISO

epoxiconazole results in decreased expression of PLA2G4C mRNA

NCBI chr19:48,047,846...48,110,817
Ensembl chr19:48,047,843...48,110,850

G

phospholipase A2 group V

increases expression

ISO

epoxiconazole results in increased expression of PLA2G5 mRNA

NCBI chr 1:20,028,408...20,091,911
Ensembl chr 1:20,028,179...20,091,911

G

phospholipase A2 group VI

increases expression
affects expression

ISO

epoxiconazole results in increased expression of PLA2G6 mRNA
epoxiconazole affects the expression of PLA2G6 mRNA

PMID:22334560 PMID:35436446

NCBI chr22:38,111,495...38,181,830
Ensembl chr22:38,111,495...38,214,778

G

phospholipase A2 activating protein

increases expression

ISO

epoxiconazole results in increased expression of PLAA mRNA

NCBI chr 9:26,903,372...26,947,242
Ensembl chr 9:26,903,372...26,947,490

G

phospholipase B domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of PLBD1 mRNA

NCBI chr12:14,503,661...14,567,883
Ensembl chr12:14,503,660...14,567,913

G

phospholipase B domain containing 2

decreases expression

ISO

epoxiconazole results in decreased expression of PLBD2 mRNA

NCBI chr12:113,358,587...113,391,629
Ensembl chr12:113,358,544...113,391,629

G

phospholipase C beta 1

decreases expression

ISO

epoxiconazole results in decreased expression of PLCB1 mRNA

NCBI chr20:8,132,266...8,884,900
Ensembl chr20:8,077,251...8,968,360

G

phospholipase C beta 4

increases expression

ISO

epoxiconazole results in increased expression of PLCB4 mRNA

NCBI chr20:9,068,678...9,480,808
Ensembl chr20:9,067,825...9,504,593

G

phosphatidylinositol specific phospholipase C X domain containing 2

affects expression

ISO

epoxiconazole affects the expression of PLCXD2 mRNA

NCBI chr 3:111,674,676...111,727,007
Ensembl chr 3:111,674,676...111,846,447

G

phosphatidylinositol specific phospholipase C X domain containing 3

increases expression

ISO

epoxiconazole results in increased expression of PLCXD3 mRNA

NCBI chr 5:41,306,952...41,510,601
Ensembl chr 5:41,306,952...41,510,601

G

phospholipase D1

decreases expression

ISO

epoxiconazole results in decreased expression of PLD1 mRNA

NCBI chr 3:171,600,404...171,810,483
Ensembl chr 3:171,600,404...171,810,950

G

plectin

decreases expression

ISO

epoxiconazole results in decreased expression of PLEC mRNA

NCBI chr 8:143,915,153...143,976,745
Ensembl chr 8:143,915,152...143,976,734

G

pleckstrin homology domain containing A3

decreases expression

ISO

epoxiconazole results in decreased expression of PLEKHA3 mRNA

NCBI chr 2:178,480,457...178,516,463
Ensembl chr 2:178,480,457...178,516,463

G

pleckstrin homology domain containing A6

decreases expression

ISO

epoxiconazole results in decreased expression of PLEKHA6 mRNA

NCBI chr 1:204,218,853...204,378,168
Ensembl chr 1:204,218,851...204,378,214

G

pleckstrin homology domain containing A8

decreases expression

ISO

epoxiconazole results in decreased expression of PLEKHA8 mRNA

NCBI chr 7:30,028,412...30,130,483
Ensembl chr 7:30,027,404...30,130,483

G

pleckstrin homology domain containing B2

decreases expression

ISO

epoxiconazole results in decreased expression of PLEKHB2 mRNA

NCBI chr 2:131,105,336...131,149,845
Ensembl chr 2:131,104,847...131,353,709

G

pleckstrin homology and FYVE domain containing 1

decreases expression

ISO

epoxiconazole results in decreased expression of PLEKHF1 mRNA

NCBI chr19:29,665,461...29,675,477
Ensembl chr19:29,665,398...29,675,477

G

pleckstrin homology and RhoGEF domain containing G1

increases expression

ISO

epoxiconazole results in increased expression of PLEKHG1 mRNA

NCBI chr 6:150,599,885...150,843,665
Ensembl chr 6:150,599,848...150,843,665

G

pleckstrin homology and RhoGEF domain containing G3

decreases expression

ISO

epoxiconazole results in decreased expression of PLEKHG3 mRNA

NCBI chr14:64,704,424...64,750,249
Ensembl chr14:64,704,102...64,750,249

G

pleckstrin homology and RUN domain containing M2

decreases expression

ISO

epoxiconazole results in decreased expression of PLEKHM2 mRNA

NCBI chr 1:15,681,506...15,734,769
Ensembl chr 1:15,681,461...15,734,769

G

pleckstrin homology domain containing O1

decreases expression

ISO

epoxiconazole results in decreased expression of PLEKHO1 mRNA

NCBI chr 1:150,149,646...150,160,065
Ensembl chr 1:150,149,183...150,164,720

G

plasminogen receptor with a C-terminal lysine

decreases expression

ISO

epoxiconazole results in decreased expression of PLGRKT mRNA

NCBI chr 9:5,357,971...5,438,377
Ensembl chr 9:5,357,966...5,438,615

G

perilipin 2

decreases expression
affects expression

ISO

epoxiconazole results in decreased expression of PLIN2 mRNA
epoxiconazole affects the expression of PLIN2 mRNA

PMID:28454766 PMID:35436446

NCBI chr 9:19,108,388...19,127,492
Ensembl chr 9:19,108,375...19,149,369

G

perilipin 3

decreases expression

ISO

epoxiconazole results in decreased expression of PLIN3 mRNA

NCBI chr19:4,838,341...4,867,667
Ensembl chr19:4,838,339...4,867,717

G

perilipin 5

decreases expression

ISO

epoxiconazole results in decreased expression of PLIN5 mRNA

PMID:22334560 PMID:35436446

NCBI chr19:4,522,531...4,535,224
Ensembl chr19:4,522,531...4,535,247

G

polo like kinase 3

affects expression

ISO

epoxiconazole affects the expression of PLK3 mRNA

NCBI chr 1:44,800,377...44,805,990
Ensembl chr 1:44,800,346...44,805,995

G

plasmolipin

increases expression

ISO

epoxiconazole results in increased expression of PLLP mRNA

NCBI chr16:57,256,097...57,284,672
Ensembl chr16:57,248,547...57,284,675

G

procollagen-lysine,2-oxoglutarate 5-dioxygenase 1

decreases expression

ISO

epoxiconazole results in decreased expression of PLOD1 mRNA

NCBI chr 1:11,934,717...11,975,537
Ensembl chr 1:11,934,205...11,975,542

G

phospholipid phosphatase 2

decreases expression

ISO

epoxiconazole results in decreased expression of PLPP2 mRNA

NCBI chr19:281,043...291,403
Ensembl chr19:278,504...291,403

G

phospholipid phosphatase 3

decreases expression

ISO

epoxiconazole results in decreased expression of PLPP3 mRNA

NCBI chr 1:56,494,761...56,579,563
Ensembl chr 1:56,494,761...56,645,301

G

phospholipid phosphatase 7 (inactive)

decreases expression

ISO

epoxiconazole results in decreased expression of PLPP7 mRNA

NCBI chr 9:131,289,723...131,309,261
Ensembl chr 9:131,289,459...131,359,022

G

phospholipid phosphatase related 2

decreases expression

ISO

epoxiconazole results in decreased expression of PLPPR2 mRNA

NCBI chr19:11,355,432...11,365,698
Ensembl chr19:11,355,386...11,365,698

G

phospholipid transfer protein

affects expression

ISO

epoxiconazole affects the expression of PLTP mRNA

NCBI chr20:45,898,620...45,912,155
Ensembl chr20:45,898,621...45,912,235

G

plasmalemma vesicle associated protein

decreases expression

ISO

epoxiconazole results in decreased expression of PLVAP mRNA

NCBI chr19:17,351,455...17,377,342
Ensembl chr19:17,351,450...17,377,356

G

plexin A2

affects expression

ISO

epoxiconazole affects the expression of PLXNA2 mRNA

NCBI chr 1:208,022,242...208,244,384
Ensembl chr 1:208,022,242...208,244,850

G

plexin A4

increases expression

ISO

epoxiconazole results in increased expression of PLXNA4 mRNA

NCBI chr 7:132,123,340...132,648,688
Ensembl chr 7:132,123,340...132,648,688

G

peptidase M20 domain containing 1

decreases expression

ISO

epoxiconazole results in decreased expression of PM20D1 mRNA

NCBI chr 1:205,828,025...205,850,132
Ensembl chr 1:205,828,025...205,850,132

G

PML nuclear body scaffold

decreases expression

ISO

epoxiconazole results in decreased expression of PML mRNA

NCBI chr15:73,994,716...74,047,827
Ensembl chr15:73,994,673...74,047,827

G

phosphomannomutase 2

decreases expression

ISO

epoxiconazole results in decreased expression of PMM2 mRNA

NCBI chr16:8,797,839...8,849,325
Ensembl chr16:8,788,823...8,862,534

G

peripheral myelin protein 22

decreases expression

ISO

epoxiconazole results in decreased expression of PMP22 mRNA

NCBI chr17:15,229,779...15,265,326
Ensembl chr17:15,229,773...15,272,292

G

peptidase, mitochondrial processing subunit beta

increases expression

ISO

epoxiconazole results in increased expression of PMPCB mRNA

NCBI chr 7:103,297,435...103,347,542
Ensembl chr 7:103,295,717...103,331,818

G

phosphomevalonate kinase

decreases expression

ISO

epoxiconazole results in decreased expression of PMVK mRNA

NCBI chr 1:154,924,740...154,942,658
Ensembl chr 1:154,924,732...154,937,008

G

PNKD metallo-beta-lactamase domain containing

increases expression

ISO

epoxiconazole results in increased expression of PNKD mRNA

NCBI chr 2:218,270,519...218,346,793
Ensembl chr 2:218,269,651...218,346,793

G

pancreatic lipase related protein 1

increases expression

ISO

epoxiconazole results in increased expression of PNLIPRP1 mRNA

NCBI chr10:116,590,959...116,609,175
Ensembl chr10:116,590,385...116,609,175

G

pancreatic lipase related protein 2 (gene/pseudogene)

increases expression

ISO

epoxiconazole results in increased expression of PNLIPRP2 mRNA

NCBI chr10:116,620,953...116,645,143
Ensembl chr10:116,620,953...116,645,143

G

PNMA family member 1

increases expression

ISO

epoxiconazole results in increased expression of PNMA1 mRNA

NCBI chr14:73,711,783...73,714,384
Ensembl chr14:73,711,783...73,714,384

G

purine nucleoside phosphorylase

affects expression
increases expression

ISO

epoxiconazole affects the expression of PNP mRNA
epoxiconazole results in increased expression of PNP2 mRNA

NCBI chr14:20,469,406...20,477,089
Ensembl chr14:20,461,992...20,477,094

G

patatin like phospholipase domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of PNPLA1 mRNA

NCBI chr 6:36,243,168...36,313,955
Ensembl chr 6:36,243,203...36,313,955

G

patatin like phospholipase domain containing 2

decreases expression

ISO

epoxiconazole results in decreased expression of PNPLA2 mRNA

NCBI chr11:818,914...825,573
Ensembl chr11:818,914...825,573

G

patatin like phospholipase domain containing 7

decreases expression

ISO

epoxiconazole results in decreased expression of PNPLA7 mRNA

NCBI chr 9:137,459,952...137,550,402
Ensembl chr 9:137,459,952...137,550,431

G

polyribonucleotide nucleotidyltransferase 1

decreases expression

ISO

epoxiconazole results in decreased expression of PNPT1 mRNA

NCBI chr 2:55,634,061...55,693,844
Ensembl chr 2:55,634,061...55,693,863

G

proline rich nuclear receptor coactivator 1

increases expression

ISO

epoxiconazole results in increased expression of PNRC1 mRNA

NCBI chr 6:89,080,751...89,085,160
Ensembl chr 6:89,080,751...89,085,160

G

POC5 centriolar protein

decreases expression

ISO

epoxiconazole results in decreased expression of POC5 mRNA

NCBI chr 5:75,674,124...75,717,437
Ensembl chr 5:75,674,124...75,717,448

G

podocan

decreases expression

ISO

epoxiconazole results in decreased expression of PODN mRNA

NCBI chr 1:53,062,213...53,085,494
Ensembl chr 1:53,061,293...53,093,681

G

pogo transposable element derived with ZNF domain

decreases expression

ISO

epoxiconazole results in decreased expression of POGZ mRNA

NCBI chr 1:151,402,724...151,459,494
Ensembl chr 1:151,402,724...151,459,494

G

DNA polymerase beta

increases expression

ISO

epoxiconazole results in increased expression of POLB mRNA

NCBI chr 8:42,338,494...42,371,808
Ensembl chr 8:42,338,454...42,371,808

G

DNA polymerase delta 1, catalytic subunit

decreases expression

ISO

epoxiconazole results in decreased expression of POLD1 mRNA

NCBI chr19:50,384,323...50,418,018
Ensembl chr19:50,384,204...50,418,018

G

DNA polymerase iota

decreases expression

ISO

epoxiconazole results in decreased expression of POLI mRNA

NCBI chr18:54,269,479...54,321,266
Ensembl chr18:54,269,510...54,321,266

G

RNA polymerase I subunit E

decreases expression

ISO

epoxiconazole results in decreased expression of POLR1E mRNA

NCBI chr 9:37,485,948...37,503,697
Ensembl chr 9:37,481,695...37,503,701

G

RNA polymerase II subunit B

decreases expression

ISO

epoxiconazole results in decreased expression of POLR2B mRNA

NCBI chr 4:56,978,896...57,031,158
Ensembl chr 4:56,977,722...57,031,158

G

RNA polymerase II subunit C

decreases expression

ISO

epoxiconazole results in decreased expression of POLR2C mRNA

NCBI chr16:57,462,679...57,472,009
Ensembl chr16:57,462,660...57,472,009

G

RNA polymerase II, I and III subunit E

decreases expression

ISO

epoxiconazole results in decreased expression of POLR2E mRNA

NCBI chr19:1,086,574...1,095,375
Ensembl chr19:1,085,104...1,095,389

G

RNA polymerase II, I and III subunit H

decreases expression

ISO

epoxiconazole results in decreased expression of POLR2H mRNA

NCBI chr 3:184,361,710...184,368,591
Ensembl chr 3:184,360,856...184,368,596

G

RNA polymerase III subunit A

decreases expression

ISO

epoxiconazole results in decreased expression of POLR3A mRNA

NCBI chr10:77,975,149...78,029,515
Ensembl chr10:77,953,148...78,029,549

G

RNA polymerase III subunit B

decreases expression

ISO

epoxiconazole results in decreased expression of POLR3B mRNA

NCBI chr12:106,357,748...106,510,198
Ensembl chr12:106,357,693...106,510,201

G

RNA polymerase III subunit G

decreases expression

ISO

epoxiconazole results in decreased expression of POLR3G mRNA

NCBI chr 5:90,473,929...90,514,557
Ensembl chr 5:90,471,748...90,514,559

G

protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)

decreases expression

ISO

epoxiconazole results in decreased expression of POMGNT1 mRNA

NCBI chr 1:46,188,683...46,220,305
Ensembl chr 1:46,188,681...46,220,305

G

protein O-mannose kinase

decreases expression

ISO

epoxiconazole results in decreased expression of POMK mRNA

NCBI chr 8:43,093,515...43,123,434
Ensembl chr 8:43,093,498...43,131,180

G

protein O-mannosyltransferase 1

decreases expression

ISO

epoxiconazole results in decreased expression of POMT1 mRNA

NCBI chr 9:131,502,918...131,523,799
Ensembl chr 9:131,502,789...131,523,806

G

protein O-mannosyltransferase 2

decreases expression

ISO

epoxiconazole results in decreased expression of POMT2 mRNA

NCBI chr14:77,274,956...77,320,883
Ensembl chr14:77,274,956...77,320,883

G

paraoxonase 3

increases expression

ISO

epoxiconazole results in increased expression of PON3 mRNA

NCBI chr 7:95,359,872...95,396,375
Ensembl chr 7:95,357,618...95,396,493

G

POP5 homolog, ribonuclease P/MRP subunit

decreases expression

ISO

epoxiconazole results in decreased expression of POP5 mRNA

NCBI chr12:120,578,764...120,581,402
Ensembl chr12:120,578,764...120,581,411

G

popeye domain cAMP effector 3

increases expression

ISO

epoxiconazole results in increased expression of POPDC3 mRNA

NCBI chr 6:105,157,900...105,180,014
Ensembl chr 6:105,157,892...105,180,447

G

cytochrome p450 oxidoreductase

increases expression
decreases expression
multiple interactions

ISO

epoxiconazole results in increased expression of POR mRNA
epoxiconazole results in decreased expression of POR mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of POR mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of POR mRNA

PMID:22334560 PMID:29038839 PMID:35436446

NCBI chr 7:75,915,155...75,986,855
Ensembl chr 7:75,899,200...75,986,855

G

POTE ankyrin domain family member J

affects expression

ISO

epoxiconazole affects the expression of POTEFAM1 mRNA

NCBI chr 2:130,611,078...130,658,037
Ensembl chr 2:130,611,440...130,658,037

G

POU class 2 homeobox associating factor 1

decreases expression

ISO

epoxiconazole results in decreased expression of POU2AF1 mRNA

NCBI chr11:111,352,255...111,379,275
Ensembl chr11:111,352,255...111,455,630

G

POU class 3 homeobox 2

increases expression

ISO

epoxiconazole results in increased expression of POU3F2 mRNA

NCBI chr 6:98,834,574...98,839,458
Ensembl chr 6:98,834,574...98,839,458

G

POU domain class 5, transcription factor 2

decreases expression

ISO

epoxiconazole results in decreased expression of POU5F2 mRNA

NCBI chr 5:93,733,220...93,741,600
Ensembl chr 5:93,733,220...93,741,600

G

inorganic pyrophosphatase 1

increases expression

ISO

epoxiconazole results in increased expression of PPA1 mRNA

NCBI chr10:70,202,835...70,233,429
Ensembl chr10:70,202,831...70,233,911

G

inorganic pyrophosphatase 2

increases expression

ISO

epoxiconazole results in increased expression of PPA2 mRNA

NCBI chr 4:105,369,077...105,474,070
Ensembl chr 4:105,369,077...105,474,113

G

peroxisome proliferator activated receptor alpha

decreases expression
affects expression

ISO

epoxiconazole results in decreased expression of PPARA mRNA
epoxiconazole affects the expression of PPARA mRNA

PMID:22334560 PMID:25689681 PMID:35436446

NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,149,924...46,243,755

G

peroxisome proliferator activated receptor gamma

affects expression

ISO

epoxiconazole affects the expression of PPARG mRNA

NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,574

G

PPARG coactivator 1 alpha

multiple interactions
increases expression

ISO

[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of PPARGC1A mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of PPARGC1A mRNA
epoxiconazole results in increased expression of PPARGC1A mRNA

PMID:29038839 PMID:35436446

NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089

G

PPARG coactivator 1 beta

affects expression

ISO

epoxiconazole affects the expression of PPARGC1B mRNA

NCBI chr 5:149,730,310...149,857,959
Ensembl chr 5:149,729,994...149,855,022

G

phosphoribosyl pyrophosphate amidotransferase

decreases expression

ISO

epoxiconazole results in decreased expression of PPAT mRNA

NCBI chr 4:56,393,362...56,435,615
Ensembl chr 4:56,393,362...56,435,616

G

protein phosphatase with EF-hand domain 1

increases expression

ISO

epoxiconazole results in increased expression of PPEF1 mRNA

NCBI chr X:18,675,067...18,827,917
Ensembl chr X:18,675,909...18,827,921

G

PTPRF interacting protein alpha 1

decreases expression

ISO

epoxiconazole results in decreased expression of PPFIA1 mRNA

NCBI chr11:70,270,690...70,384,396
Ensembl chr11:70,270,655...70,385,312

G

PTPRF interacting protein alpha 4

increases expression

ISO

epoxiconazole results in increased expression of PPFIA4 mRNA

NCBI chr 1:203,026,491...203,078,736
Ensembl chr 1:203,026,491...203,078,740

G

PPFIA binding protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of PPFIBP1 mRNA

NCBI chr12:27,524,206...27,695,564
Ensembl chr12:27,523,431...27,695,565

G

PPFIA binding protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of PPFIBP2 mRNA

NCBI chr11:7,513,999...7,667,304
Ensembl chr11:7,513,298...7,657,127

G

peptidylprolyl isomerase D

increases expression

ISO

epoxiconazole results in increased expression of PPID mRNA

NCBI chr 4:158,709,127...158,723,396
Ensembl chr 4:158,709,127...158,723,406

G

peptidylprolyl isomerase F

decreases expression

ISO

epoxiconazole results in decreased expression of PPIF mRNA

NCBI chr10:79,347,469...79,355,334
Ensembl chr10:79,347,466...79,355,337

G

peptidylprolyl isomerase like 3

increases expression

ISO

epoxiconazole results in increased expression of PPIL3 mRNA

NCBI chr 2:200,870,907...200,889,291
Ensembl chr 2:200,870,907...200,889,353

G

protein phosphatase, Mg2+/Mn2+ dependent 1D

decreases expression

ISO

epoxiconazole results in decreased expression of PPM1D mRNA

NCBI chr17:60,600,193...60,666,280
Ensembl chr17:60,599,735...60,666,280

G

protein phosphatase, Mg2+/Mn2+ dependent 1K

decreases expression

ISO

epoxiconazole results in decreased expression of PPM1K mRNA

NCBI chr 4:88,257,620...88,284,561
Ensembl chr 4:88,257,620...88,284,769

G

protein phosphatase, Mg2+/Mn2+ dependent 1L

decreases expression

ISO

epoxiconazole results in decreased expression of PPM1L mRNA

NCBI chr 3:160,756,231...161,078,902
Ensembl chr 3:160,755,602...161,078,902

G

protoporphyrinogen oxidase

decreases expression

ISO

epoxiconazole results in decreased expression of PPOX mRNA

NCBI chr 1:161,165,728...161,178,013
Ensembl chr 1:161,165,837...161,178,013

G

protein phosphatase 1 catalytic subunit gamma

increases expression

ISO

epoxiconazole results in increased expression of PPP1CC mRNA

NCBI chr12:110,708,376...110,742,891
Ensembl chr12:110,719,680...110,742,939

G

protein phosphatase 1 regulatory inhibitor subunit 14A

affects expression

ISO

epoxiconazole affects the expression of PPP1R14A mRNA

NCBI chr19:38,251,237...38,256,374
Ensembl chr19:38,251,237...38,256,557

G

protein phosphatase 1 regulatory subunit 15B

decreases expression

ISO

epoxiconazole results in decreased expression of PPP1R15B mRNA

NCBI chr 1:204,395,826...204,411,817
Ensembl chr 1:204,396,492...204,411,887

G

protein phosphatase 1 regulatory subunit 16A

decreases expression

ISO

epoxiconazole results in decreased expression of PPP1R16A mRNA

NCBI chr 8:144,477,982...144,502,121
Ensembl chr 8:144,475,989...144,502,126

G

protein phosphatase 1 regulatory inhibitor subunit 1C

decreases expression

ISO

epoxiconazole results in decreased expression of PPP1R1C mRNA

NCBI chr 2:181,954,480...182,131,385
Ensembl chr 2:181,954,241...182,131,398

G

protein phosphatase 1 regulatory subunit 36

increases expression

ISO

epoxiconazole results in increased expression of PPP1R36 mRNA

NCBI chr14:64,549,961...64,589,381
Ensembl chr14:64,549,918...64,589,384

G

protein phosphatase 1 regulatory subunit 37

increases expression

ISO

epoxiconazole results in increased expression of PPP1R37 mRNA

NCBI chr19:45,093,179...45,147,285
Ensembl chr19:45,091,396...45,148,077

G

protein phosphatase 1 regulatory subunit 3A

decreases expression

ISO

epoxiconazole results in decreased expression of PPP1R3A mRNA

NCBI chr 7:113,876,777...113,919,009
Ensembl chr 7:113,876,777...114,075,920

G

protein phosphatase 1 regulatory subunit 3B

affects expression

ISO

epoxiconazole affects the expression of PPP1R3B mRNA

NCBI chr 8:9,136,255...9,151,539
Ensembl chr 8:9,136,255...9,151,574

G

protein phosphatase 1 regulatory subunit 3C

increases expression

ISO

epoxiconazole results in increased expression of PPP1R3C mRNA

NCBI chr10:91,628,442...91,633,071
Ensembl chr10:91,628,442...91,633,071

G

protein phosphatase 1 regulatory subunit 3G

increases expression

ISO

epoxiconazole results in increased expression of PPP1R3G mRNA

NCBI chr 6:5,085,341...5,089,487
Ensembl chr 6:5,085,341...5,089,487

G

protein phosphatase 1 regulatory subunit 42

increases expression

ISO

epoxiconazole results in increased expression of PPP1R42 mRNA

PMID:22334560 PMID:23970803

NCBI chr 8:66,964,103...67,028,554
Ensembl chr 8:66,964,099...67,056,604

G

protein phosphatase 2 scaffold subunit Aalpha

decreases expression

ISO

epoxiconazole results in decreased expression of PPP2R1A mRNA

NCBI chr19:52,190,052...52,229,518
Ensembl chr19:52,170,936...52,229,518

G

protein phosphatase 2 scaffold subunit Abeta

increases expression

ISO

epoxiconazole results in increased expression of PPP2R1B mRNA

NCBI chr11:111,688,000...111,766,389
Ensembl chr11:111,726,908...111,766,658

G

protein phosphatase 2 regulatory subunit B''gamma

decreases expression

ISO

epoxiconazole results in decreased expression of PPP2R3C mRNA

NCBI chr14:35,085,472...35,122,298
Ensembl chr14:35,085,467...35,122,532

G

protein phosphatase 2 regulatory subunit B'delta

decreases expression

ISO

epoxiconazole results in decreased expression of PPP2R5D mRNA

NCBI chr 6:42,984,570...43,012,342
Ensembl chr 6:42,984,538...43,012,346

G

protein phosphatase 3 catalytic subunit alpha

decreases expression

ISO

epoxiconazole results in decreased expression of PPP3CA mRNA

NCBI chr 4:101,023,418...101,347,526
Ensembl chr 4:101,023,409...101,348,278

G

protein phosphatase 5 catalytic subunit

decreases expression

ISO

epoxiconazole results in decreased expression of PPP5C mRNA

NCBI chr19:46,347,087...46,390,975
Ensembl chr19:46,347,003...46,392,981

G

protein phosphatase targeting COQ7

decreases expression

ISO

epoxiconazole results in decreased expression of PPTC7 mRNA

NCBI chr12:110,533,245...110,583,318
Ensembl chr12:110,533,245...110,583,383

G

peptidylprolyl isomerase domain and WD repeat containing 1

increases expression

ISO

epoxiconazole results in increased expression of PPWD1 mRNA

NCBI chr 5:65,563,296...65,587,549
Ensembl chr 5:65,563,236...65,587,549

G

protease associated domain containing 1

decreases expression

ISO

epoxiconazole results in decreased expression of PRADC1 mRNA

NCBI chr 2:73,228,006...73,233,284
Ensembl chr 2:73,228,010...73,233,239

G

PEAK1 related, kinase-activating pseudokinase 1

increases expression

ISO

epoxiconazole results in increased expression of PRAG1 mRNA

NCBI chr 8:8,317,736...8,386,439
Ensembl chr 8:8,317,736...8,387,357

G

PRAME family member 4

increases expression

ISO

epoxiconazole results in increased expression of PRAMEL1 mRNA

NCBI chr 1:12,879,212...12,886,201
Ensembl chr 1:12,879,212...12,886,201

G

PR/SET domain 9

increases expression

ISO

epoxiconazole results in increased expression of PRDM9 mRNA

NCBI chr 5:23,507,155...23,528,093
Ensembl chr 5:23,443,586...23,528,093

G

prolactin regulatory element binding

decreases expression

ISO

epoxiconazole results in decreased expression of PREB mRNA

NCBI chr 2:27,130,756...27,134,636
Ensembl chr 2:27,130,752...27,134,671

G

PRELI domain containing 2

decreases expression

ISO

epoxiconazole results in decreased expression of PRELID2 mRNA

NCBI chr 5:145,228,985...145,835,342
Ensembl chr 5:145,471,799...145,835,369

G

proline and arginine rich end leucine rich repeat protein

affects expression

ISO

epoxiconazole affects the expression of PRELP mRNA

NCBI chr 1:203,475,806...203,491,352
Ensembl chr 1:203,475,777...203,491,352

G

prolyl endopeptidase like

decreases expression

ISO

epoxiconazole results in decreased expression of PREPL mRNA

NCBI chr 2:44,317,607...44,361,862
Ensembl chr 2:44,316,281...44,361,862

G

proteoglycan 4

increases expression
affects expression

ISO

epoxiconazole results in increased expression of PRG4 mRNA
epoxiconazole affects the expression of PRG4 mRNA

PMID:22334560 PMID:35436446

NCBI chr 1:186,296,273...186,314,567
Ensembl chr 1:186,296,270...186,314,567

G

proline rich membrane anchor 1

increases expression

ISO

epoxiconazole results in increased expression of PRIMA1 mRNA

NCBI chr14:93,718,298...93,788,994
Ensembl chr14:93,718,298...93,788,994

G

protein kinase AMP-activated catalytic subunit alpha 2

decreases expression

ISO

epoxiconazole results in decreased expression of PRKAA2 mRNA

NCBI chr 1:56,645,314...56,715,335
Ensembl chr 1:56,645,314...56,715,335

G

protein kinase cAMP-activated catalytic subunit alpha

decreases expression

ISO

epoxiconazole results in decreased expression of PRKACA mRNA

NCBI chr19:14,091,688...14,117,762
Ensembl chr19:14,091,688...14,118,084

G

protein kinase C eta

decreases expression

ISO

epoxiconazole results in decreased expression of PRKCH mRNA

NCBI chr14:61,187,468...61,550,976
Ensembl chr14:61,187,559...61,550,980

G

protein kinase C zeta

decreases expression

ISO

epoxiconazole results in decreased expression of PRKCZ mRNA

NCBI chr 1:2,048,504...2,185,395
Ensembl chr 1:2,050,411...2,185,395

G

parkin RBR E3 ubiquitin protein ligase

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of PRKN mRNA

NCBI chr 6:161,347,417...162,727,766
Ensembl chr 6:161,347,417...162,727,775

G

prolactin releasing hormone

increases expression

ISO

epoxiconazole results in increased expression of PRLH mRNA

NCBI chr 2:237,566,574...237,567,175
Ensembl chr 2:237,559,555...237,567,288

G

prolactin receptor

decreases expression

ISO

epoxiconazole results in decreased expression of PRLR mRNA

PMID:22334560 PMID:23970803

NCBI chr 5:35,048,756...35,230,487
Ensembl chr 5:35,048,756...35,230,533

G

protein arginine methyltransferase 5

decreases expression

ISO

epoxiconazole results in decreased expression of PRMT5 mRNA

NCBI chr14:22,920,529...22,929,376
Ensembl chr14:22,920,525...22,929,458

G

proline rich basic protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of PROB1 mRNA

NCBI chr 5:139,390,592...139,395,104
Ensembl chr 5:139,390,592...139,395,104

G

protein C, inactivator of coagulation factors Va and VIIIa

decreases expression

ISO

epoxiconazole results in decreased expression of PROC mRNA

NCBI chr 2:127,418,427...127,429,242
Ensembl chr 2:127,415,933...127,429,762

G

proline dehydrogenase 2

decreases expression

ISO

epoxiconazole results in decreased expression of PRODH2 mRNA

NCBI chr19:35,799,988...35,812,845
Ensembl chr19:35,799,975...35,813,299

G

prominin 1

increases expression

ISO

epoxiconazole results in increased expression of PROM1 mRNA

NCBI chr 4:15,968,228...16,084,023
Ensembl chr 4:15,963,076...16,084,378

G

protein S

increases expression

ISO

epoxiconazole results in increased expression of PROS1 mRNA

NCBI chr 3:93,873,051...93,973,896
Ensembl chr 3:93,873,046...93,980,003

G

prospero homeobox 1

increases expression

ISO

epoxiconazole results in increased expression of PROX1 mRNA

NCBI chr 1:213,983,151...214,041,510
Ensembl chr 1:213,982,711...214,041,510

G

protein Z, vitamin K dependent plasma glycoprotein

decreases expression

ISO

epoxiconazole results in decreased expression of PROZ mRNA

NCBI chr13:113,158,648...113,172,386
Ensembl chr13:113,158,622...113,172,387

G

pre-mRNA processing factor 19

increases expression

ISO

epoxiconazole results in increased expression of PRPF19 mRNA

NCBI chr11:60,890,547...60,906,585
Ensembl chr11:60,890,547...60,906,603

G

pre-mRNA splicing tri-snRNP complex factor PRPF4

decreases expression

ISO

epoxiconazole results in decreased expression of PRPF4 mRNA

NCBI chr 9:113,275,658...113,292,905
Ensembl chr 9:113,275,642...113,294,009

G

peripherin

increases expression

ISO

epoxiconazole results in increased expression of PRPH mRNA

NCBI chr12:49,295,147...49,298,686
Ensembl chr12:49,295,147...49,298,686

G

phosphoribosyl pyrophosphate synthetase associated protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of PRPSAP1 mRNA

NCBI chr17:76,309,478...76,354,198
Ensembl chr17:76,309,478...76,384,521

G

proline rich 13

increases expression

ISO

epoxiconazole results in increased expression of PRR13 mRNA

NCBI chr12:53,441,734...53,446,638
Ensembl chr12:53,441,308...53,446,660

G

proline rich 14

decreases expression

ISO

epoxiconazole results in decreased expression of PRR14 mRNA

NCBI chr16:30,650,778...30,656,413
Ensembl chr16:30,650,717...30,656,413

G

proline rich 14 like

decreases expression

ISO

epoxiconazole results in decreased expression of PRR14L mRNA

NCBI chr22:31,681,347...31,750,132
Ensembl chr22:31,676,256...31,750,207

G

proline rich 16

increases expression

ISO

epoxiconazole results in increased expression of PRR16 mRNA

NCBI chr 5:120,464,278...120,794,594
Ensembl chr 5:120,464,300...120,687,332

G

proline rich 29

increases expression

ISO

epoxiconazole results in increased expression of PRR29 mRNA

NCBI chr17:63,998,351...64,004,305
Ensembl chr17:63,998,351...64,004,305

G

proline rich coiled-coil 1

increases expression

ISO

epoxiconazole results in increased expression of PRRC1 mRNA

NCBI chr 5:127,517,640...127,555,085
Ensembl chr 5:127,517,617...127,555,085

G

proline rich coiled-coil 2B

decreases expression

ISO

epoxiconazole results in decreased expression of PRRC2B mRNA

NCBI chr 9:131,373,651...131,500,193
Ensembl chr 9:131,373,636...131,500,197

G

proline rich and Gla domain 4

increases expression

ISO

epoxiconazole results in increased expression of PRRG4 mRNA

NCBI chr11:32,829,789...32,858,120
Ensembl chr11:32,829,675...32,858,120

G

paired related homeobox 1

decreases expression

ISO

epoxiconazole results in decreased expression of PRRX1 mRNA

NCBI chr 1:170,662,768...170,739,421
Ensembl chr 1:170,662,728...170,739,421

G

serine protease 8

decreases expression

ISO

epoxiconazole results in decreased expression of PRSS8 mRNA

NCBI chr16:31,131,433...31,135,727
Ensembl chr16:31,131,433...31,135,727

G

proteinase 3

decreases expression

ISO

epoxiconazole results in decreased expression of PRTN3 mRNA

NCBI chr19:840,999...848,175
Ensembl chr19:840,999...848,175

G

peroxiredoxin like 2A

decreases expression

ISO

epoxiconazole results in decreased expression of PRXL2A mRNA

NCBI chr10:80,407,829...80,437,115
Ensembl chr10:80,406,443...80,437,115

G

prosaposin

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of PSAP mRNA
epoxiconazole results in decreased expression of PSAP mRNA

PMID:22334560 PMID:35436446

NCBI chr10:71,816,298...71,851,251
Ensembl chr10:71,816,289...71,851,330

G

presenilin 1

increases expression

ISO

epoxiconazole results in increased expression of PSEN1 mRNA

NCBI chr14:73,136,417...73,223,691
Ensembl chr14:73,136,418...73,223,691

G

presenilin 2

increases expression

ISO

epoxiconazole results in increased expression of PSEN2 mRNA

NCBI chr 1:226,870,616...226,903,668
Ensembl chr 1:226,870,184...226,927,726

G

PC4 and SRSF1 interacting protein 1

increases expression

ISO

epoxiconazole results in increased expression of PSIP1 mRNA

NCBI chr 9:15,464,066...15,510,970
Ensembl chr 9:15,464,065...15,511,202

G

proteasome 20S subunit alpha 3

increases expression

ISO

epoxiconazole results in increased expression of PSMA3 mRNA

NCBI chr14:58,244,843...58,272,004
Ensembl chr14:58,244,740...58,272,012

G

proteasome 20S subunit alpha 5

increases expression

ISO

epoxiconazole results in increased expression of PSMA5 mRNA

PMID:22334560 PMID:35436446

NCBI chr 1:109,399,042...109,426,448
Ensembl chr 1:109,399,042...109,426,471

G

proteasome 20S subunit alpha 6

increases expression

ISO

epoxiconazole results in increased expression of PSMA6 mRNA

NCBI chr14:35,278,558...35,317,493
Ensembl chr14:35,278,633...35,318,734

G

proteasome 20S subunit alpha 7

affects expression

ISO

epoxiconazole affects the expression of PSMA7 mRNA

NCBI chr20:62,136,733...62,143,394
Ensembl chr20:62,136,728...62,143,452

G

proteasome 20S subunit beta 1

increases expression

ISO

epoxiconazole results in increased expression of PSMB1 mRNA

NCBI chr 6:170,535,120...170,553,307
Ensembl chr 6:170,535,116...170,553,327

G

proteasome 20S subunit beta 10

decreases expression

ISO

epoxiconazole results in decreased expression of PSMB10 mRNA

NCBI chr16:67,934,506...67,936,850
Ensembl chr16:67,934,506...67,936,864

G

proteasome 20S subunit beta 2

increases expression

ISO

epoxiconazole results in increased expression of PSMB2 mRNA

NCBI chr 1:35,599,541...35,641,526
Ensembl chr 1:35,599,541...35,641,526

G

PSMC3 interacting protein

increases expression

ISO

epoxiconazole results in increased expression of PSMC3IP mRNA

NCBI chr17:42,572,310...42,577,831
Ensembl chr17:42,572,310...42,577,831

G

proteasome 26S subunit, non-ATPase 12

increases expression

ISO

epoxiconazole results in increased expression of PSMD12 mRNA

NCBI chr17:67,337,916...67,366,577
Ensembl chr17:67,337,916...67,366,605

G

proteasome activator subunit 2

decreases expression

ISO

epoxiconazole results in decreased expression of PSME2 mRNA

NCBI chr14:24,143,365...24,146,610
Ensembl chr14:24,143,362...24,147,570

G

proteasome inhibitor subunit 1

decreases expression

ISO

epoxiconazole results in decreased expression of PSMF1 mRNA

NCBI chr20:1,113,263...1,172,246
Ensembl chr20:1,113,240...1,189,415

G

proteasome assembly chaperone 4

decreases expression

ISO

epoxiconazole results in decreased expression of PSMG4 mRNA

NCBI chr 6:3,254,404...3,268,049
Ensembl chr 6:3,231,403...3,304,020

G

polypyrimidine tract binding protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of PTBP1 mRNA

NCBI chr19:797,452...812,312
Ensembl chr19:797,075...812,327

G

pre T cell antigen receptor alpha

increases expression

ISO

epoxiconazole results in increased expression of PTCRA mRNA

NCBI chr 6:42,916,053...42,925,838
Ensembl chr 6:42,915,989...42,925,838

G

phosphatidylserine synthase 2

decreases expression

ISO

epoxiconazole results in decreased expression of PTDSS2 mRNA

NCBI chr11:448,268...491,399
Ensembl chr11:448,268...491,399

G

prostaglandin D2 synthase

increases expression

ISO

epoxiconazole results in increased expression of PTGDS mRNA

NCBI chr 9:136,977,504...136,981,742
Ensembl chr 9:136,975,053...136,981,750

G

prostaglandin reductase 3

decreases expression

ISO

epoxiconazole results in decreased expression of PTGR3 mRNA

NCBI chr18:75,195,108...75,209,139
Ensembl chr18:75,195,113...75,209,139

G

parathyroid hormone

increases expression

ISO

epoxiconazole results in increased expression of PTH mRNA

NCBI chr11:13,492,054...13,496,181
Ensembl chr11:13,492,054...13,496,181

G

protein tyrosine kinase 2 beta

decreases expression

ISO

epoxiconazole results in decreased expression of PTK2B mRNA

NCBI chr 8:27,310,506...27,459,391
Ensembl chr 8:27,311,456...27,459,392

G

parathymosin

increases expression

ISO

epoxiconazole results in increased expression of PTMS mRNA

NCBI chr12:6,766,363...6,770,952
Ensembl chr12:6,765,516...6,770,952

G

protein tyrosine phosphatase non-receptor type 2

increases expression

ISO

epoxiconazole results in increased expression of PTPN2 mRNA

NCBI chr18:12,785,478...12,884,237
Ensembl chr18:12,785,478...12,929,643

G

protein tyrosine phosphatase receptor type F

decreases expression

ISO

epoxiconazole results in decreased expression of PTPRF mRNA

NCBI chr 1:43,522,051...43,623,666
Ensembl chr 1:43,525,086...43,626,579

G

PTTG1 interacting protein

decreases expression

ISO

epoxiconazole results in decreased expression of PTTG1IP mRNA

NCBI chr21:44,849,598...44,873,690
Ensembl chr21:44,849,585...44,873,903

G

pumilio RNA binding family member 1

increases expression

ISO

epoxiconazole results in increased expression of PUM1 mRNA

NCBI chr 1:30,931,506...31,065,717
Ensembl chr 1:30,931,505...31,065,991

G

purine rich element binding protein B

decreases expression

ISO

epoxiconazole results in decreased expression of PURB mRNA

NCBI chr 7:44,876,299...44,885,530
Ensembl chr 7:44,876,299...44,885,530

G

pseudouridine synthase 10

decreases expression

ISO

epoxiconazole results in decreased expression of PUS10 mRNA

NCBI chr 2:60,940,223...61,018,259
Ensembl chr 2:60,938,141...61,018,259

G

pseudouridine synthase 7

decreases expression

ISO

epoxiconazole results in decreased expression of PUS7 mRNA

NCBI chr 7:105,456,501...105,522,271
Ensembl chr 7:105,439,661...105,522,272

G

peroxisomal membrane protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of PXMP2 mRNA

NCBI chr12:132,687,587...132,704,985
Ensembl chr12:132,687,587...132,705,098

G

peroxisomal membrane protein 4

increases expression

ISO

epoxiconazole results in increased expression of PXMP4 mRNA

NCBI chr20:33,702,758...33,720,310
Ensembl chr20:33,702,758...33,720,319

G

pyridine nucleotide-disulphide oxidoreductase domain 2

decreases expression

ISO

epoxiconazole results in decreased expression of PYROXD2 mRNA

NCBI chr10:98,383,568...98,415,182
Ensembl chr10:98,383,565...98,415,210

G

PIGY upstream open reading frame

increases expression

ISO

epoxiconazole results in increased expression of PYURF mRNA

NCBI chr 4:88,520,998...88,523,776
Ensembl chr 4:88,520,998...88,523,776

G

glutaminyl-tRNA amidotransferase subunit QRSL1

increases expression

ISO

epoxiconazole results in increased expression of QRSL1 mRNA

NCBI chr 6:106,629,578...106,668,417
Ensembl chr 6:106,629,572...106,668,417

G

quiescin sulfhydryl oxidase 1

decreases expression

ISO

epoxiconazole results in decreased expression of QSOX1 mRNA

NCBI chr 1:180,154,869...180,204,030
Ensembl chr 1:180,154,869...180,204,030

G

quiescin sulfhydryl oxidase 2

decreases expression

ISO

epoxiconazole results in decreased expression of QSOX2 mRNA

NCBI chr 9:136,206,333...136,245,812
Ensembl chr 9:136,206,333...136,245,812

G

R3H domain containing 4

increases expression

ISO

epoxiconazole results in increased expression of R3HDM4 mRNA

NCBI chr19:896,503...913,219
Ensembl chr19:896,503...913,245

G

RAB11A, member RAS oncogene family

increases expression

ISO

epoxiconazole results in increased expression of RAB11A mRNA

NCBI chr15:65,869,491...65,891,989
Ensembl chr15:65,726,054...65,891,989

G

RAB11B, member RAS oncogene family

decreases expression

ISO

epoxiconazole results in decreased expression of RAB11B mRNA

NCBI chr19:8,390,360...8,404,434
Ensembl chr19:8,389,981...8,405,873

G

RAB24, member RAS oncogene family

decreases expression

ISO

epoxiconazole results in decreased expression of RAB24 mRNA

NCBI chr 5:177,301,198...177,303,719
Ensembl chr 5:177,301,198...177,303,744

G

RAB35, member RAS oncogene family

decreases expression

ISO

epoxiconazole results in decreased expression of RAB35 mRNA

NCBI chr12:120,095,099...120,116,753
Ensembl chr12:120,095,094...120,117,502

G

RAB3 GTPase activating protein catalytic subunit 1

decreases expression

ISO

epoxiconazole results in decreased expression of RAB3GAP1 mRNA

NCBI chr 2:135,052,292...135,176,396
Ensembl chr 2:135,052,283...135,176,667

G

RAB43, member RAS oncogene family

decreases expression

ISO

epoxiconazole results in decreased expression of RAB43 mRNA

NCBI chr 3:129,087,569...129,122,150
Ensembl chr 3:129,087,569...129,123,694

G

RAB4A, member RAS oncogene family

decreases expression

ISO

epoxiconazole results in decreased expression of RAB4A mRNA

NCBI chr 1:229,271,111...229,305,894
Ensembl chr 1:229,271,062...229,305,894

G

RAB5C, member RAS oncogene family

decreases expression

ISO

epoxiconazole results in decreased expression of RAB5C mRNA

NCBI chr17:42,124,979...42,154,989
Ensembl chr17:42,124,976...42,155,044

G

RAB8A, member RAS oncogene family

decreases expression

ISO

epoxiconazole results in decreased expression of RAB8A mRNA

NCBI chr19:16,111,889...16,134,234
Ensembl chr19:16,111,843...16,134,234

G

RAB8B, member RAS oncogene family

increases expression

ISO

epoxiconazole results in increased expression of RAB8B mRNA

NCBI chr15:63,189,606...63,267,776
Ensembl chr15:63,189,560...63,267,776

G

Rac family small GTPase 2

increases expression

ISO

epoxiconazole results in increased expression of RAC2 mRNA

NCBI chr22:37,225,270...37,244,269
Ensembl chr22:37,225,270...37,259,594

G

RAD51 recombinase

increases expression

ISO

epoxiconazole results in increased expression of RAD51 mRNA

NCBI chr15:40,694,733...40,732,340
Ensembl chr15:40,694,774...40,732,344

G

RAD54 like

increases expression

ISO

epoxiconazole results in increased expression of RAD54L mRNA

NCBI chr 1:46,247,688...46,278,473
Ensembl chr 1:46,246,461...46,278,482

G

RAD54 like 2

decreases expression

ISO

epoxiconazole results in decreased expression of RAD54L2 mRNA

NCBI chr 3:51,538,719...51,668,660
Ensembl chr 3:51,538,666...51,668,667

G

RAD9 checkpoint clamp component B

decreases expression

ISO

epoxiconazole results in decreased expression of RAD9B mRNA

NCBI chr12:110,502,331...110,533,556
Ensembl chr12:110,501,655...110,533,556

G

retinoic acid induced 14

increases expression

ISO

epoxiconazole results in increased expression of RAI14 mRNA

NCBI chr 5:34,656,328...34,832,612
Ensembl chr 5:34,656,328...34,832,612

G

Ral GTPase activating protein catalytic subunit alpha 1

decreases expression

ISO

epoxiconazole results in decreased expression of RALGAPA1 mRNA

NCBI chr14:35,538,356...35,809,295
Ensembl chr14:35,538,352...35,809,304

G

Ral GTPase activating protein catalytic subunit alpha 2

decreases expression

ISO

epoxiconazole results in decreased expression of RALGAPA2 mRNA

NCBI chr20:20,389,530...20,712,644
Ensembl chr20:20,389,530...20,712,644

G

Ral GEF with PH domain and SH3 binding motif 1

affects expression

ISO

epoxiconazole affects the expression of RALGPS1 mRNA

NCBI chr 9:126,914,782...127,223,166
Ensembl chr 9:126,914,774...127,223,166

G

RNA guanine-7 methyltransferase activating subunit

increases expression

ISO

epoxiconazole results in increased expression of RAMAC mRNA

NCBI chr15:82,986,210...82,991,057
Ensembl chr15:82,986,203...82,991,057

G

RAN binding protein 1

increases expression

ISO

epoxiconazole results in increased expression of RANBP1 mRNA

NCBI chr22:20,116,104...20,127,355
Ensembl chr22:20,115,877...20,127,355

G

RAN binding protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of RANBP2 mRNA

NCBI chr 2:108,719,482...109,842,301
Ensembl chr 2:108,719,437...108,785,810

G

RAN binding protein 3 like

affects expression

ISO

epoxiconazole affects the expression of RANBP3L mRNA

NCBI chr 5:36,246,913...36,301,902
Ensembl chr 5:36,246,913...36,302,114

G

RAP1A, member of RAS oncogene family

increases expression

ISO

epoxiconazole results in increased expression of RAP1A mRNA

NCBI chr 1:111,542,009...111,716,691
Ensembl chr 1:111,542,218...111,716,691

G

RAP2A, member of RAS oncogene family

increases expression

ISO

epoxiconazole results in increased expression of RAP2A mRNA

NCBI chr13:97,434,169...97,469,128
Ensembl chr13:97,434,169...97,469,128

G

Rap guanine nucleotide exchange factor 3

increases expression

ISO

epoxiconazole results in increased expression of RAPGEF3 mRNA

NCBI chr12:47,734,363...47,758,880
Ensembl chr12:47,734,363...47,771,040

G

Rap guanine nucleotide exchange factor 4

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of RAPGEF4 mRNA
epoxiconazole results in decreased expression of RAPGEF4 mRNA

PMID:22334560 PMID:35436446

NCBI chr 2:172,735,318...173,052,893
Ensembl chr 2:172,735,274...173,052,893

G

Rap guanine nucleotide exchange factor like 1

increases expression

ISO

epoxiconazole results in increased expression of RAPGEFL1 mRNA

NCBI chr17:40,177,010...40,195,650
Ensembl chr17:40,177,010...40,195,656

G

retinoic acid receptor responder 1

affects expression

ISO

epoxiconazole affects the expression of RARRES1 mRNA

NCBI chr 3:158,696,892...158,732,457
Ensembl chr 3:158,696,892...158,732,798

G

retinoic acid receptor responder 2

increases expression

ISO

epoxiconazole results in increased expression of RARRES2 mRNA

NCBI chr 7:150,338,329...150,341,629
Ensembl chr 7:150,338,314...150,342,144

G

RAS p21 protein activator 1

increases expression

ISO

epoxiconazole results in increased expression of RASA1 mRNA

NCBI chr 5:87,267,883...87,391,916
Ensembl chr 5:87,267,778...87,391,939

G

RAS protein activator like 2

decreases expression

ISO

epoxiconazole results in decreased expression of RASAL2 mRNA

NCBI chr 1:178,094,104...178,478,850
Ensembl chr 1:178,093,768...178,484,147

G

RAS protein activator like 3

increases expression

ISO

epoxiconazole results in increased expression of RASAL3 mRNA

NCBI chr19:15,451,624...15,464,544
Ensembl chr19:15,451,624...15,464,583

G

RAS and EF-hand domain containing

decreases expression

ISO

epoxiconazole results in decreased expression of RASEF mRNA

NCBI chr 9:82,979,590...83,219,224
Ensembl chr 9:82,979,590...83,063,255

G

RasGEF domain family member 1B

decreases expression

ISO

epoxiconazole results in decreased expression of RASGEF1B mRNA

NCBI chr 4:81,426,393...81,471,907
Ensembl chr 4:81,426,393...82,044,244

G

RB binding protein 8, endonuclease

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of RBBP8 mRNA
epoxiconazole results in decreased expression of RBBP8 mRNA

PMID:22334560 PMID:35436446

NCBI chr18:22,914,139...23,026,486
Ensembl chr18:22,798,261...23,026,488

G

RB binding protein 9, serine hydrolase

decreases expression

ISO

epoxiconazole results in decreased expression of RBBP9 mRNA

NCBI chr20:18,486,540...18,497,225
Ensembl chr20:18,486,540...18,497,234

G

RANBP2-type and C3HC4-type zinc finger containing 1

decreases expression

ISO

epoxiconazole results in decreased expression of RBCK1 mRNA

NCBI chr20:408,299...432,139
Ensembl chr20:407,498...432,139

G

ribosomal biogenesis factor

increases expression

ISO

epoxiconazole results in increased expression of RBIS mRNA

NCBI chr 8:85,214,048...85,220,374
Ensembl chr 8:85,214,048...85,220,793

G

RNA binding motif protein 18

affects expression

ISO

epoxiconazole affects the expression of RBM18 mRNA

NCBI chr 9:122,237,622...122,264,840
Ensembl chr 9:122,237,622...122,264,855

G

RNA binding motif protein 20

increases expression

ISO

epoxiconazole results in increased expression of RBM20 mRNA

NCBI chr10:110,643,245...110,839,468
Ensembl chr10:110,643,948...110,839,471

G

RNA binding motif protein 25

decreases expression

ISO

epoxiconazole results in decreased expression of RBM25 mRNA

NCBI chr14:73,058,534...73,123,899
Ensembl chr14:73,058,532...73,123,899

G

RNA binding motif protein 3

decreases expression

ISO

epoxiconazole results in decreased expression of RBM3 mRNA

NCBI chr X:48,574,484...48,581,162
Ensembl chr X:48,574,056...48,581,162

G

RNA binding motif protein 4

decreases expression

ISO

epoxiconazole results in decreased expression of RBM4 mRNA

NCBI chr11:66,638,703...66,668,380
Ensembl chr11:66,638,658...66,668,380

G

RNA binding motif protein 47

decreases expression

ISO

epoxiconazole results in decreased expression of RBM47 mRNA

NCBI chr 4:40,423,280...40,630,852
Ensembl chr 4:40,423,267...40,630,892

G

retinol binding protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of RBP1 mRNA

NCBI chr 3:139,517,438...139,539,742
Ensembl chr 3:139,517,434...139,539,829

G

RNA binding protein, mRNA processing factor

increases expression

ISO

epoxiconazole results in increased expression of RBPMS mRNA

NCBI chr 8:30,384,541...30,572,256
Ensembl chr 8:30,384,416...30,572,256

G

ring finger and CCCH-type domains 1

decreases expression

ISO

epoxiconazole results in decreased expression of RC3H1 mRNA

NCBI chr 1:173,931,084...174,022,357
Ensembl chr 1:173,931,084...174,022,357

G

regulator of calcineurin 1

decreases expression

ISO

epoxiconazole results in decreased expression of RCAN1 mRNA

NCBI chr21:34,516,442...34,615,113
Ensembl chr21:34,513,142...34,615,113

G

reticulocalbin 2

increases expression

ISO

epoxiconazole results in increased expression of RCN2 mRNA

NCBI chr15:76,931,749...76,954,393
Ensembl chr15:76,931,738...76,954,393

G

REST corepressor 3

increases expression

ISO

epoxiconazole results in increased expression of RCOR3 mRNA

NCBI chr 1:211,259,366...211,316,385
Ensembl chr 1:211,258,377...211,316,385

G

retinol dehydrogenase 11

decreases expression

ISO

epoxiconazole results in decreased expression of RDH11 mRNA

NCBI chr14:67,676,800...67,695,764
Ensembl chr14:67,676,800...67,695,793

G

REC8 meiotic recombination protein

increases expression

ISO

epoxiconazole results in increased expression of REC8 mRNA

NCBI chr14:24,172,080...24,180,923
Ensembl chr14:24,171,853...24,180,923

G

receptor accessory protein 1

increases expression

ISO

epoxiconazole results in increased expression of REEP1 mRNA

NCBI chr 2:86,213,993...86,338,083
Ensembl chr 2:86,213,993...86,338,083

G

receptor accessory protein 4

increases expression

ISO

epoxiconazole results in increased expression of REEP4 mRNA

NCBI chr 8:22,138,020...22,141,907
Ensembl chr 8:22,138,019...22,141,951

G

regenerating family member 3 alpha

increases expression

ISO

epoxiconazole results in increased expression of REG3A mRNA

NCBI chr 2:79,157,006...79,159,753
Ensembl chr 2:79,157,003...79,159,753

G

reelin

multiple interactions
decreases expression

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of RELN mRNA
epoxiconazole results in decreased expression of RELN mRNA

PMID:25607892 PMID:35436446

NCBI chr 7:103,471,789...103,989,658
Ensembl chr 7:103,471,381...103,989,658

G

retroelement silencing factor 1

decreases expression

ISO

epoxiconazole results in decreased expression of RESF1 mRNA

NCBI chr12:31,959,415...31,993,107
Ensembl chr12:31,959,370...31,993,114

G

reticulophagy regulator family member 3

decreases expression

ISO

epoxiconazole results in decreased expression of RETREG3 mRNA

NCBI chr17:42,579,508...42,609,427
Ensembl chr17:42,579,513...42,610,623

G

replication factor C subunit 2

increases expression

ISO

epoxiconazole results in increased expression of RFC2 mRNA

NCBI chr 7:74,231,502...74,254,399
Ensembl chr 7:74,223,231...74,254,458

G

Rieske Fe-S domain containing

increases expression

ISO

epoxiconazole results in increased expression of RFESD mRNA

NCBI chr 5:95,646,777...95,658,082
Ensembl chr 5:95,646,718...95,684,773

G

riboflavin kinase

increases expression

ISO

epoxiconazole results in increased expression of RFK mRNA

NCBI chr 9:76,385,526...76,394,426
Ensembl chr 9:76,385,526...76,394,517

G

refilin B

increases expression

ISO

epoxiconazole results in increased expression of RFLNB mRNA

NCBI chr17:439,978...445,940
Ensembl chr17:439,978...445,939

G

regulatory factor X3

decreases expression

ISO

epoxiconazole results in decreased expression of RFX3 mRNA

NCBI chr 9:3,218,297...3,526,001
Ensembl chr 9:3,218,297...3,526,022

G

regulatory factor X4

affects expression

ISO

epoxiconazole affects the expression of RFX4 mRNA

NCBI chr12:106,583,004...106,762,803
Ensembl chr12:106,582,691...106,762,803

G

regulatory factor X5

affects expression

ISO

epoxiconazole affects the expression of RFX5 mRNA

NCBI chr 1:151,340,640...151,347,252
Ensembl chr 1:151,340,640...151,347,339

G

regulatory factor X6

increases expression

ISO

epoxiconazole results in increased expression of RFX6 mRNA

NCBI chr 6:116,877,242...116,932,161
Ensembl chr 6:116,877,212...116,932,161

G

repulsive guidance molecule BMP co-receptor a

decreases expression

ISO

epoxiconazole results in decreased expression of RGMA mRNA

NCBI chr15:93,035,271...93,089,211
Ensembl chr15:93,035,271...93,089,211

G

regucalcin

decreases expression

ISO

epoxiconazole results in decreased expression of RGN mRNA

NCBI chr X:47,078,443...47,093,313
Ensembl chr X:47,078,190...47,094,419

G

RGP1 homolog, RAB6A GEF complex partner 1

decreases expression

ISO

epoxiconazole results in decreased expression of RGP1 mRNA

NCBI chr 9:35,749,287...35,790,428
Ensembl chr 9:35,748,613...35,758,600

G

regulator of G protein signaling 1

decreases expression

ISO

epoxiconazole results in decreased expression of RGS1 mRNA

NCBI chr 1:192,575,773...192,580,024
Ensembl chr 1:192,575,763...192,580,024

G

regulator of G protein signaling 13

increases expression

ISO

epoxiconazole results in increased expression of RGS13 mRNA

NCBI chr 1:192,636,147...192,660,311
Ensembl chr 1:192,636,061...192,660,311

G

regulator of G protein signaling 16

affects expression

ISO

epoxiconazole affects the expression of RGS16 mRNA

NCBI chr 1:182,598,623...182,604,389
Ensembl chr 1:182,598,623...182,604,394

G

regulator of G protein signaling 3

decreases expression

ISO

epoxiconazole results in decreased expression of RGS3 mRNA

NCBI chr 9:113,444,730...113,597,738
Ensembl chr 9:113,444,731...113,597,743

G

rhomboid domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of RHBDD1 mRNA

NCBI chr 2:226,800,159...226,999,210
Ensembl chr 2:226,835,581...226,999,215

G

Rho related BTB domain containing 1

affects expression

ISO

epoxiconazole affects the expression of RHOBTB1 mRNA

NCBI chr10:60,860,860...61,001,967
Ensembl chr10:60,869,438...61,001,441

G

ras homolog family member D

increases expression

ISO

epoxiconazole results in increased expression of RHOD mRNA

NCBI chr11:67,056,847...67,072,017
Ensembl chr11:67,056,839...67,072,019

G

ras homolog family member T2

decreases expression

ISO

epoxiconazole results in decreased expression of RHOT2 mRNA

NCBI chr16:668,083...674,174
Ensembl chr16:668,100...674,174

G

ras homolog family member U

decreases expression

ISO

epoxiconazole results in decreased expression of RHOU mRNA

NCBI chr 1:228,644,647...228,746,669
Ensembl chr 1:228,735,479...228,746,664

G

Rhox homeobox family member 1

increases expression

ISO

epoxiconazole results in increased expression of RHOX13 mRNA

NCBI chr X:120,109,051...120,120,438
Ensembl chr X:120,109,050...120,245,267

G

Rab interacting lysosomal protein

decreases expression

ISO

epoxiconazole results in decreased expression of RILP mRNA

NCBI chr17:1,646,150...1,649,866
Ensembl chr17:1,646,143...1,650,077

G

RIO kinase 2

decreases expression

ISO

epoxiconazole results in decreased expression of RIOK2 mRNA

NCBI chr 5:97,160,867...97,183,247
Ensembl chr 5:97,160,867...97,183,289

G

ripply transcriptional repressor 1

increases expression

ISO

epoxiconazole results in increased expression of RIPPLY1 mRNA

NCBI chr X:106,900,063...106,903,341
Ensembl chr X:106,900,063...106,903,341

G

regulator of microtubule dynamics 3

decreases expression

ISO

epoxiconazole results in decreased expression of RMDN3 mRNA

NCBI chr15:40,735,887...40,755,254
Ensembl chr15:40,733,696...40,755,851

G

RNA component of mitochondrial RNA processing endoribonuclease

increases expression

ISO

epoxiconazole results in increased expression of RMRP mRNA

NCBI chr 9:35,657,750...35,658,019
Ensembl chr 9:35,657,750...35,658,019

G

ribonuclease H2 subunit B

affects expression

ISO

epoxiconazole affects the expression of RNASEH2B mRNA

NCBI chr13:50,909,678...50,970,460
Ensembl chr13:50,909,747...51,024,120

G

Rho family GTPase 1

increases expression

ISO

epoxiconazole results in increased expression of RND1 mRNA

NCBI chr12:48,857,145...48,865,870
Ensembl chr12:48,857,145...48,865,870

G

Rho family GTPase 3

decreases expression

ISO

epoxiconazole results in decreased expression of RND3 mRNA

NCBI chr 2:150,468,193...150,487,695
Ensembl chr 2:150,468,195...150,539,011

G

ring finger protein 10

decreases expression

ISO

epoxiconazole results in decreased expression of RNF10 mRNA

NCBI chr12:120,534,356...120,577,588
Ensembl chr12:120,533,480...120,577,588

G

ring finger protein 121

increases expression

ISO

epoxiconazole results in increased expression of RNF121 mRNA

NCBI chr11:71,929,046...71,997,597
Ensembl chr11:71,929,018...71,997,597

G

ring finger protein 123

decreases expression

ISO

epoxiconazole results in decreased expression of RNF123 mRNA

NCBI chr 3:49,689,557...49,721,529
Ensembl chr 3:49,688,740...49,721,532

G

ring finger protein 125

increases expression

ISO

epoxiconazole results in increased expression of RNF125 mRNA

NCBI chr18:32,018,825...32,090,806
Ensembl chr18:32,018,174...32,088,144

G

ring finger protein 135

increases expression

ISO

epoxiconazole results in increased expression of RNF135 mRNA

NCBI chr17:30,958,921...30,999,911
Ensembl chr17:30,970,984...30,999,911

G

ring finger protein 144B

decreases expression

ISO

epoxiconazole results in decreased expression of RNF144B mRNA

NCBI chr 6:18,387,350...18,468,870
Ensembl chr 6:18,387,346...18,468,874

G

ring finger protein 145

decreases expression

ISO

epoxiconazole results in decreased expression of RNF145 mRNA

NCBI chr 5:159,157,409...159,210,053
Ensembl chr 5:159,157,409...159,210,053

G

ring finger protein 152

increases expression

ISO

epoxiconazole results in increased expression of RNF152 mRNA

NCBI chr18:61,808,067...61,894,412
Ensembl chr18:61,808,067...61,895,097

G

ring finger protein 167

decreases expression

ISO

epoxiconazole results in decreased expression of RNF167 mRNA

NCBI chr17:4,940,092...4,945,222
Ensembl chr17:4,939,997...4,945,222

G

ring finger protein 169

decreases expression

ISO

epoxiconazole results in decreased expression of RNF169 mRNA

NCBI chr11:74,748,849...74,842,413
Ensembl chr11:74,748,849...74,842,413

G

ring finger protein 19B

decreases expression

ISO

epoxiconazole results in decreased expression of RNF19B mRNA

NCBI chr 1:32,929,036...32,964,809
Ensembl chr 1:32,929,036...32,964,915

G

ring finger protein 2

increases expression

ISO

epoxiconazole results in increased expression of RNF2 mRNA

NCBI chr 1:185,045,558...185,102,603
Ensembl chr 1:185,044,865...185,102,603

G

ring finger protein 208

increases expression

ISO

epoxiconazole results in increased expression of RNF208 mRNA

NCBI chr 9:137,220,259...137,223,408
Ensembl chr 9:137,220,246...137,222,290

G

ring finger protein 212

decreases expression

ISO

epoxiconazole results in decreased expression of RNF212 mRNA

NCBI chr 4:1,056,251...1,113,710
Ensembl chr 4:1,056,250...1,113,564

G

ring finger protein 217

increases expression

ISO

epoxiconazole results in increased expression of RNF217 mRNA

NCBI chr 6:124,962,437...125,092,634
Ensembl chr 6:124,962,437...125,092,633

G

ring finger protein 24

decreases expression

ISO

epoxiconazole results in decreased expression of RNF24 mRNA

NCBI chr20:3,927,311...4,015,558
Ensembl chr20:3,927,309...4,015,591

G

ring finger protein 26

decreases expression

ISO

epoxiconazole results in decreased expression of RNF26 mRNA

NCBI chr11:119,334,527...119,337,309
Ensembl chr11:119,334,527...119,337,309

G

ring finger protein 34

decreases expression

ISO

epoxiconazole results in decreased expression of RNF34 mRNA

NCBI chr12:121,400,118...121,424,348
Ensembl chr12:121,400,078...121,430,623

G

ring finger protein 38

affects expression

ISO

epoxiconazole affects the expression of RNF38 mRNA

NCBI chr 9:36,336,400...36,487,669
Ensembl chr 9:36,336,396...36,487,548

G

ring finger protein 39

decreases expression

ISO

epoxiconazole results in decreased expression of RNF39 mRNA

NCBI chr 6:30,070,270...30,075,769
Ensembl chr 6:30,070,266...30,075,849

G

ring finger protein 4

decreases expression

ISO

epoxiconazole results in decreased expression of RNF4 mRNA

NCBI chr 4:2,469,106...2,515,857
Ensembl chr 4:2,462,220...2,515,859

G

ring finger protein 40

decreases expression

ISO

epoxiconazole results in decreased expression of RNF40 mRNA

NCBI chr16:30,761,612...30,776,307
Ensembl chr16:30,761,745...30,776,307

G

ring finger protein 41

decreases expression

ISO

epoxiconazole results in decreased expression of RNF41 mRNA

NCBI chr12:56,202,179...56,221,969
Ensembl chr12:56,202,179...56,224,275

G

ring finger protein 7

increases expression

ISO

epoxiconazole results in increased expression of RNF7 mRNA

NCBI chr 3:141,738,298...141,747,560
Ensembl chr 3:141,738,249...141,747,560

G

ring finger protein, transmembrane 2

affects expression

ISO

epoxiconazole affects the expression of RNFT2 mRNA

NCBI chr12:116,738,315...116,853,631
Ensembl chr12:116,738,178...116,853,631

G

arginyl aminopeptidase like 1

decreases expression

ISO

epoxiconazole results in decreased expression of RNPEPL1 mRNA

NCBI chr 2:240,568,484...240,581,372
Ensembl chr 2:240,565,804...240,581,372

G

roundabout guidance receptor 1

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ROBO1 mRNA

NCBI chr 3:78,597,239...79,767,998
Ensembl chr 3:78,597,239...79,767,998

G

roundabout guidance receptor 4

increases expression

ISO

epoxiconazole results in increased expression of ROBO4 mRNA

NCBI chr11:124,883,691...124,897,865
Ensembl chr11:124,883,666...124,898,500

G

Rho associated coiled-coil containing protein kinase 2

decreases expression

ISO

epoxiconazole results in decreased expression of ROCK2 mRNA

NCBI chr 2:11,179,759...11,345,437
Ensembl chr 2:11,179,759...11,348,330

G

rogdi atypical leucine zipper

affects expression

ISO

epoxiconazole affects the expression of ROGDI mRNA

NCBI chr16:4,796,968...4,802,633
Ensembl chr16:4,796,962...4,802,926

G

reactive oxygen species modulator 1

increases expression

ISO

epoxiconazole results in increased expression of ROMO1 mRNA

NCBI chr20:35,699,405...35,700,980
Ensembl chr20:35,699,254...35,700,984

G

rhophilin associated tail protein 1 like

increases expression

ISO

epoxiconazole results in increased expression of ROPN1L mRNA

NCBI chr 5:10,441,879...10,482,807
Ensembl chr 5:10,441,524...10,559,716

G

receptor tyrosine kinase like orphan receptor 1

decreases expression

ISO

epoxiconazole results in decreased expression of ROR1 mRNA

NCBI chr 1:63,774,017...64,181,498
Ensembl chr 1:63,774,017...64,181,498

G

RAR related orphan receptor A

increases expression

ISO

epoxiconazole results in increased expression of RORA mRNA

NCBI chr15:60,488,284...61,229,302
Ensembl chr15:60,488,284...61,229,302

G

RAR related orphan receptor C

affects expression

ISO

epoxiconazole affects the expression of RORC mRNA

NCBI chr 1:151,806,071...151,831,802
Ensembl chr 1:151,806,071...151,831,845

G

replication protein A3

increases expression

ISO

epoxiconazole results in increased expression of RPA3 mRNA

NCBI chr 7:7,636,518...7,718,607
Ensembl chr 7:7,634,843...7,718,607

G

ribosomal protein L18

decreases expression

ISO

epoxiconazole results in decreased expression of RPL18 mRNA

NCBI chr19:48,615,331...48,619,178
Ensembl chr19:48,615,284...48,619,213

G

ribosomal protein L22

increases expression

ISO

epoxiconazole results in increased expression of RPL22 mRNA

NCBI chr 1:6,185,020...6,199,595
Ensembl chr 1:6,185,020...6,209,389

G

ribosomal protein L22 like 1

increases expression

ISO

epoxiconazole results in increased expression of RPL22L1 mRNA

NCBI chr 3:170,864,875...170,870,195
Ensembl chr 3:170,864,875...170,870,402

G

ribosomal protein L27

increases expression

ISO

epoxiconazole results in increased expression of RPL27 mRNA

NCBI chr17:42,998,273...43,002,959
Ensembl chr17:42,998,273...43,002,973

G

ribosomal protein L3

increases expression

ISO

epoxiconazole results in increased expression of RPL3 mRNA

NCBI chr22:39,312,882...39,319,623
Ensembl chr22:39,312,870...39,320,389

G

ribosomal protein L31

increases expression

ISO

epoxiconazole results in increased expression of RPL31 mRNA

NCBI chr 2:101,002,289...101,019,724
Ensembl chr 2:101,002,229...101,024,032

G

ribosomal protein L32

increases expression

ISO

epoxiconazole results in increased expression of RPL32 mRNA

NCBI chr 3:12,834,485...12,841,582
Ensembl chr 3:12,834,485...12,841,582

G

ribosomal protein L35

increases expression

ISO

epoxiconazole results in increased expression of RPL35 mRNA

NCBI chr 9:124,857,883...124,861,957
Ensembl chr 9:124,857,873...124,862,017

G

ribosomal protein L36

decreases expression

ISO

epoxiconazole results in decreased expression of RPL36 mRNA

NCBI chr19:5,690,295...5,691,875
Ensembl chr19:5,674,947...5,691,881

G

ribosomal protein L37

increases expression

ISO

epoxiconazole results in increased expression of RPL37 mRNA

NCBI chr 5:40,825,262...40,835,222
Ensembl chr 5:40,825,262...40,835,269

G

ribosomal protein L37a

increases expression

ISO

epoxiconazole results in increased expression of RPL37A mRNA

NCBI chr 2:216,498,844...216,504,086
Ensembl chr 2:216,498,797...216,579,180

G

ribosomal protein L38

increases expression

ISO

epoxiconazole results in increased expression of RPL38 mRNA

NCBI chr17:74,203,678...74,210,655
Ensembl chr17:74,202,841...74,210,655

G

ribosomal protein L39

affects expression

ISO

epoxiconazole affects the expression of RPL39 mRNA

NCBI chr X:119,786,504...119,791,630
Ensembl chr X:119,786,497...119,791,662

G

ribosomal protein L7

increases expression

ISO

epoxiconazole results in increased expression of RPL7 mRNA

NCBI chr 8:73,290,242...73,294,466
Ensembl chr 8:73,290,242...73,295,789

G

ribosomal protein lateral stalk subunit P0

decreases expression

ISO

epoxiconazole results in decreased expression of RPLP0 mRNA

NCBI chr12:120,196,699...120,201,111
Ensembl chr12:120,196,699...120,201,235

G

ribonuclease P/MRP subunit p14

decreases expression

ISO

epoxiconazole results in decreased expression of RPP14 mRNA

NCBI chr 3:58,306,245...58,320,193
Ensembl chr 3:58,306,245...58,324,695

G

ribonuclease P/MRP subunit p21

increases expression

ISO

epoxiconazole results in increased expression of RPP21 mRNA

NCBI chr 6:30,345,156...30,346,857
Ensembl chr 6:30,345,125...30,346,884

G

ribonuclease P/MRP subunit p30

increases expression

ISO

epoxiconazole results in increased expression of RPP30 mRNA

NCBI chr10:90,871,974...90,908,556
Ensembl chr10:90,871,487...90,908,553

G

ribosomal protein S15

increases expression

ISO

epoxiconazole results in increased expression of RPS15 mRNA

NCBI chr19:1,438,396...1,440,495
Ensembl chr19:1,438,354...1,440,497

G

ribosomal protein S15a

increases expression

ISO

epoxiconazole results in increased expression of RPS15A mRNA

NCBI chr16:18,781,295...18,790,334
Ensembl chr16:18,781,295...18,790,383

G

ribosomal protein S17

increases expression

ISO

epoxiconazole results in increased expression of RPS17 mRNA

NCBI chr15:82,536,750...82,540,457
Ensembl chr15:82,536,748...82,540,535

G

ribosomal protein S20

increases expression

ISO

epoxiconazole results in increased expression of RPS20 mRNA

NCBI chr 8:56,067,254...56,074,506
Ensembl chr 8:56,067,254...56,074,510

G

ribosomal protein S21

affects expression

ISO

epoxiconazole affects the expression of RPS21 mRNA

NCBI chr20:62,387,103...62,388,520
Ensembl chr20:62,385,948...62,388,534

G

ribosomal protein S24

increases expression

ISO

epoxiconazole results in increased expression of RPS24 mRNA

NCBI chr10:78,033,863...78,056,806
Ensembl chr10:78,033,746...78,056,813

G

ribosomal protein S25

increases expression

ISO

epoxiconazole results in increased expression of RPS25 mRNA

NCBI chr11:119,015,717...119,018,343
Ensembl chr11:119,015,508...119,018,724

G

ribosomal protein S26

affects expression

ISO

epoxiconazole affects the expression of RPS26 mRNA

NCBI chr12:56,041,918...56,044,697
Ensembl chr12:56,041,351...56,044,697

G

ribosomal protein S27a

increases expression

ISO

epoxiconazole results in increased expression of RPS27A mRNA

NCBI chr 2:55,231,903...55,235,853
Ensembl chr 2:55,229,447...55,236,044

G

ribosomal protein S27 like

increases expression

ISO

epoxiconazole results in increased expression of RPS27L mRNA

NCBI chr15:63,148,249...63,157,477
Ensembl chr15:63,125,872...63,158,021

G

ribosomal protein S28

increases expression

ISO

epoxiconazole results in increased expression of RPS28 mRNA

NCBI chr19:8,321,496...8,323,340
Ensembl chr19:8,320,900...8,323,567

G

ribosomal protein S29

increases expression

ISO

epoxiconazole results in increased expression of RPS29 mRNA

NCBI chr14:49,570,988...49,598,710
Ensembl chr14:49,570,984...49,599,164

G

ribosomal protein S3A

increases expression

ISO

epoxiconazole results in increased expression of RPS3A1 mRNA

NCBI chr 4:151,099,628...151,104,642
Ensembl chr 4:151,099,565...151,104,652

G

ribosomal protein S4 X-linked

increases expression

ISO

epoxiconazole results in increased expression of RPS4X mRNA

NCBI chr X:72,272,042...72,277,248
Ensembl chr X:72,255,679...72,277,312

G

ribosomal protein S6 kinase A1

decreases expression

ISO

epoxiconazole results in decreased expression of RPS6KA1 mRNA

NCBI chr 1:26,529,761...26,575,025
Ensembl chr 1:26,529,756...26,575,030

G

ribosomal protein S7

increases expression

ISO

epoxiconazole results in increased expression of RPS7 mRNA

NCBI chr 2:3,575,260...3,580,920
Ensembl chr 2:3,575,198...3,580,952

G

ribosomal protein S9

affects expression

ISO

epoxiconazole affects the expression of RPS9 mRNA

NCBI chr19:54,200,858...54,207,647
Ensembl chr19:54,200,484...54,249,003

G

regulatory associated protein of MTOR complex 1

decreases expression

ISO

epoxiconazole results in decreased expression of RPTOR mRNA

NCBI chr17:80,544,838...80,966,368
Ensembl chr17:80,544,819...80,966,371

G

RAS related

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of RRAS mRNA
epoxiconazole results in decreased expression of RRAS mRNA

PMID:22334560 PMID:35436446

NCBI chr19:49,635,292...49,640,143
Ensembl chr19:49,635,292...49,640,143

G

ras responsive element binding protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of RREB1 mRNA

NCBI chr 6:7,107,743...7,251,980
Ensembl chr 6:7,107,418...7,251,982

G

ribonucleotide reductase catalytic subunit M1

decreases expression

ISO

epoxiconazole results in decreased expression of RRM1 mRNA

NCBI chr11:4,094,685...4,138,932
Ensembl chr11:4,094,707...4,138,932

G

ribonucleotide reductase regulatory subunit M2

decreases expression

ISO

epoxiconazole results in decreased expression of RRM2 mRNA

NCBI chr 2:10,122,568...10,211,010
Ensembl chr 2:10,120,698...10,211,725

G

RRN3 homolog, RNA polymerase I transcription factor

decreases expression

ISO

epoxiconazole results in decreased expression of RRN3 mRNA

NCBI chr16:15,060,022...15,094,335
Ensembl chr16:15,060,022...15,094,311

G

ribosomal RNA processing 1

decreases expression

ISO

epoxiconazole results in decreased expression of RRP1 mRNA

NCBI chr21:43,789,577...43,805,293
Ensembl chr21:43,789,513...43,805,757

G

ribosomal RNA processing 12 homolog

decreases expression

ISO

epoxiconazole results in decreased expression of RRP12 mRNA

NCBI chr10:97,356,357...97,401,370
Ensembl chr10:97,356,357...97,426,076

G

ribosomal RNA processing 1B

affects expression

ISO

epoxiconazole affects the expression of RRP1B mRNA

NCBI chr21:43,659,560...43,696,079
Ensembl chr21:43,659,560...43,696,079

G

retinoschisin 1

decreases expression

ISO

epoxiconazole results in decreased expression of RS1 mRNA

NCBI chr X:18,639,688...18,672,108
Ensembl chr X:18,639,688...18,672,108

G

radical S-adenosyl methionine domain containing 2

increases expression

ISO

epoxiconazole results in increased expression of RSAD2 mRNA

NCBI chr 2:6,865,885...6,898,239
Ensembl chr 2:6,865,557...6,898,239

G

arginine and serine rich protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of RSRP1 mRNA

NCBI chr 1:25,242,249...25,338,254
Ensembl chr 1:25,242,248...25,338,244

G

retbindin

increases expression

ISO

epoxiconazole results in increased expression of RTBDN mRNA

NCBI chr19:12,825,482...12,835,428
Ensembl chr19:12,825,477...12,838,362

G

receptor transporter protein 3

increases expression

ISO

epoxiconazole results in increased expression of RTP3 mRNA

NCBI chr 3:46,497,976...46,500,950
Ensembl chr 3:46,494,611...46,500,950

G

RNA transcription, translation and transport factor

increases expression

ISO

epoxiconazole results in increased expression of RTRAF mRNA

NCBI chr14:51,989,546...52,010,694
Ensembl chr14:51,989,441...52,010,694

G

RuvB like AAA ATPase 1

decreases expression

ISO

epoxiconazole results in decreased expression of RUVBL1 mRNA

NCBI chr 3:128,064,785...128,153,914
Ensembl chr 3:128,064,778...128,153,914

G

RuvB like AAA ATPase 2

decreases expression

ISO

epoxiconazole results in decreased expression of RUVBL2 mRNA

NCBI chr19:48,993,448...49,015,995
Ensembl chr19:48,993,562...49,015,983

G

RWD domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of RWDD1 mRNA

NCBI chr 6:116,571,504...116,597,675
Ensembl chr 6:116,571,409...116,597,675

G

RWD domain containing 2A

decreases expression

ISO

epoxiconazole results in decreased expression of RWDD2A mRNA

NCBI chr 6:83,193,357...83,198,935
Ensembl chr 6:83,193,337...83,198,935

G

RWD domain containing 4

decreases expression

ISO

epoxiconazole results in decreased expression of RWDD4A mRNA

NCBI chr 4:183,639,635...183,659,185
Ensembl chr 4:183,639,635...183,659,203

G

retinoid X receptor alpha

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of RXRA mRNA

NCBI chr 9:134,326,455...134,440,585
Ensembl chr 9:134,317,098...134,440,585

G

retinoid X receptor beta

decreases expression

ISO

epoxiconazole results in decreased expression of RXRB mRNA

NCBI chr 6:33,193,588...33,200,853
Ensembl chr 6:33,193,588...33,200,666

G

retinoid X receptor gamma

decreases expression

ISO

epoxiconazole results in decreased expression of RXRG mRNA

NCBI chr 1:165,400,922...165,445,126
Ensembl chr 1:165,400,922...165,445,355

G

ryanodine receptor 3

increases expression

ISO

epoxiconazole results in increased expression of RYR3 mRNA

NCBI chr15:33,310,967...33,866,102
Ensembl chr15:33,310,962...33,866,121

G

S100 calcium binding protein A1

increases expression

ISO

epoxiconazole results in increased expression of S100A1 mRNA

NCBI chr 1:153,628,434...153,632,039
Ensembl chr 1:153,627,926...153,632,044

G

S100 calcium binding protein A10

increases expression

ISO

epoxiconazole results in increased expression of S100A10 mRNA

NCBI chr 1:151,982,915...151,993,859
Ensembl chr 1:151,982,903...151,993,859

G

S100 calcium binding protein A11

increases expression

ISO

epoxiconazole results in increased expression of S100A11 mRNA

NCBI chr 1:152,032,506...152,037,004
Ensembl chr 1:152,032,504...152,047,907

G

S100 calcium binding protein A4

increases expression

ISO

epoxiconazole results in increased expression of S100A4 mRNA

NCBI chr 1:153,543,621...153,545,806
Ensembl chr 1:153,543,613...153,550,136

G

S100 calcium binding protein A7A

increases expression

ISO

epoxiconazole results in increased expression of S100A7A mRNA

NCBI chr 1:153,416,520...153,423,222
Ensembl chr 1:153,416,520...153,423,222

G

S100 calcium binding protein A8

increases expression

ISO

epoxiconazole results in increased expression of S100A8 mRNA

PMID:22334560 PMID:23970803

NCBI chr 1:153,390,032...153,422,583
Ensembl chr 1:153,390,032...153,391,142

G

S100 calcium binding protein P

increases expression

EXP

epoxiconazole results in increased expression of S100P mRNA

NCBI chr 4:6,693,878...6,697,170
Ensembl chr 4:6,693,878...6,697,170

G

serum amyloid A1

decreases expression

ISO

epoxiconazole results in decreased expression of SAA1 mRNA

NCBI chr11:18,266,264...18,269,967
Ensembl chr11:18,266,260...18,269,977

G

serum amyloid A3, pseudogene

increases expression

ISO

epoxiconazole results in increased expression of SAA3 mRNA

NCBI chr11:18,112,472...18,116,132
Ensembl chr11:18,112,472...18,116,132
Ensembl chr11:18,112,472...18,116,132

G

scaffold attachment factor B

increases expression

ISO

epoxiconazole results in increased expression of SAFB mRNA

NCBI chr19:5,623,083...5,668,478
Ensembl chr19:5,623,035...5,668,478

G

sterile alpha motif domain containing 9 like

affects expression

ISO

epoxiconazole affects the expression of SAMD9L mRNA

NCBI chr 7:93,130,056...93,148,385
Ensembl chr 7:93,130,056...93,148,385

G

SAMM50 sorting and assembly machinery component

decreases expression

ISO

epoxiconazole results in decreased expression of SAMM50 mRNA

NCBI chr22:43,955,442...43,996,529
Ensembl chr22:43,955,399...44,010,531

G

S-adenosylmethionine sensor upstream of mTORC1

increases expression

ISO

epoxiconazole results in increased expression of SAMTOR mRNA

NCBI chr 7:112,819,147...112,939,875
Ensembl chr 7:112,819,147...112,939,875

G

secretion associated Ras related GTPase 1B

increases expression

ISO

epoxiconazole results in increased expression of SAR1B mRNA

NCBI chr 5:134,601,149...134,632,828
Ensembl chr 5:134,601,149...134,649,271

G

sarcosine dehydrogenase

decreases expression

ISO

epoxiconazole results in decreased expression of SARDH mRNA

NCBI chr 9:133,659,418...133,739,955
Ensembl chr 9:133,663,528...133,739,976

G

SAM and SH3 domain containing 3

increases expression

ISO

epoxiconazole results in increased expression of SASH3 mRNA

NCBI chr X:129,779,949...129,795,201
Ensembl chr X:129,779,949...129,795,201

G

spermidine/spermine N1-acetyltransferase 1

increases expression

ISO

epoxiconazole results in increased expression of SAT1 mRNA

NCBI chr X:23,783,173...23,786,210
Ensembl chr X:23,783,173...23,786,210

G

salvador family WW domain containing protein 1

increases expression

ISO

epoxiconazole results in increased expression of SAV1 mRNA

NCBI chr14:50,633,580...50,668,306
Ensembl chr14:50,632,058...50,668,337

G

sterol-C5-desaturase

decreases expression

EXP

epoxiconazole results in decreased expression of SC5D mRNA

NCBI chr11:121,292,771...121,313,410
Ensembl chr11:121,292,681...121,313,410

G

SCAN domain containing 1

decreases expression

ISO

epoxiconazole results in decreased expression of SCAND1 mRNA

NCBI chr20:35,953,624...35,959,472
Ensembl chr20:35,953,617...35,959,472

G

SREBF chaperone

decreases expression

ISO

epoxiconazole results in decreased expression of SCAP mRNA

PMID:22334560 PMID:35436446

NCBI chr 3:47,413,681...47,477,127
Ensembl chr 3:47,413,681...47,477,126

G

S-phase cyclin A associated protein in the ER

decreases expression

ISO

epoxiconazole results in decreased expression of SCAPER mRNA

NCBI chr15:76,347,904...76,905,340
Ensembl chr15:76,347,904...76,905,970

G

scavenger receptor class A member 3

increases expression

ISO

epoxiconazole results in increased expression of SCARA3 mRNA

NCBI chr 8:27,633,463...27,734,141
Ensembl chr 8:27,633,414...27,676,776

G

scavenger receptor class B member 1

decreases expression

ISO

epoxiconazole results in decreased expression of SCARB1 mRNA

NCBI chr12:124,776,856...124,863,864
Ensembl chr12:124,776,856...124,882,668

G

sec1 family domain containing 2

decreases expression

ISO

epoxiconazole results in decreased expression of SCFD2 mRNA

NCBI chr 4:52,872,982...53,366,061
Ensembl chr 4:52,872,982...53,366,072

G

secretagogin, EF-hand calcium binding protein

affects expression

ISO

epoxiconazole affects the expression of SCGN mRNA

NCBI chr 6:25,652,215...25,701,783
Ensembl chr 6:25,652,201...25,701,783

G

Scm polycomb group protein homolog 1

affects expression

ISO

epoxiconazole affects the expression of SCMH1 mRNA

NCBI chr 1:41,027,202...41,242,306
Ensembl chr 1:41,027,202...41,242,306

G

sodium channel epithelial 1 subunit alpha

decreases expression

ISO

epoxiconazole results in decreased expression of SCNN1A mRNA

NCBI chr12:6,346,847...6,377,359
Ensembl chr12:6,346,843...6,383,917

G

sterol carrier protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of SCP2 mRNA

NCBI chr 1:52,927,276...53,051,698
Ensembl chr 1:52,927,276...53,051,698

G

scribble planar cell polarity protein

increases expression

ISO

epoxiconazole results in increased expression of SCRIB mRNA

NCBI chr 8:143,790,925...143,815,773
Ensembl chr 8:143,790,920...143,815,773

G

syndecan 4

decreases expression

ISO

epoxiconazole results in decreased expression of SDC4 mRNA

NCBI chr20:45,325,288...45,348,424
Ensembl chr20:45,325,288...45,348,425

G

stromal cell derived factor 2 like 1

decreases expression

ISO

epoxiconazole results in decreased expression of SDF2L1 mRNA

NCBI chr22:21,642,302...21,644,299
Ensembl chr22:21,642,302...21,644,299

G

succinate dehydrogenase complex flavoprotein subunit A

decreases expression

ISO

epoxiconazole results in decreased expression of SDHA mRNA

NCBI chr 5:218,320...268,746
Ensembl chr 5:218,274...257,083

G

short chain dehydrogenase/reductase family 9C member 7

increases expression

ISO

epoxiconazole results in increased expression of SDR9C7 mRNA

NCBI chr12:56,923,133...56,934,408
Ensembl chr12:56,923,133...56,934,408

G

serine dehydratase

decreases expression

ISO

epoxiconazole results in decreased expression of SDS mRNA

NCBI chr12:113,392,445...113,403,887
Ensembl chr12:113,392,423...113,426,301

G

SEC11 homolog A, signal peptidase complex subunit

increases expression

ISO

epoxiconazole results in increased expression of SEC11A mRNA

NCBI chr15:84,669,544...84,716,139
Ensembl chr15:84,669,529...84,716,460

G

SEC11 homolog C, signal peptidase complex subunit

increases expression

ISO

epoxiconazole results in increased expression of SEC11C mRNA

NCBI chr18:59,139,884...59,158,832
Ensembl chr18:59,139,475...59,158,837

G

SEC14 like lipid binding 3

increases expression

ISO

epoxiconazole results in increased expression of SEC14L3 mRNA

NCBI chr22:30,447,661...30,472,017
Ensembl chr22:30,447,959...30,472,056

G

SEC14 like lipid binding 4

decreases expression

ISO

epoxiconazole results in decreased expression of SEC14L4 mRNA

NCBI chr22:30,488,902...30,505,695
Ensembl chr22:30,488,902...30,505,711

G

SEC16 homolog B, endoplasmic reticulum export factor

decreases expression

ISO

epoxiconazole results in decreased expression of SEC16B mRNA

NCBI chr 1:177,928,788...177,984,284
Ensembl chr 1:177,923,956...177,984,303

G

SEC22 homolog A, vesicle trafficking protein

increases expression

ISO

epoxiconazole results in increased expression of SEC22A mRNA

NCBI chr 3:123,201,943...123,274,136
Ensembl chr 3:123,201,859...123,274,136

G

SEC22 homolog B, vesicle trafficking protein

increases expression

ISO

epoxiconazole results in increased expression of SEC22B mRNA

NCBI chr 1:120,150,898...120,176,520
Ensembl chr 1:120,150,898...120,176,520

G

SEC23 interacting protein

increases expression

ISO

epoxiconazole results in increased expression of SEC23IP mRNA

NCBI chr10:119,892,730...119,944,657
Ensembl chr10:119,892,686...119,944,657

G

SEC24 homolog A, COPII coat complex component

decreases expression

ISO

epoxiconazole results in decreased expression of SEC24A mRNA

NCBI chr 5:134,648,382...134,727,909
Ensembl chr 5:134,648,588...134,727,909

G

SEC24 homolog B, COPII coat complex component

decreases expression

ISO

epoxiconazole results in decreased expression of SEC24B mRNA

NCBI chr 4:109,433,815...109,540,896
Ensembl chr 4:109,433,602...109,540,896

G

SEC24 homolog D, COPII coat complex component

increases expression

ISO

epoxiconazole results in increased expression of SEC24D mRNA

PMID:22334560 PMID:35436446

NCBI chr 4:118,722,823...118,836,126
Ensembl chr 4:118,722,822...118,838,683

G

SEC61 translocon subunit alpha 1

increases expression

ISO

epoxiconazole results in increased expression of SEC61A1 mRNA

NCBI chr 3:128,051,641...128,071,683
Ensembl chr 3:128,051,641...128,071,705

G

SEC61 translocon subunit beta

increases expression

ISO

epoxiconazole results in increased expression of SEC61B mRNA

NCBI chr 9:99,222,282...99,230,615
Ensembl chr 9:99,222,064...99,230,615

G

SECIS binding protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of SECISBP2 mRNA

NCBI chr 9:89,318,500...89,367,117
Ensembl chr 9:89,318,460...89,363,633

G

secreted and transmembrane 1

increases expression

ISO

epoxiconazole results in increased expression of SECTM1A mRNA

NCBI chr17:82,321,024...82,333,959
Ensembl chr17:82,321,024...82,335,518

G

SEL1L family member 3

affects expression

ISO

epoxiconazole affects the expression of SEL1L3 mRNA

NCBI chr 4:25,713,964...25,863,566
Ensembl chr 4:25,747,433...25,863,760

G

selenium binding protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of SELENBP1 mRNA

NCBI chr 1:151,364,304...151,372,705
Ensembl chr 1:151,364,302...151,372,716

G

selenoprotein I

increases expression

ISO

epoxiconazole results in increased expression of SELENOI mRNA

NCBI chr 2:26,346,143...26,395,885
Ensembl chr 2:26,308,547...26,395,885

G

selenoprotein S

increases expression

ISO

epoxiconazole results in increased expression of SELENOS mRNA

PMID:22334560 PMID:35436446

NCBI chr15:101,270,809...101,277,485
Ensembl chr15:101,270,531...101,277,500

G

SEM1 26S proteasome subunit

increases expression

ISO

epoxiconazole results in increased expression of SEM1 mRNA

NCBI chr 7:96,481,626...96,709,846
Ensembl chr 7:96,481,626...96,709,891

G

semaphorin 3C

increases expression

ISO

epoxiconazole results in increased expression of SEMA3C mRNA

NCBI chr 7:80,742,538...80,922,389
Ensembl chr 7:80,742,538...80,922,379

G

semaphorin 3E

decreases expression

ISO

epoxiconazole results in decreased expression of SEMA3E mRNA

NCBI chr 7:83,363,238...83,649,139
Ensembl chr 7:83,363,238...83,649,139

G

semaphorin 3F

decreases expression

ISO

epoxiconazole results in decreased expression of SEMA3F mRNA

NCBI chr 3:50,155,058...50,189,075
Ensembl chr 3:50,155,012...50,189,075

G

semaphorin 6D

decreases expression

ISO

epoxiconazole results in decreased expression of SEMA6D mRNA

NCBI chr15:47,184,089...47,774,228
Ensembl chr15:47,184,101...47,774,228

G

SUMO peptidase family member, NEDD8 specific

increases expression

ISO

epoxiconazole results in increased expression of SENP8 mRNA

NCBI chr15:72,114,258...72,143,692
Ensembl chr15:72,114,258...72,143,692

G

selenophosphate synthetase 1

decreases expression

ISO

epoxiconazole results in decreased expression of SEPHS1 mRNA

NCBI chr10:13,317,428...13,348,293
Ensembl chr10:13,317,425...13,348,596

G

septin 2

decreases expression

ISO

epoxiconazole results in decreased expression of SEPTIN2 mRNA

NCBI chr 2:241,315,355...241,354,027
Ensembl chr 2:241,314,923...241,354,030

G

septin 7

increases expression

ISO

epoxiconazole results in increased expression of SEPTIN7 mRNA

NCBI chr 7:35,800,986...35,915,763
Ensembl chr 7:35,800,932...35,907,110

G

septin 8

increases expression

ISO

epoxiconazole results in increased expression of SEPTIN8 mRNA

NCBI chr 5:132,750,819...132,780,083
Ensembl chr 5:132,750,814...132,807,241

G

serine incorporator 2

affects expression

ISO

epoxiconazole affects the expression of SERINC2 mRNA

NCBI chr 1:31,409,777...31,434,678
Ensembl chr 1:31,409,565...31,434,680

G

serine incorporator 5

decreases expression

ISO

epoxiconazole results in decreased expression of SERINC5 mRNA

NCBI chr 5:80,111,225...80,256,048
Ensembl chr 5:80,111,228...80,256,048

G

serpin family A member 6

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of SERPINA6 mRNA
epoxiconazole results in decreased expression of SERPINA6 mRNA

PMID:22334560 PMID:35436446

NCBI chr14:94,304,248...94,323,336
Ensembl chr14:94,304,248...94,323,389

G

serpin family A member 7

increases expression

ISO

epoxiconazole results in increased expression of SERPINA7 mRNA

NCBI chr X:106,032,435...106,038,727
Ensembl chr X:106,032,425...106,038,778

G

serpin family A member 9

decreases expression
increases expression

ISO

epoxiconazole results in decreased expression of SERPINA9 mRNA
epoxiconazole results in increased expression of SERPINA9 mRNA

PMID:22334560 PMID:35436446

NCBI chr14:94,462,721...94,476,197
Ensembl chr14:94,462,717...94,481,125

G

serpin family B member 1

increases expression

ISO

epoxiconazole results in increased expression of SERPINB1A mRNA

NCBI chr 6:2,832,332...2,841,863
Ensembl chr 6:2,832,332...2,842,001

G

serpin family B member 11

increases expression

ISO

epoxiconazole results in increased expression of SERPINB11 mRNA

NCBI chr18:63,702,304...63,723,893
Ensembl chr18:63,647,579...63,726,432

G

serpin family B member 13

increases expression

ISO

epoxiconazole results in increased expression of SERPINB13 mRNA

NCBI chr18:63,587,343...63,599,192
Ensembl chr18:63,586,989...63,604,639

G

serpin family B member 3

increases expression

ISO

epoxiconazole results in increased expression of SERPINB3D mRNA

NCBI chr18:63,655,197...63,661,893
Ensembl chr18:63,653,686...63,661,893

G

serpin family B member 4

decreases expression

ISO

epoxiconazole results in decreased expression of SERPINB3A mRNA

NCBI chr18:63,637,259...63,644,256
Ensembl chr18:63,637,259...63,644,256

G

serpin family B member 8

decreases expression

ISO

epoxiconazole results in decreased expression of SERPINB8 mRNA

NCBI chr18:63,970,081...64,019,779
Ensembl chr18:63,970,029...64,019,779

G

serpin family E member 3

increases expression

ISO

epoxiconazole results in increased expression of SERPINE3 mRNA

NCBI chr13:51,339,691...51,364,735
Ensembl chr13:51,335,773...51,364,735

G

SERTA domain containing 2

affects expression

ISO

epoxiconazole affects the expression of SERTAD2 mRNA

NCBI chr 2:64,631,621...64,653,913
Ensembl chr 2:64,631,621...64,751,005

G

sestrin 1

increases expression

ISO

epoxiconazole results in increased expression of SESN1 mRNA

NCBI chr 6:108,984,309...109,094,846
Ensembl chr 6:108,984,309...109,095,074

G

sestrin 3

increases expression

ISO

epoxiconazole results in increased expression of SESN3 mRNA

NCBI chr11:95,165,513...95,232,475
Ensembl chr11:95,165,513...95,232,541

G

SET domain containing 4

increases expression

ISO

epoxiconazole results in increased expression of SETD4 mRNA

NCBI chr21:36,034,541...36,060,526
Ensembl chr21:36,034,534...36,079,389

G

senataxin

decreases expression

ISO

epoxiconazole results in decreased expression of SETX mRNA

NCBI chr 9:132,261,356...132,356,744
Ensembl chr 9:132,261,356...132,355,048

G

splicing factor 1

increases expression

ISO

epoxiconazole results in increased expression of SF1 mRNA

NCBI chr11:64,764,606...64,778,542
Ensembl chr11:64,764,606...64,778,786

G

splicing factor 3a subunit 1

decreases expression

ISO

epoxiconazole results in decreased expression of SF3A1 mRNA

NCBI chr22:30,331,988...30,356,894
Ensembl chr22:30,331,988...30,356,919

G

splicing factor 3a subunit 3

decreases expression

ISO

epoxiconazole results in decreased expression of SF3A3 mRNA

NCBI chr 1:37,956,975...37,990,022
Ensembl chr 1:37,956,975...37,990,517

G

splicing factor 3b subunit 2

decreases expression

ISO

epoxiconazole results in decreased expression of SF3B2 mRNA

NCBI chr11:66,052,364...66,069,308
Ensembl chr11:66,050,729...66,069,308

G

splicing factor proline and glutamine rich

increases expression

ISO

epoxiconazole results in increased expression of SFPQ mRNA

NCBI chr 1:35,176,380...35,193,145
Ensembl chr 1:35,176,378...35,193,446

G

secreted frizzled related protein 1

increases expression

ISO

epoxiconazole results in increased expression of SFRP1 mRNA

NCBI chr 8:41,261,962...41,309,473
Ensembl chr 8:41,261,956...41,309,511

G

SFT2 domain containing 2

decreases expression

ISO

epoxiconazole results in decreased expression of SFT2D2 mRNA

NCBI chr 1:168,226,004...168,253,021
Ensembl chr 1:168,225,938...168,253,021

G

surfactant protein A1

affects expression

ISO

epoxiconazole affects the expression of SFTPA1 mRNA

NCBI chr10:79,610,939...79,615,455
Ensembl chr10:79,610,412...79,616,115

G

surfactant protein D

increases expression

ISO

epoxiconazole results in increased expression of SFTPD mRNA

NCBI chr10:79,937,740...79,982,383
Ensembl chr10:79,937,128...79,983,996

G

sideroflexin 2

decreases expression

ISO

epoxiconazole results in decreased expression of SFXN2 mRNA

NCBI chr10:102,714,636...102,743,492
Ensembl chr10:102,714,538...102,743,492

G

sphingosine-1-phosphate lyase 1

increases expression

ISO

epoxiconazole results in increased expression of SGPL1 mRNA

NCBI chr10:70,815,948...70,881,184
Ensembl chr10:70,815,905...70,958,701

G

SH2 domain containing 3C

decreases expression

ISO

epoxiconazole results in decreased expression of SH2D3C mRNA

NCBI chr 9:127,738,317...127,778,666
Ensembl chr 9:127,738,317...127,778,727

G

SH3 domain binding protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of SH3BP2 mRNA

NCBI chr 4:2,793,085...2,841,096
Ensembl chr 4:2,793,020...2,841,291

G

SH3 domain binding protein 5

decreases expression

ISO

epoxiconazole results in decreased expression of SH3BP5 mRNA

NCBI chr 3:15,254,353...15,341,380
Ensembl chr 3:15,254,353...15,341,368

G

SH3 domain containing GRB2 like, endophilin B1

increases expression

ISO

epoxiconazole results in increased expression of SH3GLB1 mRNA

NCBI chr 1:86,704,576...86,748,184
Ensembl chr 1:86,704,520...86,748,184

G

SH3 and PX domains 2A

increases expression

ISO

epoxiconazole results in increased expression of SH3PXD2A mRNA

NCBI chr10:103,594,027...103,855,576
Ensembl chr10:103,594,027...103,855,584

G

SH3 and multiple ankyrin repeat domains 2

increases expression
multiple interactions

ISO

epoxiconazole results in increased expression of SHANK2 mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SHANK2 mRNA

PMID:25607892 PMID:35436446

NCBI chr11:70,467,854...71,253,234
Ensembl chr11:70,467,805...71,252,844

G

SHC adaptor protein 4

increases expression

ISO

epoxiconazole results in increased expression of SHC4 mRNA

NCBI chr15:48,823,741...48,963,919
Ensembl chr15:48,823,741...48,963,919

G

shisa family member 5

decreases expression

ISO

epoxiconazole results in decreased expression of SHISA5 mRNA

NCBI chr 3:48,467,876...48,504,810
Ensembl chr 3:48,467,798...48,504,826

G

shisa like 1

increases expression

ISO

epoxiconazole results in increased expression of SHISAL1 mRNA

NCBI chr22:44,243,665...44,331,714
Ensembl chr22:44,243,665...44,312,951

G

SH3KBP1 binding protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of SHKBP1 mRNA

NCBI chr19:40,576,873...40,591,397
Ensembl chr19:40,576,844...40,591,399

G

serine hydroxymethyltransferase 1

decreases expression

ISO

epoxiconazole results in decreased expression of SHMT1 mRNA

NCBI chr17:18,327,873...18,363,550
Ensembl chr17:18,327,686...18,363,550

G

serine hydroxymethyltransferase 2

decreases expression

ISO

epoxiconazole results in decreased expression of SHMT2 mRNA

NCBI chr12:57,229,711...57,234,935
Ensembl chr12:57,226,554...57,234,935

G

SHOC2 leucine rich repeat scaffold protein

increases expression

ISO

epoxiconazole results in increased expression of SHOC2 mRNA

NCBI chr10:110,919,370...111,013,665
Ensembl chr10:110,917,932...111,017,307

G

shroom family member 3

decreases expression

ISO

epoxiconazole results in decreased expression of SHROOM3 mRNA

NCBI chr 4:76,435,229...76,783,253
Ensembl chr 4:76,435,229...76,783,253

G

sialic acid acetylesterase

decreases expression
increases expression

ISO

epoxiconazole results in decreased expression of SIAE mRNA
epoxiconazole results in increased expression of SIAE mRNA

PMID:22334560 PMID:35436446

NCBI chr11:124,633,113...124,676,303
Ensembl chr11:124,633,113...124,695,707

G

siah E3 ubiquitin protein ligase 1

increases expression

ISO

epoxiconazole results in increased expression of SIAH1A mRNA

NCBI chr16:48,360,531...48,387,246
Ensembl chr16:48,356,364...48,448,402

G

SID1 transmembrane family member 2

decreases expression

ISO

epoxiconazole results in decreased expression of SIDT2 mRNA

NCBI chr11:117,178,743...117,197,442
Ensembl chr11:117,178,736...117,197,445

G

salt inducible kinase 1

affects expression

ISO

epoxiconazole affects the expression of SIK1 mRNA

NCBI chr21:43,414,483...43,427,131
Ensembl chr21:43,414,483...43,427,131

G

suppressor of IKBKE 1

affects expression

ISO

epoxiconazole affects the expression of SIKE1 mRNA

NCBI chr 1:114,769,479...114,780,685
Ensembl chr 1:114,769,479...114,780,699

G

SIL1 nucleotide exchange factor

decreases expression

ISO

epoxiconazole results in decreased expression of SIL1 mRNA

NCBI chr 5:138,946,724...139,198,368
Ensembl chr 5:138,946,720...139,293,557

G

SIN3 transcription regulator family member A

decreases expression

ISO

epoxiconazole results in decreased expression of SIN3A mRNA

NCBI chr15:75,369,379...75,455,815
Ensembl chr15:75,369,379...75,455,842

G

SIN3-HDAC complex associated factor

decreases expression

ISO

epoxiconazole results in decreased expression of SINHCAF mRNA

NCBI chr12:31,280,584...31,326,150
Ensembl chr12:31,280,584...31,327,058

G

signal induced proliferation associated 1 like 2

decreases expression

ISO

epoxiconazole results in decreased expression of SIPA1L2 mRNA

NCBI chr 1:232,397,965...232,630,496
Ensembl chr 1:232,397,622...232,631,404

G

signal regulatory protein alpha

increases expression

ISO

epoxiconazole results in increased expression of SIRPA mRNA

NCBI chr20:1,894,167...1,940,592
Ensembl chr20:1,892,726...1,940,592

G

sirtuin 4

decreases expression

ISO

epoxiconazole results in decreased expression of SIRT4 mRNA

NCBI chr12:120,291,780...120,313,249
Ensembl chr12:120,292,162...120,313,249

G

SIX homeobox 2

increases expression

ISO

epoxiconazole results in increased expression of SIX2 mRNA

NCBI chr 2:45,005,182...45,009,452
Ensembl chr 2:45,005,182...45,009,452

G

spindle and kinetochore associated complex subunit 1

decreases expression

ISO

epoxiconazole results in decreased expression of SKA1 mRNA

NCBI chr18:50,375,046...50,394,168
Ensembl chr18:50,375,017...50,394,176

G

spindle and kinetochore associated complex subunit 2

decreases expression

ISO

epoxiconazole results in decreased expression of SKA2 mRNA

NCBI chr17:59,109,857...59,155,186
Ensembl chr17:59,109,857...59,155,260

G

SKI3 subunit of superkiller complex

decreases expression

ISO

epoxiconazole results in decreased expression of SKIC3 mRNA

NCBI chr 5:95,463,894...95,554,977
Ensembl chr 5:95,461,755...95,555,050

G

SKI family transcriptional corepressor 1

increases expression

ISO

epoxiconazole results in increased expression of SKOR1 mRNA

NCBI chr15:67,825,509...67,834,582
Ensembl chr15:67,819,704...67,834,582

G

SLAIN motif family member 1

decreases expression

ISO

epoxiconazole results in decreased expression of SLAIN1 mRNA

NCBI chr13:77,697,687...77,764,229
Ensembl chr13:77,697,687...77,764,242

G

solute carrier family 10 member 1

increases expression

ISO

epoxiconazole results in increased expression of SLC10A1 mRNA

NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,358...69,797,285

G

solute carrier family 10 member 3

increases expression

ISO

epoxiconazole results in increased expression of SLC10A3 mRNA

NCBI chr X:154,487,311...154,490,629
Ensembl chr X:154,487,306...154,490,690

G

solute carrier family 12 member 4

decreases expression

ISO

epoxiconazole results in decreased expression of SLC12A4 mRNA

NCBI chr16:67,943,474...67,968,694
Ensembl chr16:67,943,474...67,969,601

G

solute carrier family 12 member 7

decreases expression

ISO

epoxiconazole results in decreased expression of SLC12A7 mRNA

NCBI chr 5:1,050,384...1,155,899
Ensembl chr 5:1,050,384...1,155,916

G

solute carrier family 13 member 3

increases expression

ISO

epoxiconazole results in increased expression of SLC13A3 mRNA

PMID:22334560 PMID:35436446

NCBI chr20:46,557,828...46,684,485
Ensembl chr20:46,557,823...46,684,467

G

solute carrier family 13 member 5

decreases expression

ISO

epoxiconazole results in decreased expression of SLC13A5 mRNA

NCBI chr17:6,684,719...6,713,369
Ensembl chr17:6,684,715...6,713,377

G

solute carrier family 15 member 4

decreases expression

ISO

epoxiconazole results in decreased expression of SLC15A4 mRNA

NCBI chr12:128,793,194...128,823,958
Ensembl chr12:128,793,193...128,824,035

G

solute carrier family 15 member 5

decreases expression

ISO

epoxiconazole results in decreased expression of SLC15A5 mRNA

NCBI chr12:16,188,485...16,277,685
Ensembl chr12:16,188,485...16,277,685

G

solute carrier family 16 member 1

increases expression

ISO

epoxiconazole results in increased expression of SLC16A1 mRNA

NCBI chr 1:112,911,847...112,956,196
Ensembl chr 1:112,911,847...112,957,593

G

solute carrier family 16 member 10

increases expression

ISO

epoxiconazole results in increased expression of SLC16A10 mRNA

NCBI chr 6:111,087,503...111,231,194
Ensembl chr 6:111,087,503...111,231,194

G

solute carrier family 16 member 12

increases expression
affects expression

ISO

epoxiconazole results in increased expression of SLC16A12 mRNA
epoxiconazole affects the expression of SLC16A12 mRNA

PMID:22334560 PMID:35436446

NCBI chr10:89,430,299...89,556,704
Ensembl chr10:89,430,174...89,556,701

G

solute carrier family 16 member 13

increases expression

ISO

epoxiconazole results in increased expression of SLC16A13 mRNA

NCBI chr17:7,036,015...7,040,117
Ensembl chr17:7,036,015...7,040,117

G

solute carrier family 16 member 2

increases expression

ISO

epoxiconazole results in increased expression of SLC16A2 mRNA

NCBI chr X:74,421,493...74,533,916
Ensembl chr X:74,421,383...74,533,918

G

solute carrier family 16 member 5

affects expression

ISO

epoxiconazole affects the expression of SLC16A5 mRNA

NCBI chr17:75,087,385...75,110,149
Ensembl chr17:75,077,226...75,106,162

G

solute carrier family 16 member 6

affects expression

ISO

epoxiconazole affects the expression of SLC16A6 mRNA

NCBI chr17:68,267,026...68,291,479
Ensembl chr17:68,267,026...68,291,267

G

solute carrier family 16 member 7

increases expression

ISO

epoxiconazole results in increased expression of SLC16A7 mRNA

NCBI chr12:59,596,029...59,789,841
Ensembl chr12:59,596,027...59,789,855

G

solute carrier family 17 member 4

increases expression

ISO

epoxiconazole results in increased expression of SLC17A4 mRNA

NCBI chr 6:25,754,699...25,781,199
Ensembl chr 6:25,753,300...25,783,316

G

solute carrier family 17 member 5

decreases expression

ISO

epoxiconazole results in decreased expression of SLC17A5 mRNA

NCBI chr 6:73,593,379...73,653,992
Ensembl chr 6:73,593,364...73,654,014

G

solute carrier family 17 member 8

decreases expression

ISO

epoxiconazole results in decreased expression of SLC17A8 mRNA

NCBI chr12:100,357,074...100,422,055
Ensembl chr12:100,356,842...100,422,055

G

solute carrier family 19 member 1

affects expression

ISO

epoxiconazole affects the expression of SLC19A1 mRNA

NCBI chr21:45,502,517...45,563,025
Ensembl chr21:45,493,572...45,573,564

G

solute carrier family 1 member 2

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLC1A2 mRNA

NCBI chr11:35,251,205...35,420,507
Ensembl chr11:35,251,205...35,420,063

G

solute carrier family 1 member 6

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLC1A6 mRNA

NCBI chr19:14,950,033...15,010,643
Ensembl chr19:14,950,033...15,022,990

G

solute carrier family 20 member 1

affects expression

ISO

epoxiconazole affects the expression of SLC20A1 mRNA

NCBI chr 2:112,645,939...112,663,825
Ensembl chr 2:112,645,854...112,663,829

G

solute carrier family 22 member 4

decreases expression

ISO

epoxiconazole results in decreased expression of SLC22A4 mRNA

NCBI chr 5:132,294,394...132,344,190
Ensembl chr 5:132,293,769...132,344,206

G

solute carrier family 22 member 7

decreases expression

ISO

epoxiconazole results in decreased expression of SLC22A7 mRNA

NCBI chr 6:43,295,714...43,305,538
Ensembl chr 6:43,295,694...43,305,543

G

solute carrier family 22 member 9

decreases expression

ISO

epoxiconazole results in decreased expression of SLC22A19 mRNA

NCBI chr11:63,369,785...63,410,294
Ensembl chr11:63,369,725...63,410,881

G

solute carrier family 23 member 1

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of SLC23A1 mRNA
epoxiconazole results in decreased expression of SLC23A1 mRNA

PMID:22334560 PMID:35436446

NCBI chr 5:139,367,196...139,385,676
Ensembl chr 5:139,367,196...139,385,495

G

solute carrier family 23 member 2

increases expression

ISO

epoxiconazole results in increased expression of SLC23A2 mRNA

NCBI chr20:4,852,358...5,010,313
Ensembl chr20:4,851,729...5,010,293

G

solute carrier family 25 member 10

decreases expression

ISO

epoxiconazole results in decreased expression of SLC25A10 mRNA

NCBI chr17:81,712,284...81,721,012
Ensembl chr17:81,711,951...81,721,969

G

solute carrier family 25 member 11

decreases expression

ISO

epoxiconazole results in decreased expression of SLC25A11 mRNA

NCBI chr17:4,937,130...4,940,046
Ensembl chr17:4,934,570...4,940,156

G

solute carrier family 25 member 12

decreases expression

ISO

epoxiconazole results in decreased expression of SLC25A12 mRNA

NCBI chr 2:171,783,405...171,894,244
Ensembl chr 2:171,781,400...171,999,859

G

solute carrier family 25 member 13

decreases expression

ISO

epoxiconazole results in decreased expression of SLC25A13 mRNA

NCBI chr 7:96,120,220...96,322,098
Ensembl chr 7:96,120,218...96,322,147

G

solute carrier family 25 member 15

decreases expression

ISO

epoxiconazole results in decreased expression of SLC25A15 mRNA

NCBI chr13:40,789,611...40,812,460
Ensembl chr13:40,789,412...40,812,460

G

solute carrier family 25 member 16

decreases expression

ISO

epoxiconazole results in decreased expression of SLC25A16 mRNA

NCBI chr10:68,477,998...68,527,523
Ensembl chr10:68,473,079...68,527,523

G

solute carrier family 25 member 19

increases expression

ISO

epoxiconazole results in increased expression of SLC25A19 mRNA

NCBI chr17:75,272,992...75,289,433
Ensembl chr17:75,272,012...75,289,968

G

solute carrier family 25 member 20

decreases expression

ISO

epoxiconazole results in decreased expression of SLC25A20 mRNA

NCBI chr 3:48,856,926...48,898,882
Ensembl chr 3:48,856,926...48,898,904

G

solute carrier family 25 member 22

decreases expression

ISO

epoxiconazole results in decreased expression of SLC25A22 mRNA

PMID:22334560 PMID:35436446

NCBI chr11:790,475...798,281
Ensembl chr11:790,474...798,316

G

solute carrier family 25 member 25

decreases expression

ISO

epoxiconazole results in decreased expression of SLC25A25 mRNA

NCBI chr 9:128,068,232...128,109,245
Ensembl chr 9:128,068,169...128,109,245

G

solute carrier family 25 member 30

affects expression

ISO

epoxiconazole affects the expression of SLC25A30 mRNA

NCBI chr13:45,393,316...45,434,016
Ensembl chr13:45,393,316...45,418,455

G

solute carrier family 25 member 31

affects expression

ISO

epoxiconazole affects the expression of SLC25A31 mRNA

NCBI chr 4:127,730,400...127,774,292
Ensembl chr 4:127,730,400...127,774,292

G

solute carrier family 25 member 35

decreases expression

ISO

epoxiconazole results in decreased expression of SLC25A35 mRNA

NCBI chr17:8,287,763...8,295,400
Ensembl chr17:8,287,763...8,295,410

G

solute carrier family 25 member 37

increases expression
affects expression

ISO

epoxiconazole results in increased expression of SLC25A37 mRNA
epoxiconazole affects the expression of SLC25A37 mRNA

PMID:22334560 PMID:35436446

NCBI chr 8:23,528,956...23,575,463
Ensembl chr 8:23,528,956...23,575,463

G

solute carrier family 25 member 39

decreases expression

ISO

epoxiconazole results in decreased expression of SLC25A39 mRNA

NCBI chr17:44,319,628...44,324,823
Ensembl chr17:44,319,625...44,325,801

G

solute carrier family 25 member 42

increases expression

ISO

epoxiconazole results in increased expression of SLC25A42 mRNA

NCBI chr19:19,063,994...19,113,030
Ensembl chr19:19,061,697...19,113,030

G

solute carrier family 25 member 44

decreases expression

ISO

epoxiconazole results in decreased expression of SLC25A44 mRNA

NCBI chr 1:156,194,104...156,212,796
Ensembl chr 1:156,193,932...156,212,796

G

solute carrier family 25 member 45

decreases expression

ISO

epoxiconazole results in decreased expression of SLC25A45 mRNA

NCBI chr11:65,375,192...65,383,701
Ensembl chr11:65,375,192...65,384,550

G

solute carrier family 25 member 47

decreases expression

ISO

epoxiconazole results in decreased expression of SLC25A47 mRNA

NCBI chr14:100,323,339...100,330,421
Ensembl chr14:100,323,339...100,330,421

G

solute carrier family 26 member 1

decreases expression

ISO

epoxiconazole results in decreased expression of SLC26A1 mRNA

NCBI chr 4:978,991...993,404
Ensembl chr 4:979,073...997,659

G

solute carrier family 26 member 11

decreases expression

ISO

epoxiconazole results in decreased expression of SLC26A11 mRNA

NCBI chr17:80,220,427...80,253,500
Ensembl chr17:80,219,699...80,253,509

G

solute carrier family 26 member 6

increases expression

ISO

epoxiconazole results in increased expression of SLC26A6 mRNA

NCBI chr 3:48,625,723...48,635,461
Ensembl chr 3:48,625,718...48,635,493

G

solute carrier family 26 member 7

increases expression

ISO

epoxiconazole results in increased expression of SLC26A7 mRNA

NCBI chr 8:91,209,496...91,398,155
Ensembl chr 8:91,209,494...91,398,155

G

solute carrier family 27 member 1

decreases expression

ISO

epoxiconazole results in decreased expression of SLC27A1 mRNA

NCBI chr19:17,468,767...17,506,168
Ensembl chr19:17,467,666...17,506,190

G

solute carrier family 27 member 4

decreases expression

ISO

epoxiconazole results in decreased expression of SLC27A4 mRNA

NCBI chr 9:128,340,527...128,361,470
Ensembl chr 9:128,340,506...128,363,283

G

solute carrier family 28 member 2

increases expression

ISO

epoxiconazole results in increased expression of SLC28A2 mRNA

NCBI chr15:45,252,234...45,277,846
Ensembl chr15:45,252,234...45,277,846

G

solute carrier family 2 member 1

decreases expression

ISO

epoxiconazole results in decreased expression of SLC2A1 mRNA

NCBI chr 1:42,925,353...42,958,868
Ensembl chr 1:42,925,353...42,958,893

G

solute carrier family 2 member 10

increases expression

ISO

epoxiconazole results in increased expression of SLC2A10 mRNA

NCBI chr20:46,708,320...46,736,347
Ensembl chr20:46,709,577...46,736,347

G

solute carrier family 2 member 5

decreases expression

ISO

epoxiconazole results in decreased expression of SLC2A5 mRNA

NCBI chr 1:9,035,106...9,094,195
Ensembl chr 1:9,035,106...9,088,478

G

solute carrier family 2 member 9

decreases expression

ISO

epoxiconazole results in decreased expression of SLC2A9 mRNA

NCBI chr 4:9,771,025...10,040,270
Ensembl chr 4:9,771,153...10,054,936

G

solute carrier family 30 member 1

decreases expression

ISO

epoxiconazole results in decreased expression of SLC30A1 mRNA

NCBI chr 1:211,571,568...211,579,161
Ensembl chr 1:211,571,568...211,579,161

G

solute carrier family 30 member 10

affects expression

ISO

epoxiconazole affects the expression of SLC30A10 mRNA

NCBI chr 1:219,910,445...219,959,098
Ensembl chr 1:219,685,427...219,959,018

G

solute carrier family 30 member 8

decreases expression

ISO

epoxiconazole results in decreased expression of SLC30A8 mRNA

NCBI chr 8:116,950,217...117,176,714
Ensembl chr 8:116,950,273...117,176,714

G

solute carrier family 35 member A3

decreases expression

ISO

epoxiconazole results in decreased expression of SLC35A3 mRNA

NCBI chr 1:99,969,996...100,035,634
Ensembl chr 1:99,969,351...100,035,634

G

solute carrier family 35 member A4

decreases expression

ISO

epoxiconazole results in decreased expression of SLC35A4 mRNA

NCBI chr 5:140,564,828...140,569,100
Ensembl chr 5:140,564,819...140,569,100

G

solute carrier family 35 member A5

decreases expression

ISO

epoxiconazole results in decreased expression of SLC35A5 mRNA

NCBI chr 3:112,561,320...112,585,579
Ensembl chr 3:112,561,269...112,587,350

G

solute carrier family 35 member B2

decreases expression

ISO

epoxiconazole results in decreased expression of SLC35B2 mRNA

NCBI chr 6:44,254,101...44,257,890
Ensembl chr 6:44,254,096...44,257,890

G

solute carrier family 35 member B4

decreases expression

ISO

epoxiconazole results in decreased expression of SLC35B4 mRNA

NCBI chr 7:134,289,332...134,320,338
Ensembl chr 7:134,289,332...134,317,117

G

solute carrier family 35 member C2

decreases expression

ISO

epoxiconazole results in decreased expression of SLC35C2 mRNA

NCBI chr20:46,345,984...46,364,425
Ensembl chr20:46,345,980...46,364,458

G

solute carrier family 35 member E2B

increases expression

ISO

epoxiconazole results in increased expression of SLC35E2 mRNA

NCBI chr 1:1,661,478...1,692,795
Ensembl chr 1:1,659,529...1,693,017

G

solute carrier family 36 member 1

decreases expression

ISO

epoxiconazole results in decreased expression of SLC36A1 mRNA

NCBI chr 5:151,344,596...151,556,085
Ensembl chr 5:151,437,046...151,492,379

G

solute carrier family 37 member 4

decreases expression

ISO

epoxiconazole results in decreased expression of SLC37A4 mRNA

NCBI chr11:119,024,112...119,030,877
Ensembl chr11:119,023,751...119,030,906

G

solute carrier family 38 member 2

decreases expression

ISO

epoxiconazole results in decreased expression of SLC38A2 mRNA

NCBI chr12:46,358,188...46,372,773
Ensembl chr12:46,358,185...46,372,832

G

solute carrier family 38 member 7

decreases expression

ISO

epoxiconazole results in decreased expression of SLC38A7 mRNA

NCBI chr16:58,665,109...58,684,770
Ensembl chr16:58,663,015...58,684,770

G

solute carrier family 39 member 1

decreases expression

ISO

epoxiconazole results in decreased expression of SLC39A1 mRNA

NCBI chr 1:153,959,110...153,968,184
Ensembl chr 1:153,959,099...153,968,667

G

solute carrier family 39 member 11

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of SLC39A11 mRNA
epoxiconazole results in decreased expression of SLC39A11 mRNA

PMID:22334560 PMID:35436446

NCBI chr17:72,645,949...73,092,688
Ensembl chr17:72,645,947...73,092,712

G

solute carrier family 39 member 12

increases expression

ISO

epoxiconazole results in increased expression of SLC39A12 mRNA

NCBI chr10:17,951,918...18,043,285
Ensembl chr10:17,951,839...18,043,292

G

solute carrier family 39 member 14

decreases expression

ISO

epoxiconazole results in decreased expression of SLC39A14 mRNA

NCBI chr 8:22,367,278...22,434,129
Ensembl chr 8:22,366,727...22,434,129

G

solute carrier family 39 member 4

decreases expression

ISO

epoxiconazole results in decreased expression of SLC39A4 mRNA

NCBI chr 8:144,412,414...144,416,844
Ensembl chr 8:144,409,742...144,416,844

G

solute carrier family 39 member 9

decreases expression

ISO

epoxiconazole results in decreased expression of SLC39A9 mRNA

NCBI chr14:69,398,384...69,462,390
Ensembl chr14:69,398,015...69,462,390

G

solute carrier family 3 member 2

decreases expression

ISO

epoxiconazole results in decreased expression of SLC3A2 mRNA

NCBI chr11:62,856,109...62,888,860
Ensembl chr11:62,855,970...62,888,910

G

solute carrier family 40 member 1

decreases expression

ISO

epoxiconazole results in decreased expression of SLC40A1 mRNA

NCBI chr 2:189,560,590...189,580,786
Ensembl chr 2:189,560,538...189,583,758

G

solute carrier family 41 member 2

affects expression

ISO

epoxiconazole affects the expression of SLC41A2 mRNA

NCBI chr12:104,801,801...104,958,746
Ensembl chr12:104,801,801...104,958,759

G

solute carrier family 43 member 1

decreases expression

ISO

epoxiconazole results in decreased expression of SLC43A1 mRNA

NCBI chr11:57,484,534...57,515,702
Ensembl chr11:57,484,064...57,515,780

G

solute carrier family 43 member 2

decreases expression

ISO

epoxiconazole results in decreased expression of SLC43A2 mRNA

NCBI chr17:1,569,254...1,630,088
Ensembl chr17:1,569,268...1,630,103

G

solute carrier family 44 member 3

decreases expression

ISO

epoxiconazole results in decreased expression of SLC44A3 mRNA

NCBI chr 1:94,820,357...94,895,247
Ensembl chr 1:94,820,278...94,895,246

G

solute carrier family 45 member 3

decreases expression

ISO

epoxiconazole results in decreased expression of SLC45A3 mRNA

NCBI chr 1:205,657,851...205,680,509
Ensembl chr 1:205,657,851...205,680,990

G

solute carrier family 46 member 3

affects expression

ISO

epoxiconazole affects the expression of SLC46A3 mRNA

NCBI chr13:28,700,080...28,718,970
Ensembl chr13:28,700,064...28,719,012

G

solute carrier family 47 member 2

increases expression

ISO

epoxiconazole results in increased expression of SLC47A2 mRNA

NCBI chr17:19,678,317...19,718,979
Ensembl chr17:19,678,288...19,718,979

G

solute carrier family 48 member 1

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of SLC48A1 mRNA
epoxiconazole results in decreased expression of SLC48A1 mRNA

PMID:22334560 PMID:35436446

NCBI chr12:47,753,934...47,782,751
Ensembl chr12:47,753,916...47,782,751

G

solute carrier family 50 member 1

increases expression

ISO

epoxiconazole results in increased expression of SLC50A1 mRNA

NCBI chr 1:155,135,375...155,138,853
Ensembl chr 1:155,135,344...155,138,857

G

solute carrier family 51 member A

affects expression

ISO

epoxiconazole affects the expression of SLC51A mRNA

NCBI chr 3:196,216,534...196,233,427
Ensembl chr 3:196,211,487...196,243,178

G

SLC51 subunit beta

decreases expression

ISO

epoxiconazole results in decreased expression of SLC51B mRNA

NCBI chr15:65,045,387...65,053,397
Ensembl chr15:65,045,387...65,053,397

G

solute carrier family 52 member 2

decreases expression

ISO

epoxiconazole results in decreased expression of SLC52A2 mRNA

NCBI chr 8:144,358,552...144,361,272
Ensembl chr 8:144,333,957...144,361,447

G

solute carrier family 5 member 6

affects expression

ISO

epoxiconazole affects the expression of SLC5A6 mRNA

NCBI chr 2:27,199,587...27,212,787
Ensembl chr 2:27,199,587...27,212,958

G

solute carrier family 66 member 2

decreases expression

ISO

epoxiconazole results in decreased expression of SLC66A2 mRNA

NCBI chr18:79,902,420...79,951,653
Ensembl chr18:79,902,420...79,951,676

G

solute carrier family 6 member 11

increases expression

ISO

epoxiconazole results in increased expression of SLC6A11 mRNA

NCBI chr 3:10,816,228...10,940,714
Ensembl chr 3:10,816,201...10,940,714

G

solute carrier family 6 member 13

decreases expression

ISO

epoxiconazole results in decreased expression of SLC6A13 mRNA

NCBI chr12:220,622...262,836
Ensembl chr12:220,621...262,873

G

solute carrier family 6 member 14

decreases expression

ISO

epoxiconazole results in decreased expression of SLC6A14 mRNA

NCBI chr X:116,436,606...116,461,458
Ensembl chr X:116,436,606...116,461,458

G

solute carrier family 6 member 17

increases expression

ISO

epoxiconazole results in increased expression of SLC6A17 mRNA

NCBI chr 1:110,150,494...110,202,202
Ensembl chr 1:110,150,494...110,202,202

G

solute carrier family 6 member 19

increases expression

ISO

epoxiconazole results in increased expression of SLC6A19 mRNA

NCBI chr 5:1,201,595...1,225,111
Ensembl chr 5:1,201,595...1,225,111

G

solute carrier family 6 member 3

decreases expression

ISO

epoxiconazole results in decreased expression of SLC6A3 mRNA

NCBI chr 5:1,392,794...1,445,440
Ensembl chr 5:1,392,794...1,445,514

G

solute carrier family 6 member 8

decreases expression

ISO

epoxiconazole results in decreased expression of SLC6A8 mRNA

NCBI chr X:153,687,926...153,696,593
Ensembl chr X:153,687,926...153,696,591

G

solute carrier family 6 member 9

affects expression

ISO

epoxiconazole affects the expression of SLC6A9 mRNA

NCBI chr 1:43,996,483...44,031,462
Ensembl chr 1:43,991,500...44,031,467

G

solute carrier family 7 member 2

decreases expression

ISO

epoxiconazole results in decreased expression of SLC7A2 mRNA

NCBI chr 8:17,494,069...17,570,566
Ensembl chr 8:17,496,975...17,570,573

G

solute carrier family 7 member 7

decreases expression

ISO

epoxiconazole results in decreased expression of SLC7A7 mRNA

NCBI chr14:22,773,222...22,819,791
Ensembl chr14:22,773,222...22,829,820

G

solute carrier family 8 member B1

decreases expression

ISO

epoxiconazole results in decreased expression of SLC8B1 mRNA

NCBI chr12:113,298,771...113,335,109
Ensembl chr12:113,298,759...113,359,502

G

solute carrier family 9 member A6

decreases expression

ISO

epoxiconazole results in decreased expression of SLC9A6 mRNA

NCBI chr X:135,973,837...136,047,269
Ensembl chr X:135,973,841...136,047,269

G

solute carrier family 9 member A8

decreases expression

ISO

epoxiconazole results in decreased expression of SLC9A8 mRNA

NCBI chr20:49,812,828...49,892,242
Ensembl chr20:49,812,713...49,892,242

G

solute carrier organic anion transporter family member 2B1

decreases expression

ISO

epoxiconazole results in decreased expression of SLCO2B1 mRNA

NCBI chr11:75,151,107...75,206,549
Ensembl chr11:75,100,563...75,206,549

G

solute carrier organic anion transporter family member 3A1

increases expression

ISO

epoxiconazole results in increased expression of SLCO3A1 mRNA

NCBI chr15:91,853,708...92,172,435
Ensembl chr15:91,853,708...92,172,435

G

schlafen family member 11

increases expression

ISO

epoxiconazole results in increased expression of SLFN9 mRNA

NCBI chr17:35,350,305...35,373,621
Ensembl chr17:35,350,305...35,373,701

G

SRA stem-loop interacting RNA binding protein

increases expression

ISO

epoxiconazole results in increased expression of SLIRP mRNA

NCBI chr14:77,708,071...77,717,598
Ensembl chr14:77,708,045...77,761,104

G

slit guidance ligand 1

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLIT1 mRNA

NCBI chr10:96,998,038...97,185,959
Ensembl chr10:96,998,038...97,185,959

G

SLIT and NTRK like family member 4

increases expression

ISO

epoxiconazole results in increased expression of SLITRK4 mRNA

NCBI chr X:143,622,790...143,636,101
Ensembl chr X:143,622,790...143,636,101

G

SLIT and NTRK like family member 5

increases expression

ISO

epoxiconazole results in increased expression of SLITRK5 mRNA

NCBI chr13:87,671,371...87,679,616
Ensembl chr13:87,671,371...87,696,272

G

secreted LY6/PLAUR domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of SLURP1 mRNA

NCBI chr 8:142,740,949...142,742,406
Ensembl chr 8:142,740,949...142,742,406

G

SLX1 homolog A, structure-specific endonuclease subunit

decreases expression

ISO

epoxiconazole results in decreased expression of SLX1B mRNA

NCBI chr16:30,193,843...30,197,566
Ensembl chr16:30,193,875...30,197,566

G

SLX4 interacting protein

decreases expression

ISO

epoxiconazole results in decreased expression of SLX4IP mRNA

NCBI chr20:10,435,305...10,628,030
Ensembl chr20:10,435,299...10,636,829

G

SMAD family member 6

decreases expression

ISO

epoxiconazole results in decreased expression of SMAD6 mRNA

NCBI chr15:66,702,236...66,782,849
Ensembl chr15:66,702,236...66,782,849

G

SMAD family member 7

decreases expression

ISO

epoxiconazole results in decreased expression of SMAD7 mRNA

NCBI chr18:48,919,853...48,950,965
Ensembl chr18:48,919,853...48,952,020

G

SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4

decreases expression

ISO

epoxiconazole results in decreased expression of SMARCA4 mRNA

NCBI chr19:10,961,030...11,062,273
Ensembl chr19:10,960,824...11,079,426

G

SNF2 related chromatin remodeling ATPase 5

increases expression

ISO

epoxiconazole results in increased expression of SMARCA5 mRNA

NCBI chr 4:143,513,702...143,557,486
Ensembl chr 4:143,513,445...143,557,486

G

SWI/SNF related BAF chromatin remodeling complex subunit B1

decreases expression

ISO

epoxiconazole results in decreased expression of SMARCB1 mRNA

NCBI chr22:23,786,966...23,838,009
Ensembl chr22:23,786,931...23,838,009

G

SWI/SNF related BAF chromatin remodeling complex subunit C1

decreases expression

ISO

epoxiconazole results in decreased expression of SMARCC1 mRNA

NCBI chr 3:47,585,269...47,781,893
Ensembl chr 3:47,585,269...47,782,106

G

structural maintenance of chromosomes flexible hinge domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of SMCHD1 mRNA

NCBI chr18:2,655,726...2,805,017
Ensembl chr18:2,655,668...2,805,017

G

single-pass membrane protein with coiled-coil domains 4

increases expression

ISO

epoxiconazole results in increased expression of SMCO4 mRNA

NCBI chr11:93,478,472...93,553,979
Ensembl chr11:93,478,468...93,543,764

G

SMG5 nonsense mediated mRNA decay factor

increases expression

ISO

epoxiconazole results in increased expression of SMG5 mRNA

NCBI chr 1:156,249,224...156,291,516
Ensembl chr 1:156,249,223...156,282,844

G

SMG6 nonsense mediated mRNA decay factor

decreases expression

ISO

epoxiconazole results in decreased expression of SMG6 mRNA

NCBI chr17:2,059,839...2,303,785
Ensembl chr17:2,059,839...2,303,785

G

small integral membrane protein 1 (Vel blood group)

increases expression

ISO

epoxiconazole results in increased expression of SMIM1 mRNA

NCBI chr 1:3,772,749...3,775,956
Ensembl chr 1:3,772,655...3,776,709

G

small integral membrane protein 13

increases expression

ISO

epoxiconazole results in increased expression of SMIM13 mRNA

NCBI chr 6:11,093,834...11,138,733
Ensembl chr 6:11,093,834...11,138,733

G

small integral membrane protein 15

increases expression

ISO

epoxiconazole results in increased expression of SMIM15 mRNA

NCBI chr 5:61,157,704...61,162,468
Ensembl chr 5:61,157,704...61,163,142

G

small integral membrane protein 35

increases expression

ISO

epoxiconazole results in increased expression of SMIM35 mRNA

NCBI chr11:118,003,634...118,086,963
Ensembl chr11:118,003,634...118,088,299

G

small integral membrane protein 41

decreases expression

ISO

epoxiconazole results in decreased expression of SMIM41 mRNA

NCBI chr12:52,079,704...52,108,255
Ensembl chr12:52,079,704...52,108,255

G

small integral membrane protein 8

increases expression

ISO

epoxiconazole results in increased expression of SMIM8 mRNA

NCBI chr 6:87,322,588...87,342,329
Ensembl chr 6:87,322,580...87,399,749

G

small leucine rich protein 1

increases expression

ISO

epoxiconazole results in increased expression of SMLR1 mRNA

NCBI chr 6:130,827,406...130,837,135
Ensembl chr 6:130,827,406...130,837,135

G

survival of motor neuron 1, telomeric

increases expression

ISO

epoxiconazole results in increased expression of SMN1 mRNA

NCBI chr 5:70,924,941...70,966,375
Ensembl chr 5:70,925,030...70,953,942
Ensembl chr 5:70,925,030...70,953,942

G

sphingomyelin phosphodiesterase 2

decreases expression

ISO

epoxiconazole results in decreased expression of SMPD2 mRNA

NCBI chr 6:109,440,724...109,443,919
Ensembl chr 6:109,440,678...109,443,920

G

sphingomyelin phosphodiesterase 3

increases expression

ISO

epoxiconazole results in increased expression of SMPD3 mRNA

PMID:22334560 PMID:23970803

NCBI chr16:68,358,327...68,448,508
Ensembl chr16:68,358,327...68,448,508

G

sphingomyelin phosphodiesterase 4

decreases expression

ISO

epoxiconazole results in decreased expression of SMPD4 mRNA

NCBI chr 2:130,151,392...130,181,757
Ensembl chr 2:130,151,392...130,183,901

G

submaxillary gland androgen regulated protein 3A

increases expression

ISO

epoxiconazole results in increased expression of SMR3A mRNA

NCBI chr 4:70,360,760...70,367,158
Ensembl chr 4:70,360,760...70,367,158

G

SMAD specific E3 ubiquitin protein ligase 1

decreases expression

ISO

epoxiconazole results in decreased expression of SMURF1 mRNA

NCBI chr 7:99,027,440...99,144,108
Ensembl chr 7:99,027,435...99,144,164

G

synaptosome associated protein 47

decreases expression

ISO

epoxiconazole results in decreased expression of SNAP47 mRNA

NCBI chr 1:227,728,168...227,781,226
Ensembl chr 1:227,728,200...227,781,826

G

small nuclear RNA activating complex polypeptide 1

increases expression

ISO

epoxiconazole results in increased expression of SNAPC1 mRNA

NCBI chr14:61,762,420...61,796,428
Ensembl chr14:61,762,325...61,796,443

G

synuclein gamma

increases expression

ISO

epoxiconazole results in increased expression of SNCG mRNA

NCBI chr10:86,955,759...86,963,258
Ensembl chr10:86,955,771...86,963,261

G

small nuclear ribonucleoprotein D2 polypeptide

increases expression

ISO

epoxiconazole results in increased expression of SNRPD2 mRNA

NCBI chr19:45,687,454...45,692,316
Ensembl chr19:45,687,460...45,692,569

G

small nuclear ribonucleoprotein polypeptide E

increases expression

ISO

epoxiconazole results in increased expression of SNRPE mRNA

NCBI chr 1:203,861,599...203,871,152
Ensembl chr 1:203,861,598...203,871,152

G

small nuclear ribonucleoprotein polypeptide G

increases expression

ISO

epoxiconazole results in increased expression of SNRPG mRNA

NCBI chr 2:70,281,362...70,293,740
Ensembl chr 2:70,281,362...70,293,740

G

syntrophin beta 1

decreases expression

ISO

epoxiconazole results in decreased expression of SNTB1 mRNA

NCBI chr 8:120,535,756...120,812,046
Ensembl chr 8:120,535,745...120,813,273

G

snurportin 1

decreases expression

ISO

epoxiconazole results in decreased expression of SNUPN mRNA

NCBI chr15:75,598,086...75,626,461
Ensembl chr15:75,598,083...75,626,469

G

sorting nexin 1

decreases expression

ISO

epoxiconazole results in decreased expression of SNX1 mRNA

NCBI chr15:64,095,982...64,144,231
Ensembl chr15:64,094,123...64,146,090

G

sorting nexin 17

decreases expression

ISO

epoxiconazole results in decreased expression of SNX17 mRNA

PMID:22334560 PMID:35436446

NCBI chr 2:27,370,616...27,377,535
Ensembl chr 2:27,370,496...27,377,535

G

sorting nexin 20

increases expression

ISO

epoxiconazole results in increased expression of SNX20 mRNA

NCBI chr16:50,666,300...50,681,312
Ensembl chr16:50,666,300...50,681,743

G

sorting nexin 25

decreases expression

ISO

epoxiconazole results in decreased expression of SNX25 mRNA

NCBI chr 4:185,204,237...185,378,642
Ensembl chr 4:185,204,237...185,390,928

G

sorting nexin 29

decreases expression

ISO

epoxiconazole results in decreased expression of SNX29 mRNA

NCBI chr16:11,976,734...12,574,287
Ensembl chr16:11,976,734...12,574,287

G

sorting nexin 32

decreases expression

ISO

epoxiconazole results in decreased expression of SNX32 mRNA

NCBI chr11:65,833,963...65,853,701
Ensembl chr11:65,833,834...65,856,896

G

sorting nexin 4

decreases expression

ISO

epoxiconazole results in decreased expression of SNX4 mRNA

NCBI chr 3:125,446,650...125,520,202
Ensembl chr 3:125,446,644...125,520,233

G

sorting nexin 5

increases expression

ISO

epoxiconazole results in increased expression of SNX5 mRNA

NCBI chr20:17,941,600...17,968,794
Ensembl chr20:17,941,597...17,969,022

G

sterol O-acyltransferase 1

decreases expression

ISO

epoxiconazole results in decreased expression of SOAT1 mRNA

NCBI chr 1:179,293,797...179,358,680
Ensembl chr 1:179,293,440...179,358,680

G

suppressor of cytokine signaling 2

affects expression

ISO

epoxiconazole affects the expression of SOCS2 mRNA

NCBI chr12:93,569,969...93,626,236
Ensembl chr12:93,569,808...93,583,487

G

suppressor of cytokine signaling 6

decreases expression

ISO

epoxiconazole results in decreased expression of SOCS6 mRNA

NCBI chr18:70,289,045...70,330,199
Ensembl chr18:70,288,888...70,330,199

G

suppressor of cytokine signaling 7

increases expression

ISO

epoxiconazole results in increased expression of SOCS7 mRNA

NCBI chr17:38,351,844...38,405,593
Ensembl chr17:38,351,844...38,405,593

G

superoxide dismutase 3

decreases expression

ISO

epoxiconazole results in decreased expression of SOD3 mRNA

NCBI chr 4:24,795,573...24,800,842
Ensembl chr 4:24,789,912...24,800,848

G

sorbitol dehydrogenase

decreases expression

ISO

epoxiconazole results in decreased expression of SORD mRNA

NCBI chr15:45,023,195...45,077,185
Ensembl chr15:45,023,147...45,077,185

G

SOS Ras/Rho guanine nucleotide exchange factor 2

affects expression

ISO

epoxiconazole affects the expression of SOS2 mRNA

NCBI chr14:50,117,130...50,231,882
Ensembl chr14:50,117,130...50,231,906

G

sosondowah ankyrin repeat domain family member A

increases expression

ISO

epoxiconazole results in increased expression of SOWAHA mRNA

NCBI chr 5:132,813,302...132,816,786
Ensembl chr 5:132,813,302...132,816,786

G

SRY-box transcription factor 10

decreases expression

ISO

epoxiconazole results in decreased expression of SOX10 mRNA

NCBI chr22:37,972,312...37,984,555
Ensembl chr22:37,970,686...37,987,422

G

SRY-box transcription factor 13

increases expression

ISO

epoxiconazole results in increased expression of SOX13 mRNA

NCBI chr 1:204,073,115...204,127,743
Ensembl chr 1:204,073,111...204,127,743

G

SP110 nuclear body protein

increases expression

ISO

epoxiconazole results in increased expression of SP110 mRNA

NCBI chr 2:230,165,186...230,225,636
Ensembl chr 2:230,165,186...230,225,729

G

Sp4 transcription factor

affects expression

ISO

epoxiconazole affects the expression of SP4 mRNA

NCBI chr 7:21,428,083...21,514,822
Ensembl chr 7:21,428,043...21,514,822

G

sperm acrosome associated 4

decreases expression

ISO

epoxiconazole results in decreased expression of SPACA4 mRNA

NCBI chr19:48,606,742...48,607,714
Ensembl chr19:48,606,742...48,607,714

G

SPARC like 1

decreases expression

ISO

epoxiconazole results in decreased expression of SPARCL1 mRNA

NCBI chr 4:87,473,335...87,529,376
Ensembl chr 4:87,473,329...87,531,118

G

spartin

decreases expression

ISO

epoxiconazole results in decreased expression of SPART mRNA

NCBI chr13:36,301,638...36,370,180
Ensembl chr13:36,301,638...36,370,215

G

spermatogenesis associated 1

decreases expression

ISO

epoxiconazole results in decreased expression of SPATA1 mRNA

NCBI chr 1:84,506,386...84,567,379
Ensembl chr 1:84,506,300...84,567,379

G

spermatogenesis associated 2 like

decreases expression

ISO

epoxiconazole results in decreased expression of SPATA2L mRNA

NCBI chr16:89,696,357...89,701,705
Ensembl chr16:89,696,357...89,701,705

G

spermatogenesis associated 33

increases expression

ISO

epoxiconazole results in increased expression of SPATA33 mRNA

NCBI chr16:89,657,776...89,670,458
Ensembl chr16:89,657,740...89,671,272

G

spermatogenesis associated 6

decreases expression

ISO

epoxiconazole results in decreased expression of SPATA6 mRNA

NCBI chr 1:48,261,389...48,472,204
Ensembl chr 1:48,295,373...48,472,279

G

SPC25 component of NDC80 kinetochore complex

decreases expression

ISO

epoxiconazole results in decreased expression of SPC25 mRNA

NCBI chr 2:168,861,521...168,890,430
Ensembl chr 2:168,834,132...168,913,371

G

signal peptidase complex subunit 2

increases expression

ISO

epoxiconazole results in increased expression of SPCS2 mRNA

PMID:22334560 PMID:35436446

NCBI chr11:74,949,266...74,979,033
Ensembl chr11:74,949,259...74,979,033

G

spen family transcriptional repressor

decreases expression

ISO

epoxiconazole results in decreased expression of SPEN mRNA

NCBI chr 1:15,847,707...15,940,456
Ensembl chr 1:15,836,095...15,940,456

G

SPG21 abhydrolase domain containing, maspardin

increases expression

ISO

epoxiconazole results in increased expression of SPG21 mRNA

NCBI chr15:64,963,022...64,989,914
Ensembl chr15:64,963,022...64,990,312

G

SPG7 matrix AAA peptidase subunit, paraplegin

decreases expression

ISO

epoxiconazole results in decreased expression of SPG7 mRNA

NCBI chr16:89,490,970...89,499,282
Ensembl chr16:89,490,719...89,557,766

G

Spi-1 proto-oncogene

increases expression

ISO

epoxiconazole results in increased expression of SPI1 mRNA

NCBI chr11:47,354,860...47,378,547
Ensembl chr11:47,354,860...47,409,369

G

Spi-C transcription factor

decreases expression

ISO

epoxiconazole results in decreased expression of SPIC mRNA

NCBI chr12:101,475,336...101,486,997
Ensembl chr12:101,475,336...101,486,997

G

serine peptidase inhibitor Kazal type 2

increases expression

ISO

epoxiconazole results in increased expression of SPINK2 mRNA

NCBI chr 4:56,809,860...56,821,869
Ensembl chr 4:56,809,860...56,821,742

G

serine peptidase inhibitor Kazal type 5

decreases expression

ISO

epoxiconazole results in decreased expression of SPINK5 mRNA

NCBI chr 5:148,063,980...148,137,382
Ensembl chr 5:148,025,683...148,137,382

G

serine peptidase inhibitor Kazal type 9

increases expression

ISO

epoxiconazole results in increased expression of SPINK12 mRNA

NCBI chr 5:148,321,305...148,339,852
Ensembl chr 5:148,321,203...148,339,852

G

serine peptidase inhibitor, Kunitz type 3

increases expression

ISO

epoxiconazole results in increased expression of SPINT3 mRNA

NCBI chr20:45,512,461...45,515,622
Ensembl chr20:45,512,461...45,515,622

G

SPNS lysolipid transporter 2, sphingosine-1-phosphate

decreases expression

ISO

epoxiconazole results in decreased expression of SPNS2 mRNA

NCBI chr17:4,498,881...4,539,035
Ensembl chr17:4,498,850...4,539,036

G

spondin 2

increases expression

ISO

epoxiconazole results in increased expression of SPON2 mRNA

NCBI chr 4:1,166,932...1,208,844
Ensembl chr 4:1,166,932...1,208,962

G

sprouty related EVH1 domain containing 2

increases expression

ISO

epoxiconazole results in increased expression of SPRED2 mRNA

NCBI chr 2:65,307,175...65,432,599
Ensembl chr 2:65,310,851...65,432,637

G

shadow of prion protein

increases expression

ISO

epoxiconazole results in increased expression of SPRN mRNA

NCBI chr10:133,420,666...133,424,625
Ensembl chr10:133,420,666...133,424,625

G

small proline rich protein 2F

increases expression

ISO

epoxiconazole results in increased expression of SPRR2F mRNA

NCBI chr 1:153,112,121...153,119,468
Ensembl chr 1:153,112,121...153,113,516

G

SPRY domain containing 7

increases expression

ISO

epoxiconazole results in increased expression of SPRYD7 mRNA

NCBI chr13:49,912,702...49,936,340
Ensembl chr13:49,912,702...49,936,490

G

spectrin beta, non-erythrocytic 2

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SPTBN2 mRNA

NCBI chr11:66,682,497...66,744,682
Ensembl chr11:66,682,496...66,744,670

G

squalene epoxidase

decreases expression
increases expression

ISO
EXP

epoxiconazole results in decreased expression of SQLE mRNA
epoxiconazole results in increased expression of SQLE mRNA

PMID:34182286 PMID:35436446

NCBI chr 8:124,998,505...125,022,283
Ensembl chr 8:124,998,467...125,022,287

G

sulfide quinone oxidoreductase

decreases expression

ISO

epoxiconazole results in decreased expression of SQOR mRNA

NCBI chr15:45,631,148...45,691,281
Ensembl chr15:45,631,148...45,691,299

G

SRC proto-oncogene, non-receptor tyrosine kinase

increases expression

ISO

epoxiconazole results in increased expression of SRC mRNA

NCBI chr20:37,344,699...37,406,050
Ensembl chr20:37,344,673...37,406,050

G

steroid 5 alpha-reductase 1

decreases expression
increases expression

ISO

epoxiconazole results in decreased expression of SRD5A1 mRNA
epoxiconazole results in increased expression of SRD5A1 mRNA

PMID:22334560 PMID:35436446

NCBI chr 5:6,633,440...6,674,386
Ensembl chr 5:6,633,290...6,676,539

G

steroid 5 alpha-reductase 2

decreases expression

ISO

epoxiconazole results in decreased expression of SRD5A2 mRNA

NCBI chr 2:31,522,480...31,663,009
Ensembl chr 2:31,522,480...31,580,941

G

sterol regulatory element binding transcription factor 2

decreases expression

ISO

epoxiconazole results in decreased expression of SREBF2 mRNA

NCBI chr22:41,833,105...41,907,305
Ensembl chr22:41,833,099...41,907,308

G

SREK1 interacting protein 1

increases expression

ISO

epoxiconazole results in increased expression of SREK1IP1 mRNA

NCBI chr 5:64,718,148...64,768,691
Ensembl chr 5:64,718,148...64,768,692

G

serum response factor binding protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of SRFBP1 mRNA

NCBI chr 5:121,961,975...122,078,935
Ensembl chr 5:121,961,965...122,075,570

G

spermidine synthase

decreases expression

ISO

epoxiconazole results in decreased expression of SRM mRNA

NCBI chr 1:11,054,589...11,060,018
Ensembl chr 1:11,054,584...11,060,053

G

src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites

decreases expression

ISO

epoxiconazole results in decreased expression of SRMS mRNA

NCBI chr20:63,538,489...63,547,749
Ensembl chr20:63,538,489...63,547,749

G

signal recognition particle 54

increases expression

ISO

epoxiconazole results in increased expression of SRP54A mRNA

NCBI chr14:34,982,992...35,029,567
Ensembl chr14:34,981,957...35,029,686

G

signal recognition particle 9

increases expression

ISO

epoxiconazole results in increased expression of SRP9 mRNA

NCBI chr 1:225,777,826...225,790,464
Ensembl chr 1:225,777,699...225,790,670

G

SRP receptor subunit alpha

increases expression

ISO

epoxiconazole results in increased expression of SRPRA mRNA

NCBI chr11:126,235,930...126,268,895
Ensembl chr11:126,262,912...126,269,144

G

SRP receptor subunit beta

decreases expression

ISO

epoxiconazole results in decreased expression of SRPRB mRNA

NCBI chr 3:133,784,023...133,828,574
Ensembl chr 3:133,784,023...133,825,772

G

serine/arginine repetitive matrix 4

increases expression

ISO

epoxiconazole results in increased expression of SRRM4 mRNA

NCBI chr12:118,981,541...119,163,051
Ensembl chr12:118,981,541...119,163,051

G

serine and arginine rich splicing factor 5

increases expression

ISO

epoxiconazole results in increased expression of SRSF5 mRNA

NCBI chr14:69,767,142...69,772,005
Ensembl chr14:69,726,893...69,773,904

G

serine and arginine rich splicing factor 9

increases expression

ISO

epoxiconazole results in increased expression of SRSF9 mRNA

NCBI chr12:120,461,672...120,469,748
Ensembl chr12:120,456,138...120,495,946

G

sulfiredoxin 1

increases expression

ISO

epoxiconazole results in increased expression of SRXN1 mRNA

PMID:22334560 PMID:23970803

NCBI chr20:646,615...653,200
Ensembl chr20:646,615...653,378

G

small RNA binding exonuclease protection factor La

increases expression

ISO

epoxiconazole results in increased expression of SSB mRNA

NCBI chr 2:169,798,871...169,812,064
Ensembl chr 2:169,791,933...169,812,091

G

single stranded DNA binding protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of SSBP2 mRNA

NCBI chr 5:81,412,804...81,751,807
Ensembl chr 5:81,412,804...81,752,038

G

single stranded DNA binding protein 3

decreases expression

ISO

epoxiconazole results in decreased expression of SSBP3 mRNA

NCBI chr 1:54,225,432...54,413,490
Ensembl chr 1:54,225,432...54,413,479

G

sarcospan

increases expression

ISO

epoxiconazole results in increased expression of SSPN mRNA

NCBI chr12:26,121,991...26,234,777
Ensembl chr12:26,121,991...26,299,290

G

signal sequence receptor subunit 2

increases expression

ISO

epoxiconazole results in increased expression of SSR2 mRNA

NCBI chr 1:156,009,048...156,020,951
Ensembl chr 1:156,009,041...156,020,968

G

somatostatin receptor 2

increases expression

ISO

epoxiconazole results in increased expression of SSTR2 mRNA

NCBI chr17:73,165,010...73,176,633
Ensembl chr17:73,165,010...73,176,633

G

SSX family member 2 interacting protein

increases expression

ISO

epoxiconazole results in increased expression of SSX2IP mRNA

NCBI chr 1:84,643,706...84,690,745
Ensembl chr 1:84,643,706...84,690,955

G

ST18 C2H2C-type zinc finger transcription factor

increases expression

ISO

epoxiconazole results in increased expression of ST18 mRNA

NCBI chr 8:52,110,838...52,409,879
Ensembl chr 8:52,110,838...52,460,983

G

ST3 beta-galactoside alpha-2,3-sialyltransferase 1

increases expression

ISO

epoxiconazole results in increased expression of ST3GAL1 mRNA

NCBI chr 8:133,454,848...133,571,887
Ensembl chr 8:133,454,848...133,572,518

G

ST3 beta-galactoside alpha-2,3-sialyltransferase 5

decreases expression

ISO

epoxiconazole results in decreased expression of ST3GAL5 mRNA

NCBI chr 2:85,837,120...85,889,034
Ensembl chr 2:85,837,120...85,905,199

G

ST6 beta-galactoside alpha-2,6-sialyltransferase 1

decreases expression

ISO

epoxiconazole results in decreased expression of ST6GAL1 mRNA

NCBI chr 3:186,930,526...187,078,553
Ensembl chr 3:186,930,325...187,078,932

G

stabilin 1

decreases expression

ISO

epoxiconazole results in decreased expression of STAB1 mRNA

NCBI chr 3:52,495,338...52,524,495
Ensembl chr 3:52,495,337...52,524,512

G

stabilin 2

decreases expression

ISO

epoxiconazole results in decreased expression of STAB2 mRNA

NCBI chr12:103,587,273...103,766,719
Ensembl chr12:103,587,273...103,766,719

G

signal transducing adaptor molecule

increases expression

ISO

epoxiconazole results in increased expression of STAM mRNA

NCBI chr10:17,644,151...17,716,824
Ensembl chr10:17,644,124...17,716,824

G

signal transducing adaptor family member 2

decreases expression

ISO

epoxiconazole results in decreased expression of STAP2 mRNA

NCBI chr19:4,324,043...4,338,827
Ensembl chr19:4,324,040...4,342,786

G

steroidogenic acute regulatory protein

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of STAR mRNA

NCBI chr 8:38,142,700...38,150,952
Ensembl chr 8:38,141,747...38,151,061

G

StAR related lipid transfer domain containing 13

affects expression

ISO

epoxiconazole affects the expression of STARD13 mRNA

NCBI chr13:33,103,137...33,676,794
Ensembl chr13:33,103,137...33,350,630

G

StAR related lipid transfer domain containing 5

decreases expression

ISO

epoxiconazole results in decreased expression of STARD5 mRNA

NCBI chr15:81,309,053...81,324,141
Ensembl chr15:81,309,053...81,324,183

G

StAR related lipid transfer domain containing 8

decreases expression

ISO

epoxiconazole results in decreased expression of STARD8 mRNA

NCBI chr X:68,647,666...68,725,836
Ensembl chr X:68,647,666...68,725,842

G

signal transducer and activator of transcription 2

decreases expression

ISO

epoxiconazole results in decreased expression of STAT2 mRNA

NCBI chr12:56,341,597...56,360,107
Ensembl chr12:56,341,597...56,360,274

G

signal transducer and activator of transcription 3

decreases expression

ISO

epoxiconazole results in decreased expression of STAT3 mRNA

NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568

G

signal transducer and activator of transcription 5A

decreases expression

ISO

epoxiconazole results in decreased expression of STAT5A mRNA

NCBI chr17:42,287,439...42,311,943
Ensembl chr17:42,287,547...42,311,943

G

signal transducer and activator of transcription 5B

decreases activity

ISO

epoxiconazole results in decreased activity of STAT5B protein

NCBI chr17:42,199,177...42,288,370
Ensembl chr17:42,199,176...42,288,633

G

starch binding domain 1

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of STBD1 mRNA
epoxiconazole results in decreased expression of STBD1 mRNA

PMID:22334560 PMID:29038839 PMID:35436446

NCBI chr 4:76,306,733...76,311,130
Ensembl chr 4:76,306,733...76,311,130

G

STEAP3 metalloreductase

increases expression

ISO

epoxiconazole results in increased expression of STEAP3 mRNA

NCBI chr 2:119,223,834...119,265,652
Ensembl chr 2:119,222,447...119,265,652

G

stromal interaction molecule 1

decreases expression

ISO

epoxiconazole results in decreased expression of STIM1 mRNA

NCBI chr11:3,854,604...4,093,210
Ensembl chr11:3,854,527...4,093,210

G

stromal interaction molecule 2

affects expression

ISO

epoxiconazole affects the expression of STIM2 mRNA

NCBI chr 4:26,860,841...27,025,381
Ensembl chr 4:26,857,601...27,025,381

G

stress induced phosphoprotein 1

decreases expression

ISO

epoxiconazole results in decreased expression of STIP1 mRNA

NCBI chr11:64,185,272...64,204,543
Ensembl chr11:64,185,272...64,204,548

G

serine/threonine kinase 16

decreases expression

ISO

epoxiconazole results in decreased expression of STK16 mRNA

NCBI chr 2:219,245,479...219,250,337
Ensembl chr 2:219,245,455...219,250,339

G

serine/threonine kinase 31

increases expression

ISO

epoxiconazole results in increased expression of STK31 mRNA

NCBI chr 7:23,710,082...23,832,513
Ensembl chr 7:23,710,203...23,832,513

G

serine/threonine kinase 32C

increases expression

ISO

epoxiconazole results in increased expression of STK32C mRNA

NCBI chr10:132,207,482...132,332,235
Ensembl chr10:132,207,483...132,331,847

G

serine/threonine kinase 35

increases expression

ISO

epoxiconazole results in increased expression of STK35 mRNA

NCBI chr20:2,101,827...2,148,555
Ensembl chr20:2,101,767...2,177,038

G

serine/threonine kinase 38 like

decreases expression

ISO

epoxiconazole results in decreased expression of STK38L mRNA

NCBI chr12:27,244,286...27,325,959
Ensembl chr12:27,243,968...27,325,959

G

stathmin 2

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of STMN2 mRNA

NCBI chr 8:79,611,117...79,666,158
Ensembl chr 8:79,611,117...79,666,159

G

sperm tail PG-rich repeat containing 2

decreases expression

ISO

epoxiconazole results in decreased expression of STPG2 mRNA

NCBI chr 4:97,441,249...98,143,476
Ensembl chr 4:97,184,093...98,143,476

G

STRA6 like, pseudogene

affects expression

ISO

epoxiconazole affects the expression of STRA6L mRNA

NCBI chr 9:97,290,853...97,294,111

G

STE20 related adaptor beta

increases expression

ISO

epoxiconazole results in increased expression of STRADB mRNA

NCBI chr 2:201,451,740...201,480,846
Ensembl chr 2:201,387,858...201,480,850

G

serine/threonine kinase receptor associated protein

decreases expression

ISO

epoxiconazole results in decreased expression of STRAP mRNA

NCBI chr12:15,882,387...15,903,478
Ensembl chr12:15,882,356...15,903,478

G

striatin interacting protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of STRIP1 mRNA

NCBI chr 1:110,031,577...110,054,641
Ensembl chr 1:110,031,577...110,074,641

G

steroid sulfatase

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of STS mRNA

NCBI chr X:7,147,290...7,354,641
Ensembl chr X:7,147,237...7,804,358

G

STT3 oligosaccharyltransferase complex catalytic subunit A

increases expression

ISO

epoxiconazole results in increased expression of STT3A mRNA

NCBI chr11:125,591,769...125,623,091
Ensembl chr11:125,591,712...125,625,215

G

syntaxin binding protein 1

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of STXBP1 mRNA

NCBI chr 9:127,611,912...127,696,029
Ensembl chr 9:127,579,370...127,696,027

G

serine/threonine/tyrosine interacting protein

increases expression

ISO

epoxiconazole results in increased expression of STYX mRNA

NCBI chr14:52,730,166...52,774,989
Ensembl chr14:52,730,043...52,774,989

G

SUB1 regulator of transcription

increases expression

ISO

epoxiconazole results in increased expression of SUB1 mRNA

NCBI chr 5:32,585,557...32,604,079
Ensembl chr 5:32,531,633...32,604,507

G

succinate receptor 1

increases expression

ISO

epoxiconazole results in increased expression of SUCNR1 mRNA

NCBI chr 3:151,873,643...151,884,619
Ensembl chr 3:151,873,643...151,884,619

G

SUN domain containing ossification factor

decreases expression

ISO

epoxiconazole results in decreased expression of SUCO mRNA

NCBI chr 1:172,532,349...172,611,833
Ensembl chr 1:172,532,349...172,611,833

G

SURP and G-patch domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of SUGP1 mRNA

NCBI chr19:19,276,033...19,320,509
Ensembl chr19:19,276,018...19,320,511

G

sulfatase 1

decreases expression

ISO

epoxiconazole results in decreased expression of SULF1 mRNA

NCBI chr 8:69,466,781...69,660,912
Ensembl chr 8:69,466,624...69,660,935

G

sulfotransferase family 1D member 1, pseudogene

increases expression

ISO

epoxiconazole results in increased expression of SULT1D1 mRNA

NCBI chr 4:69,791,873...69,813,872
Ensembl chr 4:69,791,872...69,813,888

G

sulfotransferase family 2B member 1

decreases expression

EXP

epoxiconazole results in decreased expression of SULT2B1 mRNA

NCBI chr19:48,552,172...48,599,427
Ensembl chr19:48,552,172...48,599,425

G

sulfatase modifying factor 1

decreases expression

ISO

epoxiconazole results in decreased expression of SUMF1 mRNA

NCBI chr 3:3,700,814...3,800,875
Ensembl chr 3:3,700,814...4,467,273

G

sulfite oxidase

increases expression

ISO

epoxiconazole results in increased expression of SUOX mRNA

NCBI chr12:55,997,276...56,005,525
Ensembl chr12:55,996,855...56,006,641

G

SPT16 homolog, facilitates chromatin remodeling subunit

decreases expression

ISO

epoxiconazole results in decreased expression of SUPT16 mRNA

NCBI chr14:21,351,476...21,384,019
Ensembl chr14:21,351,472...21,384,042

G

SPT3 homolog, SAGA and STAGA complex component

decreases expression

ISO

epoxiconazole results in decreased expression of SUPT3 mRNA

NCBI chr 6:44,809,057...45,377,934
Ensembl chr 6:44,809,317...45,377,953

G

SPT6 homolog, histone chaperone and transcription elongation factor

decreases expression

ISO

epoxiconazole results in decreased expression of SUPT6 mRNA

NCBI chr17:28,662,205...28,702,679
Ensembl chr17:28,661,929...28,702,682

G

SPT7 like, STAGA complex subunit gamma

increases expression

ISO

epoxiconazole results in increased expression of SUPT7L mRNA

NCBI chr 2:27,642,568...27,663,614
Ensembl chr 2:27,650,809...27,663,841

G

sushi domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of SUSD1 mRNA

NCBI chr 9:112,040,783...112,175,297
Ensembl chr 9:112,040,777...112,175,486

G

sushi domain containing 4

decreases expression

ISO

epoxiconazole results in decreased expression of SUSD4 mRNA

NCBI chr 1:223,220,831...223,365,235
Ensembl chr 1:223,220,819...223,365,279

G

SUV39H1 histone lysine methyltransferase

decreases expression

ISO

epoxiconazole results in decreased expression of SUV39H1 mRNA

NCBI chr X:48,695,554...48,709,016
Ensembl chr X:48,695,554...48,709,016

G

SUV39H2 histone lysine methyltransferase

decreases expression

ISO

epoxiconazole results in decreased expression of SUV39H2 mRNA

NCBI chr10:14,878,866...14,904,315
Ensembl chr10:14,878,820...14,904,315

G

SWIM-type zinc finger 7 associated protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of SWSAP1 mRNA

NCBI chr19:11,374,666...11,376,169
Ensembl chr19:11,374,666...11,376,951

G

synaptonemal complex central element protein 2

increases expression

ISO

epoxiconazole results in increased expression of SYCE2 mRNA

NCBI chr19:12,898,786...12,919,293
Ensembl chr19:12,898,786...12,919,306

G

synapse defective Rho GTPase homolog 2

affects expression

ISO

epoxiconazole affects the expression of SYDE2 mRNA

NCBI chr 1:85,152,491...85,201,016
Ensembl chr 1:85,156,851...85,201,724

G

synapsin III

decreases expression

ISO

epoxiconazole results in decreased expression of SYN3 mRNA

NCBI chr22:32,507,820...33,058,381
Ensembl chr22:32,507,820...33,058,381

G

synaptic Ras GTPase activating protein 1

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of SYNGAP1 mRNA

NCBI chr 6:33,418,167...33,453,689
Ensembl chr 6:33,419,661...33,453,689

G

synaptogyrin 2

decreases expression

ISO

epoxiconazole results in decreased expression of SYNGR2 mRNA

NCBI chr17:78,168,545...78,172,964
Ensembl chr17:78,168,567...78,173,527

G

synaptophysin

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of SYP mRNA

NCBI chr X:49,187,815...49,200,193
Ensembl chr X:49,187,807...49,200,218

G

synaptotagmin 4

increases expression

ISO

epoxiconazole results in increased expression of SYT4 mRNA

NCBI chr18:43,267,892...43,277,490
Ensembl chr18:43,267,892...43,277,535

G

synaptotagmin 9

increases expression

ISO

epoxiconazole results in increased expression of SYT9 mRNA

NCBI chr11:7,238,778...7,469,043
Ensembl chr11:7,238,778...7,469,043

G

SZT2 subunit of KICSTOR complex

affects expression

ISO

epoxiconazole affects the expression of SZT2 mRNA

NCBI chr 1:43,389,899...43,454,247
Ensembl chr 1:43,389,882...43,454,247

G

trace amine associated receptor 1

increases expression

ISO

epoxiconazole results in increased expression of TAAR1 mRNA

NCBI chr 6:132,643,312...132,659,182
Ensembl chr 6:132,643,312...132,659,182

G

TGF-beta activated kinase 1 (MAP3K7) binding protein 2

increases expression

ISO

epoxiconazole results in increased expression of TAB2 mRNA

NCBI chr 6:149,217,926...149,411,607
Ensembl chr 6:149,218,641...149,411,613

G

tachykinin receptor 3

decreases expression

ISO

epoxiconazole results in decreased expression of TACR3 mRNA

NCBI chr 4:103,586,031...103,719,985
Ensembl chr 4:103,586,031...103,719,985

G

TATA-box binding protein associated factor 15

increases expression

ISO

epoxiconazole results in increased expression of TAF15 mRNA

NCBI chr17:35,809,484...35,847,242
Ensembl chr17:35,809,481...35,864,615

G

TATA-box binding protein associated factor, RNA polymerase I subunit A

decreases expression

ISO

epoxiconazole results in decreased expression of TAF1A mRNA

NCBI chr 1:222,554,105...222,589,933
Ensembl chr 1:222,557,902...222,590,162

G

TATA-box binding protein associated factor 4b

decreases expression

ISO

epoxiconazole results in decreased expression of TAF4B mRNA

NCBI chr18:26,226,445...26,391,685
Ensembl chr18:26,226,393...26,391,685

G

TATA-box binding protein associated factor 5

increases expression

ISO

epoxiconazole results in increased expression of TAF5 mRNA

NCBI chr10:103,367,976...103,389,065
Ensembl chr10:103,367,964...103,389,065

G

TATA-box binding protein associated factor 5 like

decreases expression

ISO

epoxiconazole results in decreased expression of TAF5L mRNA

NCBI chr 1:229,593,134...229,626,122
Ensembl chr 1:229,593,111...229,626,122

G

TAFA chemokine like family member 2

affects expression

ISO

epoxiconazole affects the expression of TAFA2 mRNA

NCBI chr12:61,708,273...62,260,034
Ensembl chr12:61,707,341...62,279,150

G

tafazzin, phospholipid-lysophospholipid transacylase

decreases expression

ISO

epoxiconazole results in decreased expression of TAFAZZIN mRNA

NCBI chr X:154,411,539...154,421,726
Ensembl chr X:154,409,456...154,421,726

G

TAL bHLH transcription factor 2

increases expression

ISO

epoxiconazole results in increased expression of TAL2 mRNA

NCBI chr 9:105,662,457...105,663,124
Ensembl chr 9:105,662,457...105,663,124

G

transport and golgi organization 2 homolog

decreases expression

ISO

epoxiconazole results in decreased expression of TANGO2 mRNA

NCBI chr22:20,017,023...20,067,164
Ensembl chr22:20,016,615...20,067,164

G

TAO kinase 2

decreases expression

ISO

epoxiconazole results in decreased expression of TAOK2 mRNA

NCBI chr16:29,973,868...29,992,261
Ensembl chr16:29,973,868...29,992,261

G

TAP binding protein

decreases expression

ISO

epoxiconazole results in decreased expression of TAPBP mRNA

NCBI chr 6:33,299,694...33,314,078
Ensembl chr 6:33,299,694...33,314,284

G

TAR (HIV-1) RNA binding protein 1

increases expression

ISO

epoxiconazole results in increased expression of TARBP1 mRNA

NCBI chr 1:234,391,313...234,479,179
Ensembl chr 1:234,391,313...234,479,197

G

threonyl-tRNA synthetase 1

affects expression

ISO

epoxiconazole affects the expression of TARS1 mRNA

NCBI chr 5:33,440,696...33,468,091
Ensembl chr 5:33,440,696...33,469,531

G

threonyl-tRNA synthetase 3

decreases expression

ISO

epoxiconazole results in decreased expression of TARS3 mRNA

NCBI chr15:101,653,596...101,724,473
Ensembl chr15:101,653,596...101,724,565

G

taste 1 receptor member 1

affects expression

ISO

epoxiconazole affects the expression of TAS1R1 mRNA

NCBI chr 1:6,555,307...6,579,755
Ensembl chr 1:6,555,307...6,579,755

G

taste 1 receptor member 2

increases expression

ISO

epoxiconazole results in increased expression of TAS1R2 mRNA

NCBI chr 1:18,839,599...18,859,660
Ensembl chr 1:18,839,599...18,859,660

G

taste 2 receptor member 1

increases expression

ISO

epoxiconazole results in increased expression of TAS2R119 mRNA

NCBI chr 5:9,627,347...9,903,876
Ensembl chr 5:9,627,347...9,712,378

G

taste 2 receptor member 10

decreases expression

ISO

epoxiconazole results in decreased expression of TAS2R114 mRNA

NCBI chr12:10,825,219...10,826,358
Ensembl chr12:10,825,219...10,826,358

G

taste 2 receptor member 16

decreases expression

ISO

epoxiconazole results in decreased expression of TAS2R118 mRNA

NCBI chr 7:122,994,704...122,995,700
Ensembl chr 7:122,994,704...122,995,700

G

tyrosine aminotransferase

decreases expression

ISO

epoxiconazole results in decreased expression of TAT mRNA

NCBI chr16:71,565,660...71,577,092
Ensembl chr16:71,565,660...71,577,095

G

TatD DNase domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of TATDN1 mRNA

NCBI chr 8:124,488,494...124,539,088
Ensembl chr 8:124,488,485...124,539,458

G

TatD DNase domain containing 2

decreases expression

ISO

epoxiconazole results in decreased expression of TATDN2 mRNA

NCBI chr 3:10,248,459...10,281,218
Ensembl chr 3:10,248,023...10,281,218

G

TBC1 domain family member 10B

decreases expression

ISO

epoxiconazole results in decreased expression of TBC1D10B mRNA

NCBI chr16:30,357,102...30,370,494
Ensembl chr16:30,357,102...30,370,529

G

TBC1 domain family member 15

decreases expression

ISO

epoxiconazole results in decreased expression of TBC1D15 mRNA

NCBI chr12:71,839,759...71,924,313
Ensembl chr12:71,839,707...71,927,248

G

TBC1 domain family member 17

decreases expression

ISO

epoxiconazole results in decreased expression of TBC1D17 mRNA

NCBI chr19:49,877,702...49,888,750
Ensembl chr19:49,877,501...49,888,751

G

TBC1 domain family member 25

affects expression

ISO

epoxiconazole affects the expression of TBC1D25 mRNA

NCBI chr X:48,539,714...48,562,609
Ensembl chr X:48,539,684...48,562,609

G

TBC1 domain family member 2B

decreases expression

ISO

epoxiconazole results in decreased expression of TBC1D2B mRNA

NCBI chr15:77,994,985...78,077,711
Ensembl chr15:77,984,036...78,077,724

G

TBC1 domain family member 32

decreases expression

ISO

epoxiconazole results in decreased expression of TBC1D32 mRNA

NCBI chr 6:121,079,494...121,334,729
Ensembl chr 6:121,079,494...121,334,745

G

TBC1 domain family member 4

increases expression

ISO

epoxiconazole results in increased expression of TBC1D4 mRNA

NCBI chr13:75,283,503...75,482,169
Ensembl chr13:75,283,503...75,482,651

G

TBC1 domain family member 9B

decreases expression

ISO

epoxiconazole results in decreased expression of TBC1D9B mRNA

NCBI chr 5:179,862,071...179,907,897
Ensembl chr 5:179,862,058...179,907,911

G

tubulin folding cofactor A

increases expression

ISO

epoxiconazole results in increased expression of TBCA mRNA

NCBI chr 5:77,691,166...77,776,339
Ensembl chr 5:77,691,166...77,868,780

G

tubulin folding cofactor E like

affects expression

ISO

epoxiconazole affects the expression of TBCEL mRNA

NCBI chr11:121,024,102...121,090,776
Ensembl chr11:121,024,072...121,090,776

G

TBC1 domain containing kinase

increases expression

ISO

epoxiconazole results in increased expression of TBCK mRNA

NCBI chr 4:106,041,599...106,316,683
Ensembl chr 4:106,041,599...106,316,683

G

T-box brain transcription factor 1

increases expression

ISO

epoxiconazole results in increased expression of TBR1 mRNA

NCBI chr 2:161,416,297...161,425,870
Ensembl chr 2:161,416,297...161,425,870

G

transforming growth factor beta regulator 1

decreases expression

ISO

epoxiconazole results in decreased expression of TBRG1 mRNA

NCBI chr11:124,622,864...124,635,926
Ensembl chr11:124,622,836...124,635,926

G

T-box transcription factor 10

increases expression

ISO

epoxiconazole results in increased expression of TBX10 mRNA

NCBI chr11:67,631,303...67,641,754
Ensembl chr11:67,631,303...67,639,763

G

T-box transcription factor 19

decreases expression

ISO

epoxiconazole results in decreased expression of TBX19 mRNA

NCBI chr 1:168,280,877...168,314,426
Ensembl chr 1:168,280,877...168,314,426

G

T-box transcription factor 3

increases expression

ISO

epoxiconazole results in increased expression of TBX3 mRNA

NCBI chr12:114,670,255...114,684,175
Ensembl chr12:114,670,255...114,684,175

G

thromboxane A synthase 1

increases expression

ISO

epoxiconazole results in increased expression of TBXAS1 mRNA

NCBI chr 7:139,778,242...140,020,293
Ensembl chr 7:139,777,051...140,020,325

G

tandem C2 domains, nuclear

increases expression

ISO

epoxiconazole results in increased expression of TC2N mRNA

NCBI chr14:91,779,746...91,867,536
Ensembl chr14:91,779,746...91,867,536

G

transcription elongation factor A like 6

increases expression

ISO

epoxiconazole results in increased expression of TCEAL6 mRNA

NCBI chr X:102,138,502...102,142,481
Ensembl chr X:102,140,476...102,142,970

G

transcription elongation factor A like 9

increases expression

ISO

epoxiconazole results in increased expression of TCEAL9 mRNA

NCBI chr X:103,356,506...103,358,462
Ensembl chr X:103,356,461...103,358,472

G

transcription elongation factor A N-terminal and central domain containing

decreases expression

ISO

epoxiconazole results in decreased expression of TCEANC mRNA

NCBI chr X:13,653,141...13,665,409
Ensembl chr X:13,653,078...13,681,964

G

transcription elongation factor A N-terminal and central domain containing 2

affects expression

ISO

epoxiconazole affects the expression of TCEANC2 mRNA

NCBI chr 1:54,053,608...54,112,520
Ensembl chr 1:54,052,867...54,112,519

G

transcription factor 7 like 2

increases expression

ISO

epoxiconazole results in increased expression of TCF7L2 mRNA

NCBI chr10:112,950,247...113,167,678
Ensembl chr10:112,950,205...113,167,678

G

transcriptional and immune response regulator

decreases expression

ISO

epoxiconazole results in decreased expression of TCIM mRNA

NCBI chr 8:40,153,482...40,155,310
Ensembl chr 8:40,153,482...40,155,310

G

T cell immune regulator 1, ATPase H+ transporting V0 subunit a3

decreases expression

ISO

epoxiconazole results in decreased expression of TCIRG1 mRNA

NCBI chr11:68,039,025...68,053,762
Ensembl chr11:68,039,025...68,050,895

G

t-complex 1

decreases expression

ISO

epoxiconazole results in decreased expression of TCP1 mRNA

NCBI chr 6:159,778,498...159,789,602
Ensembl chr 6:159,778,498...159,789,703

G

t-complex 11 like 1

decreases expression

ISO

epoxiconazole results in decreased expression of TCP11L1 mRNA

NCBI chr11:33,039,572...33,073,563
Ensembl chr11:33,039,417...33,105,943

G

t-complex 11 family, X-linked 2

decreases expression

ISO

epoxiconazole results in decreased expression of TCP11X2 mRNA

NCBI chr X:102,460,315...102,471,812
Ensembl chr X:102,456,862...102,471,842

G

tyrosyl-DNA phosphodiesterase 2

decreases expression

ISO

epoxiconazole results in decreased expression of TDP2 mRNA

NCBI chr 6:24,649,979...24,666,899
Ensembl chr 6:24,649,978...24,666,930

G

tudor domain containing 5

decreases expression

ISO

epoxiconazole results in decreased expression of TDRD5 mRNA

NCBI chr 1:179,591,613...179,691,272
Ensembl chr 1:179,591,613...179,691,272

G

tectonin beta-propeller repeat containing 2

increases expression

ISO

epoxiconazole results in increased expression of TECPR2 mRNA

NCBI chr14:102,362,941...102,502,477
Ensembl chr14:102,362,941...102,502,477

G

tubulin epsilon and delta complex 2

decreases expression

ISO

epoxiconazole results in decreased expression of TEDC2 mRNA

NCBI chr16:2,460,109...2,464,963
Ensembl chr16:2,460,086...2,464,963

G

TEF transcription factor, PAR bZIP family member

decreases expression

ISO

epoxiconazole results in decreased expression of TEF mRNA

NCBI chr22:41,367,455...41,399,326
Ensembl chr22:41,367,333...41,399,326

G

transcription elongation factor, mitochondrial

decreases expression

ISO

epoxiconazole results in decreased expression of TEFM mRNA

NCBI chr17:30,898,986...30,906,238
Ensembl chr17:30,897,336...30,906,249

G

tektin 5

increases expression

ISO

epoxiconazole results in increased expression of TEKT5 mRNA

NCBI chr16:10,627,501...10,694,930
Ensembl chr16:10,627,501...10,694,930

G

teneurin transmembrane protein 3

increases expression

ISO

epoxiconazole results in increased expression of TENM3 mRNA

NCBI chr 4:181,447,613...182,803,024
Ensembl chr 4:182,143,918...182,803,024

G

teneurin transmembrane protein 4

increases expression

ISO

epoxiconazole results in increased expression of TENM4 mRNA

NCBI chr11:78,652,829...79,441,030
Ensembl chr11:78,652,829...79,441,030

G

terminal nucleotidyltransferase 5A

decreases expression

ISO

epoxiconazole results in decreased expression of TENT5A mRNA

NCBI chr 6:81,745,730...81,752,681
Ensembl chr 6:81,491,439...81,752,774

G

telomeric repeat binding factor 2

decreases expression

ISO

epoxiconazole results in decreased expression of TERF2 mRNA

NCBI chr16:69,355,567...69,386,007
Ensembl chr16:69,355,464...69,408,571

G

TERF2 interacting protein

increases expression

ISO

epoxiconazole results in increased expression of TERF2IP mRNA

NCBI chr16:75,760,050...75,914,672
Ensembl chr16:75,647,773...75,761,872

G

testis expressed metallothionein like protein

affects expression

ISO

epoxiconazole affects the expression of TESMIN mRNA

NCBI chr11:68,704,796...68,751,520
Ensembl chr11:68,707,440...68,751,568

G

testis expressed 10

increases expression

ISO

epoxiconazole results in increased expression of TEX10 mRNA

NCBI chr 9:100,302,084...100,352,942
Ensembl chr 9:100,302,072...100,352,957

G

testis expressed 13A

increases expression

ISO

epoxiconazole results in increased expression of TEX13A mRNA

NCBI chr X:105,218,929...105,220,694
Ensembl chr X:105,218,929...105,220,694

G

TEX13 family member D

increases expression

ISO

epoxiconazole results in increased expression of TEX13D mRNA

NCBI chr X:124,332,660...124,336,863
Ensembl chr X:124,246,249...124,336,863

G

testis expressed 2

increases expression

ISO

epoxiconazole results in increased expression of TEX2 mRNA

NCBI chr17:64,147,227...64,263,260
Ensembl chr17:64,147,227...64,263,291

G

testis expressed 30

affects expression

ISO

epoxiconazole affects the expression of TEX30 mRNA

NCBI chr13:102,765,888...102,773,786
Ensembl chr13:102,765,888...102,773,811

G

testis expressed 47

increases expression

ISO

epoxiconazole results in increased expression of TEX47 mRNA

NCBI chr 7:88,794,106...88,795,737
Ensembl chr 7:88,794,106...88,795,737

G

transcription factor Dp-1

decreases expression

ISO

epoxiconazole results in decreased expression of TFDP1 mRNA

NCBI chr13:113,584,688...113,641,473
Ensembl chr13:113,584,525...113,641,509

G

tuftelin interacting protein 11

decreases expression

ISO

epoxiconazole results in decreased expression of TFIP11 mRNA

NCBI chr22:26,491,240...26,512,473
Ensembl chr22:26,490,988...26,512,505

G

tissue factor pathway inhibitor 2

affects expression

ISO

epoxiconazole affects the expression of TFPI2 mRNA

NCBI chr 7:93,885,396...93,890,753
Ensembl chr 7:93,885,396...93,890,753

G

transferrin receptor 2

decreases expression

ISO

epoxiconazole results in decreased expression of TFR2 mRNA

NCBI chr 7:100,620,420...100,641,552
Ensembl chr 7:100,620,416...100,642,779

G

transferrin receptor

decreases expression

ISO

epoxiconazole results in decreased expression of TFRC mRNA

NCBI chr 3:196,049,284...196,082,090
Ensembl chr 3:196,012,511...196,082,162

G

TDP-glucose 4,6-dehydratase

increases expression

ISO

epoxiconazole results in increased expression of TGDS mRNA

NCBI chr13:94,574,054...94,596,273
Ensembl chr13:94,574,054...94,596,276

G

transforming growth factor alpha

increases expression

ISO

epoxiconazole results in increased expression of TGFA mRNA

NCBI chr 2:70,447,284...70,553,826
Ensembl chr 2:70,447,284...70,554,193

G

transforming growth factor beta 1

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of TGFB1 mRNA

NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,961

G

transforming growth factor beta induced

decreases expression

ISO

epoxiconazole results in decreased expression of TGFBI mRNA

NCBI chr 5:136,028,988...136,063,818
Ensembl chr 5:136,028,988...136,063,818

G

transforming growth factor beta receptor 2

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of TGFBR2 mRNA
epoxiconazole results in decreased expression of TGFBR2 mRNA

PMID:22334560 PMID:35436446

NCBI chr 3:30,606,356...30,694,142
Ensembl chr 3:30,606,478...30,694,249

G

transforming growth factor beta receptor 3

decreases expression

ISO

epoxiconazole results in decreased expression of TGFBR3 mRNA

NCBI chr 1:91,680,343...91,906,002
Ensembl chr 1:91,680,343...91,906,335

G

transforming growth factor beta receptor associated protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of TGFBRAP1 mRNA

NCBI chr 2:105,249,404...105,329,735
Ensembl chr 2:105,264,359...105,329,735

G

trimethylguanosine synthase 1

decreases expression

ISO

epoxiconazole results in decreased expression of TGS1 mRNA

NCBI chr 8:55,773,446...55,826,445
Ensembl chr 8:55,773,432...55,826,445

G

thioesterase superfamily member 4

decreases expression

ISO

epoxiconazole results in decreased expression of THEM4 mRNA

NCBI chr 1:151,870,866...151,909,511
Ensembl chr 1:151,870,866...151,909,637

G

thioesterase superfamily member 7, pseudogene

decreases expression

ISO

epoxiconazole results in decreased expression of THEM7 mRNA

NCBI chr11:32,112,049...32,168,823
Ensembl chr11:32,112,049...32,254,395

G

thymocyte selection associated

decreases expression

ISO

epoxiconazole results in decreased expression of THEMIS mRNA

NCBI chr 6:127,696,628...127,918,595
Ensembl chr 6:127,708,072...127,918,631

G

THO complex subunit 2

decreases expression

ISO

epoxiconazole results in decreased expression of THOC2 mRNA

NCBI chr X:123,600,569...123,733,052
Ensembl chr X:123,600,561...123,733,056

G

THO complex subunit 7

increases expression

ISO

epoxiconazole results in increased expression of THOC7 mRNA

NCBI chr 3:63,833,870...63,864,484
Ensembl chr 3:63,833,870...63,863,868

G

thrombopoietin

increases expression

ISO

epoxiconazole results in increased expression of THPO mRNA

NCBI chr 3:184,371,935...184,379,688
Ensembl chr 3:184,371,935...184,381,968

G

thyroid hormone receptor alpha

increases expression

ISO

epoxiconazole results in increased expression of THRA mRNA

NCBI chr17:40,062,193...40,093,867
Ensembl chr17:40,058,290...40,093,867

G

thyroid hormone responsive

decreases expression

ISO

epoxiconazole results in decreased expression of THRSP mRNA

NCBI chr11:78,063,861...78,068,351
Ensembl chr11:78,063,861...78,068,351

G

TIA1 cytotoxic granule associated RNA binding protein

decreases expression

ISO

epoxiconazole results in decreased expression of TIA1 mRNA

NCBI chr 2:70,209,444...70,248,793
Ensembl chr 2:70,209,444...70,248,761

G

TRAF interacting protein with forkhead associated domain

affects expression

ISO

epoxiconazole affects the expression of TIFA mRNA

NCBI chr 4:112,274,537...112,285,904
Ensembl chr 4:112,272,968...112,285,955

G

TP53 induced glycolysis regulatory phosphatase

increases expression

ISO

epoxiconazole results in increased expression of TIGAR mRNA

NCBI chr12:4,321,213...4,360,028
Ensembl chr12:4,307,763...4,360,028

G

T cell immunoglobulin and mucin domain containing 4

increases expression

ISO

epoxiconazole results in increased expression of TIMD4 mRNA

NCBI chr 5:156,919,292...156,963,226
Ensembl chr 5:156,919,292...156,963,226

G

timeless circadian regulator

decreases expression

ISO

epoxiconazole results in decreased expression of TIMELESS mRNA

NCBI chr12:56,416,363...56,449,426
Ensembl chr12:56,416,363...56,449,445

G

translocase of inner mitochondrial membrane 10

decreases expression

ISO

epoxiconazole results in decreased expression of TIMM10 mRNA

NCBI chr11:57,528,464...57,530,754
Ensembl chr11:57,528,406...57,531,031

G

translocase of inner mitochondrial membrane 10B

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of TIMM10B mRNA

NCBI chr11:6,481,501...6,484,681
Ensembl chr11:6,481,496...6,484,683

G

translocase of inner mitochondrial membrane 29

decreases expression

ISO

epoxiconazole results in decreased expression of TIMM29 mRNA

NCBI chr19:10,928,811...10,930,254
Ensembl chr19:10,928,811...10,933,535

G

translocase of inner mitochondrial membrane 44

decreases expression

ISO

epoxiconazole results in decreased expression of TIMM44 mRNA

NCBI chr19:7,926,718...7,943,666
Ensembl chr19:7,926,718...7,943,773

G

translocase of inner mitochondrial membrane 50

decreases expression

ISO

epoxiconazole results in decreased expression of TIMM50 mRNA

NCBI chr19:39,480,838...39,493,779
Ensembl chr19:39,479,795...39,493,785

G

translocase of inner mitochondrial membrane 8A

decreases expression

ISO

epoxiconazole results in decreased expression of TIMM8A1 mRNA

NCBI chr X:101,345,661...101,348,742
Ensembl chr X:101,345,652...101,349,001

G

translocase of inner mitochondrial membrane 9

increases expression

ISO

epoxiconazole results in increased expression of TIMM9 mRNA

NCBI chr14:58,408,494...58,427,531
Ensembl chr14:58,407,461...58,427,655

G

TIMP metallopeptidase inhibitor 3

decreases expression

ISO

epoxiconazole results in decreased expression of TIMP3 mRNA

NCBI chr22:32,801,705...32,863,041
Ensembl chr22:32,801,576...32,863,042

G

tubulointerstitial nephritis antigen

increases expression

ISO

epoxiconazole results in increased expression of TINAG mRNA

NCBI chr 6:54,307,862...54,390,142
Ensembl chr 6:54,307,859...54,390,142

G

tight junction protein 3

decreases expression

ISO

epoxiconazole results in decreased expression of TJP3 mRNA

NCBI chr19:3,708,384...3,750,813
Ensembl chr19:3,708,356...3,750,813

G

triokinase and FMN cyclase

decreases expression

ISO

epoxiconazole results in decreased expression of TKFC mRNA

NCBI chr11:61,333,228...61,353,426
Ensembl chr11:61,333,210...61,353,295

G

transketolase like 1

increases expression

ISO

epoxiconazole results in increased expression of TKTL1 mRNA

NCBI chr X:154,295,795...154,330,350
Ensembl chr X:154,295,795...154,330,350

G

TLC domain containing 3B

increases expression

ISO

epoxiconazole results in increased expression of TLCD3B mRNA

NCBI chr16:30,024,427...30,053,040
Ensembl chr16:30,024,426...30,052,978

G

toll like receptor 2

increases expression

ISO

epoxiconazole results in increased expression of TLR2 mRNA

NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,708,537

G

toll like receptor 3

increases expression

ISO

epoxiconazole results in increased expression of TLR3 mRNA

NCBI chr 4:186,069,156...186,088,073
Ensembl chr 4:186,068,911...186,088,073

G

toll like receptor 8

decreases expression

ISO

epoxiconazole results in decreased expression of TLR8 mRNA

NCBI chr X:12,906,620...12,923,169
Ensembl chr X:12,906,620...12,923,169

G

T cell leukemia homeobox 3

increases expression

ISO

epoxiconazole results in increased expression of TLX3 mRNA

NCBI chr 5:171,309,248...171,312,139
Ensembl chr 5:171,309,248...171,312,139

G

TM2 domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of TM2D1 mRNA

NCBI chr 1:61,681,046...61,725,141
Ensembl chr 1:61,673,636...61,725,423

G

TM2 domain containing 2

affects expression

ISO

epoxiconazole affects the expression of TM2D2 mRNA

NCBI chr 8:38,988,808...38,996,990
Ensembl chr 8:38,988,808...38,996,824

G

transmembrane 4 L six family member 1

decreases expression

ISO

epoxiconazole results in decreased expression of TM4SF1 mRNA

NCBI chr 3:149,369,022...149,377,649
Ensembl chr 3:149,369,022...149,377,692

G

transmembrane 4 L six family member 4

increases expression

ISO

epoxiconazole results in increased expression of TM4SF4 mRNA

NCBI chr 3:149,474,697...149,503,394
Ensembl chr 3:149,474,697...149,503,394

G

transmembrane 6 superfamily member 2

decreases expression

ISO

epoxiconazole results in decreased expression of TM6SF2 mRNA

NCBI chr19:19,264,366...19,273,301
Ensembl chr19:19,264,109...19,273,391

G

transmembrane 7 superfamily member 2

increases expression

EXP

epoxiconazole results in increased expression of TM7SF2 mRNA

NCBI chr11:65,111,872...65,116,230
Ensembl chr11:65,111,845...65,116,384

G

transmembrane 9 superfamily member 4

increases expression

ISO

epoxiconazole results in increased expression of TM9SF4 mRNA

NCBI chr20:32,109,714...32,167,256
Ensembl chr20:32,109,714...32,167,258

G

transmembrane BAX inhibitor motif containing 4

increases expression

ISO

epoxiconazole results in increased expression of TMBIM4 mRNA

PMID:22334560 PMID:35436446

NCBI chr12:66,135,846...66,169,996
Ensembl chr12:66,135,846...66,170,027

G

transmembrane channel like 7

decreases expression

ISO

epoxiconazole results in decreased expression of TMC7 mRNA

NCBI chr16:18,983,934...19,063,942
Ensembl chr16:18,983,934...19,063,942

G

transmembrane channel like 8

increases expression

ISO

epoxiconazole results in increased expression of TMC8 mRNA

NCBI chr17:78,130,771...78,142,968
Ensembl chr17:78,130,770...78,142,968

G

transmembrane and coiled-coil domains 4

decreases expression

ISO

epoxiconazole results in decreased expression of TMCO4 mRNA

NCBI chr 1:19,682,240...19,799,916
Ensembl chr 1:19,682,207...19,800,500

G

transmembrane p24 trafficking protein 1

increases expression

ISO

epoxiconazole results in increased expression of TMED1 mRNA

NCBI chr19:10,832,067...10,836,212
Ensembl chr19:10,832,067...10,836,318

G

transmembrane p24 trafficking protein 10

increases expression

ISO

epoxiconazole results in increased expression of TMED10 mRNA

NCBI chr14:75,131,469...75,176,612
Ensembl chr14:75,131,443...75,176,652

G

transmembrane p24 trafficking protein 3

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of TMED3 mRNA
epoxiconazole results in decreased expression of TMED3 mRNA

PMID:22334560 PMID:35436446

NCBI chr15:79,311,112...79,413,886
Ensembl chr15:79,311,109...79,427,432

G

transmembrane p24 trafficking protein family member 8

decreases expression

ISO

epoxiconazole results in decreased expression of TMED8 mRNA

NCBI chr14:77,335,021...77,377,094
Ensembl chr14:77,335,029...77,377,097

G

transmembrane protein 102

increases expression

ISO

epoxiconazole results in increased expression of TMEM102 mRNA

NCBI chr17:7,435,435...7,437,679
Ensembl chr17:7,435,430...7,437,679

G

transmembrane protein 104

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM104 mRNA

NCBI chr17:74,776,499...74,839,753
Ensembl chr17:74,776,477...74,839,753

G

transmembrane protein 109

increases expression

ISO

epoxiconazole results in increased expression of TMEM109 mRNA

NCBI chr11:60,914,158...60,923,443
Ensembl chr11:60,912,521...60,923,443

G

transmembrane protein 119

increases expression

ISO

epoxiconazole results in increased expression of TMEM119 mRNA

NCBI chr12:108,589,851...108,598,084
Ensembl chr12:108,589,851...108,598,320

G

transmembrane protein 129, E3 ubiquitin ligase

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM129 mRNA

NCBI chr 4:1,715,952...1,721,323
Ensembl chr 4:1,715,951...1,721,358

G

transmembrane protein 131

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM131 mRNA

NCBI chr 2:97,756,336...97,995,948
Ensembl chr 2:97,756,333...97,996,226

G

transmembrane 131 like

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM131L mRNA

NCBI chr 4:153,466,360...153,636,711
Ensembl chr 4:153,466,307...153,637,612

G

transmembrane protein 134

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM134 mRNA

NCBI chr11:67,461,710...67,469,251
Ensembl chr11:67,461,710...67,469,288

G

transmembrane protein 138

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM138 mRNA

NCBI chr11:61,362,374...61,376,870
Ensembl chr11:61,361,964...61,377,890

G

transmembrane protein 147

increases expression

ISO

epoxiconazole results in increased expression of TMEM147 mRNA

NCBI chr19:35,545,626...35,547,526
Ensembl chr19:35,545,600...35,547,527

G

transmembrane protein 150A

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM150A mRNA

NCBI chr 2:85,598,547...85,602,698
Ensembl chr 2:85,598,547...85,603,201

G

transmembrane protein 167A

increases expression

ISO

epoxiconazole results in increased expression of TMEM167 mRNA

PMID:22334560 PMID:35436446

NCBI chr 5:83,052,846...83,077,394
Ensembl chr 5:83,052,846...83,077,863

G

transmembrane protein 167B

increases expression

ISO

epoxiconazole results in increased expression of TMEM167B mRNA

NCBI chr 1:109,090,764...109,096,934
Ensembl chr 1:109,090,367...109,096,935

G

transmembrane protein 176A

increases expression

ISO

epoxiconazole results in increased expression of TMEM176A mRNA

NCBI chr 7:150,800,769...150,805,118
Ensembl chr 7:150,799,598...150,805,122

G

transmembrane protein 176B

increases expression

ISO

epoxiconazole results in increased expression of TMEM176B mRNA

NCBI chr 7:150,791,301...150,801,360
Ensembl chr 7:150,790,382...150,803,404

G

transmembrane protein 179B

increases expression

ISO

epoxiconazole results in increased expression of TMEM179B mRNA

NCBI chr11:62,787,402...62,790,400
Ensembl chr11:62,787,387...62,790,403

G

transmembrane protein 181

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM181A mRNA

NCBI chr 6:158,536,640...158,635,429
Ensembl chr 6:158,536,436...158,635,435

G

transmembrane protein 184A

increases expression

ISO

epoxiconazole results in increased expression of TMEM184A mRNA

NCBI chr 7:1,542,235...1,556,205
Ensembl chr 7:1,542,235...1,560,821

G

transmembrane protein 185A

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM185A mRNA

NCBI chr X:149,596,556...149,631,792
Ensembl chr X:149,596,556...149,631,912

G

transmembrane protein 201

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM201 mRNA

NCBI chr 1:9,588,911...9,614,877
Ensembl chr 1:9,588,721...9,614,877

G

transmembrane protein 214

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM214 mRNA

NCBI chr 2:27,032,965...27,041,694
Ensembl chr 2:27,032,910...27,041,697

G

transmembrane protein 217

increases expression

ISO

epoxiconazole results in increased expression of TMEM217 mRNA

NCBI chr 6:37,212,181...37,258,144
Ensembl chr 6:37,212,180...37,258,155

G

transmembrane protein 219

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM219 mRNA

NCBI chr16:29,962,079...29,973,048
Ensembl chr16:29,940,885...29,973,052

G

transmembrane protein 233

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM233 mRNA

NCBI chr12:119,593,774...119,654,295
Ensembl chr12:119,593,774...119,643,075

G

transmembrane protein 242

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM242 mRNA

NCBI chr 6:157,289,025...157,323,519
Ensembl chr 6:157,289,025...157,323,601

G

transmembrane protein 243

increases expression

ISO

epoxiconazole results in increased expression of TMEM243 mRNA

NCBI chr 7:87,196,160...87,220,587
Ensembl chr 7:87,196,158...87,220,597

G

transmembrane protein 253

increases expression

ISO

epoxiconazole results in increased expression of TMEM253 mRNA

NCBI chr14:21,098,836...21,103,724
Ensembl chr14:21,098,811...21,103,724

G

transmembrane protein 256

increases expression

ISO

epoxiconazole results in increased expression of TMEM256 mRNA

NCBI chr17:7,402,975...7,404,097
Ensembl chr17:7,402,975...7,404,097

G

transmembrane protein 258

increases expression

ISO

epoxiconazole results in increased expression of TMEM258 mRNA

NCBI chr11:61,788,949...61,792,599
Ensembl chr11:61,768,501...61,792,802

G

transmembrane protein 26

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM26 mRNA

NCBI chr10:61,406,642...61,453,381
Ensembl chr10:61,406,642...61,453,381

G

transmembrane protein 267

increases expression

ISO

epoxiconazole results in increased expression of TMEM267 mRNA

NCBI chr 5:43,444,252...43,484,387
Ensembl chr 5:43,444,252...43,484,476

G

transmembrane protein 39A

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM39A mRNA

NCBI chr 3:119,428,949...119,463,615
Ensembl chr 3:119,428,949...119,468,854

G

transmembrane protein 41A

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM41A mRNA

NCBI chr 3:185,489,601...185,499,035
Ensembl chr 3:185,476,496...185,499,057

G

transmembrane protein 41B

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM41B mRNA

NCBI chr11:9,280,654...9,314,593
Ensembl chr11:9,280,654...9,314,636

G

transmembrane protein 43

increases expression

ISO

epoxiconazole results in increased expression of TMEM43 mRNA

NCBI chr 3:14,125,052...14,143,680
Ensembl chr 3:14,125,015...14,143,681

G

transmembrane protein 45A

increases expression

ISO

epoxiconazole results in increased expression of TMEM45A mRNA

NCBI chr 3:100,492,619...100,577,444
Ensembl chr 3:100,492,219...100,579,281

G

transmembrane protein 47

increases expression

ISO

epoxiconazole results in increased expression of TMEM47 mRNA

NCBI chr X:34,627,075...34,657,285
Ensembl chr X:34,627,075...34,657,285

G

transmembrane protein 50A

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM50A mRNA

NCBI chr 1:25,338,334...25,362,361
Ensembl chr 1:25,338,295...25,362,362

G

transmembrane protein 51

increases expression

ISO

epoxiconazole results in increased expression of TMEM51 mRNA

NCBI chr 1:15,152,566...15,220,478
Ensembl chr 1:15,152,498...15,220,484

G

transmembrane protein 60

affects expression

ISO

epoxiconazole affects the expression of TMEM60 mRNA

NCBI chr 7:77,793,728...77,798,434
Ensembl chr 7:77,793,728...77,799,484

G

transmembrane protein 63A

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM63A mRNA

NCBI chr 1:225,840,556...225,882,380
Ensembl chr 1:225,845,536...225,884,071

G

transmembrane protein 63B

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM63B mRNA

NCBI chr 6:44,126,633...44,155,519
Ensembl chr 6:44,126,614...44,155,520

G

transmembrane protein 68

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM68 mRNA

NCBI chr 8:55,738,758...55,773,378
Ensembl chr 8:55,696,424...55,773,407

G

transmembrane protein 80

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM80 mRNA

NCBI chr11:695,639...705,028
Ensembl chr11:695,591...705,028

G

transmembrane protein 86A

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM86A mRNA

NCBI chr11:18,698,779...18,704,785
Ensembl chr11:18,693,122...18,704,785

G

transmembrane protein 88B

increases expression

ISO

epoxiconazole results in increased expression of TMEM278 mRNA

NCBI chr 1:1,425,871...1,430,255
Ensembl chr 1:1,425,871...1,430,255

G

transmembrane protein 89

increases expression

ISO

epoxiconazole results in increased expression of TMEM89 mRNA

NCBI chr 3:48,620,759...48,621,769
Ensembl chr 3:48,620,759...48,621,769

G

transmembrane protein 94

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM94 mRNA

NCBI chr17:75,456,635...75,500,452
Ensembl chr17:75,441,159...75,500,452

G

transmembrane protein 97

decreases expression

ISO

epoxiconazole results in decreased expression of TMEM97 mRNA

NCBI chr17:28,319,200...28,328,685
Ensembl chr17:28,319,200...28,328,685

G

transmembrane inner ear

increases expression

ISO

epoxiconazole results in increased expression of TMIE mRNA

NCBI chr 3:46,693,778...46,710,886
Ensembl chr 3:46,694,528...46,710,886

G

tropomodulin 2

increases expression

ISO

epoxiconazole results in increased expression of TMOD2 mRNA

NCBI chr15:51,751,597...51,816,363
Ensembl chr15:51,751,564...51,816,363

G

tropomodulin 4

decreases expression

ISO

epoxiconazole results in decreased expression of TMOD4 mRNA

NCBI chr 1:151,169,987...151,175,981
Ensembl chr 1:151,169,984...151,176,284

G

transmembrane serine protease 4

increases expression

ISO

epoxiconazole results in increased expression of TMPRSS4 mRNA

NCBI chr11:118,077,078...118,125,505
Ensembl chr11:118,077,012...118,125,510

G

thymosin beta 10

decreases expression

ISO

epoxiconazole results in decreased expression of TMSB10 mRNA

NCBI chr 2:84,905,656...84,906,671
Ensembl chr 2:84,904,923...84,906,680

G

thymosin beta 4 X-linked

increases expression

ISO

epoxiconazole results in increased expression of TMSB4X mRNA

NCBI chr X:12,975,110...12,977,223
Ensembl chr X:12,975,107...12,977,227

G

thiol methyltransferase 1A

increases expression

ISO

epoxiconazole results in increased expression of TMT1A mRNA

NCBI chr12:50,925,015...50,932,508
Ensembl chr12:50,923,472...50,932,510

G

transmembrane O-mannosyltransferase targeting cadherins 2

decreases expression

ISO

epoxiconazole results in decreased expression of TMTC2 mRNA

NCBI chr12:82,686,906...83,134,866
Ensembl chr12:82,686,880...83,134,870

G

thioredoxin related transmembrane protein 2

increases expression

ISO

epoxiconazole results in increased expression of TMX2 mRNA

NCBI chr11:57,712,593...57,740,973
Ensembl chr11:57,712,562...57,742,987

G

TNF alpha induced protein 2

increases expression

ISO

epoxiconazole results in increased expression of TNFAIP2 mRNA

NCBI chr14:103,121,469...103,137,439
Ensembl chr14:103,121,407...103,137,441

G

TNF alpha induced protein 6

increases expression

ISO

epoxiconazole results in increased expression of TNFAIP6 mRNA

NCBI chr 2:151,357,592...151,381,340
Ensembl chr 2:151,357,592...151,380,046

G

TNF alpha induced protein 8

increases expression

ISO

epoxiconazole results in increased expression of TNFAIP8 mRNA

NCBI chr 5:119,268,759...119,399,688
Ensembl chr 5:119,268,692...119,399,688

G

TNF receptor superfamily member 12A

increases expression

ISO

epoxiconazole results in increased expression of TNFRSF12A mRNA

NCBI chr16:3,020,368...3,022,383
Ensembl chr16:3,018,445...3,022,385

G

TNF receptor superfamily member 18

increases expression

ISO

epoxiconazole results in increased expression of TNFRSF18 mRNA

NCBI chr 1:1,203,508...1,206,592
Ensembl chr 1:1,203,508...1,206,592

G

TNF receptor superfamily member 19

increases expression

ISO

epoxiconazole results in increased expression of TNFRSF19 mRNA

PMID:22334560 PMID:23970803

NCBI chr13:23,570,412...23,676,093
Ensembl chr13:23,570,370...23,676,104

G

TNF receptor superfamily member 1A

decreases expression

ISO

epoxiconazole results in decreased expression of TNFRSF1A mRNA

NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114

G

TNF receptor superfamily member 1B

affects expression

ISO

epoxiconazole affects the expression of TNFRSF1B mRNA

NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,977...12,209,228

G

TNF receptor superfamily member 4

decreases expression

ISO

epoxiconazole results in decreased expression of TNFRSF4 mRNA

NCBI chr 1:1,211,340...1,214,153
Ensembl chr 1:1,211,326...1,214,153

G

TNF superfamily member 10

decreases expression

ISO

epoxiconazole results in decreased expression of TNFSF10 mRNA

NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,476

G

TNF superfamily member 18

decreases expression

ISO

epoxiconazole results in decreased expression of TNFSF18 mRNA

NCBI chr 1:173,039,202...173,050,941
Ensembl chr 1:173,039,202...173,050,941

G

TNF superfamily member 4

increases expression

ISO

epoxiconazole results in increased expression of TNFSF4 mRNA

NCBI chr 1:173,172,870...173,450,733
Ensembl chr 1:173,162,645...173,477,583

G

tankyrase 2

decreases expression

ISO

epoxiconazole results in decreased expression of TNKS2 mRNA

NCBI chr10:91,798,426...91,865,475
Ensembl chr10:91,798,426...91,865,475

G

troponin C1, slow skeletal and cardiac type

increases expression

ISO

epoxiconazole results in increased expression of TNNC1 mRNA

NCBI chr 3:52,451,100...52,454,041
Ensembl chr 3:52,451,100...52,454,041

G

transportin 3

decreases expression

ISO

epoxiconazole results in decreased expression of TNPO3 mRNA

NCBI chr 7:128,954,185...129,056,193
Ensembl chr 7:128,954,180...129,055,173

G

trinucleotide repeat containing adaptor 6C

affects expression

ISO

epoxiconazole affects the expression of TNRC6C mRNA

NCBI chr17:77,957,557...78,108,835
Ensembl chr17:77,958,624...78,108,822

G

tensin 3

decreases expression

ISO

epoxiconazole results in decreased expression of TNS3 mRNA

NCBI chr 7:47,275,154...47,582,586
Ensembl chr 7:47,275,154...47,582,558

G

transducer of ERBB2, 2

decreases expression

ISO

epoxiconazole results in decreased expression of TOB2 mRNA

NCBI chr22:41,433,494...41,446,801
Ensembl chr22:41,433,489...41,446,801

G

toll interacting protein

decreases expression

ISO

epoxiconazole results in decreased expression of TOLLIP mRNA

NCBI chr11:1,274,371...1,309,632
Ensembl chr11:1,274,371...1,310,258

G

target of myb1 like 2 membrane trafficking protein

decreases expression

ISO

epoxiconazole results in decreased expression of TOM1L2 mRNA

NCBI chr17:17,843,511...17,972,400
Ensembl chr17:17,843,507...17,972,469

G

translocase of outer mitochondrial membrane 20 like

increases expression

ISO

epoxiconazole results in increased expression of TOMM20L mRNA

NCBI chr14:58,395,930...58,417,080
Ensembl chr14:58,395,928...58,408,702

G

translocase of outer mitochondrial membrane 40

decreases expression

ISO

epoxiconazole results in decreased expression of TOMM40 mRNA

NCBI chr19:44,891,254...44,903,689
Ensembl chr19:44,890,569...44,903,695

G

translocase of outer mitochondrial membrane 7

increases expression

ISO

epoxiconazole results in increased expression of TOMM7 mRNA

NCBI chr 7:22,812,974...22,822,849
Ensembl chr 7:22,812,628...22,822,849

G

DNA topoisomerase III beta

decreases expression

ISO

epoxiconazole results in decreased expression of TOP3B mRNA

NCBI chr22:21,957,025...21,982,787
Ensembl chr22:21,957,025...21,982,813

G

DNA topoisomerase II binding protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of TOPBP1 mRNA

NCBI chr 3:133,600,238...133,661,941
Ensembl chr 3:133,598,175...133,662,380

G

torsin family 1 member A

decreases expression

ISO

epoxiconazole results in decreased expression of TOR1A mRNA

NCBI chr 9:129,812,942...129,824,136
Ensembl chr 9:129,812,942...129,824,244

G

torsin family 1 member B

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of TOR1B mRNA
epoxiconazole results in decreased expression of TOR1B mRNA

PMID:22334560 PMID:35436446

NCBI chr 9:129,803,184...129,811,281
Ensembl chr 9:129,803,157...129,811,281

G

thymocyte selection associated high mobility group box

decreases expression

ISO

epoxiconazole results in decreased expression of TOX mRNA

NCBI chr 8:58,805,412...59,119,147
Ensembl chr 8:58,805,412...59,119,279

G

TOX high mobility group box family member 2

increases expression

ISO

epoxiconazole results in increased expression of TOX2 mRNA

NCBI chr20:43,914,852...44,069,616
Ensembl chr20:43,914,844...44,069,616

G

TOX high mobility group box family member 4

decreases expression

ISO

epoxiconazole results in decreased expression of TOX4 mRNA

NCBI chr14:21,477,195...21,499,170
Ensembl chr14:21,476,597...21,499,175

G

tumor protein p53

decreases expression

ISO

epoxiconazole results in decreased expression of TRP53 mRNA

NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546

G

tumor protein p53 inducible protein 11

decreases expression

ISO

epoxiconazole results in decreased expression of TRP53I11 mRNA

NCBI chr11:44,932,348...44,951,306
Ensembl chr11:44,885,903...44,951,306

G

tumor protein p53 inducible nuclear protein 1

increases expression

ISO

epoxiconazole results in increased expression of TRP53INP1 mRNA

NCBI chr 8:94,925,972...94,949,378
Ensembl chr 8:94,925,972...94,949,395

G

tumor protein p53 inducible nuclear protein 2

affects expression

ISO

epoxiconazole affects the expression of TRP53INP2 mRNA

NCBI chr20:34,704,344...34,713,436
Ensembl chr20:34,701,662...34,713,439

G

trophoblast glycoprotein

increases expression

ISO

epoxiconazole results in increased expression of TPBG mRNA

NCBI chr 6:82,362,983...82,367,420
Ensembl chr 6:82,363,206...82,367,420

G

two pore segment channel 1

decreases expression

ISO

epoxiconazole results in decreased expression of TPCN1 mRNA

NCBI chr12:113,221,464...113,298,585
Ensembl chr12:113,221,050...113,298,589

G

TPD52 like 1

decreases expression

ISO

epoxiconazole results in decreased expression of TPD52L1 mRNA

NCBI chr 6:125,153,773...125,264,407
Ensembl chr 6:125,119,049...125,264,407

G

tubulin polyglutamylase complex subunit 2

increases expression

ISO

epoxiconazole results in increased expression of TPGS2 mRNA

NCBI chr18:36,780,024...36,829,002
Ensembl chr18:36,777,647...36,829,216

G

tropomyosin 3

decreases expression

ISO

epoxiconazole results in decreased expression of TPM3 mRNA

NCBI chr 1:154,155,308...154,192,100
Ensembl chr 1:154,155,308...154,194,648

G

tripeptidyl peptidase 1

decreases expression

ISO

epoxiconazole results in decreased expression of TPP1 mRNA

NCBI chr11:6,612,768...6,619,422
Ensembl chr11:6,612,768...6,619,448

G

tubulin polymerization promoting protein

increases expression

ISO

epoxiconazole results in increased expression of TPPP mRNA

NCBI chr 5:659,862...700,727
Ensembl chr 5:659,862...693,997

G

translocated promoter region, nuclear basket protein

decreases expression

ISO

epoxiconazole results in decreased expression of TPR mRNA

NCBI chr 1:186,311,652...186,375,253
Ensembl chr 1:186,311,652...186,375,693

G

tumor protein p63 regulated 1

increases expression

ISO

epoxiconazole results in increased expression of TPRG1 mRNA

NCBI chr 3:188,997,227...189,325,304
Ensembl chr 3:188,947,214...189,325,304

G

tetrapeptide repeat homeobox 2

decreases expression

ISO

epoxiconazole results in decreased expression of RHOX2A mRNA

NCBI chr19:47,859,235...47,861,721
Ensembl chr19:47,859,235...47,861,721

G

tumor protein, translationally-controlled 1

increases expression

ISO

epoxiconazole results in increased expression of TPT1 mRNA

NCBI chr13:45,333,471...45,341,183
Ensembl chr13:45,333,471...45,341,284

G

TNF receptor associated factor 2

decreases expression

ISO

epoxiconazole results in decreased expression of TRAF2 mRNA

NCBI chr 9:136,881,958...136,926,607
Ensembl chr 9:136,881,903...136,929,221

G

TNF receptor associated factor 4

decreases expression

ISO

epoxiconazole results in decreased expression of TRAF4 mRNA

NCBI chr17:28,744,011...28,750,956
Ensembl chr17:28,744,011...28,750,956

G

TNF receptor associated factor 5

increases expression

ISO

epoxiconazole results in increased expression of TRAF5 mRNA

NCBI chr 1:211,326,635...211,374,946
Ensembl chr 1:211,326,325...211,375,036

G

TNF receptor associated protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of TRAP1 mRNA

NCBI chr16:3,658,037...3,717,524
Ensembl chr16:3,651,639...3,717,591

G

trafficking protein particle complex subunit 2

increases expression

ISO

epoxiconazole results in increased expression of TRAPPC2 mRNA

NCBI chr X:13,712,245...13,734,620
Ensembl chr X:13,712,244...13,734,635
Ensembl chr19:13,712,244...13,734,635

G

trafficking protein particle complex subunit 2L

increases expression

ISO

epoxiconazole results in increased expression of TRAPPC2L mRNA

NCBI chr16:88,856,220...88,862,678
Ensembl chr16:88,856,220...88,862,686

G

tribbles pseudokinase 1

decreases expression

ISO

epoxiconazole results in decreased expression of TRIB1 mRNA

NCBI chr 8:125,430,358...125,438,403
Ensembl chr 8:125,430,358...125,438,403

G

tripartite motif containing 2

increases expression

ISO

epoxiconazole results in increased expression of TRIM2 mRNA

NCBI chr 4:153,152,163...153,339,317
Ensembl chr 4:153,152,163...153,339,319

G

tripartite motif containing 26

decreases expression

ISO

epoxiconazole results in decreased expression of TRIM26 mRNA

NCBI chr 6:30,184,455...30,213,406
Ensembl chr 6:30,184,446...30,213,435

G

tripartite motif containing 27

increases expression

ISO

epoxiconazole results in increased expression of TRIM27 mRNA

NCBI chr 6:28,903,002...28,923,985
Ensembl chr 6:28,903,002...28,923,988

G

tripartite motif containing 28

affects expression

ISO

epoxiconazole affects the expression of TRIM28 mRNA

NCBI chr19:58,544,064...58,550,715
Ensembl chr19:58,543,740...58,550,773

G

tripartite motif containing 32

increases expression

ISO

epoxiconazole results in increased expression of TRIM32 mRNA

NCBI chr 9:116,687,305...116,701,299
Ensembl chr 9:116,687,305...116,701,300

G

tripartite motif containing 5

decreases expression

ISO

epoxiconazole results in decreased expression of TRIM5 mRNA

NCBI chr11:5,588,635...5,685,074
Ensembl chr11:5,663,195...5,938,619

G

tripartite motif containing 52

increases expression

ISO

epoxiconazole results in increased expression of TRIM52 mRNA

NCBI chr 5:181,249,062...181,261,143
Ensembl chr 5:181,254,077...181,262,068

G

tripartite motif containing 59

increases expression

ISO

epoxiconazole results in increased expression of TRIM59 mRNA

NCBI chr 3:160,435,503...160,449,786
Ensembl chr 3:160,432,445...160,485,773

G

tripartite motif containing 63

increases expression

ISO

epoxiconazole results in increased expression of TRIM63 mRNA

NCBI chr 1:26,051,301...26,067,630
Ensembl chr 1:26,051,301...26,068,436

G

TRIO and F-actin binding protein

decreases expression

ISO

epoxiconazole results in decreased expression of TRIOBP mRNA

NCBI chr22:37,697,048...37,776,556
Ensembl chr22:37,697,048...37,776,556

G

triple QxxK/R motif containing

increases expression

ISO

epoxiconazole results in increased expression of TRIQK mRNA

NCBI chr 8:92,883,534...93,017,665
Ensembl chr 8:92,883,530...93,017,786

G

tRNA methyltransferase 1

decreases expression

ISO

epoxiconazole results in decreased expression of TRMT1 mRNA

NCBI chr19:13,104,907...13,116,740
Ensembl chr19:13,104,899...13,117,567

G

tRNA methyltransferase activator subunit 11-2

decreases expression

ISO

epoxiconazole results in decreased expression of TRMT112 mRNA

NCBI chr11:64,316,460...64,318,596
Ensembl chr11:64,316,460...64,318,074

G

tRNA methyltransferase 2 homolog B

decreases expression

ISO

epoxiconazole results in decreased expression of TRMT2B mRNA

NCBI chr X:100,973,366...101,052,111
Ensembl chr X:101,009,346...101,052,135

G

tRNA methyltransferase 5

affects expression

ISO

epoxiconazole affects the expression of TRMT5 mRNA

NCBI chr14:60,971,441...60,981,690
Ensembl chr14:60,971,441...60,981,170

G

trophinin

increases expression

ISO

epoxiconazole results in increased expression of TRO mRNA

NCBI chr X:54,920,824...54,931,431
Ensembl chr X:54,920,462...54,931,436

G

transient receptor potential cation channel subfamily C member 4 associated protein

decreases expression

ISO

epoxiconazole results in decreased expression of TRPC4AP mRNA

NCBI chr20:35,002,404...35,092,807
Ensembl chr20:34,995,209...35,092,868

G

transient receptor potential cation channel subfamily C member 5

increases expression

ISO

epoxiconazole results in increased expression of TRPC5 mRNA

NCBI chr X:111,768,011...112,082,776
Ensembl chr X:111,768,011...112,082,776

G

TSC complex subunit 2

multiple interactions
decreases expression

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of TSC2 mRNA
epoxiconazole results in decreased expression of TSC2 mRNA

PMID:25607892 PMID:35436446

NCBI chr16:2,047,985...2,089,491
Ensembl chr16:2,047,345...2,089,491

G

TSC22 domain family member 1

affects expression

ISO

epoxiconazole affects the expression of TSC22D1 mRNA

NCBI chr13:44,432,143...44,577,344
Ensembl chr13:44,432,143...44,577,316

G

TSC22 domain family member 3

decreases expression

ISO

epoxiconazole results in decreased expression of TSC22D3 mRNA

NCBI chr X:107,713,221...107,775,988
Ensembl chr X:107,713,221...107,777,342

G

tRNA splicing endonuclease subunit 15

decreases expression

ISO

epoxiconazole results in decreased expression of TSEN15 mRNA

NCBI chr 1:184,051,730...184,097,485
Ensembl chr 1:184,051,651...184,123,978

G

tRNA splicing endonuclease subunit 54

affects expression

ISO

epoxiconazole affects the expression of TSEN54 mRNA

NCBI chr17:75,516,528...75,524,735
Ensembl chr17:75,515,944...75,524,736

G

tsukushi, small leucine rich proteoglycan

affects expression

ISO

epoxiconazole affects the expression of TSKU mRNA

NCBI chr11:76,782,280...76,798,144
Ensembl chr11:76,781,403...76,798,157

G

translin

decreases expression

ISO

epoxiconazole results in decreased expression of TSN mRNA

NCBI chr 2:121,755,651...121,767,853
Ensembl chr 2:121,737,103...121,767,853

G

translin associated factor X interacting protein 1

increases expression

ISO

epoxiconazole results in increased expression of TSNAXIP1 mRNA

NCBI chr16:67,806,889...67,828,068
Ensembl chr16:67,806,765...67,832,148

G

tetraspanin 14

decreases expression

ISO

epoxiconazole results in decreased expression of TSPAN14 mRNA

NCBI chr10:80,454,310...80,522,631
Ensembl chr10:80,454,162...80,533,124

G

tetraspanin 15

decreases expression

ISO

epoxiconazole results in decreased expression of TSPAN15 mRNA

NCBI chr10:69,451,465...69,549,508
Ensembl chr10:69,451,150...69,507,676

G

tetraspanin 3

increases expression

ISO

epoxiconazole results in increased expression of TSPAN3 mRNA

NCBI chr15:77,041,404...77,071,109
Ensembl chr15:77,041,404...77,083,984

G

tetraspanin 4

decreases expression

ISO

epoxiconazole results in decreased expression of TSPAN4 mRNA

NCBI chr11:842,852...867,111
Ensembl chr11:840,686...867,120

G

tetraspanin 8

decreases expression

ISO

epoxiconazole results in decreased expression of TSPAN8 mRNA

NCBI chr12:71,125,096...71,157,999
Ensembl chr12:71,124,454...71,441,898

G

tetraspanin 9

decreases expression

ISO

epoxiconazole results in decreased expression of TSPAN9 mRNA

NCBI chr12:3,077,379...3,286,559
Ensembl chr12:3,077,355...3,286,564

G

thiosulfate sulfurtransferase like domain containing 1

decreases expression

ISO

epoxiconazole results in decreased expression of TSTD1 mRNA

NCBI chr 1:161,037,631...161,038,964
Ensembl chr 1:161,037,631...161,038,977

G

tetratricopeptide repeat domain 13

decreases expression

ISO

epoxiconazole results in decreased expression of TTC13 mRNA

NCBI chr 1:230,906,243...230,978,861
Ensembl chr 1:230,902,945...230,978,893

G

tetratricopeptide repeat domain 21B

decreases expression

ISO

epoxiconazole results in decreased expression of TTC21B mRNA

NCBI chr 2:165,873,362...165,953,776
Ensembl chr 2:165,857,475...165,953,851

G

tetratricopeptide repeat domain 23

decreases expression

ISO

epoxiconazole results in decreased expression of TTC23 mRNA

NCBI chr15:99,136,323...99,251,225
Ensembl chr15:99,136,323...99,251,226

G

tetratricopeptide repeat domain 3

decreases expression

ISO

epoxiconazole results in decreased expression of TTC3 mRNA

NCBI chr21:37,073,254...37,203,118
Ensembl chr21:37,073,226...37,203,112

G

tetratricopeptide repeat domain 38

decreases expression

ISO

epoxiconazole results in decreased expression of TTC38 mRNA

NCBI chr22:46,268,008...46,294,008
Ensembl chr22:46,267,961...46,295,097

G

tetratricopeptide repeat domain 39C

decreases expression

ISO

epoxiconazole results in decreased expression of TTC39C mRNA

PMID:22334560 PMID:35436446

NCBI chr18:23,992,887...24,135,600
Ensembl chr18:23,992,773...24,135,970

G

tetratricopeptide repeat domain 7A

decreases expression

ISO

epoxiconazole results in decreased expression of TTC7 mRNA

NCBI chr 2:46,915,866...47,076,123
Ensembl chr 2:46,915,869...47,076,137

G

tetratricopeptide repeat domain 7B

affects expression

ISO

epoxiconazole affects the expression of TTC7B mRNA

NCBI chr14:90,524,564...90,816,430
Ensembl chr14:90,524,564...90,816,500

G

tetratricopeptide repeat domain 8

affects expression

ISO

epoxiconazole affects the expression of TTC8 mRNA

NCBI chr14:88,824,153...88,881,079
Ensembl chr14:88,824,153...88,881,078

G

TELO2 interacting protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of TTI1 mRNA

NCBI chr20:37,983,021...38,033,456
Ensembl chr20:37,983,007...38,033,461

G

tubulin tyrosine ligase

decreases expression

ISO

epoxiconazole results in decreased expression of TTL mRNA

NCBI chr 2:112,482,156...112,541,739
Ensembl chr 2:112,482,113...112,541,739

G

TTL family tubulin polyglutamylase complex subunit L1

affects expression

ISO

epoxiconazole affects the expression of TTLL1 mRNA

NCBI chr22:43,039,516...43,089,391
Ensembl chr22:43,039,516...43,089,427

G

tubulin tyrosine ligase like 9

increases expression

ISO

epoxiconazole results in increased expression of TTLL9 mRNA

NCBI chr20:31,870,634...31,945,000
Ensembl chr20:31,870,634...31,945,000

G

tweety family member 2

decreases expression

ISO

epoxiconazole results in decreased expression of TTYH2 mRNA

NCBI chr17:74,213,571...74,262,020
Ensembl chr17:74,213,518...74,262,020

G

tubulin alpha 1a

decreases expression

ISO

epoxiconazole results in decreased expression of TUBA1A mRNA

NCBI chr12:49,184,795...49,189,080
Ensembl chr12:49,184,686...49,189,324

G

tubulin alpha 4a

increases expression

ISO

epoxiconazole results in increased expression of TUBA4A mRNA

NCBI chr 2:219,249,710...219,254,740
Ensembl chr 2:219,249,710...219,277,902

G

tubulin beta class I

decreases expression

ISO

epoxiconazole results in decreased expression of TUBB5 mRNA

NCBI chr 6:30,720,352...30,725,422
Ensembl chr 6:30,717,435...30,725,538

G

tubulin beta 4A class IVa

decreases expression

ISO

epoxiconazole results in decreased expression of TUBB4A mRNA

NCBI chr19:6,494,319...6,502,848
Ensembl chr19:6,494,319...6,502,848

G

tubulin gamma 1

decreases expression

ISO

epoxiconazole results in decreased expression of TUBG1 mRNA

NCBI chr17:42,609,683...42,615,238
Ensembl chr17:42,609,637...42,615,241

G

taurine up-regulated 1

decreases expression

ISO

epoxiconazole results in decreased expression of TUG1 mRNA

NCBI chr22:30,969,265...30,979,395
Ensembl chr22:30,969,245...30,979,395

G

TUB like protein 1

increases expression

ISO

epoxiconazole results in increased expression of TULP1 mRNA

NCBI chr 6:35,497,874...35,512,896
Ensembl chr 6:35,497,874...35,512,896

G

TUB like protein 4

decreases expression

ISO

epoxiconazole results in decreased expression of TULP4 mRNA

NCBI chr 6:158,232,195...158,511,828
Ensembl chr 6:158,232,236...158,511,828

G

tumor suppressor candidate 1

increases expression

ISO

epoxiconazole results in increased expression of TUSC1 mRNA

NCBI chr 9:25,676,969...25,678,444
Ensembl chr 9:25,676,969...25,678,444

G

twinkle mtDNA helicase

decreases expression

ISO

epoxiconazole results in decreased expression of TWNK mRNA

NCBI chr10:100,987,543...100,994,403
Ensembl chr10:100,987,367...100,994,403

G

thioredoxin

increases expression

ISO

epoxiconazole results in increased expression of TXN1 mRNA

NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,604

G

thioredoxin 2

decreases expression

ISO

epoxiconazole results in decreased expression of TXN2 mRNA

NCBI chr22:36,467,046...36,481,640
Ensembl chr22:36,466,895...36,482,072

G

thioredoxin domain containing 11

decreases expression

ISO

epoxiconazole results in decreased expression of TXNDC11 mRNA

NCBI chr16:11,679,083...11,742,857
Ensembl chr16:11,679,079...11,742,907

G

thioredoxin domain containing 16

increases expression

ISO

epoxiconazole results in increased expression of TXNDC16 mRNA

NCBI chr14:52,430,596...52,552,505
Ensembl chr14:52,429,472...52,553,563

G

thioredoxin domain containing 17

increases expression

ISO

epoxiconazole results in increased expression of TXNDC17 mRNA

NCBI chr17:6,641,060...6,644,541
Ensembl chr17:6,640,712...6,644,541

G

thioredoxin interacting protein

decreases expression

ISO

epoxiconazole results in decreased expression of TXNIP mRNA

NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,580

G

thioredoxin like 1

increases expression

ISO

epoxiconazole results in increased expression of TXNL1 mRNA

NCBI chr18:56,597,209...56,638,592
Ensembl chr18:56,597,209...56,651,600

G

thioredoxin like 4A

decreases expression

ISO

epoxiconazole results in decreased expression of TXNL4A mRNA

NCBI chr18:79,970,813...80,033,936
Ensembl chr18:79,970,813...80,033,949

G

tyrosine kinase 2

increases expression

ISO

epoxiconazole results in increased expression of TYK2 mRNA

NCBI chr19:10,350,533...10,380,572
Ensembl chr19:10,350,528...10,380,608

G

tyrosinase

increases expression

ISO

epoxiconazole results in increased expression of TYR mRNA

NCBI chr11:89,177,875...89,295,759
Ensembl chr11:89,177,875...89,295,759

G

U2 small nuclear RNA auxiliary factor 2

decreases expression

ISO

epoxiconazole results in decreased expression of U2AF2 mRNA

NCBI chr19:55,655,035...55,674,716
Ensembl chr19:55,654,146...55,674,716

G

ubiquitin like modifier activating enzyme 1

decreases expression

ISO

epoxiconazole results in decreased expression of UBA1 mRNA

NCBI chr X:47,190,847...47,215,128
Ensembl chr X:47,190,713...47,215,173

G

ubiquitin like modifier activating enzyme 2

increases expression

ISO

epoxiconazole results in increased expression of UBA2 mRNA

NCBI chr19:34,428,381...34,471,251
Ensembl chr19:34,428,352...34,471,251

G

ubiquitin like modifier activating enzyme 5

increases expression

ISO

epoxiconazole results in increased expression of UBA5 mRNA

NCBI chr 3:132,654,430...132,679,794
Ensembl chr 3:132,654,446...132,679,794

G

ubiquitin associated protein 1 like

increases expression

ISO

epoxiconazole results in increased expression of UBAP1L mRNA

NCBI chr15:65,092,760...65,115,200
Ensembl chr15:65,092,760...65,115,200

G

ubiquitin associated protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of UBAP2 mRNA

NCBI chr 9:33,921,693...34,049,199
Ensembl chr 9:33,921,691...34,049,420

G

ubiquitin associated and SH3 domain containing B

decreases expression

ISO

epoxiconazole results in decreased expression of UBASH3B mRNA

NCBI chr11:122,655,722...122,814,473
Ensembl chr11:122,655,722...122,814,473

G

ubiquitin B

increases expression

ISO

epoxiconazole results in increased expression of UBB mRNA

NCBI chr17:16,380,779...16,382,745
Ensembl chr17:16,380,667...16,382,745

G

ubiquitin conjugating enzyme E2 A

increases expression

ISO

epoxiconazole results in increased expression of UBE2A mRNA

NCBI chr X:119,574,563...119,584,423
Ensembl chr X:119,474,802...119,591,083

G

ubiquitin conjugating enzyme E2 D2

increases expression

ISO

epoxiconazole results in increased expression of UBE2D2A mRNA

NCBI chr 5:139,526,240...139,628,434
Ensembl chr 5:139,526,431...139,628,434

G

ubiquitin conjugating enzyme E2 D3

increases expression

ISO

epoxiconazole results in increased expression of UBE2D3 mRNA

NCBI chr 4:102,794,383...102,868,895
Ensembl chr 4:102,793,516...102,869,287

G

ubiquitin conjugating enzyme E2 U

decreases expression

ISO

epoxiconazole results in decreased expression of UBE2U mRNA

NCBI chr 1:64,203,623...64,267,368
Ensembl chr 1:64,203,623...64,267,368

G

ubiquitin conjugating enzyme E2 V2

increases expression

ISO

epoxiconazole results in increased expression of UBE2V2 mRNA

NCBI chr 8:47,997,437...48,064,708
Ensembl chr 8:48,008,410...48,064,708

G

ubiquitin protein ligase E3B

decreases expression

ISO

epoxiconazole results in decreased expression of UBE3B mRNA

NCBI chr12:109,477,634...109,547,829
Ensembl chr12:109,477,402...109,536,705

G

ubiquitination factor E4A

decreases expression

ISO

epoxiconazole results in decreased expression of UBE4A mRNA

NCBI chr11:118,359,600...118,399,211
Ensembl chr11:118,359,587...118,399,211

G

ubiquitination factor E4B

decreases expression

ISO

epoxiconazole results in decreased expression of UBE4B mRNA

NCBI chr 1:10,032,958...10,181,239
Ensembl chr 1:10,032,832...10,181,244

G

UbiA prenyltransferase domain containing 1

increases expression

ISO

epoxiconazole results in increased expression of UBIAD1 mRNA

NCBI chr 1:11,273,198...11,299,574
Ensembl chr 1:11,273,198...11,296,049

G

ubiquitin like 4B

increases expression

ISO

epoxiconazole results in increased expression of UBL4B mRNA

NCBI chr 1:110,112,443...110,113,947
Ensembl chr 1:110,112,443...110,113,947

G

ubiquitin like 5

increases expression

ISO

epoxiconazole results in increased expression of UBL5 mRNA

NCBI chr19:9,827,918...9,830,115
Ensembl chr19:9,827,892...9,830,137

G

ubiquitin like 7

decreases expression

ISO

epoxiconazole results in decreased expression of UBL7 mRNA

NCBI chr15:74,445,977...74,461,188
Ensembl chr15:74,445,187...74,461,182

G

ubinuclein 1

decreases expression

ISO

epoxiconazole results in decreased expression of UBN1 mRNA

NCBI chr16:4,847,481...4,882,401
Ensembl chr16:4,846,665...4,882,401

G

ubiquilin 2

multiple interactions

ISO

[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of UBQLN2 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of UBQLN2 mRNA

NCBI chr X:56,563,627...56,567,868
Ensembl chr X:56,563,627...56,567,868

G

ubiquitin protein ligase E3 component n-recognin 2

decreases expression

ISO

epoxiconazole results in decreased expression of UBR2 mRNA

NCBI chr 6:42,564,029...42,693,505
Ensembl chr 6:42,563,995...42,693,505

G

UBX domain protein 6

decreases expression

ISO

epoxiconazole results in decreased expression of UBXN6 mRNA

NCBI chr19:4,445,006...4,457,879
Ensembl chr19:4,444,999...4,457,794

G

UBX domain protein 8

decreases expression

ISO

epoxiconazole results in decreased expression of UBXN8 mRNA

NCBI chr 8:30,729,135...30,767,006
Ensembl chr 8:30,729,131...30,767,009

G

uridine-cytidine kinase 1

decreases expression

ISO

epoxiconazole results in decreased expression of UCK1 mRNA

NCBI chr 9:131,523,801...131,531,263
Ensembl chr 9:131,523,786...131,531,280

G

uncoupling protein 2

decreases expression

ISO

epoxiconazole results in decreased expression of UCP2 mRNA

NCBI chr11:73,974,672...73,983,202
Ensembl chr11:73,974,061...73,983,542

G

ubiquitin-fold modifier conjugating enzyme 1

increases expression

ISO

epoxiconazole results in increased expression of UFC1 mRNA

NCBI chr 1:161,153,978...161,158,856
Ensembl chr 1:161,152,776...161,158,856

G

ubiquitin fold modifier 1

increases expression

ISO

epoxiconazole results in increased expression of UFM1 mRNA

NCBI chr13:38,349,851...38,363,619
Ensembl chr13:38,349,826...38,363,619

G

UDP-glucose 6-dehydrogenase

decreases expression

ISO

epoxiconazole results in decreased expression of UGDH mRNA

NCBI chr 4:39,498,755...39,527,439
Ensembl chr 4:39,498,755...39,528,311

G

UDP-glucose glycoprotein glucosyltransferase 2

decreases expression

ISO

epoxiconazole results in decreased expression of UGGT2 mRNA

NCBI chr13:95,801,580...96,053,401
Ensembl chr13:95,801,580...96,053,482

G

UDP glucuronosyltransferase family 1 member A1

increases expression
multiple interactions

ISO

epoxiconazole results in increased expression of UGT1A1 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of UGT1A1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of UGT1A1 mRNA

NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300

G

UDP glucuronosyltransferase family 1 member A9

increases expression

ISO

epoxiconazole results in increased expression of UGT1A9 mRNA

NCBI chr 2:233,671,898...233,773,300
Ensembl chr 2:233,671,898...233,773,300

G

UDP glucuronosyltransferase family 2 member B17

increases expression
multiple interactions

ISO

epoxiconazole results in increased expression of UGT2B1 mRNA
[cyproconazole co-treated with epoxiconazole] results in increased expression of UGT2B1 mRNA

NCBI chr 4:68,537,173...68,576,322
Ensembl chr 4:68,537,146...68,576,413

G

UDP glucuronosyltransferase family 2 member B7

increases expression
decreases expression

ISO

epoxiconazole results in increased expression of UGT2B34 mRNA
epoxiconazole results in decreased expression of UGT2B34 mRNA

PMID:22334560 PMID:35436446

NCBI chr 4:69,051,375...69,112,987
Ensembl chr 4:69,051,363...69,112,987

G

unc-51 like autophagy activating kinase 1

decreases expression

ISO

epoxiconazole results in decreased expression of ULK1 mRNA

NCBI chr12:131,894,622...131,923,150
Ensembl chr12:131,894,621...131,923,161

G

unc-119 lipid binding chaperone B

decreases expression

ISO

epoxiconazole results in decreased expression of UNC119B mRNA

NCBI chr12:120,710,458...120,723,640
Ensembl chr12:120,710,440...120,723,640

G

unc-5 netrin receptor B

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of UNC5B mRNA

NCBI chr10:71,212,570...71,302,864
Ensembl chr10:71,212,523...71,302,885

G

unc-79 homolog, NALCN channel complex subunit

increases expression

ISO

epoxiconazole results in increased expression of UNC79 mRNA

NCBI chr14:93,333,182...93,707,876
Ensembl chr14:93,333,219...93,707,876

G

uridine phosphorylase 2

decreases expression

ISO

epoxiconazole results in decreased expression of UPP2 mRNA

NCBI chr 2:157,995,179...158,136,154
Ensembl chr 2:157,876,557...158,136,154

G

ubiquinol-cytochrome c reductase, complex III subunit X

increases expression

ISO

epoxiconazole results in increased expression of UQCR10 mRNA

NCBI chr22:29,767,369...29,770,413
Ensembl chr22:29,767,369...29,770,413

G

ubiquinol-cytochrome c reductase binding protein

increases expression

ISO

epoxiconazole results in increased expression of UQCRB mRNA

NCBI chr 8:96,222,947...96,235,545
Ensembl chr 8:96,222,947...96,235,564

G

ubiquinol-cytochrome c reductase core protein 1

decreases expression

ISO

epoxiconazole results in decreased expression of UQCRC1 mRNA

NCBI chr 3:48,599,002...48,609,646
Ensembl chr 3:48,599,002...48,610,976

G

ubiquinol-cytochrome c reductase hinge protein

increases expression

ISO

epoxiconazole results in increased expression of UQCRH mRNA

NCBI chr 1:46,303,698...46,316,776
Ensembl chr 1:46,300,900...46,316,796

G

ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase

decreases expression

ISO

epoxiconazole results in decreased expression of URAD mRNA

NCBI chr13:27,977,717...27,988,693
Ensembl chr13:27,977,717...27,988,693

G

URB1 ribosome biogenesis homolog

decreases expression

ISO

epoxiconazole results in decreased expression of URB1 mRNA

NCBI chr21:32,311,018...32,393,012
Ensembl chr21:32,311,018...32,393,029

G

urocanate hydratase 1

decreases expression

ISO

epoxiconazole results in decreased expression of UROC1 mRNA

NCBI chr 3:126,481,166...126,517,773
Ensembl chr 3:126,481,165...126,517,777

G

U6 snRNA biogenesis phosphodiesterase 1

decreases expression

ISO

epoxiconazole results in decreased expression of USB1 mRNA

NCBI chr16:57,999,603...58,021,618
Ensembl chr16:57,999,546...58,021,618

G

unconventional SNARE in the ER 1

decreases expression

ISO

epoxiconazole results in decreased expression of USE1 mRNA

NCBI chr19:17,215,357...17,219,829
Ensembl chr19:17,215,346...17,220,237

G

ubiquitin specific peptidase 11

decreases expression

ISO

epoxiconazole results in decreased expression of USP11 mRNA

NCBI chr X:47,233,009...47,248,328
Ensembl chr X:47,232,866...47,248,328

G

ubiquitin specific peptidase 19

decreases expression

ISO

epoxiconazole results in decreased expression of USP19 mRNA

NCBI chr 3:49,108,050...49,120,823
Ensembl chr 3:49,108,046...49,120,938

G

ubiquitin specific peptidase 2

affects expression

ISO

epoxiconazole affects the expression of USP2 mRNA

NCBI chr11:119,355,215...119,381,690
Ensembl chr11:119,355,215...119,381,711

G

ubiquitin specific peptidase 21

decreases expression

ISO

epoxiconazole results in decreased expression of USP21 mRNA

NCBI chr 1:161,159,500...161,165,723
Ensembl chr 1:161,159,450...161,165,723

G

ubiquitin specific peptidase 22

decreases expression

ISO

epoxiconazole results in decreased expression of USP22 mRNA

NCBI chr17:20,999,596...21,043,419
Ensembl chr17:20,999,596...21,043,760

G

ubiquitin specific peptidase 27 X-linked

increases expression

ISO

epoxiconazole results in increased expression of USP27X mRNA

NCBI chr X:49,879,484...49,882,558
Ensembl chr X:49,879,484...49,882,558

G

ubiquitin specific peptidase 36

decreases expression

ISO

epoxiconazole results in decreased expression of USP36 mRNA

NCBI chr17:78,787,381...78,841,439
Ensembl chr17:78,787,381...78,841,441

G

ubiquitin specific peptidase 5

decreases expression

ISO

epoxiconazole results in decreased expression of USP5 mRNA

NCBI chr12:6,852,150...6,866,632
Ensembl chr12:6,852,122...6,866,632

G

USP6 N-terminal like

increases expression

ISO

epoxiconazole results in increased expression of USP6NL mRNA

NCBI chr10:11,460,510...11,611,650
Ensembl chr10:11,460,328...11,611,803

G

UTP14A small subunit processome component

decreases expression

ISO

epoxiconazole results in decreased expression of UTP14A mRNA